Skip to main content Skip to search

Hematología Traslacional

Publicaciones

2022

Recher, C, Rollig, C, Berard, E, Bertoli, S, Dumas, PY, Tavitian, S, Kramer, M, Serve, H, Bornhauser, M, Platzbecker, U, Muller-Tidow, C, Baldus, CD, Martinez-Cuadron, D, Serrano, J, Martinez-Sanchez, P, Arboli, ER, Gil, C, Bergua, J, Bernal, T, Burguera, AD, Delabesse, E, Bidet, A, Pigneux, A, Montesinos, P (2022).

Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries

LEUKEMIA. Article. 36(4):913-922.
[doi:10.1038/s41375-021-01425-9]
Colmenares R, Álvarez N, Barrio S, Martínez-López J, Ayala R (2022).

The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies.

Cancers. Article. 14(5).
[doi:10.3390/cancers14051310]
Bishop, MR, Dickinson, M, Purtill, D, Barba, P, Santoro, A, Hamad, N, Kato, K, Sureda, A, Greil, R, Thieblemont, C, Morschhauser, F, Janz, M, Flinn, I, Rabitsch, W, Kwong, YL, Kersten, MJ, Minnema, MC, Holte, H, Chan, EHL, Martinez-Lopez, J, Muller, AMS, Maziarz, RT, McGuirk, JP, Bachy, E, Le Gouill, S, Dreyling, M, Harigae, H, Bond, D, Andreadis, C, McSweeney, P, Kharfan-Dabaja, M, Newsome, S, Degtyarev, E, Awasthi, R, del Corral, C, Andreola, G, Masood, A, Schuster, SJ, Jager, U, Borchmann, P, Westin, JR (2022).

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

NEW ENGLAND JOURNAL OF MEDICINE. Article. 386(7):629-639.
[doi:10.1056/NEJMoa2116596]
Seiffert, AP, Gomez-Grande, A, Castro-Leal, G, Rodriguez, A, Palomino-Fernandez, D, Gomez, EJ, Sanchez-Gonzalez, P, Bueno, H (2022).

An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [F-18]FDG PET/CT

INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY. Article. 17(2):373-383.
[doi:10.1007/s11548-021-02508-9]
Schjesvold FH, Dimopoulos MA, Delimpasi S, Robak P, Coriu D, Legiec W, Pour L, Špicka I, Masszi T, Doronin V, Minarik J, Salogub G, Alekseeva Y, Lazzaro A, Maisnar V, Mikala G, Rosiñol L, Liberati AM, Symeonidis A, Moody V, Thuresson M, Byrne C, Harmenberg J, Bakker NA, Hájek R, Mateos MV, Richardson PG, Sonneveld P, OCEAN (OP-103) Investigators, Joaquin Martinez Lopez (2022).

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.

Lancet Haematology. Article. 9(2).
[doi:10.1016/S2352-3026(21)00381-1]
Fowler NH, Dickinson M, Dreyling M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Zia A, Awasthi R, Masood A, Anak O, Schuster SJ, Thieblemont C (2022).

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.

NATURE MEDICINE. Article. 28(2):325-332.
[doi:10.1038/s41591-021-01622-0]
Ribera J, Granada I, Morgades M, González T, Ciudad J, Such E, Calasanz MJ, Mercadal S, Coll R, González-Campos J, Tormo M, García-Cadenas I, Gil C, Cervera M, Barba P, Costa D, Ayala R, Bermúdez A, Orfao A, Ribera JM (2022).

Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.

BRITISH JOURNAL OF HAEMATOLOGY. Article. 196(3):670-675.
[doi:10.1111/bjh.17844]
Botta C, Maia C, Garcés JJ, Termini R, Perez C, Manrique I, Burgos L, Zabaleta A, Alignani D, Sarvide S, Merino J, Puig N, Cedena MT, Rossi M, Tassone P, Gentile M, Correale P, Borrello I, Terpos E, Jelinek T, Paiva A, Roccaro A, Goldschmidt H, Avet-Loiseau H, Rosinol L, Mateos MV, Martinez-Lopez J, Lahuerta JJ, Bladé J, San-Miguel JF, Paiva B (2022).

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology.

Blood Advances. Article. 6(2):690-703.
[doi:10.1182/bloodadvances.2021005198]
Alonso R, Lahuerta JJ (2022).

Tumor Reduction in Multiple Myeloma: New Concepts for New Therapeutics.

Frontiers in oncology. Article. 11:800309-800309.
[doi:10.3389/fonc.2021.800309]
Rodríguez-García A, Linares M, Morales ML, Allain-Maillet S, Mennesson N, Sanchez R, Alonso R, Leivas A, Pérez-Rivilla A, Bigot-Corbel E, Hermouet S, Martínez-López J (2022).

Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma.

Frontiers in immunology. Article. 12:797209-797209.
[doi:10.3389/fimmu.2021.797209]

2021

Martinez-Lopez, J, Hernandez-Ibarburu, G, Alonso, R, Sanchez-Pina, JM, Zamanillo, I, Lopez-Munoz, N, Iñiguez R, Cuellar, C, Calbacho, M, Paciello, ML, Ayala, R, Garcia-Barrio, N, Perez-Rey, D, Meloni, L, Cruz, J, Pedrera-Jimenez, M, Serrano-Balazote, P, de la Cruz, J (2021).

Impact of COVID-19 in patients with multiple myeloma based on a global data network.

BLOOD CANCER JOURNAL. Article. 11(12):198-198.
[doi:10.1038/s41408-021-00588-z]
Wong SW, Shah N, Ledergor G, Martin T, Wolf J, Shui AM, Huang CY, Martinez-Lopez J (2021).

Early Dynamics and Depth of Response in Multiple Myeloma Patients Treated With BCMA CAR-T Cells.

Frontiers in oncology. Article. 11:783703-783703.
[doi:10.3389/fonc.2021.783703]
Palanques-Pastor T, Megías-Vericat JE, Martínez P, López Lorenzo JL, Cornago Navascués J, Rodriguez Macias G, Cano I, Arnan Sangerman M, Vidriales Vicente MB, Algarra Algarra JL, Foncillas MÁ, Herrera P, Botella Prieto C, Vives S, Figuera Álvarez Á, Cuevas Palomares L, Sobas M, Contento Gonzalo A, Cuello García R, Amutio Diez ME, De Miguel Llorente D, Navas Elorza B, Bergua Burgues JM, Bernal Del Castillo T, Mateos Rodríguez MC, de Cabo López E, Franco Villegas AC, García Boyero R, Escolano Escobar C, Seri Merino C, Cervero C, Roldán Pérez A, Hermosín Ramos L, Cervera Calvo M, Olave MT, Villafuerte Gutiérrez P, de Laiglesiai A, Serrano J, Najera Irazu MJ, Piñana JL, Sanz MÁ, Martínez-López J, Montesinos P (2021).

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.

LEUKEMIA & LYMPHOMA. Article. 62(12):2928-2938.
[doi:10.1080/10428194.2021.1948031]
Kayser, S, Rahme, R, Martinez-Cuadron, D, Ghiaur, G, Thomas, X, Sobas, M, Guerci-Bresler, A, Garrido, A, Pigneux, A, Gil, C, Raffoux, E, Tormo, M, Vey, N, De la Serna, J, Salamero, O, Lengfelder, E, Levis, MJ, Fenaux, P, Sanz, MA, Platzbecker, U, Schlenk, RF, Ades, L, Montesinos, P (2021).

Outcome of older (>= 70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study (vol 34, pg 2333, 2020)

LEUKEMIA. Correction. 35(12):3631-3631.
[doi:10.1038/s41375-021-01358-3]
Spanjaart AM, Ljungman P, de La Camara R, Tridello G, Ortiz-Maldonado V, Urbano-Ispizua A, Barba P, Kwon M, Caballero D, Sesques P, Bachy E, Di Blasi R, Thieblemont C, Calkoen F, Mutsaers P, Maertens J, Giannoni L, Nicholson E, Collin M, Vaz CP, Metafuni E, Martinez-Lopez J, Dignan FL, Ribera JM, Nagler A, Folber F, Sanderson R, Bloor A, Ciceri F, Knelange N, Ayuk F, Kroger N, Kersten MJ, Mielke S (2021).

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.

LEUKEMIA. Letter. 35(12):3585-3588.
[doi:10.1038/s41375-021-01466-0]
Varghese, LN, Carreño-Tarragona G, Levy, G, Gutiérrez-López de Ocáriz X, Rapado, I, Martinez-Lopez, J, Ayala, R, Constantinescu, SN (2021).

MPL S505C enhances driver mutations at W515 in essential thrombocythemia

BLOOD CANCER JOURNAL. Letter. 11(11):188-188.
[doi:10.1038/s41408-021-00583-4]
Jiménez-Ubieto A, Paiva B, Puig N, Cedena MT, Martínez-López J, Oriol A, Blanchard MJ, Ríos R, Martin J, Martínez R, Sureda A, Hernández MT, de la Rubia J, Krnisk I, Cabañas V, Palomera L, Sánchez-Pina JM, Bargay J, Mateos MV, Rosiñol L, Blade J, San Miguel J, Lahuerta JJ (2021).

Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?

BLOOD. Article. 138(19):1901-1905.
[doi:10.1182/blood.2021012319]
Haertle L, Barrio S, Munawar U, Han S, Zhou X, Vogt C, Alonso R, Bittrich M, Ruiz-Heredia Y, Da-Via M, Zovko J, Garitano-Trojaola A, Bolli N, Ruckdeschel A, Stühmer T, Chatterjee M, Kull M, Krönke J, Agirre X, Martin-Subero I, Raab P, Einsele H, Rasche L, Martinez-Lopez J, Haaf T, Kortüm KM (2021).

Cereblon Enhancer Methylation and IMiD Resistance in Multiple Myeloma.

BLOOD. Article. 138(18):1721-1726.
[doi:10.1182/blood.2020010452]
Pernas S, Villagrasa P, Vivancos A, Scaltriti M, Rodón J, Burgués O, Nuciforo P, Canes J, Paré L, Dueñas M, Vidal M, Cejalvo JM, Perelló A, Llommbard-Cussac A, Dorca J, Montaño A, Pascual T, Oliveira M, Ribas G, Rapado I, Prat A, Ciruelos E (2021).

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.

Frontiers in oncology. Article. 11:744112-744112.
[doi:10.3389/fonc.2021.744112]
Carreño-Tarragona G, Varghese LN, Sebastián E, Gálvez E, Marín-Sánchez A, López-Muñoz N, Nam-Cha S, Martínez-López J, Constantinescu SN, Sevilla J, Ayala R (2021).

A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline.

LEUKEMIA. Letter. 35(11):3295-3298.
[doi:10.1038/s41375-021-01239-9]
Stefania Infante M, Fernández-Cruz A, Núñez L, Carpio C, Jiménez-Ubieto A, López-Jiménez J, Vásquez L, Del Campo R, Romero S, Alonso C, Morillo D, Prat M, Luis Plana J, Villafuerte P, Bastidas G, Bocanegra A, Serna Á, De Nicolás R, Marquet J, Mas-Ochoa C, Cordoba R, García-Suárez J, Comai A, Martín X, Bastos-Oreiro M, Seri C, Navarro-Matilla B, López-Guillermo A, Martínez-López J, Ángel Hernández-Rivas J, Ruiz-Camps I, Grande C, Grupo Español de Linfomas y Trasplante Autólogo de Medula Ósea (GELTAMO) (2021).

Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study.

Cancer Medicine. Article. 10(21):7629-7640.
[doi:10.1002/cam4.4293]
Ríos-Tamayo R, Puig N, Algarín M, García de Veas Silva JL, Barbosa N, Encinas C, Hernández JÁ, Alonso R, Campos ML, Rodríguez T, Leivas A, Olivares MJ, Sánchez MJ, Paiva B, Lahuerta JJ, Martínez-López J (2021).

The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach.

Diagnostics. Review. 11(11).
[doi:10.3390/diagnostics11112020]
Alameda D, Goicoechea I, Vicari M, Arriazu E, Nevone A, Rodriguez S, Lasa M, Puig N, Cedena MT, Alignani D, Garate S, Lara-Astiaso D, Vilas-Zornoza A, Sarvide S, Ocio EM, Lecumberri R, Garcia de Coca A, Labrador J, Gonzalez ME, Palomera L, Gironella M, Cabañas V, Casanova M, Oriol A, Krsnik I, Perez-Montaña A, de la Rubia J, de la Puerta JE, de Arriba F, Fazio VM, Martinez-Lopez J, Lahuerta JJ, Mateos MV, Odero MD, Prosper F, Weiner A, Amit I, Nuvolone M, San Miguel JF, Paiva B (2021).

Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development.

BLOOD. Article. 138(17):1583-1589.
[doi:10.1182/blood.2020009754]
Castaño-Bonilla T, Alonso-Dominguez JM, Barragán E, Rodríguez-Veiga R, Sargas C, Gil C, Chillón C, Vidriales MB, García R, Martínez-López J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodríguez-Medina C, Bilbao-Syeiro C, López-López JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sánchez-García J, Mateos M, Blas C, López-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martínez-Cuadrón D, Sanz MA, Montesinos P (2021).

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.

SCIENTIFIC REPORTS. Article. 11(1):20745-20745.
[doi:10.1038/s41598-021-00050-x]
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF, ConPlas-19 Study Group (2021).

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.

JOURNAL OF CLINICAL INVESTIGATION. Article. 131(20).
[doi:10.1172/JCI152740]
Pagano, L, Salmanton-Garcia, J, Marchesi, F, Busca, A, Corradini, P, Hoenigl, M, Klimko, N, Koehler, P, Pagliuca, A, Passamonti, F, Verga, L, Visek, B, Ilhan, O, Nadali, G, Weinbergerova, B, Cordoba-Mascunano, R, Marchetti, M, Collins, GP, Farina, F, Cattaneo, C, Cabirta, A, Gomes-Silva, M, Itri, F, van Doesum, J, Ledoux, MP, Cernan, M, Jaksic, O, Duarte, RF, Magliano, G, Omrani, AS, Fracchiolla, NS, Kulasekararaj, A, Valkovic, T, Poulsen, CB, Machado, M, Glenthoj, A, Stoma, I, Racil, Z, Piukovics, K, Navratil, M, Emarah, Z, Sili, U, Maertens, J, Blennow, O, Bergantim, R, Garcia-Vidal, C, Prezioso, L, Guidetti, A, del Principe, MI, Popova, M, de Jonge, N, Ormazabal-Velez, I, Fernandez, N, Falces-Romero, I, Cuccaro, A, Meers, S, Buquicchio, C, Antic, D, Al-Khabori, M, Garcia-Sanz, R, Biernat, MM, Tisi, MC, Sal, E, Rahimli, L, Colovic, N, Schonlein, M, Calbacho, M, Tascini, C, Miranda-Castillo, C, Khanna, N, Mendez, GA, Petzer, V, Novak, J, Besson, C, Dulery, R, Lamure, S, Nucci, M, Zambrotta, G, Zak, P, Seval, GC, Bonuomo, V, Mayer, J, Lopez-Garcia, A, Sacchi, MV, Booth, S, Ciceri, F, Oberti, M, Salvini, M, Izuzquiza, M, Nunes-Rodrigues, R, Ammatuna, E, Obr, A, Herbrecht, R, Nunez-Martin-Buitrago, L, Mancini, V, Shwaylia, H, Sciume, M, Essame, J, Nygaard, M, Batinic, J, Gonzaga, Y, Regalado-Artamendi, I, Karlsson, LK, Shapetska, M, Hanakova, M, El-Ashwah, S, Borbenyi, Z, Colak, GM, Nordlander, A, Dragonetti, G, Maraglino, AME, Rinaldi, A, De Ramon-Sanchez, C, Cornely, OA, EPICOVIDEHA Working Grp (2021).

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

JOURNAL OF HEMATOLOGY & ONCOLOGY. Article. 14(1).
[doi:10.1186/s13045-021-01177-0]
Leivas A, Risueño RM, Guzmán A, Sánchez-Vega L, Pérez M, Megías D, Fernández L, Alonso R, Pérez-Martínez A, Rapado I, Martínez-López J (2021).

Natural killer cells efficiently target multiple myeloma clonogenic tumor cells.

CANCER IMMUNOLOGY IMMUNOTHERAPY. Article. 70(10):2911-2924.
[doi:10.1007/s00262-021-02901-y]
Genescà E, Morgades M, González-Gil C, Fuster-Tormo F, Haferlach C, Meggendorfer M, Montesinos P, Barba P, Gil C, Coll R, Moreno MJ, Martínez-Carballeira D, García-Cadenas I, Vives S, Ribera J, González-Campos J, Díaz-Beya M, Mercadal S, Artola MT, Cladera A, Tormo M, Bermúdez A, Vall-Llovera F, Martínez-Sánchez P, Amigo ML, Monsalvo S, Novo A, Cervera M, García-Guiñon A, Ciudad J, Cervera J, Hernández-Rivas JM, Granada I, Haferlach T, Orfao A, Solé F, Ribera JM (2021).

Adverse prognostic impact of complex karyotype (=3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL).

LEUKEMIA RESEARCH. Article. 109:106612-106612.
[doi:10.1016/j.leukres.2021.106612]
Ribera JM, Morgades M, Coll R, Barba P, López-Lorenzo JL, Montesinos P, Foncillas MA, Cabrero M, Gómez-Centurión I, Morales MD, Varela MR, Herrera P, García-Cadenas I, Calbacho M, Torrent A, Maluquer C, Calabuig M, Garcia-Guiñon A, Bautista G, Llorente L, Gil C, Artola MT, González-Campos J, Fernández-Moreno A, Bárez A, Giménez-Pérez T, Bergua J, Sánchez-Sánchez MJ, Mateos MC, Piñana JL (2021).

Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Article. 21(10):801-809.
[doi:10.1016/j.clml.2021.06.024]
Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Al Zahrani, M, Apperley J, Berceanu A, Bofarull RM, Calbacho M, Ciceri F, Lopez-Corral L, Crippa C, Fox ML, Grassi A, Jimenez MJ, Demir SK, Kwon M, Llamas CV, Lorenzo, JLL, Mielke S, Orchard K, Porras RP, Vallisa D, Xhaard A, Knelange NS, Cedillo A, Kroger, N, Pinana, JL, Styczynski J (2021).

COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

LEUKEMIA. Article. 35(10):1-10.
[doi:10.1038/s41375-021-01302-5]
López-Valle A, García-Reyne A, Loinaz-Segurola C, Sanchez-Pina J, Rodríguez-Peralto JL, Zarco-Olivo C (2021).

Toxic epidermal necrolysis-like graft vs host disease following orthotopic liver transplantation: a case with skin chimerism.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. Letter. 35(10):663-665.
[doi:10.1111/jdv.17371]
Garcia-Villena, J, Torres, JE, Aguilar, C, Lin, L, Bermejo-Pelaez, D, Dacal, E, Mousa, A, Ortega, MD, Martinez, A, Vladimirov, A, Cuadrado, D, Postigo, M, Ordi, J, Bassat, Q, Salamanca, J, Rodriguez-Peralto, JL, Linares, M, Ortuno, JE, Ledesma-Carbayo, MJ, Santos, A, Luengo-Oroz, M (2021).

3D-Printed Portable Robotic Mobile Microscope for Remote Diagnosis of Global Health Diseases

Electronics. Article. 10(19).
[doi:10.3390/electronics10192408]
Ribera JM, Morgades M, Genescà E, Chapchap EC, Montesinos P, Acuña-Cruz E, Gil C, García-Cadenas I, Barba P, González-Campos J, Queipo de Llano MP, Torrent A, Ribera J, Granada I, Bernal T, Díaz-Beyá M, Amigo ML, Coll R, Tormo M, Vall-Llovera F, Gómez-Centurión I, Sánchez-Sánchez MJ, Soria B, Cladera A, Artola MT, Garcia-Guiñon A, Giménez-Conca A, Amador ML, Martínez-Sánchez P, Algarra JL, Vidal MJ, Alonso N, Maluquer C, Llorente L, García-Boyero R, Ciudad J, Feliu E, Orfao A, on behalf of the PETHEMA Group (2021).

Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.

HEMATOLOGICAL ONCOLOGY. Article. 39(4):529-538.
[doi:10.1002/hon.2910]
Puig N, Flores-Montero J, Burgos L, Cedena MT, Cordón L, Pérez JJ, Sanoja-Flores L, Manrique I, Rodríguez-Otero P, Rosiñol L, Martínez-López J, Mateos MV, Lahuerta JJ, Bladé J, San Miguel JF, Orfao A, Paiva B (2021).

Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.

Cancers. Article. 13(19).
[doi:10.3390/cancers13194924]
González-Rincón J, Garcia-Vela JA, Gómez S, Fernández-Cuevas B, Nova-Gurumeta S, Pérez-Sanz N, Alcoceba M, González M, Anguita E, López-Jiménez J, González-Barca E, Yáñez L, Pérez-Persona E, de la Serna J, Fernández-Zarzoso M, Deben G, Peñalver FJ, Fernández MC, de Oteyza JP, Andreu MÁ, Ruíz-Guinaldo MÁ, Paz-Arias R, García-Malo MD, Recasens V, Collado R, Córdoba R, Navarro-Matilla B, Sánchez-Beato M, García-Marco JA (2021).

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).

PLOS ONE. Article. 16(9).
[doi:10.1371/journal.pone.0257353]
McLornan D, Eikema DJ, Czerw T, Kröger N, Koster L, Reinhardt HC, Angelucci E, Robin M, Bornhäuser M, Passweg J, Clark A, Vydra J, Blau IE, Niittyvuopio R, Platzbecker U, Cornelissen JJ, Chevallier P, Srour M, Stamatovic D, Martinez-Lopez J, de Wreede L, Hayden P, Hernández-Boluda JC, Yakoub-Agha I (2021).

Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis.

BONE MARROW TRANSPLANTATION. Article. 56(9):2160-2172.
[doi:10.1038/s41409-021-01305-x]
Álvarez N, Rodríguez-García A, Morales ML, Gutiérrez M, Montero M, Poza M, López N, Carreño G, Sánchez R, Cedena T, Rapado I, Martínez-López J, Ayala R (2021).

Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathology.

LEUKEMIA RESEARCH. Letter. 108:106613-106613.
[doi:10.1016/j.leukres.2021.106613]
Onecha E, Rapado I, Morales ML, Carreño-Tarragona G, Martinez-Sanchez P, Gutierrez X, Sáchez Pina JM, Linares M, Gallardo M, Martinez-López J, Ayala R (2021).

Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse.

HAEMATOLOGICA. Article. 106(9):2325-2333.
[doi:10.3324/haematol.2020.254623]
Poza M, Íñiguez R, Zamanillo I, Redondo S, Alonso R, Martínez-López J, Jiménez-Ubieto A (2021).

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia.

Therapeutic Advances In Hematology. Case Reports. 12.
[doi:10.1177/20406207211039326]
Martinez-Lopez J, Alonso R, Wong SW, Rios R, Shah N, Ruiz-Heredia Y, Sanchez-Pina JM, Sanchez R, Bahri N, Zamanillo I, Poza M, Buenache N, Encinas C, Juarez L, Miras F, Collado L, Barrio S, Martin T, Cedena MT, Wolf J (2021).

Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.

JOURNAL OF HEMATOLOGY & ONCOLOGY. Letter. 14(1):126-126.
[doi:10.1186/s13045-021-01135-w]
Leivas A, Valeri A, Córdoba L, García-Ortiz A, Ortiz A, Sánchez-Vega L, Graña-Castro O, Fernández L, Carreño-Tarragona G, Pérez M, Megías D, Paciello ML, Sánchez-Pina J, Pérez-Martínez A, Lee DA, Powell DJ Jr, Río P, Martínez-López J (2021).

NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma.

BLOOD CANCER JOURNAL. Article. 11(8):146-146.
[doi:10.1038/s41408-021-00537-w]
Lozano, ML, Mingot-Castellano, ME, Perera, MM, Jarque, I, Campos-Alvarez, RM, Gonzalez-Lopez, TJ, Carreno-Tarragona, G, Bermejo, N, Lopez-Fernandez, MF, de Andres, A, Valcarcel, D, Casado-Montero, LF, Alvarez-Roman, MT, Orts, MI, Novelli, S, Revilla, N, Gonzalez-Porras, JR, Bolanos, E, Rodriguez-Lopez, MA, Orna-Montero, E, Vicente, V (2021).

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (vol 11, 16867, 2021)

SCIENTIFIC REPORTS. Correction. 11(1).
[doi:10.1038/s41598-021-95732-x]
Paiva, B, Vidriales, MB, Sempere, A, Tarin, F, Colado, E, Benavente, C, Cedena, MT, Sanchez, J, Caballero-Velazquez, T, Cordon, L, Garces, JJ, Simoes, C, Martinez-Cuadron, D, Bernal, T, Botella, C, Grille, S, Serrano, J, Rodriguez-Medina, C, Algarra, L, Alonso-Dominguez, JM, Amigo, ML, Barrios, M, Garcia-Boyero, R, Colorado, M, Perez-Oteyza, J, Perez-Encinas, M, Costilla-Barriga, L, Sayas, MJ, Perez, O, Gonzalez-Diaz, M, Perez-Simon, JA, Martinez-Lopez, J, Sossa, C, Orfao, A, San Miguel, JF, Sanz, MA, Montesinos, P, PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) coo (2021).

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

LEUKEMIA. Article. 35(8):2358-2370.
[doi:10.1038/s41375-021-01126-3]
Martínez-López J, Mustjoki S, Porkka K, Klisovic RB, Wolf D, Busque L, Hernández-Boluda JC, Swanink R, Martin Regueira P, Lipton JH (2021).

The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study.

LEUKEMIA & LYMPHOMA. Letter. 62(8):1-7.
[doi:10.1080/10428194.2021.1889536]
Rodríguez Rodríguez M, Castro Quismondo N, Zafra Torres D, Gil Alos D, Ayala R, Martinez-Lopez J (2021).

Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. Letter. 43(4):152-155.
[doi:10.1111/ijlh.13476]
Macauda A, Piredda C, Clay-Gilmour AI, Sainz J, Buda G, Markiewicz M, Barington T, Ziv E, Hildebrandt MAT, Belachew AA, Varkonyi J, Prejzner W, Druzd-Sitek A, Spinelli J, Andersen NF, Hofmann JN, Dudzinski M, Martinez-Lopez J, Iskierka-Jazdzewska E, Milne RL, Mazur G, Giles GG, Ebbesen LH, Rymko M, Jamroziak K, Subocz E, Reis RM, Garcia-Sanz R, Suska A, Haastrup EK, Zawirska D, Grzasko N, Vangsted AJ, Dumontet C, Kruszewski M, Dutka M, Camp NJ, Waller RG, Tomczak W, Pelosini M, Razny M, Marques H, Abildgaard N, Watek M, Jurczyszyn A, Brown EE, Berndt S, Butrym A, Vachon CM, Norman AD, Slager SL, Gemignani F, Canzian F, Campa D (2021).

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.

INTERNATIONAL JOURNAL OF CANCER. Article. 149(2):327-336.
[doi:10.1002/ijc.33547]
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL (2021).

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.

NEW ENGLAND JOURNAL OF MEDICINE. Article. 385(1):46-58.
[doi:10.1056/NEJMoa2028631]
Arribalzaga K, Martínez-Alfonzo I, Díaz-Aizpún C, Gutiérrez-Jomarrón I, Rodríguez M, Castro Quismondo N, Pérez-Fernández E, Velasco-Rodríguez D, Gómez E, Fernández B, Vilches A, Martín-Herrero S, Castilla L, Blanco MJ, Gutiérrez MDM, Rivas I, Pascual C, Rosado B, Sola E, Vidal-Laso R, Asenjo S, Mora Casado MA, Benito-Parra L, Carmona I, Marín K, Acedo N, García-León N, Marcheco A, Guillén C, Fernández C, Rodríguez R, Pardo L, Silva P, Montero L, Meijón M, Massó P, Llamas-Sillero P, Asociación Madrileña de Hematología y Hemoterapia (AMHH) (2021).

Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.

THROMBOSIS RESEARCH. Article. 203:93-100.
[doi:10.1016/j.thromres.2021.05.001]
Linares M, López-Ejeda N, Álvarez P, Culebras E, Díaz E, García MT, Majano C, Morales ML, Rodríguez-García A, Rodríguez-Avial I, Utrilla CL, Valenzuela MV, Valderrama MJ (2021).

Service-Learning, Movies, and Infectious Diseases: Implementation of an Active Educational Program in Microbiology as a Tool for Engagement in Social Justice.

FRONTIERS IN MICROBIOLOGY. Article. 12:589401-589401.
[doi:10.3389/fmicb.2021.589401]
Ruiz-Heredia Y, Ortiz-Ruiz A, Samur MK, Garrido V, Rufian L, Sanchez R, Aguilar-Garrido P, Barrio S, Martín MA, Bolli N, Tai YT, Szalat R, Fulciniti M, Munshi N, Martínez-López J, Linares M, Gallardo M (2021).

Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma.

Cancers. Article. 13(13).
[doi:10.3390/cancers13133189]
Hutchings M, Morschhauser F, Iacoboni G, Carlo-Stella C, Offner FC, Sureda A, Salles G, Martínez-Lopez J, Crump M, Thomas DN, Morcos PN, Ferlini C, Bröske AE, Belousov A, Bacac M, Dimier N, Carlile DJ, Lundberg L, Perez-Callejo D, Umaña P, Moore T, Weisser M, Dickinson MJ (2021).

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial.

JOURNAL OF CLINICAL ONCOLOGY. Article. 39(18):1959-1970.
[doi:10.1200/JCO.20.03175]
Moreau P, Dimopoulos MA, Mikhael J, Yong K, Capra M, Facon T, Hajek R, Špicka I, Baker R, Kim K, Martinez G, Min CK, Pour L, Leleu X, Oriol A, Koh Y, Suzuki K, Risse ML, Asset G, Macé S, Martin T (2021).

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.

LANCET. Article. 397(10292):2361-2371.
[doi:10.1016/S0140-6736(21)00592-4]
Barbui T, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Rossi G, Harrison C, Alvarez-Larran A, Elli EM, Kiladjian JJ, Gasior Kabat M, Marin Sanchez A, Palandri F, Andrade-Campos MM, Vannucchi AM, Carreno-Tarragona G, Papadopoulos P, Quiroz Cervantes K, Angeles Foncillas M, Fox ML, Sagues Serrano M, Rumi E, Osorio S, Benevolo G, Patriarca A, Navas Elorza B, Garcia-Gutierrez V, Magro Mazo E, Lunghi F, Bonifacio M, De Stefano V, Hernandez-Boluda JC, Lopez Abadia E, Angona A, Xicoy Cirici B, Ruggeri M, Koschmieder S, Sobas MA, Cuevas B, Cattaneo D, Daffini R, Bellini M, Curto-Garcia N, Garrote M, Cavalca F, Benajiba L, Bellosillo B, Guglielmelli P, Borsani O, Betti S, Salmoiraghi S, Rambaldi A (2021).

Long-term follow-up of recovered MPN patients with COVID-19.

BLOOD CANCER JOURNAL. Letter. 11(6):115-115.
[doi:10.1038/s41408-021-00509-0]
Vives S, Martínez-Cuadrón D, Bergua Burgues J, Algarra L, Tormo M, Martínez-Sánchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, López-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MÁ, Amador Barciela ML, Olave MT, Colorado M, Gascón A, Fernández MÁ, Simiele A, Pérez-Encinas MM, Rodríguez-Veiga R, García O, Martínez-López J, Barragán E, Paiva B, Sanz MÁ, Montesinos P, PETHEMA Group (2021).

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.

CANCER. Article. 127(12):2003-2014.
[doi:10.1002/cncr.33403]
Martínez Sánchez MP, Megías-Vericat JE, Rodríguez-Veiga R, Vives S, Bergua JM, Torrent A, Suárez-Varela S, Boluda B, Martínez-López J, Cano-Ferri I, Acuña-Cruz E, Torres-Miñana L, Martín-Herreros B, Serrano A, Sempere A, Barragán E, Sargas C, Sanz M, Martínez-Cuadrón D, Montesinos P, PETHEMA group (2021).

A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.

ANNALS OF HEMATOLOGY. Article. 100(6):1497-1508.
[doi:10.1007/s00277-021-04542-8]
González Vicent M, Díaz de Heredia C, González de Pablo J, Molina B, Regueiro A, Pérez Martinez A, Palomo P, López Corral L, García E, Fernández JM, Pérez A, Jiménez MJ, Guerreiro M, Vallejo C, Gallardo AI, López O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Jiménez Ubieto A, González P, Gómez Centurión I, Costilla L, Beléndez C, Esquirol A, Espigado I, Lavilla E, Díaz MÁ (2021).

Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH).

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 106(6):842-850.
[doi:10.1111/ejh.13618]
Rodriguez-Otero P, Sirvent M, González-Rodríguez AP, Lavilla E, de Coca AG, Arguiñano JM, Martí JM, Cabañas V, Motlló C, de Cabo E, Encinas C, Murillo I, Hernández-Rivas JÁ, Pérez-Persona E, Casado F, Sampol A, García R, Blanchard MJ, Anguita M, Lafuente AP, Iñigo B, López A, Ribas P, Arnao M, Maldonado R, Bladé J, Mateos MV, Lahuerta JJ, San Miguel JF (2021).

Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Article. 21(6):413-420.
[doi:10.1016/j.clml.2021.02.004]
Martínez-Cuadrón D, Serrano J, Gil C, Tormo M, Martínez-Sánchez P, Pérez-Simón JA, García-Boyero R, Rodríguez-Medina C, López-Pavía M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Domínguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodríguez-Macías G, Vives S, Pérez-Encinas MM, López A, Noriega V, García-Fortes M, Ramos F, Rodríguez-Gutiérrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodríguez-Veiga R, Martínez-López J, Sanz MA, Montesinos P (2021).

Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?

LEUKEMIA. Article. 35(6):1571-1585.
[doi:10.1038/s41375-020-01058-4]
Novelli S, Bento L, Garcia I, Prieto L, López L, Gutierrez G, Hernani R, Pérez A, Esquirol A, Solano C, Bastos M, Dorado N, Rodríguez N, Rodríguez G, Piñana JL, Montoro J, Herrera P, Luna A, Parody R, Martín C, García E, López O, Heras I, Zanabili J, Moraleda JM, Yañez L, Gutierrez A, Zudaire T, Córdoba R, Varela R, Ferra C, Martínez J, Martínez C, Gonzalez-Barca E, Martino R, Caballero D, GELTAMO and GETH (2021).

Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers.

Transplantation And Cellular Therapy. Article. 27(6).
[doi:10.1016/j.jtct.2021.03.014]
Puig N, Hernández MT, Rosiñol L, González E, de Arriba F, Oriol A, González-Calle V, Escalante F, de la Rubia J, Gironella M, Ríos R, García-Sánchez R, Arguiñano JM, Alegre A, Martín J, Gutiérrez NC, Calasanz MJ, Martín ML, Couto MDC, Casanova M, Arnao M, Pérez-Persona E, Garzón S, González MS, Martín-Sánchez G, Ocio EM, Coleman M, Encinas C, Vale AM, Teruel AI, Cortés-Rodríguez M, Paiva B, Cedena MT, San-Miguel JF, Lahuerta JJ, Bladé J, Niesvizky R, Mateos MV (2021).

Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.

BLOOD CANCER JOURNAL. Article. 11(5):101-101.
[doi:10.1038/s41408-021-00490-8]
Bailén R, Vicario JL, Solán L, Sánchez-Vadillo I, Herrera P, Calbacho M, Alenda R, López-Lorenzo JL, Humala K, Chinea A, Sánchez-Pina J, Balas A, Moreno MÁ, Arzuaga J, Pradillo V, Dorado N, Oarbeascoa G, Anguita J, Díez-Martín JL, Kwon M (2021).

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.

Frontiers in immunology. Article. 12:674658-674658.
[doi:10.3389/fimmu.2021.674658]
Ayala R, Rapado I, Onecha E, Martínez-Cuadrón D, Carreño-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, López Lorenzo JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Paiva B, Barragán E, Prosper F, Sanz MÁ, Martínez-López J, Montesinos P (2021).

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.

Cancers. Article. 13(10).
[doi:10.3390/cancers13102458]
Bastos Oreiro M, Martín R, Gomez P, López Muñoz N, Rodriguez A, Liébana M, Navarro B, Sánchez-González B, Marí P, Pérez de Oteiza J, Gutiérrez A, Bento L, Domingo Doménech E, Vidal MJ, Del Campo R, Pérez Ceballos E, Infante M, Roldán A, García Belmonte D, Santero M, Sureda A, Sanz RG (2021).

SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment.

Cancers. Article. 13(10).
[doi:10.3390/cancers13102412]
Gómez García LM, Escudero A, Mestre C, Fuster Soler JL, Martínez AP, Vagace Valero JM, Vela M, Ruz B, Navarro A, Fernández L, Fernández A, Leivas A, Martínez-López J, Ferreras C, De Paz R, Blanquer M, Galán V, González B, Corral D, Sisinni L, Mirones I, Balas A, Vicario JL, Valle P, Borobia AM, Pérez-Martínez A (2021).

Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL-Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Article. 21(5):328.
[doi:10.1016/j.clml.2021.01.013]
Iacoboni G, Villacampa G, Martinez-Cibrian N, Bailén R, Lopez Corral L, Sanchez JM, Guerreiro M, Caballero AC, Mussetti A, Sancho JM, Hernani R, Abrisqueta P, Solano C, Sureda A, Briones J, Martin Garcia-Sancho A, Kwon M, Reguera-Ortega JL, Barba P, GETH, GELTAMO Spanish Groups (2021).

Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma.

Cancer Medicine. Article. 10(10):3214-3223.
[doi:10.1002/cam4.3881]
Fürstenau M, Fink AM, Schilhabel A, Weiss J, Robrecht S, Eckert R, de la Serna J, Crespo M, Coscia M, Vitale C, Böttcher S, Weppner G, Ritgen M, Stilgenbauer S, Tausch E, Fischer K, Hallek M, Eichhorst B, Brüggemann M, Herling CD (2021).

B-cell Acute Lymphoblastic Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Lenalidomide.

BLOOD. Letter. 137(16):2267-2271.
[doi:10.1182/blood.2020008609]
Melaiu O, Macauda A, Sainz J, Calvetti D, Facioni MS, Maccari G, Ter Horst R, Netea MG, Li Y, Grzasko N, Moreno V, Jurczyszyn A, Jerez A, Watek M, Varkonyi J, Garcia-Sanz R, Kruszewski M, Dudzinski M, Kadar K, Jacobsen SEH, Mazur G, Andersen V, Rybicka M, Zawirska D, Razny M, Zaucha JM, Ostrovsky O, Iskierka-Jazdzewska E, Reis RM, Stepien A, Beider K, Nagler A, Druzd-Sitek A, Marques H, Martìnez-Lopez J, Lesueur F, Avet-Loiseau H, Vangsted AJ, Krawczyk-Kulis M, Butrym A, Jamroziak K, Dumontet C, Vogel U, Rymko M, Pelosini M, Subocz E, Szombath G, Sarasquete ME, Silvestri R, Morani F, Landi S, Campa D, Canzian F, Gemignani F (2021).

Common gene variants within 3 '-untranslated regions as modulators of multiple myeloma risk and survival

INTERNATIONAL JOURNAL OF CANCER. Article. 148(8):1887-1894.
[doi:10.1002/ijc.33377]
Giaccherini M, Macauda A, Orciuolo E, Rymko M, Gruenpeter K, Dumontet C, Razny M, Moreno V, Buda G, Beider K, Varkonyi J, Avet-Loiseau H, Martinez-Lopez J, Marques H, Watek M, Sarasquete ME, Andersen V, Karlin L, Suska A, Kruszewski M, Abildgaard N, Dudzinski M, Butrym A, Nagler A, Vangsted AJ, Kadar K, Waldemar T, Jamroziak K, Jacobsen SEH, Ebbesen LH, Taszner M, Mazur G, Lesueur F, Pelosini M, Garcia-Sanz R, Jurczyszyn A, Demangel D, Reis RM, Iskierka-Jazdzewska E, Markiewicz M, Gemignani F, Subocz E, Zawirska D, Druzd-Sitek A, Stepien A, Alonso MH, Sainz J, Canzian F, Campa D (2021).

Genetically determined telomere length and multiple myeloma risk and outcome.

BLOOD CANCER JOURNAL. Article. 11(4):74-74.
[doi:10.1038/s41408-021-00462-y]
Malaney P, Velasco-Estevez M, Aguilar-Garrido P, Aitken MJL, Chan LE, Zhang X, Post SM, Gallardo M (2021).

The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies.

Frontiers in immunology. Article. 12:634584-634584.
[doi:10.3389/fimmu.2021.634584]
Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genescà E, Barba P, Ribera J, García-Cadenas I, Moreno MJ, Martínez-Carballeira D, Torrent A, Martínez-Sánchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, González-Campos J, Rodríguez C, Bermúdez A, Novo A, Soria B, Coll R, Amigo ML, López-Martínez A, Fernández-Martín R, Serrano J, Mercadal S, Cladera A, Giménez-Conca A, Peñarrubia MJ, Abella E, Vall-Llovera F, Hernández-Rivas JM, Garcia-Guiñon A, Bergua JM, de Rueda B, Sánchez-Sánchez MJ, Serrano A, Calbacho M, Alonso N, Méndez-Sánchez JÁ, García-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A (2021).

Chemotherapy or Allogeneic Transplantation in High-Risk Philadelphia Chromosome-Negative Adult Lymphoblastic Leukemia.

BLOOD. Article. 137(14):1879-1894.
[doi:10.1182/blood.2020007311]
Rodríguez-Arbolí E, Martínez-Cuadrón D, Rodríguez-Veiga R, Carrillo-Cruz E, Gil-Cortés C, Serrano-López J, Bernal Del Castillo T, Martínez-Sánchez MDP, Rodríguez-Medina C, Vidriales B, Bergua JM, Benavente C, García-Boyero R, Herrera-Puente P, Algarra L, Sayas-Lloris MJ, Fernández R, Labrador J, Lavilla-Rubira E, Barrios-García M, Tormo M, Serrano-Maestro A, Sossa-Melo CL, García-Belmonte D, Vives S, Rodríguez-Gutiérrez JI, Albo-López C, Garrastazul-Sánchez MP, Colorado-Araujo M, Mariz J, Sanz MÁ, Pérez-Simón JA, Montesinos P, PETHEMA (Programa Español de Tratamientos en Hematología) and GETH (Grupo Españo (2021).

Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.

Transplantation And Cellular Therapy. Article. 27(4).
[doi:10.1016/j.jtct.2020.12.029]
Montoro J, Chorao, P, Bento L, Cabrero M, Martín C, Novelli S, Cadenas IG, Gutiérrez G, López-Godino O, Ferrá C, Bastos-Oreiro M, Pérez A, Parody R, Simon, JAP, Yanez, L, Sánchez A, Zanabili J, Varela MR, Córdoba R, Zudaire T, Jiménez-Ubieto A, Sanz J, Sureda A, Caballero D, Pinana, JL, GETH GELTAMO Grp (2021).

Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors

BONE MARROW TRANSPLANTATION. Letter. 56(4):992-996.
[doi:10.1038/s41409-020-01161-1]
Macauda A, Giaccherini M, Sainz J, Gemignani F, Sgherza N, Sánchez-Maldonado JM, Gora-Tybor J, Martinez-Lopez J, Carreño-Tarragona G, Jerez A, Spadano R, Golos A, Jurado M, Hernández-Mohedo F, Mazur G, Tavano F, Butrym A, Várkonyi J, Canzian F, Campa D (2021).

Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

INTERNATIONAL JOURNAL OF CANCER. Article. 148(7):1616-1624.
[doi:10.1002/ijc.33337]
López-Medrano F, Pérez-Jacoiste Asín MA, Fernández-Ruiz M, Carretero O, Lalueza A, Maestro de la Calle G, Caro JM, de la Calle C, Catalán M, García-García R, Martínez-López J, Origüen J, Ripoll M, San Juan R, Trujillo H, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Gómez C, Silva JT, García-Ruiz de Morales D, Saro-Buendía M, Marrero-Sánchez Á, Chiara-Graciani G, Bueno H, Paz-Artal E, Lumbreras C, Pablos JL, Aguado JM, H12O Immunomodulation Therapy for COVID-19 Group (2021).

Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: a single-center retrospective study.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Article. 105:487-494.
[doi:10.1016/j.ijid.2021.02.099]
de la Calle C, López-Medrano F, Pablos JL, Lora-Tamayo J, Calle GM, Sánchez-Fernández M, Fernández-Ruiz M, Asín MAP, Caro-Teller JM, García-García R, Catalán M, Martínez-López J, Sevillano Á, Origüen J, Ripoll M, Juan RS, Lalueza A, de Miguel B, Carretero O, Aguilar F, Gómez C, Paz-Artal E, Bueno H, Lumbreras C, Aguado JM (2021).

Effectiveness of anakinra for tocilizumab-refractory severe COVID-19. A single centre retrospective comparative study.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Article. 105:319-325.
[doi:10.1016/j.ijid.2021.02.041]
Ortiz-Ruiz A, Ruiz-Heredia Y, Morales ML, Aguilar-Garrido P, García-Ortiz A, Valeri A, Bárcena C, García-Martin RM, Garrido V, Moreno L, Gimenez A, Navarro-Aguadero MÁ, Velasco-Estevez M, Lospitao E, Cedena MT, Barrio S, Martínez-López J, Linares M, Gallardo M (2021).

Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma.

Cancers. Article. 13(7).
[doi:10.3390/cancers13071662]
Lahuerta JJ, Paiva B, Jiménez de Ubieto A, Sánchez-Pina J, Mateos MV, Bladé J, San-Miguel JF (2021).

Early detection of treatment failure and early rescue intervention in multiple myeloma: time for new approaches.

Blood Advances. Letter. 5(5):1340-1343.
[doi:10.1182/bloodadvances.2020003996]
Regalado-Artamendi I, Jiménez-Ubieto A, Hernández-Rivas JÁ, Navarro B, Núñez L, Alaez C, Córdoba R, Peñalver FJ, Cannata J, Estival P, Quiroz-Cervantes K, Riaza Grau R, Velasco A, Martos R, Domingo-González A, Benito-Parra L, Gómez-Sanz E, López-Jiménez J, Matilla A, Herraez MR, Penalva MJ, García-Suárez J, Díez-Martín JL, Bastos-Oreiro M (2021).

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study.

Hemasphere. Article. 5(3).
[doi:10.1097/HS9.0000000000000538]
Alvarez-Larrán A, Angona A, Andrade-Campos M, Soledad Noya M, Teresa Gómez-Casares M, Cuevas B, Caballero G, García-Hernández C, García-Gutiérrez V, Palomino A, Ferrer-Marín F, Isabel Mata-Vázquez M, Moretó A, Magro E, Murillo I, Manuel Alonso-Domínguez J, María Guerra J, Guerrero L, María Raya J, Pérez-Encinas M, Carreño-Tarragona G, Fox L, Pastor-Galán I, Bellosillo B, Hernández-Boluda JC, MPN Spanish Group (GEMFIN) (2021).

Cytoreductive treatment in patients withCALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia

BRITISH JOURNAL OF HAEMATOLOGY. Article. 192(6):988-996.
[doi:10.1111/bjh.16988]
Kuendgen A, Nomdedeu M, Tuechler H, Garcia-Manero G, Komrokji RS, Sekeres MA, Della Porta MG, Cazzola M, DeZern AE, Roboz GJ, Steensma DP, Van de Loosdrecht AA, Schlenk RF, Grau J, Calvo X, Blum S, Pereira A, Valent P, Costa D, Giagounidis A, Xicoy B, Döhner H, Platzbecker U, Pedro C, Lübbert M, Oiartzabal I, Díez-Campelo M, Cedena MT, Machherndl-Spandl S, López-Pavía M, Baldus CD, Martinez-de-Sola M, Stauder R, Merchan B, List A, Ganster C, Schroeder T, Voso MT, Pfeilstöcker M, Sill H, Hildebrandt B, Esteve J, Nomdedeu B, Cobo F, Haas R, Sole F, Germing U, Greenberg PL, Haase D, Sanz G (2021).

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

LEUKEMIA. Article. 35(3):835-849.
[doi:10.1038/s41375-020-0917-7]
Simoes C, Paiva B, Martínez-Cuadrón D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MÁ, Montesinos P (2021).

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial.

Blood Advances. Article. 5(3):760-770.
[doi:10.1182/bloodadvances.2020003195]
Barbui, T, De Stefano, V, Alvarez-Larran, A, Iurlo, A, Masciulli, A, Carobbio, A, Ghirardi, A, Ferrari, A, Cancelli, V, Elli, EM, Andrade-Campos, MM, Kabat, MG, Kiladjian, JJ, Palandri, F, Benevolo, G, Garcia-Gutierrez, V, Fox, ML, Foncillas, MA, Morcillo, CM, Rumi, E, Osorio, S, Papadopoulos, P, Bonifacio, M, Cervantes KSQ, Serrano, MS, Carreno-Tarragona, G, Sobas, MA, Lunghi, F, Patriarca, A, Elorza, BN, Angona, A, Mazo, EM, Koschmieder, S, Carli, G, Cuevas, B, Hernandez-Boluda, JC, Abadia, EL, Cirici, BX, Guglielmelli, P, Garrote, M, Cattaneo, D, Daffini, R, Cavalca, F, Bellosillo, B, Benajiba, L, Curto-Garcia, N, Bellini, M, Betti, S, Harrison, C, Rambaldi, A, Vannucchi, AM (2021).

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

BLOOD CANCER JOURNAL. Article. 11(2):21-21.
[doi:10.1038/s41408-021-00417-3]
Fernandez, A, Navarro-Zapata, A, Escudero, A, Matamala, N, Ruz-Caracuel, B, Mirones, I, Pernas, A, Cobo, M, Casado, G, Lanzarot, D, Rodriguez-Antolin, C, Vela, M, Ferreras, C, Mestre, C, Viejo, A, Leivas, A, Martinez, J, Fernandez, L, Perez-Martinez, A (2021).

Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy

Cancers. Article. 13(3).
[doi:10.3390/cancers13030577]
Fernández-Ruiz M, López-Medrano F, Pérez-Jacoiste Asín MA, Maestro de la Calle G, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Pablos JL, Ripoll M, San Juan R, Trujillo H, Lumbreras C, Aguado JM (2021).

Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

JOURNAL OF MEDICAL VIROLOGY. Article. 93(2):831-842.
[doi:10.1002/jmv.26308]
Ocio EM, Motlló C, Rodríguez-Otero P, Martínez-López J, Cejalvo MJ, Martín-Sánchez J, Bladé J, García-Malo MD, Dourdil MV, García-Mateo A, de Arriba F, García-Sanz R, de la Rubia J, Oriol A, Lahuerta JJ, San-Miguel JF, Mateos MV (2021).

Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group

BRITISH JOURNAL OF HAEMATOLOGY. Article. 192(3):522-530.
[doi:10.1111/bjh.16788]
Barbui, T, Vannucchi, AM, Alvarez-Larran, A, Iurlo, A, Masciulli, A, Carobbio, A, Ghirardi, A, Ferrari, A, Rossi, G, Elli, E, Andrade-Campos, MM, Kabat, MG, Kiladjian, JJ, Palandri, F, Benevolo, G, Garcia-Gutierrez, V, Fox, ML, Foncillas, MA, Morcillo, CM, Rumi, E, Osorio, S, Papadopoulos, P, Bonifacio, M, Cervantes KSQ, Serrano, MS, Carreno-Tarragona, G, Sobas, MA, Lunghi, F, Patriarca, A, Elorza, BN, Angona, A, Mazo, EM, Koschmieder, S, Ruggeri, M, Cuevas, B, Hernandez-Boluda, JC, Abadia, EL, Cirici, BX, Guglielmelli, P, Garrote, M, Cattaneo, D, Daffini, R, Cavalca, F, Bellosillo, B, Benajiba, L, Curto-Garcia, N, Bellini, M, Betti, S, De Stefano, V, Harrison, C, Rambaldi, A (2021).

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

LEUKEMIA. Article. 35(2):485-493.
[doi:10.1038/s41375-020-01107-y]
Gomez-Cebrian, N, Rojas-Benedicto, A, Albors-Vaquer, A, Bellosillo, B, Besses, C, Martinez-Lopez, J, Pineda-Lucena, A, Puchades-Carrasco, L (2021).

Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients

Cancers. Article. 13(3).
[doi:10.3390/cancers13030482]
Lozano, ML, Mingot-Castellano, ME, Perera, MM, Jarque, I, Campos-Alvarez, RM, Gonzalez-Lopez, TJ, Carreño-Tarragona G, Bermejo, N, Lopez-Fernandez, MF, de Andres, A, Valcarcel, D, Casado-Montero, LF, Alvarez-Roman, MT, Orts, MI, Novelli, S, Gonzalez-Porras, JR, Bolaños E, Lopez-Ansoar, E, Orna-Montero, E, Vicente, V (2021).

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients

BLOOD CELLS MOLECULES AND DISEASES. Article. 86:102505-102505.
[doi:10.1016/j.bcmd.2020.102505]
Alvarez-Larrán A, Díaz-González A, Such E, Mora E, Andrade-Campos M, García-Hernández C, Gómez-Casares MT, García-Gutiérrez V, Carreno-Tarragona, G, Garrote M, Fernández-Ibarrondo L, Cervera J, Bellosillo B, Cervantes F, Hernández-Boluda JC (2021).

Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea.

LEUKEMIA. Letter. 35(2):623-627.
[doi:10.1038/s41375-020-0849-2]
García-Ortiz A, Rodríguez-García Y, Encinas J, Maroto-Martín E, Castellano E, Teixidó J, Martínez-López J (2021).

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression.

Cancers. Review. 13(2).
[doi:10.3390/cancers13020217]
Piris-Villaespesa M, Álvarez-Larrán A, Saez-Marín A, Nuñez-Torrón C, Muñoz-Martin G, Sánchez R, Del Castillo FJ, Villarrubia J, Lopez-Jimenez J, Martinez-Lopez J, Garcia-Gutierrez V (2021).

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera.

SCIENTIFIC REPORTS. Article. 11(1):209-209.
[doi:10.1038/s41598-020-80459-y]
Goicoechea I, Puig N, Cedena MT, Burgos L, Cordón L, Vidriales MB, Flores-Montero J, Gutierrez NC, Calasanz MJ, Ramos MM, Lara-Astiaso D, Vilas-Zornoza A, Alignani D, Rodriguez I, Sarvide S, Alameda D, Garcés JJ, Rodriguez S, Fresquet V, Celay J, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Rios R, Martin-Sanchez J, Martinez-Martinez R, Sarra J, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Martinez-Climent JA, Orfao A, Rosiñol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel J, Paiva B (2021).

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma

BLOOD. Article. 137(1):49-60.
[doi:10.1182/blood.2020006731]
Cuenca, I, Alameda, D, Sanchez-Vega, B, Gomez-Sanchez, D, Alignani, D, Lasa, M, Onecha, E, Lecumberri, R, Prosper, F, Ocio, EM, Gonzalez, ME, García de Coca A, de la Rubia, J, Gironella, M, Palomera, L, Oriol, A, Casanova, M, Cabanas, V, Taboada, F, Perez-Montana, A, De Arriba, F, Puig, N, Carreno-Tarragona, G, Barrio, S, Enrique de la Puerta J, Ramirez-Payer, A, Krsnik, I, Bargay, JJ, Lahuerta, JJ, Mateos, MV, San-Miguel, JF, Paiva, B, Lopez, JM (2021).

Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis

LEUKEMIA. Article. 35(1):245-249.
[doi:10.1038/s41375-020-0800-6]
Carreras P, González I, Gallardo M, Ortiz-Ruiz A, Morales ML, Encinas J, Martínez-López J (2021).

Long-Term Human Hematopoietic Stem Cell Culture in Microdroplets

MICROMACHINES. Article. 12(1).
[doi:10.3390/mi12010090]

2020

Chari, A, Samur, MK, Martinez-Lopez, J, Cook, G, Biran, N, Yong, K, Hungria, V, Engelhardt, M, Gay, F, García Feria A, Oliva, S, Oostvogels, R, Gozzetti, A, Rosenbaum, C, Kumar, S, Stadtmauer, EA, Einsele, H, Beksac, M, Weisel, K, Anderson, KC, Mateos, MV, Moreau, P, San-Miguel, J, Munshi, NC, Avet-Loiseau, H (2020).

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.

BLOOD. Article. 136(26):3033-3040.
[doi:10.1182/blood.2020008150]
Misiewicz-Krzeminska, I, de Ramon, C, Corchete, LA, Krzeminski, P, Rojas, EA, Isidro, I, Garcia-Sanz, R, Martinez-Lopez, J, Oriol, A, Blade, J, Lahuerta, JJ, San Miguel, J, Rosinol, L, Mateos, MV, Gutierrez, NC, Grp Espanol Mieloma Programa Estud (2020).

Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma

Blood Advances. Article. 4(23):6023-6033.
[doi:10.1182/bloodadvances.2020002711]
Puig, N, Corchete-Sanchez, LA, Perez-Moran, JJ, Davila, J, Paino, T, de la Rubia, J, Oriol, A, Martin-Sanchez, J, de Arriba, F, Blad, J, Blanchard, MJ, Gonzalez-Calle, V, Garcia-Sanz, R, Paiva, B, Lahuerta, JJ, San-Miguel, JF, Mateos, MV, Ocio, EM (2020).

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.

Cancers. Article. 12(12).
[doi:10.3390/cancers12123615]
Kater, AP, Wu, JQ, Kipps, T, Eichhorst, B, Hillmen, P, D'Rozario, J, Assouline, S, Owen, C, Robak, T, de la Serna, J, Jaeger, U, Cartron, G, Montillo, M, Dubois, J, Eldering, E, Mellink, C, Van Der Kevie-Kersemaekers, AM, Kim, SY, Chyla, B, Punnoose, E, Bolen, CR, Assaf, ZJ, Jiang, YW, Wang, J, Lefebure, M, Boyer, M, Humphrey, K, Seymour, JF (2020).

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study

JOURNAL OF CLINICAL ONCOLOGY. Article. 38(34):4042-4054.
[doi:10.1200/JCO.20.00948]
Chase, A, Score, J, Lin, F, Bryant, C, Waghorn, K, Yap, S, Carreno-Tarragona, G, Aranaz, P, Villasante, A, Ernst, T, Cross NCP (2020).

Mutational mechanisms of EZH2 inactivation in myeloid neoplasms.

LEUKEMIA. Article. 34(12):3206-3214.
[doi:10.1038/s41375-020-0816-y]
Villegas, C, Poza, M, Talayero, P, Teller JMC, Zafra, D, Garcia, C, Vera, E, Hidalgo, M, Lopez, N, Cuellar, C, Zamanillo, I, Íñiguez R, Paz-Artal, E, Aguado, JM, Martinez-Lopez, J (2020).

IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection.

ANNALS OF HEMATOLOGY. Letter. 99(12):1-4.
[doi:10.1007/s00277-020-04160-w]
Gutiérrez López de Ocáriz X, Castro Quismondo N, Vera Guerrero E, Rodriguez, MR, Ayala Díaz R, Martínez López J (2020).

Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. Letter. 42(6):280-282.
[doi:10.1111/ijlh.13320]
Rodriguez-Garcia, A, Garcia-Vicente, R, Morales, ML, Ortiz-Ruiz, A, Martinez-Lopez, J, Linares, M (2020).

Protein Carbonylation and Lipid Peroxidation in Hematological Malignancies.

Antioxidants. Review. 9(12).
[doi:10.3390/antiox9121212]
Turrubiartes-Martinez, E, Bodega-Mayor, I, Delgado-Wicke, P, Molina-Jimenez, F, Casique-Aguirre, D, Gonzalez-Andrade, M, Rapado, I, Camos, M, Diaz-de-Heredia, C, Barragan, E, Ramirez-Orellana, M, Aguado, B, Figuera, A, Martinez-Lopez, J, Fernandez-Ruiz, E (2020).

TYK2 Variants in B-Acute Lymphoblastic Leukaemia.

Genes. Article. 11(12).
[doi:10.3390/genes11121434]
Bartlett, NL, Herrera, AF, Domingo-Domenech, E, Mehta, A, Forero-Torres, A, Garcia-Sanz, R, Armand, P, Devata, S, Rodriguez Izquierdo A, Lossos, IS, Reeder, C, Sher, T, Chen, R, Schwarz, SE, Alland, L, Strassz, A, Prier, K, Choe-Juliak, C, Ansell, SM (2020).

A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.

BLOOD. Article. 136(21):2401-2409.
[doi:10.1182/blood.2019004701]
Sargas C, Ayala R, Chillón MC, Larráyoz MJ, Carrillo-Cruz E, Bilbao C, Yébenes-Ramírez M, Llop M, Rapado I, García-Sanz R, Vázquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martínez-Cuadrón D, Bergua J, Amigo ML, Martínez-Sánchez P, Tormo M, Bernal T, Herrera-Puente P, García R, Algarra L, Sayas MJ, Costilla-Barriga L, Pérez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Domínguez JM, Sanz MÁ, Sánchez-Garcia J, Gómez-Casares MT, Pérez-Simón JA, Calasanz MJ, González-Díaz M, Martínez-López J, Barragán E, Montesinos P (2020).

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project.

HAEMATOLOGICA. Article. Online ahead of print(12):3079-3089.
[doi:10.3324/haematol.2020.263806]
Mellid, S, Coloma, J, Calsina, B, Monteagudo, M, Roldan-Romero, JM, Santos, M, Leandro-Garcia, LJ, Lanillos, J, Martinez-Montes, AM, Rodriguez-Antona, C, Montero-Conde, C, Martinez-Lopez, J, Ayala, R, Matias-Guiu, X, Robledo, M, Cascon, A (2020).

Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.

Cancers. Article. 12(11).
[doi:10.3390/cancers12113304]
Sanchez-Pina, JM, Rodriguez, MR, Castro Quismondo N, Gil Manso R, Colmenares, R, Gil Alos D, Paciello, ML, Zafra, D, Garcia-Sanchez, C, Villegas, C, Cuellar, C, Carreño-Tarragona G, Zamanillo, I, Poza, M, Iñiguez R, Gutierrez, X, Alonso, R, Rodriguez, A, Folgueira, MD, Delgado, R, Ferrari, JM, Lizasoain, M, Aguado, JM, Ayala, R, Martinez-Lopez, J, Calbacho, M (2020).

Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 105(5):597-607.
[doi:10.1111/ejh.13493]
Garcés JJ, Bretones G, Burgos L, Valdes-Mas R, Puig N, Cedena MT, Alignani D, Rodriguez I, Puente DÁ, Álvarez MG, Goicoechea I, Rodriguez S, Calasanz MJ, Agirre X, Flores-Montero J, Sanoja-Flores L, Rodriguez-Otero P, Rios R, Martinez-Lopez J, Millacoy P, Palomera L, Del Orbe R, Pérez-Montaña A, El Omri H, Prosper F, Mateos MV, Rosiñol L, Blade J, Lahuerta JJ, Orfao A, Lopez-Otin C, San Miguel JF, Paiva B, GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica (2020).

Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.

LEUKEMIA. Article. 34(11):3007-3018.
[doi:10.1038/s41375-020-0883-0]
Medina, A, Puig, N, Flores-Montero, J, Jimenez, C, Sarasquete, ME, Garcia-Alvarez, M, Prieto-Conde, I, Chillon, C, Alcoceba, M, Gutierrez, NC, Oriol, A, Rosinol, L, Blade, J, Gironella, M, Hernandez, MT, Gonzalez-Calle, V, Cedena, MT, Paiva, B, San-Miguel, JF, Lahuerta, JJ, Mateos, MV, Martinez-Lopez, J, Orfao, A, Gonzalez, M, Garcia-Sanz, R (2020).

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma.

BLOOD CANCER JOURNAL. Article. 10(10):108-108.
[doi:10.1038/s41408-020-00377-0]
Martinez-Lopez, J, Mateos, MV, Encinas, C, Sureda, A, Hernandez-Rivas, JA, Lopez de la Guía A, Conde, D, Krsnik, I, Prieto, E, Riaza Grau R, Gironella, M, Blanchard, MJ, Caminos, N, Fernández de Larrea C, Senin, MA, Escalante, F, de la Puerta, JE, Gimenez, E, Martinez-Barranco, P, Mateos, JJ, Casado, LF, Blad, J, Lahuerta, JJ, de la Cruz, J, San-Miguel, J (2020).

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality.

BLOOD CANCER JOURNAL. Article. 10(10):103-103.
[doi:10.1038/s41408-020-00372-5]
Garcia-Suarez, J, de la Cruz, J, Cedillo, A, Llamas, P, Duarte, R, Jimenez-Yuste, V, Hernandez-Rivas, JA, Gil-Manso, R, Kwon, M, Sanchez-Godoy, P, Martinez-Barranco, P, Colas-Lahuerta, B, Herrera, P, Benito-Parra, L, Alegre, A, Velasco, A, Matilla, A, Alaez-Uson, MC, Martos-Martinez, R, Martinez-Chamorro, C, Susana-Quiroz, K, Del Campo, JF, de la Fuente, A, Herraez, R, Pascual, A, Gomez, E, Perez-Oteyza, J, Ruiz, E, Alonso, A, Gonzalez-Medina, J, Martin-Buitrago, LN, Canales, M, Gonzalez-Gascon, I, Vicente-Ayuso, MC, Valenciano, S, Roa, MG, Monteliu, PE, Lopez-Jimenez, J, Escobar, CE, Ortiz-Martin, J, Diez-Martin, JL, Martinez-Lopez, J, Asociación Madrileña de Hematología y Hemoterapia (AMHH) (2020).

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.

JOURNAL OF HEMATOLOGY & ONCOLOGY. Article. 13(1):133-133.
[doi:10.1186/s13045-020-00970-7]
Ferrer-Marin, F, Arroyo, AB, Bellosillo, B, Cuenca, EJ, Zamora, L, Hernandez-Rivas, JM, Hernandez-Boluda, JC, Fernandez-Rodriguez, C, Luno, E, García Hernandez C, Kerguelen, A, Fiallo-Suarez, DV, Gomez-Casares, MT, Ayala, R, Velez, P, Boque, C, Garcia-Gutierrez, V, Arrizabalaga, B, Estrada, N, Cifuentes, R, Arcas, I, de los Reyes-garcia, AM, Besses, C, Vicente, V, Alvarez-Larran, A, Teruel-Montoya, R, Gonzalez-Conejero, R, Martinez, C, GEMFIN Group (2020).

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk.

LEUKEMIA. Article. 34(10):2648-2659.
[doi:10.1038/s41375-020-0767-3]
Laguna-Goya, R, Utrero-Rico, A, Talayero, P, Lasa-Lazaro, M, Ramirez-Fernandez, A, Naranjo, L, Segura-Tudela, A, Cabrera-Marante, O, Rodriguez de Frias E, Garcia-Garcia, R, Fernandez-Ruiz, M, Aguado, JM, Martinez-Lopez, J, Lopez, EA, Catalan, M, Serrano, A, Paz-Artal, E (2020).

IL-6-based mortality risk model for hospitalized patients with COVID-19.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Article. 146(4):799.
[doi:10.1016/j.jaci.2020.07.009]
Montaño A, Hernandez-Sanchez, J, Forero-Castro, M, Matorra-Miguel, M, Lumbreras, E, Miguel, C, Santos, S, Ramirez-Maldonado, V, Fuster, JL, de las Heras, N, Garcia-de Coca, A, Sierra, M, Davila, J, de la Fuente, I, Olivier, C, Olazabal, J, Martinez, J, Vega-Garcia, N, Gonzalez, T, Hernandez-Rivas, JM, Benito, R (2020).

Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients.

Journal of Personalized Medicine. Article. 10(3).
[doi:10.3390/jpm10030137]
Sevilla-Movilla, S, Arellano-Sanchez, N, Martinez-Moreno, M, Gajate, C, Sanchez-Vencells, A, Valcarcel, LV, Agirre, X, Valeri, A, Martinez-Lopez, J, Prosper, F, Mollinedo, F, Teixido, J (2020).

Upregulated expression and function of the a4ß1 integrin in multiple myeloma cells resistant to bortezomib.

JOURNAL OF PATHOLOGY. Article. 252(1):29-40.
[doi:10.1002/path.5480]
Rodriguez-Medina, C, Martinez-Cuadron, D, Cano, I, Gil, C, Tormo, M, Del Pilar Martínez-Sánchez M, del Castillo, TB, Serrano-Lopez, J, Benavente, C, Herrera-Puente, P, Garcia-Boyero, R, Lavilla-Rubira, E, Luz Amigo M, Sayas-Lloris, MJ, Bergua-Burgues, JM, Perez-Simon, JA, Rodriguez, G, Espadana, A, Vidriales-Vicente, B, Fernandez, R, Lopez-Lorenzo, JL, Lopez, M, Garcia-Fortes, M, Gomez, JL, Colorado-Araujo, M, Sossa-Melo, CL, Aguilar, E, Montesinos, P (2020).

Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352].

LEUKEMIA RESEARCH. Correction. 96:106388-106388.
[doi:10.1016/j.leukres.2020.106388]
Ghia, P, Pluta, A, Wach, M, Lysak, D, Kozak, T, Simkovic, M, Kaplan, P, Kraychok, I, Illes, A, de la Serna, J, Dolan, S, Campbell, P, Musuraca, G, Jacob, A, Avery, E, Lee, JH, Liang, W, Patel, P, Quah, C, Jurczak, W (2020).

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

JOURNAL OF CLINICAL ONCOLOGY. Article. 38(25):2849-2861.
[doi:10.1200/JCO.19.03355]
Kayser, S, Rahme, R, Martinez-Cuadron, D, Ghiaur, G, Thomas, X, Sobas, M, Guerci-Bresler, A, Garrido, A, Pigneux, A, Gil, C, Raffoux, E, Tormo, M, Vey, N, de la Serna, J, Salamero, O, Lengfelder, E, Levis, MJ, Fenaux, P, Sanz, MA, Platzbecker, U, Schlenk, RF, Ades, L, Montesinos, P (2020).

Outcome of older (>/=70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.

LEUKEMIA. Article. 34(9):2333-2341.
[doi:10.1038/s41375-020-0758-4]
Seibold, M, Stuhmer, T, Kremer, N, Mottok, A, Scholz, CJ, Schlosser, A, Leich, E, Holzgrabe, U, Brunnert, D, Barrio, S, Kortum, KM, Solimando, AG, Chatterjee, M, Einsele, H, Rosenwald, A, Bargou, RC, Steinbrunn, T (2020).

RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS.

HAEMATOLOGICA. Article. 105(9):2316-2326.
[doi:10.3324/haematol.2019.223024]
Giaccherini, M, Macauda, A, Sgherza, N, Sainz, J, Gemignani, F, Maldonado JMS, Jurado, M, Tavano, F, Mazur, G, Jerez, A, Gora-Tybor, J, Golos, A, Mohedo, FH, Lopez, JM, Varkonyi, J, Spadano, R, Butrym, A, Canzian, F, Campa, D (2020).

Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms.

BLOOD CANCER JOURNAL. Article. 10(8):89-89.
[doi:10.1038/s41408-020-00356-5]
Pastor-Galan, I, Hernandez-Boluda, JC, Correa, JG, Alvarez-Larran, A, Ferrer-Marin, F, Raya, JM, Ayala, R, Velez, P, Perez-Encinas, M, Estrada, N, Garcia-Gutierrez, V, Fox, ML, Payer, A, Kerguelen, A, Cuevas, B, Duran, MA, Ramirez, MJ, Gomez-Casares, MT, Mata-Vazquez, MI, Mora, E, Martinez-Valverde, C, Arbelo, E, Angona, A, Magro, E, Antelo, ML, Somolinos, N, Cervantes, F, en representacion del Grupo Espanol de Enfermedades Mieloproliferativas Filadelf (2020).

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis.

MEDICINA CLINICA. Article. 155(4):152-158.
[doi:10.1016/j.medcli.2019.11.007]
Ribera JM, García O, Chapchap EC, Gil C, González-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martínez-Carballeira D, Mercadal S, Hernández-Rivas JM, Vall-Llovera F, Genescà E, Cladera A, Novo A, Abella E, García-Cadenas I, Monteserín C, Bermúdez A, Piernas S, Montesinos P, López JL, García-Guiñón A, Serrano A, Martínez MP, Olivares M, López A, Serrano J, PETHEMA Group, Spanish Society of Hematology (2020).

Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Article. 20(8):513.
[doi:10.1016/j.clml.2020.03.011]
Martinez, C, Carpio, C, Heras, I, Rios-Herranz, E, Buch, J, Gutierrez, A, Romero, S, Zeberio, I, Garcia-Garcia, I, Rodriguez-Izquierdo, A, Alonso, R, Bargay, J, Barrenetxea, C, Domingo-Domenech, E, de Haro, ME, Palomera, L, Garcia-Sanz, R, Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO) (2020).

Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Article. 26(8):1534-1542.
[doi:10.1016/j.bbmt.2020.02.003]
Martinez-Lopez, J, Wong, SW, Shah, N, Bahri, N, Zhou, KL, Sheng, Y, Huang, CY, Martin, T, Wolf, J (2020).

Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma.

Blood Advances. Article. 4(14):3295-3301.
[doi:10.1182/bloodadvances.2020002037]
Perez C, Botta C, Zabaleta A, Puig N, Cedena MT, Goicoechea I, Alameda D, San José-Eneriz E, Merino J, Rodríguez-Otero P, Maia CADS, Alignani D, Maiso P, Manrique I, Lara-Astiaso D, Vilas-Zornoza A, Sarvide S, Riillo C, Rossi M, Rosinol L, Oriol A, Blanchard MJ, Rios R, Sureda A, Martin J, Martinez R, Bargay J, de la Rubia J, Hernandez MT, Martinez-Lopez J, Orfao A, Agirre X, Prosper F, Mateos MV, Lahuerta JJ, Blade J, San-Miguel JF, Paiva B (2020).

Immunogenomic identification and characterization of granulocytic myeloid derived suppressor cells in multiple myeloma.

BLOOD. Article. 136(2):199-209.
[doi:10.1182/blood.2019004537]
Velasco, R, Mercadal, S, Vidal, N, Alañá M, Barcelo, MI, Ibáñez-Juliá MJ, Bobillo, S, Caldú Agud R, García Molina E, Martinez, P, Cacabelos, P, Muntañola A, Garcia-Catalan, G, Sancho, JM, Camro, I, Lado, T, Erro, ME, Gomez-Vicente, L, Salar, A, Caballero, AC, Sole-Rodriguez, M, Gállego Pérez-Larraya J, Huertas, N, Estela, J, Baron, M, Barbero-Bordallo, N, Encuentra, M, Dlouhy, I, Bruna, J, Graus, F, GELTAMO and GENOSEN group (2020).

Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.

JOURNAL OF NEURO-ONCOLOGY. Article. 148(3):545-554.
[doi:10.1007/s11060-020-03547-z]
Maia C, Puig N, Cedena MT, Goicoechea I, Valdes-Mas R, Vazquez I, Chillon MC, Aguirre P, Sarvide S, Gracia-Aznárez FJ, Alkorta G, Calasanz MJ, Garcia-Sanz R, Gonzalez M, Gutierrez NC, Martinez-Lopez J, Perez JJ, Merino J, Moreno C, Burgos L, Alignani D, Botta C, Prosper F, Matarraz S, Orfao A, Oriol A, Teruel AI, de Paz R, de Arriba F, Hernandez MT, Palomera L, Martinez R, Rosiñol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel JF, Paiva B (2020).

Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.

BLOOD. Article. 135(26):2375-2387.
[doi:10.1182/blood.2019003382]
Burgos, L, Puig, N, Cedena, MT, Mateos, MV, Lahuerta, JJ, Paiva, B, San-Miguel, JF (2020).

Measurable residual disease in multiple myeloma: ready for clinical practice?

JOURNAL OF HEMATOLOGY & ONCOLOGY. Review. 13(1):82-82.
[doi:10.1186/s13045-020-00911-4]
Genesca, E, Morgades, M, Montesinos, P, Barba, P, Gil, C, Guàrdia R, Moreno, MJ, Martinez-Carballeira, D, Garcia-Cadenas, I, Vives, S, Ribera, J, Gonzalez-Campos, J, Gonzalez-Gil, C, Zamora, L, Ramirez, JL, Diaz-Beya, M, Mercadal, S, Artola, MT, Cladera, A, Tormo, M, Bermudez, A, Vall-Llovera, F, Martinez, P, Amigo, ML, Monsalvo, S, Novo, A, Cervera, M, Garcia-Guinon, A, Junca, J, Ciudad, J, Orfao, A, Ribera, JM (2020).

Unique clinico-biological, genetic and prognostic features of adult early T cell precursor acute lymphoblastic leukemia.

HAEMATOLOGICA. Letter. 105(6):294-297.
[doi:10.3324/haematol.2019.225078]
Alonso, R, Cedena, MT, Wong, S, Shah, N, Rios-Tamayo, R, Moraleda, JM, Lopez-Jimenez, J, Garcia, C, Bahri, N, Valeri, A, Sanchez, R, Collado-Yurrita, L, Martin, T, Wolf, J, Lahuerta, JJ, Martinez-Lopez, J (2020).

Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma.

Blood Advances. Article. 4(10):2163-2171.
[doi:10.1182/bloodadvances.2020001508]
Vij, R, Nath, R, Afar DEH, Mateos, MV, Berdeja, JG, Raab, MS, Guenther, A, Martinez-Lopez, J, Jakubowiak, AJ, Leleu, X, Weisel, K, Wong, S, Gulbranson, S, Sheridan, JP, Reddy, A, Paiva, B, Singhal, A, San-Miguel, JF, Moreau, P (2020).

First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma.

CLINICAL CANCER RESEARCH. Article. 26(10):2308-2317.
[doi:10.1158/1078-0432.CCR-19-1431]
Barrio, S, Munawar, U, Zhu, YX, Giesen, N, Shi, CX, Da Via, M, Sanchez, R, Bruins, L, Demler, T, Muller, N, Haertle, L, Garitano, A, Steinbrunn, T, Danhof, S, Cuenca, I, Barrio-Garcia, C, Braggio, E, Rosenwald, A, Martinez-Lopez, J, Rasche, L, Raab, MS, Stewart, AK, Einsele, H, Stuhmer, T, Kortum, KM (2020).

IKZF1/3 and CRL4-CRBN E3 ubiquitin ligase mutations and IMiD resistance in multiple myeloma.

HAEMATOLOGICA. Letter. 105(5):237-241.
[doi:10.3324/haematol.2019.217943]
Gutierrez, A, Bento, L, Diaz-Lopez, A, Barranco, G, Garcia-Recio, M, Lopez-Guillermo, A, Dlouhy, I, Rovira, J, Rodriguez, M, Sanchez Pina JM, Baile, M, Martín A, Novelli, S, Sancho, JM, García O, Salar, A, Bastos-Oreiro, M, Rodriguez-Salazar, MJ, Fernandez, R, de la Cruz, F, Queizan, JA, González de Villambrosia S, Cordoba, R, López A, Luzardo, H, García D, Sastre-Serra, J, Garcia, JF, Montalban, C, Cabanillas, F, Rodríguez J (2020).

Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 104(5):400-408.
[doi:10.1111/ejh.13364]
Rodriguez-Medina, C, Martinez-Cuadron, D, Cano, I, Gil, C, Tormo, M, Del Pilar Martínez-Sánchez M, del Castillo, TB, Serrano-Lopez, J, Benavente, C, Herrera-Puente, P, Garcia-Boyero, R, Lavilla-Rubira, E, Amigo, ML, Sayas-Llorisn, MJ, Bergua-Burgues, JM, Perez-Simon, JA, Rodriguez, G, Espadana, A, Vidriales-Vicente, B, Fernandez, R, Lopez-Lorenzo, JL, Lopez, M, Garcia-Fortes, M, Labrador Gómez J, Colorado-Araujo, M, Sossa-Melo, CL, Aguilar, E, Montesinos Fernández P (2020).

Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study.

LEUKEMIA RESEARCH. Article. 92:106352-106352.
[doi:10.1016/j.leukres.2020.106352]
Onecha, E, Ruiz-Heredia, Y, Martinez-Cuadron, D, Barragan, E, Martinez-Sanchez, P, Linares, M, Rapado, I, Perez-Oteyza, J, Magro, E, Herrera, P, Rojas, JL, Gorrochategui, J, Villoria, J, Boluda, B, Sargas, C, Ballesteros, J, Montesinos, P, Martinez-Lopez, J, Ayala, R (2020).

Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.

BRITISH JOURNAL OF HAEMATOLOGY. Article. 189(4):672-683.
[doi:10.1111/bjh.16432]
Sánchez Prieto I, López Rubio M, Arranz, E, Ayala, R, Callejas Charavía M, Martín Guerrero Y, Gil Fernández JJ, Valenciano Martínez S, Castilla García L, Argüello Marina M, Aspa Cilleruelo JM, Martínez Vázquez C, García Suárez J (2020).

Jumping Translocation in a Patient with Acute Leukemia and Fatal Evolution.

Case reports in oncology. Case Reports. 13(2):1026-1030.
[doi:10.1159/000508999]
Galera-Monge, T, Zurita-Diaz, F, Canals, I, Hansen, MG, Rufian-Vazquez, L, Ehinger, JK, Elmer, E, Martin, MA, Garesse, R, Ahlenius, H, Gallardo, ME (2020).

Mitochondrial Dysfunction and Calcium Dysregulation in Leigh Syndrome Induced Pluripotent Stem Cell Derived Neurons.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Article. 21(9).
[doi:10.3390/ijms21093191]
Sanchez, R, Ribera, J, Morgades, M, Ayala, R, Onecha, E, Ruiz-Heredia, Y, Juarez-Rufian, A, de Nicolas, R, Sanchez-Pina, J, Vives, S, Zamora, L, Mercadal, S, Coll, R, Cervera, M, Garcia, O, Ribera, JM, Martinez-Lopez, J (2020).

A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.

BLOOD CANCER JOURNAL. Article. 10(4):43-43.
[doi:10.1038/s41408-020-0308-3]
Ibanez, M, Such, E, Onecha, E, Gomez-Segui, I, Liquori, A, Selles, J, Hervas-Marin, D, Barragan, E, Ayala, R, Llop, M, Lopez-Pavia, M, Rapado, I, Neef, A, Sanjuan-Pla, A, Sargas, C, Gonzalez-Romero, E, Boluda-Navarro, M, Andreu, R, Senent, L, Montesinos, P, Martinez-Lopez, J, Angel Sanz M, Sanz, G, Cervera, J (2020).

Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype.

SCIENTIFIC REPORTS. Article. 10(1):5904-5904.
[doi:10.1038/s41598-020-61589-9]
Gomez-Massa, E, Talayero, P, Utrero-Rico, A, Laguna-Goya, R, Andres, A, Mancebo, E, Leivas, A, Polanco-Fernandez, N, Justo, I, Jimenez-Romero, C, Pleguezuelo, D, Paz-Artal, E (2020).

Number and function of circulatory helper innate lymphoid cells are unaffected by immunosuppressive drugs used in solid organ recipients - a single centre cohort study.

TRANSPLANT INTERNATIONAL. Article. 33(4):402-413.
[doi:10.1111/tri.13567]
Ribera, JM, Morgades, M, Montesinos, P, Tormo, M, Martinez-Carballeira, D, Gonzalez-Campos, J, Gil, C, Barba, P, Garcia-Boyero, R, Coll, R, Pedreno, M, Ribera, J, Mercadal, S, Vives, S, Novo, A, Genesca, E, Hernandez-Rivas, JM, Bergua, J, Amigo, ML, Vall-Llovera, F, Martinez-Sanchez, P, Calbacho, M, Garcia-Cadenas, I, Garcia-Guinon, A, Sanchez-Sanchez, MJ, Cervera, M, Feliu, E, Orfao, A, PETHEMA Group, Spanish Society of Hematology (2020).

A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.

Cancer Medicine. Article. 9(7):2317-2329.
[doi:10.1002/cam4.2814]
Gonzalez-Acosta, M, Marin, F, Puliafito, B, Bonifaci, N, Fernandez, A, Navarro, M, Salvador, H, Balaguer, F, Iglesias, S, Velasco, A, Grau Garces E, Moreno, V, Gonzalez-Granado, LI, Guerra-Garcia, P, Ayala, R, Florkin, B, Kratz, C, Ripperger, T, Rosenbaum, T, Januszkiewicz-Lewandowska, D, Azizi, AA, Ragab, I, Nathrath, M, Pander, HJ, Lobitz, S, Suerink, M, Dahan, K, Imschweiler, T, Demirsoy, U, Brunet, J, Lazaro, C, Rueda, D, Wimmer, K, Capella, G, Pineda, M (2020).

High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers.

JOURNAL OF MEDICAL GENETICS. Article. 57(4):269-273.
[doi:10.1136/jmedgenet-2019-106272]
Paiva B, Puig N, Cedena MT, Rosiñol L, Cordón L, Vidriales MB, Burgos L, Flores-Montero J, Sanoja-Flores L, Lopez-Anglada L, Maldonado R, de la Cruz J, Gutierrez NC, Calasanz MJ, Martin-Ramos ML, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Blanchard MJ, Rios R, Martin J, Martinez-Martinez R, Sureda A, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Van Dongen JJM, Orfao A, Mateos MV, Blade J, San-Miguel JF, Lahuerta JJ, GEM (Grupo Español de Mieloma)/PETHEMA (Programa Para el Estudio de la Terapéuti (2020).

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.

JOURNAL OF CLINICAL ONCOLOGY. Article. 38(8):784-792.
[doi:10.1200/JCO.19.01231]
Bento L, Díaz-López A, Barranco G, Martín-Moreno AM, Baile M, Martín A, Sancho JM, García O, Rodríguez M, Sánchez-Pina JM, Novelli S, Salar A, Bastos M, Rodríguez-Salazar MJ, González de Villambrosia S, Córdoba R, García-Recio M, Martínez-Serra J, Del Campo R, Luzardo H, García D, Hong A, Abrisqueta P, Sastre-Serra J, Roca P, Rodríguez J, Gutiérrez A, Grupo Español de Linfomas y Trasplante Autólogo (GELTAMO) (2020).

New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).

BRITISH JOURNAL OF HAEMATOLOGY. Article. 188(6):888-897.
[doi:10.1111/bjh.16263]
Sobas M, Rodriguez-Veiga R, Vellenga E, Paluszewska M, de la Serna J, García-Álvarez F, Gil C, Brunet S, Bergua J, González-Campos J, Ribera JM, Tormo M, González M, Fernández I, Benavente C, González-Sanmiguel JD, Esteve J, Pérez-Encinas M, Salamero O, Manso F, Lowenberg B, Sanz MA, Montesinos P, PETHEMA, HOVON, PALG, GATLA cooperative groups (2020).

Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 104(3):162-169.
[doi:10.1111/ejh.13346]
Palomo, L, Ibáñez M, Abaigar, M, Vazquez, I, Alvarez, S, Cabezon, M, Tazon-Vega, B, Rapado, I, Fuster-Tormo, F, Cervera, J, Benito, R, Larrayoz, MJ, Cigudosa, JC, Zamora, L, Valcarcel, D, Cedena, MT, Acha, P, Hernandez-Sanchez, JM, Fernandez-Mercado, M, Sanz, G, Hernandez-Rivas, JM, Calasanz, MJ, Sole, F, Such, E, Spanish Grp MDS GESMD (2020).

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

BRITISH JOURNAL OF HAEMATOLOGY. Article. 188(5):605-622.
[doi:10.1111/bjh.16175]
Carreras, P, Gonzalez, I, Gallardo, M, Ortiz-Ruiz, A, Martinez-Lopez, J (2020).

Droplet Microfluidics for the ex Vivo Expansion of Human Primary Multiple Myeloma Cells.

MICROMACHINES. Article. 11(3).
[doi:10.3390/mi11030261]
Medina, A, Jimenez, C, Sarasquete, ME, Gonzalez, M, Chillon, MC, Balanzategui, A, Prieto-Conde, I, Garcia-Alvarez, M, Puig, N, Gonzalez-Calle, V, Alcoceba, M, Cuenca, I, Barrio, S, Escalante, F, Gutierrez, NC, Gironella, M, Hernandez, MT, Sureda, A, Oriol, A, Blade, J, Lahuerta, JJ, San Miguel, JF, Mateos, MV, Martinez-Lopez, J, Calasanz, MJ, Garcia-Sanz, R (2020).

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.

BLOOD CANCER JOURNAL. Article. 10(2):14-14.
[doi:10.1038/s41408-020-0283-8]
Garces, JJ, Simicek, M, Vicari, M, Brozova, L, Burgos, L, Bezdekova, R, Alignani, D, Calasanz, MJ, Growkova, K, Goicoechea, I, Agirre, X, Pour, L, Prosper, F, Rios, R, Martinez-Lopez, J, Millacoy, P, Palomera, L, Del Orbe, R, Perez-Montana, A, Garate, S, Blanco, L, Lasa, M, Maiso, P, Flores-Montero, J, Sanoja-Flores, L, Chyra, Z, Vdovin, A, Sevcikova, T, Jelinek, T, Botta, C, El Omri, H, Keats, J, Orfao, A, Hajek, R, San-Miguel, JF, Paiva, B (2020).

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

LEUKEMIA. Article. 34(2):589-603.
[doi:10.1038/s41375-019-0588-4]
Gonzalez-Rodriguez, AP, Lopez-Corral, L, Fajardo DFM, Gonzalez-Huerta, AJ, Palomo, P, Bermudez, A, Ripa, TZ, Santos-Diaz, P, Gonzalez-Muniz, S, Zanabilli, J, Ubieto, AJ, de Arriba, F, Arnao-Herraiz, M, Sordo-Bahamonde, C, Lopez-Soto, A, Gonzalez, S, Rosiñol L, Mateos, MV (2020).

Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT.

BONE MARROW TRANSPLANTATION. Letter. 55(2):461-463.
[doi:10.1038/s41409-019-0525-1]
Provencio, M, Perez-Barrios, C, Barquin, M, Calvo, V, Franco, F, Sanchez, E, Sanchez, R, Marsden, D, Cristóbal Sánchez J, Martin Acosta P, Laza-Briviesca, R, Cruz-Bermudez, A, Romero, A (2020).

Next-generation sequencing for tumor mutation quantification using liquid biopsies.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. Article. 58(2):306-313.
[doi:10.1515/cclm-2019-0745]
Ortuno, JE, Lin, L, Ortega, MD, Garcia-Villena, J, Cuadrado, D, Linares, M, Santos, A, Ledesma-Carbayo, MJ, Luengo-Oroz, M (2020).

STITCHING METHODOLOGY FOR WHOLE SLIDE LOW-COST ROBOTIC MICROSCOPE BASED ON A SMARTPHONE

Ieee International Symposium On Biomedical Imaging. Proceedings Paper. 503-507.
Piñana JL, Martino, R, Garcia-Garcia, I, Parody, R, Morales, MD, Benzo, G, Gomez-Catalan, I, Coll, R, De la Fuente, I, Luna, A, Merchan, B, Chinea, A, de Miguel, D, Serrano, A, Perez, C, Diaz, C, Lopez, JL, Saez, AJ, Bailen, R, Zudaire, T, Martinez, D, Jurado, M, Calbacho, M, Vazquez, L, Garcia-Cadenas, I, Fox, L, Pimentel, AI, Bautista, G, Nieto, A, Fernandez, P, Vallejo, JC, Solano, C, Valero, M, Espigado, I, Saldaña R, Sisinni, L, Ribera, JM, Jimenez, MJ, Trabazo, M, Gonzalez-Vicent, M, Fernandez, N, Talarn, C, Montoya, MC, Cedillo, A, Sureda, A, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Tr (2020).

Risk factors and outcome of COVID-19 in patients with hematological malignancies.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY. Article. 9(1):21-21.
[doi:10.1186/s40164-020-00177-z]
Cedena, MT, Martin-Clavero, E, Wong, S, Shah, N, Bahri, N, Alonso, R, Barcenas, C, Valeri, A, Salazar Tabares J, Sanchez-Pina, J, Cuellar, C, Martin, T, Wolf, J, Lahuerta, JJ, Martinez-Lopez, J (2020).

The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements.

PLOS ONE. Article. 15(8).
[doi:10.1371/journal.pone.0237155]
Gallardo, M, Malaney, P, Aitken MJL, Zhang, XR, Link, TM, Shah, V, Alybayev, S, Wu, MH, Pageon, LR, Ma, HX, Jacamo, R, Yu, L, Xu-Monette, ZY, Steinman, H, Lee, HJ, Sarbassov, D, Rapado, I, Barton, MC, Martinez-Lopez, J, Bueso-Ramos, C, Young, KH, Post, SM (2020).

Uncovering the role of hnRNP K, an RNA-binding protein, in B-cell lymphomas.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. Article. 112(1):95-106.
[doi:10.1093/jnci/djz078]
Carreras, P, Gallardo, M, Ortiz, A, Morales, ML, Cedena, T, Gonzalez, I, Martinez-Lopez, J (2020).

Microfluidic-assisted engineering of multilayered microcapsules for 3D stem cell culture

Proceedings Of Spie. Proceedings Paper. 11235.
[doi:10.1117/12.2558441]

2019

Morales, ML, Arenas, A, Ortiz-Ruiz, A, Leivas, A, Rapado, I, Rodriguez-Garcia, A, Castro, N, Zagorac, I, Quintela-Fandino, M, Gomez-Lopez, G, Gallardo, M, Ayala, R, Linares, M, Martinez-Lopez, J (2019).

MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia.

SCIENTIFIC REPORTS. Article. 9(1):18630-18630.
[doi:10.1038/s41598-019-54901-9]
Munawar, U, Roth, M, Barrio, S, Wajant, H, Siegmund, D, Bargou, RC, Kortum, KM, Stuhmer, T (2019).

Assessment of TP53 lesions for p53 system functionality and drug resistance in multiple myeloma using an isogenic cell line model.

SCIENTIFIC REPORTS. Article. 9(1):18062-18062.
[doi:10.1038/s41598-019-54407-4]
Durrant, ST, Nagler, A, Guglielmelli, P, Lavie, D, le Coutre, P, Gisslinger, H, Chuah, C, Maffioli, M, Bharathy, S, Dong, TC, Wroclawska, M, Martinez-Lopez J (2019).

Results from HARMONY: an open-label, multicentre, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis.

HAEMATOLOGICA. Letter. 104(12):551-554.
[doi:10.3324/haematol.2018.209965]
Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Rodriguez A, Lorza L, Martín A, Coria E, López-Guillermo A, Salar A, José Lahuerta J, GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Stu (2019).

Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy.

Hematology/Oncology and Stem Cell Therapy. Article. 12(4):194-203.
[doi:10.1016/j.hemonc.2019.06.001]
Colom-Fernandez, B, Kreutzman, A, Marcos-Jimenez, A, Garcia-Gutierrez, V, Cuesta-Mateos, C, Portero-Sainz, I, Perez-Garcia, Y, Casado, LF, Sanchez-Guijo, F, Martinez-Lopez, J, Ayala, RM, Boque, C, Xicoy, B, Montero, I, Soto, C, Paz, R, Silva, G, Vega-Piris, L, Steegmann, JL, Muñoz-Calleja C (2019).

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients.

Frontiers In Pharmacology. Article. 10:1340-1340.
[doi:10.3389/fphar.2019.01340]
Lozano, ML, Mingot-Castellano, ME, Perera, MM, Jarque, I, Campos-Alvarez, RM, Gonzalez-Lopez, TJ, Carreño-Tarragona G, Bermejo, N, Lopez-Fernandez, MF, de Andres, A, Valcarcel, D, Casado-Montero, LF, Alvarez-Roman, MT, Orts, MI, Novelli, S, Revilla, N, Gonzalez-Porras, JR, Bolaños E, Rodriguez-Lopez, MA, Orna-Montero, E, Vicente, V (2019).

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

SCIENTIFIC REPORTS. Article. 9(1):16680-16680.
[doi:10.1038/s41598-019-53209-y]
Ribera, J, Zamora, L, Morgades, M, Vives, S, Granada, I, Montesinos, P, Gomez-Segui, I, Mercadal, S, Guàrdia R, Nomdedeu, J, Pratcorona, M, Tormo, M, Martinez-Lopez, J, Hernandez-Rivas, JM, Ciudad, J, Orfao, A, Gonzalez-Campos, J, Barba, P, Escoda, L, Esteve, J, Genesca, E, Sole, F, Feliu, E, Ribera, JM, Spanish PETHEMA Group, Spanish Soc Hematology (2019).

Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

GENES CHROMOSOMES & CANCER. Article. 58(11):815-819.
[doi:10.1002/gcc.22788]
Salamero O, Martínez-Cuadrón D, Sobas M, Benavente C, Vives S, De la Serna J, Pérez-Encinas M, Escoda L, Gil C, Brunet S, Ramos F, Esteve J, Amigo M, Krsnik I, Manso F, Arias J, González-Campos J, Serrano J, Oleksiuk J, Barrios M, García-Boyero R, Novo A, Sanz MA, Montesinos P, PETHEMA and PALG Groups (2019).

Real life outcomes of patients aged =75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry.

LEUKEMIA & LYMPHOMA. Article. 60(11):1-13.
[doi:10.1080/10428194.2019.1607327]
Garcia-Marco, JA, Lopez Jimenez J, Recasens, V, Fernandez Zarzoso M, Gonzalez-Barca, E, Somolinos De Marcos N, Ramirez, MJ, Penalver Parraga FJ, Yanez, L, De La Serna Torroba J, Garcia Malo MD, Deben Ariznavarreta G, Perez Persona E, Ruiz Guinaldo MA, De Paz Arias R, Banas Llanos E, Jarque, I, Fernandez Valle MDC, Carral Tatay A, Perez De Oteyza J, Donato Martin E, Perez Fernandez I, Martinez, RM, Andreu Costa MA, Champ, D, Garcia Suarez J, Gonzalez Diaz M, Ferrer, S, Carbonell, F, Garcia-Vela, JA, GELLC (Grupo Espanol de Leucemia Linfocitica Cronica) Study Group (2019).

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by a three-year rituximab maintenance.

HAEMATOLOGICA. Article. 104(11):2249-2257.
[doi:10.3324/haematol.2018.204891]
Fernandez-Navarro, P, Lopez-Nieva, P, Piñeiro-Yañez E, Carreño-Tarragona G, Martinez-Lopez, J, Sanchez Perez, R, Aroca, A, Al-Shahrour, F, Cobos-Fernandez, MA, Fernandez-Piqueras, J (2019).

The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.

BMC CANCER. Article. 19(1):1005-1005.
[doi:10.1186/s12885-019-6209-9]
Rodriguez-Garcia, A, Morales, ML, Garrido-Garcia, V, Garcia-Baquero, I, Leivas, A, Carreño-Tarragona G, Sanchez, R, Arenas, A, Cedena, T, Ayala, RM, Bautista, JM, Martinez-Lopez, J, Linares, M (2019).

Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy.

Antioxidants. Article. 8(11).
[doi:10.3390/antiox8110508]
Rosiñol L, Oriol, A, Rios, R, Sureda, A, Blanchard, MJ, Hernandez, MT, Martinez-Martinez, R, Moraleda, JM, Jarque, I, Bargay, J, Gironella, M, de Arriba, F, Palomera, L, Gonzalez-Montes, Y, Marti, JM, Krsnik, I, Arguiñano JM, Gonzalez, ME, Gonzalez, AP, Casado, LF, Lopez-Anglada, L, Paiva, B, Mateos, MV, San Miguel, JF, Lahuerta, JJ, Blade, J (2019).

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplantation in multiple myeloma.

BLOOD. Article. 134(16):1337-1345.
[doi:10.1182/blood.2019000241]
Fernandez, L, Fernandez, A, Mirones, I, Escudero, A, Cardoso, L, Vela, M, Lanzarot, D, de Paz, R, Leivas, A, Gallardo, M, Marcos, A, Romero, AB, Martinez-Lopez, J, Perez-Martinez, A (2019).

GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy

Frontiers in immunology. Article. 10:2361-2361.
[doi:10.3389/fimmu.2019.02361]
Angenendt, L, Röllig C, Montesinos, P, Martinez-Cuadron, D, Barragan, E, Garcia, R, Botella, C, Martinez, P, Ravandi, F, Kadia, T, Kantarjian, HM, Cortes, J, Juliusson, G, Lazarevic, V, Höglund M, Lehmann, S, Recher, C, Pigneux, A, Bertoli, S, Dumas, PY, Dombret, H, Preudhomme, C, Micol, JB, Terre, C, Racil, Z, Novak, J, Žák P, Wei, AH, Tiong, IS, Wall, M, Estey, E, Shaw, C, Exeler, R, Wagenfuhr, L, Stölzel F, Thiede, C, Stelljes, M, Lenz, G, Mikesch, JH, Serve, H, Ehninger, G, Berdel, WE, Kramer, M, Krug, U, Schliemann, C (2019).

Chromosomal Abnormalities and Prognosis in NPM1 -Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.

JOURNAL OF CLINICAL ONCOLOGY. Article. 37(29):2632-2642.
[doi:10.1200/JCO.19.00416]
Munawar, U, Rasche, L, Muller, N, Vogt, C, Da-Via, M, Haertle, L, Arampatzi, P, Dietrich, S, Roth, M, Garitano-Trojaola, A, Steinhardt, MJ, Strifler, S, Gallardo, M, Martinez-Lopez, J, Bargou, RC, Heckel, T, Einsele, H, Stuhmer, T, Kortum, KM, Barrio, S (2019).

Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness.

BLOOD. Article. 134(10):836-840.
[doi:10.1182/blood.2019000080]
Dagnew, AF, Ilhan, O, Lee, WS, Woszczyk, D, Kwak, JY, Bowcock, S, Sohn, SK, Rodriguez Macías G, Chiou, TJ, Quiel, D, Aoun, M, Navarro Matilla MB, de la Serna, J, Milliken, S, Murphy, J, McNeil, SA, Salaun, B, Di Paolo, E, Campora, L, Lopez-Fauqued, M, El Idrissi, M, Schuind, A, Heineman, TC, Van den Steen, P, Oostvogels, L, Zoster-039 study group (2019).

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.

LANCET INFECTIOUS DISEASES. Article. 19(9):988-1000.
[doi:10.1016/S1473-3099(19)30163-X]
Pertesi, M, Vallee, M, Wei, XM, Revuelta, MV, Galia, P, Demangel, D, Oliver, J, Foll, M, Chen, S, Perrial, E, Garderet, L, Corre, J, Leleu, X, Boyle, EM, Decaux, O, Rodon, P, Kolb, B, Slama, B, Mineur, P, Voog, E, Le Bris, C, Fontan, J, Maigre, M, Beaumont, M, Azais, I, Sobol, H, Vignon, M, Royer, B, Perrot, A, Fuzibet, JG, Dorvaux, V, Anglaret, B, Cony-Makhoul, P, Berthou, C, Desquesnes, F, Pegourie, B, Leyvraz, S, Mosser, L, Frenkiel, N, Augeul-Meunier, K, Leduc, I, Leyronnas, C, Voillat, L, Casassus, P, Mathiot, C, Cheron, N, Paubelle, E, Moreau, P, Bignon, YJ, Joly, B, Bourquard, P, Caillot, D, Naman, H, Rigaudeau, S, Marit, G, Macro, M, Lambrecht, I, Cliquennois, M, Vincent, L, Helias, P, Avet-Loiseau, H, Moreno, V, Reis, RM, Varkonyi, J, Kruszewski, M, Vangsted, AJ, Jurczyszyn, A, Zaucha, JM, Sainz, J, Krawczyk-Kulis, M, Watek, M, Pelosini, M, Iskierka-Jazdzewska, E, Grzasko, N, Martinez-Lopez, J, Jerez, A, Campa, D, Buda, G, Lesueur, F, Dudzinski, M, Garcia-Sanz, R, Nagler, A, Rymko, M, Jamroziak, K, Butrym, A, Canzian, F, Obazee, O, Nilsson, B, Klein, RJ, Lipkin, SM, McKay, JD, Dumontet, C (2019).

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

LEUKEMIA. Letter. 33(9):2324-2330.
[doi:10.1038/s41375-019-0452-6]
Blanes, M, Lorenzo, JI, Ribas, P, Jimenez, A, Gonzalez, JD, Cejalvo, MJ, Solano, C, Alegre, A, de la Rubia, J (2019).

Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma.

ANNALS OF HEMATOLOGY. Letter. 98(8):2013-2015.
[doi:10.1007/s00277-019-03663-5]
Chari, A, Martinez-Lopez, J, Mateos, MV, Blade, J, Benboubker, L, Oriol, A, Arnulf, B, Rodriguez-Otero, P, Pineiro, L, Jakubowiak, A, de Boer, C, Wang, JP, Clemens, PL, Ukropec, J, Schecter, J, Lonial, S, Moreau, P (2019).

Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma

BLOOD. Article. 134(5):421-431.
[doi:10.1182/blood.2019000722]
Alonso, R, Cedena, MT, Gomez-Grande, A, Rios, R, Moraleda, JM, Cabañas V, Moreno, MJ, Lopez-Jimenez, J, Martin, F, Sanz, A, Valeri, A, Jimenez, A, Sanchez, R, Lahuerta, JJ, Martinez-Lopez, J (2019).

Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma.

AMERICAN JOURNAL OF HEMATOLOGY. Article. 94(8):853-861.
[doi:10.1002/ajh.25507]
Fiuza-Luces, C, Valenzuela, PL, Laine-Menendez, S, Fernandez-de la Torre, M, Bermejo-Gomez, V, Rufian-Vazquez, L, Arenas, J, Martin, MA, Lucia, A, Moran, M (2019).

Physical Exercise and Mitochondrial Disease: Insights From a Mouse Model.

Frontiers In Neurology. Article. 10:790-790.
[doi:10.3389/fneur.2019.00790]
Marin-Ramos, NI, Balabasquer, M, Ortega-Nogales, FJ, Torrecillas, IR, Gil-Ordonez, A, Marcos-Ramiro, B, Aguilar-Garrido, P, Cushman, I, Romero, A, Medrano, FJ, Gajate, C, Mollinedo, F, Philips, MR, Campillo, M, Gallardo, M, Martin-Fontecha, M, Lopez-Rodriguez, ML, Ortega-Gutierrez, S (2019).

A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia

JOURNAL OF MEDICINAL CHEMISTRY. Article. 62(13):6035-6046.
[doi:10.1021/acs.jmedchem.9b00145]
Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, López-Jiménez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, Gaidano G, Lee JJ, Abhyankar S, Solano C, Perez de Oteyza J, Satlin MJ, Schwartz S, Campins M, Rocci A, Vallejo Llamas C, Lee DG, Tan SM, Johnston AM, Grigg A, Boeckh MJ, Campora L, Lopez-Fauqued M, Heineman TC, Stadtmauer EA, Sullivan KM, ZOE-HSCT Study Group Collaborators (2019).

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Article. 322(2):123-133.
[doi:10.1001/jama.2019.9053]
Ribera J, Granada I, Morgades M, Vives S, Genesca E, Gonzalez C, Nomdedeu J, Escoda L, Montesinos P, Mercadal S, Coll R, Gonzalez-Campos J, Abella E, Barba P, Bermudez A, Gil C, Tormo M, Pedreno M, Martinez-Carballeira D, Hernandez-Rivas JM, Orfao A, Martinez-Lopez J, Esteve J, Bravo P, Garcia-Guinon A, Deben G, Moraleda JM, Quiezan JA, Ortin X, Moreno MJ, Feliu E, Sole F, Ribera JM, PETHEMA Group, Spanish Society of Haematology (2019).

The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients.

BRITISH JOURNAL OF HAEMATOLOGY. Article. 186(2):263-268.
[doi:10.1111/bjh.15887]
Lahuerta, JJ, Jimenez-Ubieto, A, Paiva, B, Martinez-Lopez, J, Gonzalez-Medina, J, Lopez-Anglada, L, Cedena, MT, Puig, N, Oriol, A, Blanchard, MJ, Rios, R, Martin, J, Martinez, R, Sureda, A, Hernandez, MT, de la Rubia, J, Krsnik, I, Cabañas V, Palomera, L, Bargay, J, Mateos, MV, Rosiñol L, San Miguel, JF, Blade, J (2019).

Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease.

BLOOD. Article. 133(25):2664-2668.
[doi:10.1182/blood.2019000671]
Sanchez, R, Ayala, R, Martinez-Lopez, J (2019).

Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Review. 20(11).
[doi:10.3390/ijms20112832]
Campa, D, Martino, A, Macauda, A, Dudzinski, M, Suska, A, Druzd-Sitek, A, Raab, MS, Moreno, V, Huhn, S, Butrym, A, Sainz, J, Szombath, G, Rymko, M, Marques, H, Lesueur, F, Vangsted, AJ, Vogel, U, Kruszewski, M, Subocz, E, Buda, G, Iskierka-Jazdzewska, E, Rios, R, Merz, M, Schottker, B, Mazur, G, Perrial, E, Martinez-Lopez, J, Butterbach, K, Garcia Sanz R, Goldschmidt, H, Brenner, H, Jamroziak, K, Reis, RM, Kadar, K, Dumontet, C, Watek, M, Haastrup, EK, Helbig, G, Jurczyszyn, A, Jerez, A, Varkonyi, J, Barington, T, Grzasko, N, Zaucha, JM, Andersen, V, Zawirska, D, Canzian, F (2019).

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study.

LEUKEMIA & LYMPHOMA. Article. 60(7):1-9.
[doi:10.1080/10428194.2018.1551536]
Carreño-Tarragona G, Cedena, T, Montejano, L, Alonso, R, Miras, F, Valeri, A, Rivero, A, Lahuerta, JJ, Martinez-Lopez, J (2019).

Papain-treated panels are a simple method for the identification of alloantibodies in multiple myeloma patients treated with anti-CD38-based therapies.

TRANSFUSION MEDICINE. Article. 29(3):193-196.
[doi:10.1111/tme.12508]
Ruiz-Heredia, Y, Sanchez-Vega, B, Barrio, S, Linares, M, Rapado, I, Braggio, E, Stewart, K, Folgueira, MD, Ramos, A, Collado, L, Ruiz, J, Toldos, O, Hernandez-Lain, A, Martinez-Lopez, J (2019).

Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. Article. 25(4):998-1002.
[doi:10.1177/1078155218769367]
Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, García-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H, Schjesvold F, Chen WM, Abildgaard N, Lipe BC, Dytfeld D, Wirk BM, Drake M, Cavo M, Lahuerta JJ, Lentzsch S (2019).

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.

LANCET ONCOLOGY. Article. 20(6):302-312.
[doi:10.1016/S1470-2045(19)30309-2]
Hernandez, JA, Martinez-Lopez, J, Lahuerta, JJ (2019).

Timing treatment for smoldering myeloma: is earlier better?

EXPERT REVIEW OF HEMATOLOGY. Review. 12(5):345-354.
[doi:10.1080/17474086.2019.1599281]
Magnano, L, Alonso-Alvarez, S, Alcoceba, M, Rivas-Delgado, A, Muntanola, A, Nadeu, F, Setoain, X, Rodriguez, S, Andrade-Campos, M, Espinosa-Lara, N, Rodriguez, G, Sancho, JM, Moreno, M, Mercadal, S, Carro, I, Salar, A, Garcia-Pallarols, F, Arranz, R, Cannata, J, Terol, MJ, Teruel, AI, Jimenez-Ubiet, A, Rodrigue, A, Gonzalez de Villambrosia S, Bell, JL, Lopez, L, Novelli, S, de Cabo, E, Infante, ME, Pardal, E, Monsalvo, S, Gonzalez, M, Martin, A, Caballero, MD, Lopez-Guillermo, A, Grupo Espanol de Linfomas y Trasplante Autologo de Medula Osea (GELTAMO) (2019).

Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.

BRITISH JOURNAL OF HAEMATOLOGY. Article. 185(3):480-491.
[doi:10.1111/bjh.15805]
Puig, N, Paiva, B, Lasa, M, Burgos, L, Perez, JJ, Merino, J, Moreno, C, Vidriales, MB, Toboso, DG, Cedena, MT, Ocio, EM, Lecumberri, R, Garcia de Coca A, Labrador, J, Gonzalez, ME, Palomera, L, Gironella, M, Cabanas, V, Casanova, M, Oriol, A, Krsnik, I, Perez-Montana, A, de la Rubia, J, de la Puerta, JE, de Arriba, F, Prosper, F, Martinez-Lopez, J, Lecrevisse, Q, Verde, J, Mateos, MV, Lahuerta, JJ, Orfao, A, San Miguel, JF (2019).

Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis.

LEUKEMIA. Article. 33(5):1256-1267.
[doi:10.1038/s41375-018-0308-5]
Arenas Cortes A, Ayala Diaz R, Hernandez-Campo, P, Gorrochategui, J, Primo, D, Robles, A, Morales, ML, Ballesteros, J, Rapado, I, Gallardo, M, Linares, M, Martinez-Lopez, J (2019).

Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms.

HAEMATOLOGICA. Article. 104(5):937-946.
[doi:10.3324/haematol.2018.201038]
Labrador J, Luno E, Vellenga E, Brunet S, Gonzalez-Campos J, Chillon MC, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel JD, Gil C, Tormo M, Salamero O, Manso F, Fernandez I, de laSerna J, Moreno MJ, Perez-Encinas M, Krsnik I, Ribera JM, Cervera J, Calasanz MJ, Boluda B, Sobas M, Lowenberg B, Sanz MA, Montesinos P (2019).

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.

LEUKEMIA & LYMPHOMA. Article. 60(5):1-10.
[doi:10.1080/10428194.2018.1522438]
Sobas M, Montesinos P, Boluda B, Bernal T, Vellenga E, Nomdedeu J, Gonzalez-Campos J, Chillon M, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel JD, Gil-Cortes C, Tormo M, Salamero O, Manso F, Fernandez I, de la Serna J, Moreno MJ, Perez-Encinas M, Krsnik I, Ribera JM, Escoda L, Lowenberg B, Sanz MA, PETHEMA, HOVON, PALG, and GATLA cooperative groups (2019).

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens.

LEUKEMIA & LYMPHOMA. Article. 60(4):1-6.
[doi:10.1080/10428194.2018.1516875]
Sainz de Aja J, Menchero, S, Rollan, I, Barral, A, Tiana, M, Jawaid, W, Cossio, I, Alvarez, A, Carreno-Tarragona, G, Badia-Careaga, C, Nichols, J, Gottgens, B, Isern, J, Manzanares, M (2019).

The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1.

EMBO JOURNAL. Article. 38(7).
[doi:10.15252/embj.201899122]
Calvo, AC, Cibreiro, GA, Merino, PT, Roy, JF, Galiana, A, Rufian, AJ, Cano, JM, Martin, MA, Moreno, L, Larrode, P, Vazquez, PC, Galan, L, Mora, J, Muñoz-Blanco JL, Muñoz MJ, Zaragoza, P, Pegoraro, E, Soraru, G, Mora, M, Lunetta, C, Penco, S, Tarlarini, C, Esteban, J, Osta, R, Redondo, AG (2019).

Collagen XIX Alpha 1 Improves Prognosis in Amyotrophic Lateral Sclerosis.

Aging and Disease. Article. 10(2):278-292.
[doi:10.14336/AD.2018.0917]
Rodriguez-Otero, P, Mateos, MV, Martinez-Lopez, J, Hernandez, MT, Ocio, EM, Rosinol, L, Martinez, R, Teruel, AI, Gutierrez, NC, Bargay, J, Bengoechea, E, Gonzalez, Y, de Oteyza, JP, Gironella, M, Nunez-Cordoba, JM, Encinas, C, Martin, J, Cabrera, C, Palomera, L, de Arriba, F, Cedena, MT, Puig, N, Oriol, A, Paiva, B, Blade, J, Lahuerta, JJ, San Miguel, JF (2019).

Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature.

BLOOD CANCER JOURNAL. Article. 9(4):36-36.
[doi:10.1038/s41408-019-0176-x]
Alonso, CM, Llop, M, Sargas, C, Pedrola, L, Panadero, J, Hervas, D, Cervera, J, Such, E, Ibanez, M, Ayala, R, Martinez-Lopez, J, Onecha, E, de Juan, I, Palanca, S, Martinez-Cuadron, D, Rodriguez-Veiga, R, Boluda, B, Montesinos, P, Sanz, G, Sanz, MA, Barragan, E (2019).

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics

JOURNAL OF MOLECULAR DIAGNOSTICS. Article. 21(2):228-240.
[doi:10.1016/j.jmoldx.2018.09.009]
Barrio, S, Stuhmer, T, Da-Via, M, Barrio-Garcia, C, Lehners, N, Besse, A, Cuenca, I, Garitano-Trojaola, A, Fink, S, Leich, E, Chatterjee, M, Driessen, C, Martinez-Lopez, J, Rosenwald, A, Beckmann, R, Bargou, RC, Braggio, E, Stewart, AK, Raab, MS, Einsele, H, Kortum, KM (2019).

Spectrum and functional validation of PSMB5 mutations in multiple myeloma

LEUKEMIA. Article. 33(2):447-456.
[doi:10.1038/s41375-018-0216-8]
Onecha, E, Linares, M, Rapado, I, Ruiz-Heredia, Y, Martinez-Sanchez, P, Cedena, T, Pratcorona, M, Perez Oteyza J, Herrera, P, Barragan, E, Montesinos, P, Garcia Vela JA, Magro, E, Anguita, E, Figuera, A, Riaza, R, Martinez-Barranco, P, Sanchez-Vega, B, Nomdedeu, J, Gallardo, M, Martinez-Lopez, J, Ayala, R (2019).

A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia

HAEMATOLOGICA. Article. 104(2):288-296.
[doi:10.3324/haematol.2018.194712]
Sargas, C, Ayala, R, Chillon, C, Carrillo, E, Larrayoz, MJ, Bilbao, C, Serrano, J, Rodriguez-Veiga, R, Rapado, I, Garcia-Sanz, R, Perez-Simon, JA, Calasanz, MJ, Gomez-Casares, MT, Sanchez, J, Juarez, A, Gonzalez, M, Garcia-Calderon, C, Prosper, F, Rodriguez, C, Serrano, J, Montesinos, P, Martinez, J, Barragan, E (2019).

Multicentre Implementation of Next Generation Sequencing to Acute Myeloid Leukemia Patients in PETHEMA Spanish Collaborative Group

ANNALS OF HEMATOLOGY. Meeting Abstract. 98:38-39.
Linares, M, Postigo, M, Cuadrado, D, Ortiz-Ruiz, A, Gil-Casanova, S, Vladimirov, A, Garcia-Villena, J, Nunez-Escobedo, JM, Martinez-Lopez, J, Rubio, JM, Ledesma-Carbayo, MJ, Santos, A, Bassat, Q, Luengo-Oroz, M (2019).

Collaborative intelligence and gamification for on-line malaria species differentiation

MALARIA JOURNAL. Article. 18(1):21-21.
[doi:10.1186/s12936-019-2662-9]
Arenaza, A, Diez, R, Esteve, J, Di Nicolantonio, R, Gostkorzewicz, J, Martinez, C, Llinas, DM, Martinez-Lopez, J, Montesinos, P, Moure-Fernandez, A, Sierra, J, Vinent, JL (2019).

Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain

ClinicoEconomics and Outcomes Research. Article. 11:683-694.
[doi:10.2147/CEOR.S222879]
Li, N, Lopez, MA, Linares, M, Kumar, S, Oliva, S, Martinez-Lopez, J, Xu, L, Xu, Y, Perini, T, Senapedis, W, Baloglu, E, Shammas, MA, Hunter, Z, Anderson, KC, Treon, SP, Munshi, NC, Fulciniti, M (2019).

Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenstrom Macroglobulinemia

CLINICAL CANCER RESEARCH. Article. 25(1):369-377.
[doi:10.1158/1078-0432.CCR-18-1776]
Barba P, Morgades M, Montesinos P, Gil C, Fox ML, Ciudad J, Moreno MJ, Gonzalez-Campos J, Genesca E, Martinez-Carballeira D, Martino R, Vives S, Guardia R, Mercadal S, Artola MT, Cladera A, Tormo M, Esteve J, Bergua J, Vall-Llovera F, Ribera J, Martinez-Sanchez P, Amigo ML, Bermudez A, Calbacho M, Hernandez-Rivas JM, Feliu E, Orfao A, Ribera JM, PETHEMA Group (2019).

Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 102(1):79-86.
[doi:10.1111/ejh.13178]
Martinez-Cuadron D, Gil C, Serrano J, Rodriguez G, Perez-Oteyza J, Garcia-Boyero R, Jimenez-Bravo S, Vives S, Vidriales MB, Lavilla E, Perez-Simon JA, Tormo M, Colorado M, Bergua J, Lopez JA, Herrera P, Hernandez-Campo P, Gorrochategui J, Primo D, Rojas JL, Villoria J, Moscardo F, Troconiz I, Linares Gomez M, Martinez-Lopez J, Ballesteros J, Sanz M, Montesinos P, Spanish PETHEMA group (2019).

A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients

LEUKEMIA RESEARCH. Article. 76:1-10.
[doi:10.1016/j.leukres.2018.11.006]
Megias-Vericat JE, Martinez-Cuadron D, Lopez JM, Bergua JM, Tormo M, Serrano J, Gonzalez A, de Oteyza JP, Vives S, Vidriales B, Herrera P, Vera JA, Martinez AL, de la Fuente A, Amador ML, Hernandez-Rivas JA, Fernandez MA, Cervero CJ, Morillo D, Campo PH, Gorrochategui J, Primo D, Rojas JL, Guenova M, Ballesteros J, Sanz M, Montesinos P (2019).

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia.

Mediterranean Journal of Hematology and Infectious Diseases. Article. 11(1).
[doi:10.4084/MJHID.2019.016]

2018

Hernandez-Boluda, JC, Pereira, A, Pastor-Galan, I, Alvarez-Larran, A, Savchuk, A, Puerta, JM, Sanchez-Pina, JM, Collado, R, Diaz-Gonzalez, A, Angona, A, Sagues, M, Garcia-Gutierrez, V, Boque, C, Osorio, S, Vallansot, R, Palomera, L, Mendizabal, A, Casado, LF, Perez-Encinas, M, Perez-Lopez, R, Ferrer-Marin, F, Sanchez-Guijo, F, Garcia, C, Heras NL, Lopez-Lorenzo, JL, Cervantes, F, Steegmann, JL, Grupo Espanol de Leucemia Mieloide Cronica (GELMC) (2018).

Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients

BLOOD CANCER JOURNAL. Article. 8(10):91-91.
[doi:10.1038/s41408-018-0125-0]
Jimenez-Ubieto, A, Grande, C, Caballero, D, Yanez, L, Novelli, S, Hernandez-Garcia, MT, Manzanares, M, Arranz, R, Ferreiro, JJ, Bobillo, S, Mercadal, S, Galeo, A, Jimenez, JL, Moraleda, JM, Vallejo, C, Albo, C, Perez, E, Marrero, C, Magnano, L, Palomera, L, Jarque, I, Martinez-Sanchez, P, Martin, A, Coria, E, Lopez-Guillermo, A, Salar, A, Lahuerta, JJ, GELTAMO (Grupo Espanol de Linfomas y Trasplantes de Medula Osea) Cooperative Stu (2018).

Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment

HEMATOLOGICAL ONCOLOGY. Article. 36(5):765-772.
[doi:10.1002/hon.2553]
Usmani, SZ, Hoering, A, Cavo, M, Miguel JS, Goldschimdt, H, Hajek, R, Turesson, I, Lahuerta, JJ, Attal, M, Barlogie, B, Lee, JH, Kumar, S, Lenhoff, S, Morgan, G, Rajkumar, SV, Durie BGM, Moreau, P (2018).

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project

BLOOD CANCER JOURNAL. Article. 8(12):123-123.
[doi:10.1038/s41408-018-0155-7]
Alvarez-Larran, A, Martinez, D, Arenillas, L, Rubio, A, Arellano-Rodrigo, E, Hernandez Boluda JC, Papaleo, N, Caballero, G, Martinez, C, Ferrer-Marin, F, Mata, MI, Perez-Encinas, M, Duran, MA, Alonso, JM, Carreno-Tarragona, G, Alonso, JM, Noya, S, Magro, E, Perez, R, Lopez-Guerra, M, Pastor-Galan, I, Cervantes, F, Besses, C, Colomo, L, Rozman, M (2018).

Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes

JOURNAL OF CLINICAL PATHOLOGY. Article. 71(11):975-980.
[doi:10.1136/jclinpath-2018-205227]
Osorio, S, Escudero-Vilaplana, V, Gomez-Centurion, I, Perez-Lopez, R, Ayala, R, Vall-Llovera, F, Garcia-Gutierrez, V, Gomez Casares MT, Gonzalez San Miguel JD, Hernandez-Rivas, JA, Sanchez-Guijo, F, Martinez-Garcia, AB, Villalon, L, Conesa-Garcia, V, Rodriguez, A, Casado, F, Garcia-Gonzalez, X, Saez Perdomo MN, Banos, U, Steegmann, JL (2018).

Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

ANNALS OF HEMATOLOGY. Article. 97(11):2089-2098.
[doi:10.1007/s00277-018-3413-7]
Rodriguez-Otero, P, Mateos, MV, Martinez-Lopez, J, Martin-Calvo, N, Hernandez, MT, Ocio, EM, Rosinol, L, Martinez, R, Teruel, AI, Gutierrez, NC, Bargay, J, Bengoechea, E, Gonzalez, Y, de Oteyza, JP, Gironella, M, Encinas, C, Martin, J, Cabrera, C, Palomera, L, de Arriba, F, Cedena, MT, Paiva, B, Puig, N, Oriol, A, Blade, J, Lahuerta, JJ, San Miguel, JF (2018).

Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

LEUKEMIA. Article. 32(11):2427-2434.
[doi:10.1038/s41375-018-0072-6]
Macauda, A, Castelli, E, Buda, G, Pelosini, M, Butrym, A, Watek, M, Kruszewski, M, Vangsted, AJ, Rymko, M, Jamroziak, K, Abildgaard, N, Haastrup, EK, Mazur, G, Rios, R, Jurczyszyn, A, Zawirska, D, Dudzinski, M, Razny, M, Dutka, M, Tomczak, W, Suska, A, Druzd-Sitek, A, Marques, H, Petrini, M, Markiewicz, M, Martinez-Lopez, J, Ebbesen, LH, Iskierka-Jazdzewska, E, Sainz, J, Canzian, F, Campa, D (2018).

Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

BRITISH JOURNAL OF HAEMATOLOGY. Article. 183(3):375-384.
[doi:10.1111/bjh.15521]
Ruiz-Heredia Y, Sanchez-Vega B, Onecha E, Barrio S, Alonso R, Martinez-Avila JC, Cuenca I, Agirre X, Braggio E, Hernandez MT, Martinez R, Rosinol L, Gutierrez N, Martin-Ramos M, Ocio EM, Echeveste MA, Perez de Oteyza J, Oriol A, Bargay J, Gironella M, Ayala R, Blade J, Mateos MV, Kortum KM, Stewart K, Garcia-Sanz R, San Miguel J, Lahuerta JJ, Martinez-Lopez J (2018).

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

HAEMATOLOGICA. Letter. 103(11):544-548.
[doi:10.3324/haematol.2018.188839]
Carreras, P, Chaves, RC, Gallardo, M, Ortiz, A, Lopez, JM, Sia, SK (2018).

Microengineering double layer hydrogel structures towards the recapitulation of the hematopoietic stem cell niche

SCIENCE BULLETIN. Editorial Material. 63(20):1319-1323.
[doi:10.1016/j.scib.2018.09.003]
Gay F, Jackson G, Rosinol L, Holstein SA, Moreau P, Spada S, Davies F, Lahuerta JJ, Leleu X, Bringhen S, Evangelista A, Hulin C, Panzani U, Cairns DA, Di Raimondo F, Macro M, Liberati AM, Pawlyn C, Offidani M, Spencer A, Hajek R, Terpos E, Morgan GJ, Blade J, Sonneveld P, San-Miguel J, McCarthy PL, Ludwig H, Boccadoro M, Mateos MV, Attal M (2018).

Maintenance Treatment and Survival in Patients With Myeloma A Systematic Review and Network Meta-analysis

JAMA oncology. Review. 4(10):1389-1397.
[doi:10.1001/jamaoncol.2018.2961]
Lopez-Anglada L, Cueto-Felgueroso C, Rosinol L, Oriol A, Teruel AI, Lopez de la Guia A, Bengoechea E, Palomera L, de Arriba F, Hernandez JM, Granell M, Penalver FJ, Garcia-Sanz R, Besalduch J, Gonzalez Y, Martinez RB, Hernandez MT, Gutierrez NC, Puerta P, Valeri A, Paiva B, Blade J, Mateos MV, San Miguel J, Lahuerta JJ, Martinez-Lopez J, GEM (Grupo Espanol de MM)/PETHEMA (Programa para el Estudio de la Terapeutica en (2018).

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

PLOS ONE. Article. 13(9).
[doi:10.1371/journal.pone.0203392]
Moreno-Carralero, MI, Horta-Herrera, S, Morado-Arias, M, Ricard-Andres, MP, Lemes-Castellano, A, Abio-Calvete, M, Cedena-Romero, MT, Gonzalez-Fernandez, FA, Llorente-Gonzalez, L, Periago-Peralta, AM, de-la-Iglesia-Inigo, S, Mendez, M, Moran-Jimenez, MJ (2018).

Clinical and genetic features of congenital dyserythropoietic anemia (CDA)

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 101(3):368-378.
[doi:10.1111/ejh.13112]
Montalban, C, Diaz-Lopez, A, Martin, A, Baile, M, Sanchez, JM, Sancho, JM, Garcia, O, Novelli, S, Monter-Rovira, A, Salar, A, Bastos, M, Gutierrez, A, Bento, L, Córdoba R, Arquero, T, González de Villambrosia S, Barranco, G, De Oña R, López Guillermo A, Rodriguez Salazar MJ, Dominguez, JF, Fernandez, R, Queizan, JA, Rodriguez, J, Abraira, V, Garcia, JF, GELTAMO-IPI Project Investigators (2018).

Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm

BRITISH JOURNAL OF HAEMATOLOGY. Article. 182(4):534-541.
[doi:10.1111/bjh.15446]
Genesca, E, Lazarenkov, A, Morgades, M, Berbis, G, Ruiz-Xiville, N, Gomez-Marzo, P, Ribera, J, Junca, J, Gonzalez-Perez, A, Mercadal, S, Guardia, R, Artola, MT, Moreno, MJ, Martinez-Lopez, J, Zamora, L, Barba, P, Gil, C, Tormo, M, Cladera, A, Novo, A, Pratcorona, M, Nomdedeu, J, Gonzalez-Campos, J, Almeida, M, Cervera, J, Montesinos, P, Batlle, M, Vives, S, Esteve, J, Feliu, E, Sole, F, Orfao, A, Ribera, JM (2018).

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

JOURNAL OF HEMATOLOGY & ONCOLOGY. Article. 11(1):96-96.
[doi:10.1186/s13045-018-0639-8]
Cedena MT, Rapado I, Santos-Lozano A, Ayala R, Onecha E, Abaigar M, Such E, Ramos F, Cervera J, Diez-Campelo M, Sanz G, Rivas JH, Lucia A, Martinez-Lopez J (2018).

Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.

Oncotarget. Article. 9(56):30936-30936.
[doi:10.18632/oncotarget.25856]
Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L, Medina Perez A, Coscia M, Laurenti L, Musuraca G, Farina L, Rivas Delgado A, Orlandi EM, Galieni P, Mauro FR, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, Eyre TA, Kennedy B, Bowles KM, Vignetti M, de la Serna J, Moreno C, Foa R, Ghia P (2018).

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

HAEMATOLOGICA. Article. 103(7):1209-1217.
[doi:10.3324/haematol.2018.189837]
Ribera, JM, Morgades, M, Montesinos, P, Martino, R, Barba, P, Soria, B, Bermudez, A, Moreno, MJ, Gonzalez-Campos, J, Vives, S, Gil, C, Abella, E, Guàrdia R, Martinez-Carballeira, D, Martinez-Sanchez, P, Amigo, ML, Mercadal, S, Serrano, A, Lopez-Martinez, A, Vall-Llovera, F, Sanchez-Sanchez, MJ, Peñarrubia MJ, Calbacho, M, Mendez, JA, Bergua, J, Cladera, A, Tormo, M, Garcia-Belmonte, D, Feliu, E, Ciudad, J, Orfao, A, PETHEMA Group, Spanish Society of Hematology (2018).

Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia

LEUKEMIA & LYMPHOMA. Article. 59(7):1634-1643.
[doi:10.1080/10428194.2017.1397661]
Gonzalez-Vicent, M, Sanz, J, Fuster, JL, Cid, J, de Heredia, CD, Morillo, D, Fernandez, JM, Pascual, A, Badell, I, Serrano, D, Fox, L, de la Serna, J, Benito, A, Couselo, JM, Molina, B, Diaz, MA, Sanz, MA (2018).

Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Espanol De Trasplante de Medula Osea en Nimos (GETMON) and the Grupo Espanol de Trasplante Hematopoyetico (GETH)

TRANSFUSION MEDICINE REVIEWS. Review. 32(3):179-185.
[doi:10.1016/j.tmrv.2018.02.005]
Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Hernández-Garcia MT, Novelli S, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Martínez-Sánchez P, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta JJ, GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Stu (2018).

Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry

BONE MARROW TRANSPLANTATION. Letter. 53(6):780-783.
[doi:10.1038/s41409-018-0096-6]
Saussele, S, Richter, J, Guilhot, J, Gruber, FX, Hjorth-Hansen, H, Almeida, A, Janssen JJWM, Mayer, J, Koskenvesa, P, Panayiotidis, P, Olsson-Stromberg, U, Martinez-Lopez, J, Rousselot, P, Vestergaard, H, Ehrencrona, H, Kairisto, V, Machova Polakova K, Muller, MC, Mustjoki, S, Berger, MG, Fabarius, A, Hofmann, WK, Hochhaus, A, Pfirrmann, M, Mahon, FX, EURO-SKI Investigators (2018).

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

LANCET ONCOLOGY. Article. 19(6):747-757.
[doi:10.1016/S1470-2045(18)30192-X]
Dumontet, C, Hulin, C, Dimopoulos, MA, Belch, A, Dispenzieri, A, Ludwig, H, Rodon, P, Van Droogenbroeck, J, Qiu, LG, Cavo, M, Van de Velde, A, Lahuerta, JJ, Allangba, O, Lee, JH, Boyle, E, Perrot, A, Moreau, P, Manier, S, Attal, M, Roussel, M, Mohty, M, Mary, JY, Civet, A, Costa, B, Tinel, A, Gaston-Mathe, Y, Facon, T (2018).

A predictive model for risk of early grade >= 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial

LEUKEMIA. Article. 32(6):1404-1413.
[doi:10.1038/s41375-018-0133-x]
Fernandez, L, Leivas, A, Valentin, J, Escudero, A, Corral, D, de Paz, R, Vela, M, Bueno, D, Rodriguez, R, Torres, JM, Diaz-Almiron, M, Lopez-Collazo, E, Martinez-Lopez, J, Perez-Martinez, A (2018).

How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?

TRANSFUSION. Article. 58(6):1340-1347.
[doi:10.1111/trf.14573]
Vela, M, Corral, D, Carrasco, P, Fernandez, L, Valentin, J, Gonzalez, B, Escudero, A, Balas, A, de Paz, R, Torres, J, Leivas, A, Martinez-Lopez, J, Perez-Martinez, A (2018).

Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia

CANCER LETTERS. Article. 422:107-117.
[doi:10.1016/j.canlet.2018.02.033]
Primo D, Scarfo L, Xochelli A, Mattsson M, Ranghetti P, Espinosa AB, Robles A, Gorrochategui J, Martinez-Lopez J, de la Serna J, Gonzalez M, Gil AC, Anguita E, Iraheta S, Munugalavadla V, Queva C, Tannheimer S, Rosenquist R, Stamatopoulos K, Ballesteros J, Ghia P (2018).

A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia.

Oncotarget. Article. 9(40):26019-26031.
[doi:10.18632/oncotarget.25419]
Ribera, JM, Garcia, O, Gil, C, Mercadal, S, Garcia-Cadenas, I, Montesinos, P, Barba, P, Vives, S, Gonzalez-Campos, J, Tormo, M, Esteve, J, Lopez, A, Moreno, MJ, Ribera, J, Alonso, N, Bermudez, A, Amigo, ML, Genesca, E, Garcia, D, Vall-Llovera, F, Bergua, JM, Guardia, R, Monteserin, MC, Bernal, T, Calbacho, M, Martinez, MP, Feliu, E, PETHEMA Grp (2018).

Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia

LEUKEMIA RESEARCH. Article. 68:79-84.
[doi:10.1016/j.leukres.2018.03.010]
Falantes, J, Pleyer, L, Thepot, S, Almeida, AM, Maurillo, L, Martinez-Robles, V, Stauder, R, Itzykson, R, Pinto, R, Venditti, A, Bargay, J, Burgstaller, S, Martinez, MP, Seegers, V, Cortesão E, Foncillas, MA, Gardin, C, Montesinos, P, Musto, P, Fenaux, P, Greil, R, Sanz, MA, Ramos, F, European ALMA?+?Investigators (2018).

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA plus )

LEUKEMIA & LYMPHOMA. Article. 59(5):1113-1120.
[doi:10.1080/10428194.2017.1365854]
Font, P, Subira, D, Matarraz, S, Benavente, C, Cedena, MT, Morado, M, Pérez Corral A, Bellon, JM, Diez-Martin, JL (2018).

Multicenter comparison of CD34+myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

CYTOMETRY PART B-CLINICAL CYTOMETRY. Article. 94(3):527-535.
[doi:10.1002/cyto.b.21538]
Martínez-Laperche C, Kwon M, Franco-Villegas AC, Chillón MC, Castro N, Anguita E, Dolz S, Rodríguez-Medina C, Hermosín L, Bellón JM, Prieto-Conde MI, Barragán E, Gómez-Casares M, Ayala R, Martínez-López J, González-Díaz M, Díez-Martin JL, Buño I (2018).

Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology

BRITISH JOURNAL OF HAEMATOLOGY. Letter. 181(4):542-546.
[doi:10.1111/bjh.14635]
Hernández-Boluda JC, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raya JM, Martínez-López J, Velez P, Pérez-Encinas M, Estrada N, García-Gutiérrez V, Fox ML, Luño E, Kerguelen A, Cuevas B, Durán MA, Ramírez MJ, Gómez-Casares M, Mata-Vázquez MI, Regadera A, Pereira A, Cervantes F, Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN) (2018).

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia

BRITISH JOURNAL OF HAEMATOLOGY. Letter. 181(3):397-400.
[doi:10.1111/bjh.14601]
Diez-Campelo, M, Lorenzo, JI, Itzykson, R, Rojas, SM, Berthon, C, Luno, E, Beyne-Rauzy, O, Perez-Oteyza, J, Vey, N, Bargay, J, Park, S, Cedena, T, Bordessoule, D, Munoz, JA, Gyan, E, Such, E, Visanica, S, Lopez-Cadenas, F, de Botton, S, Hernandez-Rivas, JM, Ame, S, Stamatoullas, A, Delaunay, J, Salanoubat, C, Isnard, F, Guieze, R, Perez Guallar J, Badiella, L, Sanz, G, Canizo, C, Fenaux, P (2018).

Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries

BRITISH JOURNAL OF HAEMATOLOGY. Article. 181(3):350-359.
[doi:10.1111/bjh.15190]
Blade, J, Calleja, MA, Lahuerta, JJ, Poveda, JL, de Paz, HD, Lizan, L (2018).

Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

BMJ OPEN. Article. 8(2).
[doi:10.1136/bmjopen-2017-018850]
Martínez-Cuadrón D, Boluda B, Martínez P, Bergua J, Rodríguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordón L, Sempere A, Jiménez-Ubieto A, Prieto-Delgado J, Díaz-Beyá M, Garrido A, Benavente C, Pérez-Simón JA, Moscardó F, Sanz MA, Fernández PM, CETLAM and PETHEMA groups (2018).

A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

ANNALS OF HEMATOLOGY. Article. 97(5):763-772.
[doi:10.1007/s00277-018-3229-5]
Hernandez-Boluda, JC, Pereira, A, Correa, JG, Alvarez-Larran, A, Ferrer-Marin, F, Raya, JM, Martinez-Lopez, J, Velez, P, Perez-Encinas, M, Estrada, N, Garcia-Gutierrez, V, Fox, ML, Payer, A, Kerguelen, A, Cuevas, B, Duran, MA, Ramirez, MJ, Gomez-Casares, MT, Mata-Vazquez, MI, Mora, E, Gomez, M, Cervantes, F (2018).

Prognostic risk models for transplant decision-making in myelofibrosis

ANNALS OF HEMATOLOGY. Article. 97(5):813-820.
[doi:10.1007/s00277-018-3240-x]
Martinez-Cuadron D, Boluda B, Martinez P, Bergua J, Rodriguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordon L, Sempere A, Jimenez-Ubieto A, Prieto-Delgado J, Diaz-Beya M, Garrido A, Benavente C, Perez-Simon JA, Moscardo F, Sanz MA, Montesinos P, CETLAM and PETHEMA groups (2018).

A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia (vol 97, pg 763, 2018)

ANNALS OF HEMATOLOGY. Correction. 97(5):923-923.
[doi:10.1007/s00277-018-3277-x]
Misiewicz-Krzeminska, I, Corchete, LA, Rojas, EA, Martinez-Lopez, J, Garcia-Sanz, R, Oriol, A, Blade, J, Lahuerta, JJ, Miguel JS, Mateos, MV, Gutierrez, NC (2018).

A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility

HAEMATOLOGICA. Article. 103(5):880-889.
[doi:10.3324/haematol.2017.181628]
Musto P, Anderson KC, Attal M, Richardson PG, Badros A, Hou J, Comenzo R, Du J, Durie BGM, San Miguel J, Einsele H, Chen WM, Garderet L, Pietrantuono G, Hillengass J, Kyle RA, Moreau P, Lahuerta JJ, Landgren O, Ludwig H, Larocca A, Mahindra A, Cavo M, Mazumder A, McCarthy PL, Nouel A, Rajkumar SV, Reiman A, Riva E, Sezer O, Terpos E, Turesson I, Usmani S, Weiss BM, Palumbo A (2018).

Second primary malignancies in multiple myeloma: an overview and IMWG consensus (vol 28, pg 228, 2017)

ANNALS OF ONCOLOGY. Correction. 29(4):1074-1074.
[doi:10.1093/annonc/mdx160]
Garcia-Ortiz, A, Serrador, JM (2018).

Nitric Oxide Signaling in T Cell-Mediated Immunity

TRENDS IN MOLECULAR MEDICINE. Review. 24(4):412-427.
[doi:10.1016/j.molmed.2018.02.002]
Arana P, Paiva B, Cedena MT, Puig N, Cordon L, Vidriales MB, Gutierrez NC, Chiodi F, Burgos L, Anglada LL, Martinez-Lopez J, Hernandez MT, Teruel AI, Gironella M, Echeveste MA, Rosiñol L, Martinez R, Oriol A, De la Rubia J, Orfao A, Blade J, Lahuerta JJ, Mateos MV, Miguel JFS (2018).

Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials

LEUKEMIA. Article. 32(4):971-978.
[doi:10.1038/leu.2017.320]
Seymour, JF, Kipps, TJ, Eichhorst, B, Hillmen, P, D'Rozario, J, Assouline, S, Owen, C, Gerecitano, J, Robak, T, De la Serna, J, Jaeger, U, Cartron, G, Montillo, M, Humerickhouse, R, Punnoose, EA, Li, Y, Boyer, M, Humphrey, K, Mobasher, M, Kater, AP (2018).

Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

NEW ENGLAND JOURNAL OF MEDICINE. Article. 378(12):1107-1120.
[doi:10.1056/NEJMoa1713976]
Alencar, N, Sola, I, Linares, M, Juarez-Jimenez, J, Pont, C, Viayna, A, Vilchez, D, Sampedro, C, Abad, P, Perez-Benavente, S, Lameira, J, Bautista, JM, Muñoz-Torrero D, Luque, FJ (2018).

First homology model of Plasmodium falciparum glucose-6-phosphate dehydrogenase: Discovery of selective substrate analog-based inhibitors as novel antimalarial agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. Article. 146:108-122.
[doi:10.1016/j.ejmech.2018.01.044]
Hernández-Boluda JC, Pereira A, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raya JM, Martínez-López J, Pérez-Encinas M, Estrada N, Velez P, Fox ML, García-Gutiérrez V, Payer A, Kerguelen A, Cuevas B, Durán MA, Ramírez MJ, Gómez-Casares MT, Mata-Vázquez MI, Mora E, Martínez-Valverde C, Gómez M, Cervantes F (2018).

Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis

LEUKEMIA. Letter. 32(2):553-555.
[doi:10.1038/leu.2017.297]
Engay, BM, Roy, A, Atutxa, K, Diaz-Morant, V, Garcia-Frade, J, Hernandez-Martin, R, Luno, E, Noya, S, de la Serna, J, Villalon, L, Giraldo, P (2018).

Multimorbidity in type 1 Gaucher disease patients under miglustat therapy

MOLECULAR GENETICS AND METABOLISM. Meeting Abstract. 123(2):93-94.
[doi:10.1016/j.ymgme.2017.12.245]
Giraldo, P, Andrade-Campos, M, Alfonso, P, Irun, P, Atutxa, K, Acedo, A, Barez, A, Blanes, M, Diaz-Morant, V, Fernandez-Galan, MA, Franco, R, Gil-Cortes, C, Giner, V, Ibañez A, Latre, P, Loyola, I, Luño E, Hernandez-Martin, R, Medrano-Engay, B, Puerta, J, Roig, I, de la Serna, J, Salamero, O, Villalon, L, Pocovi, M (2018).

Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project

BLOOD CELLS MOLECULES AND DISEASES. Article. 68:173-179.
[doi:10.1016/j.bcmd.2016.10.017]
Dols-Icardo, O, Garcia-Redondo, A, Rojas-Garcia, R, Borrego-Hernandez, D, Illan-Gala, I, Muñoz-Blanco JL, Rabano, A, Cervera-Carles, L, Juarez-Rufian, A, Spataro, N, De Luna, N, Galan, L, Cortes-Vicente, E, Fortea, J, Blesa, R, Grau-Rivera, O, Lleo, A, Esteban-Perez, J, Gelpi, E, Clarimon, J (2018).

Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. Article. 89(2):162-168.
[doi:10.1136/jnnp-2017-316820]
Ortiz-Ruiz, A, Postigo, M, Gil-Casanova, S, Cuadrado, D, Bautista, JM, Rubio, JM, Luengo-Oroz, M, Linares, M (2018).

Plasmodium species differentiation by non-expert on-line volunteers for remote malaria field diagnosis

MALARIA JOURNAL. Article. 17(1):54-54.
[doi:10.1186/s12936-018-2194-8]
Martínez-Cuadrón D, Montesinos P, Vellenga E, Bernal T, Salamero O, Holowiecka A, Brunet S, Gil C, Benavente C, Ribera JM, Pérez-Encinas M, De la Serna J, Esteve J, Rubio V, González-Campos J, Escoda L, Amutio ME, Arnan M, Arias J, Negri S, Lowënberg B, Sanz MA (2018).

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

LEUKEMIA. Article. 32(1):21-29.
[doi:10.1038/leu.2017.178]
Rawstron, AC, Kreuzer, KA, Soosapilla, A, Spacek, M, Stehlikova, O, Gambell, P, McIver-Brown, N, Villamor, N, Psarra, K, Arroz, M, Milani, R, de la Serna, J, Cedena, MT, Jaksic, O, Nomdedeu, J, Moreno, C, Rigolin, GM, Cuneo, A, Johansen, P, Johnsen, HE, Rosenquist, R, Niemann, CU, Kern, W, Westerman, D, Trneny, M, Mulligan, S, Doubek, M, Pospisilova, S, Hillmen, P, Oscier, D, Hallek, M, Ghia, P, Montserrat, E (2018).

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

CYTOMETRY PART B-CLINICAL CYTOMETRY. Article. 94(1):121-128.
[doi:10.1002/cyto.b.21595]

2017

Cedena MT, Rapado I, Santos-Lozano A, Ayala R, Onecha E, Abaigar M, Such E, Ramos F, Cervera J, Díez-Campelo M, Sanz G, Rivas JH, Lucía A, Martínez-López J (2017).

Mutations in the DNA methylation pathway and number of driver mutations; predict response to azacitidine in myelodysplastic syndromes

Oncotarget. Article. 8(63):106948-106961.
[doi:10.18632/oncotarget.22157]
Nomdedeu M, Pereira A, Calvo X, Colomer J, Sole F, Arias A, Gomez C, Luño E, Cervera J, Arnan M, Pomares H, Ramos F, Oiartzabal I, Espinet B, Pedro C, Arrizabalaga B, Blanco ML, Tormo M, Hernandez-Rivas JM, Díez-Campelo M, Ortega M, Valcárcel D, Cedena MT, Collado R, Grau J, Granada I, Sanz G, Campo E, Esteve J, Costa D, Spanish MDS Group (2017).

Clinical and biological significance of isolated Y chromosome loss in; myelodysplastic syndromes and chronic myelomonocytic leukemia. A report; from the Spanish MDS Group

LEUKEMIA RESEARCH. Article. 63:85-89.
[doi:10.1016/j.leukres.2017.10.011]
Azcárate IG, Sánchez-Jaut S, Marín-García P, Linares M, Pérez-Benavente S, García-Sánchez M, Uceda J, Kamali AN, Morán-Jiménez MJ, Puyet A, Diez A, Bautista JM (2017).

Iron supplementation in mouse expands cellular innate defences in spleen; and defers lethal malaria infection

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. Article. 1863(12):3049-3059.
[doi:10.1016/j.bbadis.2017.09.027]
García-Sanz R, Corchete LA, Alcoceba M, Chillon MC, Jiménez C, Prieto I, García-Álvarez M, Puig N, Rapado I, Barrio S, Oriol A, Blanchard MJ, de la Rubia J, Martínez R, Lahuerta JJ, González Díaz M, Mateos MV, San Miguel JF, Martínez-López J, Sarasquete ME, GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en (2017).

Prediction of peripheral neuropathy in multiple myeloma patients; receiving bortezomib and thalidomide: a genetic study based on a single; nucleotide polymorphism array

HEMATOLOGICAL ONCOLOGY. Article. 35(4):746-751.
[doi:10.1002/hon.2337]
Kumar SK, Dimopoulos MA, Kastritis E, Terpos E, Nahi H, Goldschmidt H, Hillengass J, Leleu X, Beksac M, Alsina M, Oriol A, Cavo M, Ocio EM, Mateos MV, O'Donnell EK, Vij R, Lokhorst HM, van de Donk NWCJ, Min C, Mark T, Turesson I, Hansson M, Ludwig H, Jagannath S, Delforge M, Kyriakou C, Hari P, Mellqvist U, Usmani SZ, Dytfeld D, Badros AZ, Moreau P, Kim K, Otero PR, Lee JH, Shustik C, Waller D, Chng WJ, Ozaki S, Lee JJ, de la Rubia J, Eom HS, Rosinol L, Lahuerta JJ, Sureda A, Kim JS, Durie BGM (2017).

Natural history of relapsed myeloma, refractory to immunomodulatory; drugs and proteasome inhibitors: a multicenter IMWG study

LEUKEMIA. Article. 31(11):2443-2448.
[doi:10.1038/leu.2017.138]
Ribera J, Zamora L, Morgades M, Mallo M, Solanes N, Batlle M, Vives S, Granada I, Juncà J, Malinverni R, Genescà E, Guàrdia R, Mercadal S, Escoda L, Martinez-Lopez J, Tormo M, Esteve J, Pratcorona M, Martinez-Losada C, Solé F, Feliu E, Ribera JM, Spanish PETHEMA Group and the Spanish Society of Hematology (2017).

Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms

GENES CHROMOSOMES & CANCER. Article. 56(11):810-820.
[doi:10.1002/gcc.22486]
Salar A, Domingo-Domenech E, Panizo C, Nicolás C, Bargay J, Muntañola A, Canales M, Bello JL, Sancho JM, Tomás JF, Rodríguez MJ, Peñalver J, Grande C, Sánchez-Blanco JJ, Palomera L, Arranz R, Conde E, García M, García JF, Caballero D, Montalbán C (2017).

Long-term results of a phase 2 study of rituximab and bendamustine for; mucosa-associated lymphoid tissue lymphoma

BLOOD. Letter. 130(15):1772-1774.
[doi:10.1182/blood-2017-07-795302]
Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, López Jiménez J, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Martínez-Sánchez P, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta JJ (2017).

Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable; Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Article. 23(10):1631-1640.
[doi:10.1016/j.bbmt.2017.05.021]
Fernández L, Metais JY, Escudero A, Vela M, Valentín J, Vallcorba I, Leivas A, Torres J, Valeri A, Patiño-García A, Martínez-López J, Leung W, Pérez-Martínez A (2017).

Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma; Cells

CLINICAL CANCER RESEARCH. Article. 23(19):5824-5835.
[doi:10.1158/1078-0432.CCR-17-0075]
Flores-Montero J, Sanoja-Flores L, Paiva B, Puig N, García-Sánchez O, Böttcher S, van der Velden VH, Pérez-Morán JJ, Vidriales MB, García-Sanz R, Jimenez C, González M, Martínez-López J, Corral-Mateos A, Grigore GE, Fluxá R, Pontes R, Caetano J, Sedek L, Del Cañizo MC, Bladé J, Lahuerta JJ, Aguilar C, Bárez A, García-Mateo A, Labrador J, Leoz P, Aguilera-Sanz C, San-Miguel J, Mateos MV, Durie B, van Dongen JJ, Orfao A (2017).

Next Generation Flow for highly sensitive and standardized detection of; minimal residual disease in multiple myeloma

LEUKEMIA. Article. 31(10):2094-2103.
[doi:10.1038/leu.2017.29]
Lahuerta JJ, Paiva B, Vidriales MB, Cordón L, Cedena MT, Puig N, Martinez-Lopez J, Rosiñol L, Gutierrez NC, Martín-Ramos ML, Oriol A, Teruel AI, Echeveste MA, de Paz R, de Arriba F, Hernandez MT, Palomera L, Martinez R, Martin A, Alegre A, De la Rubia J, Orfao A, Mateos MV, Blade J, San-Miguel JF, GEM (Grupo Español de Mieloma)/PETHEMA (Programa para el Estudio de la Terapéuti (2017).

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three; PETHEMA/GEM Clinical Trials

JOURNAL OF CLINICAL ONCOLOGY. Article. 35(25):2900-2910.
[doi:10.1200/JCO.2016.69.2517]
Alvarez-Larrán A, Senín A, Fernández-Rodríguez C, Pereira A, Arellano-Rodrigo E, Gómez M, Ferrer-Marin F, Martínez-López J, Camacho L, Colomer D, Angona A, Navarro B, Cervantes F, Besses C, Bellosillo B, Hernández-Boluda JC (2017).

Impact of genotype on leukaemic transformation in polycythaemia vera and; essential thrombocythaemia

BRITISH JOURNAL OF HAEMATOLOGY. Article. 178(5):764-771.
[doi:10.1111/bjh.14762]
Alonso-Álvarez S, Magnano L, Alcoceba M, Andrade-Campos M, Espinosa-Lara N, Rodríguez G, Mercadal S, Carro I, Sancho JM, Moreno M, Salar A, García-Pallarols F, Arranz R, Cannata J, Terol MJ, Teruel AI, Rodríguez A, Jiménez-Ubieto A, González de Villambrosia S, Bello JL, López L, Monsalvo S, Novelli S, de Cabo E, Infante MS, Pardal E, García-Álvarez M, Delgado J, González M, Martín A, López-Guillermo A, Caballero MD (2017).

Risk of, and survival following, histological transformation in; follicular lymphoma in the rituximab era. A retrospective multicentre; study by the Spanish GELTAMO group

BRITISH JOURNAL OF HAEMATOLOGY. Article. 178(5):699-708.
[doi:10.1111/bjh.14831]
Rosiñol L, Oriol A, Teruel AI, de la Guía AL, Blanchard M, de la Rubia J, Granell M, Sampol M, Palomera L, González Y, Etxebeste M, Martínez-Martínez R, Hernández MT, de Arriba F, Alegre A, Cibeira M, Mateos M, Martínez-López J, Lahuerta JJ, San Miguel J, Bladé J (2017).

Bortezomib and thalidomide maintenance after stem cell transplantation; for multiple myeloma: a PETHEMA/GEM trial

LEUKEMIA. Article. 31(9):1922-1927.
[doi:10.1038/leu.2017.35]
Pellicer M, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Rueda D, Martínez J, Pachón V, Longo F, Martínez V, Iglesias I, Salvador S, Sanjurjo M, López-Fernández LA (2017).

Use of exome sequencing to determine the full profile of genetic; variants in the fluoropyrimidine pathway in colorectal cancer patients; affected by severe toxicity

Pharmacogenomics. Article. 18(13):1215-1223.
[doi:10.2217/pgs-2017-0118]
Garcia-Noblejas, A, Cannata-Ortiz, J, Conde, E, Barca, EB, Gutierrez, N, Rojas, R, Vidal, MJ, Ramirez, MJ, Jimenez-Ubieto, A, Garcia-Ruiz, JC, Sancho, JM, Lopez, A, Rull, PR, Novelli, S, Albo, C, Deben, G, Lopez-Guillermo, A, Nicolas, C, de Villambrosia, SG, Mercadal, S, Garcia-Sancho, AM, Arranz, R (2017).

Autologous stem cell transplantation (ASCT) in patients with mantle cell; lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

ANNALS OF HEMATOLOGY. Article. 96(8):1323-1330.
[doi:10.1007/s00277-017-2998-6]
Alonso-Dominguez JM, Casado LF, Anguita E, Gomez-Casares MT, Buño I, Ferrer-Marín F, Arenas A, Del Orbe R, Ayala R, Llamas P, Salgado RN, Osorio S, Sanchez-Godoy P, Burgaleta C, Mahíllo-Fernández I, Garcia-Gutierrez V, Steegmann JL, Martinez-Lopez J (2017).

PTCH1 is a reliable marker for predicting imatinib response in chronic; myeloid leukemia patients in chronic phase

PLOS ONE. Article. 12(7).
[doi:10.1371/journal.pone.0181366]
Forero-Castro M, Robledo C, Benito R, Bodega-Mayor I, Rapado I, Hernández-Sánchez M, Abáigar M, Maria Hernández-Sánchez J, Quijada-Álamo M, María Sánchez-Pina J, Sala-Valdés M, Araujo-Silva F, Kohlmann A, Luis Fuster J, Arefi M, de Las Heras N, Riesco S, Rodríguez JN, Hermosín L, Ribera J, Camos Guijosa M, Ramírez M, de Heredia Rubio CD, Barragán E, Martínez J, Ribera JM, Fernández-Ruiz E, Hernández-Rivas JM (2017).

Mutations in TP53 and JAK2 are independent prognostic biomarkers in; B-cell precursor acute lymphoblastic leukaemia

BRITISH JOURNAL OF CANCER. Article. 117(2):256-265.
[doi:10.1038/bjc.2017.152]
García-Granero DB, Vera DG, Grande C, Jimenez RB, Rodriguez CF, Bobolea I (2017).

Modern challenges of allergic bronchopulmonary aspergillosis diagnosis; and management Finding from a case study with a history of rituximab use

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. Letter. 119(1):93-94.
[doi:10.1016/j.anai.2017.05.009]
Sanchez R, Ayala R, Alonso RA, Martínez MP, Ribera J, García O, Sanchez-Pina J, Mercadal S, Montesinos P, Martino R, Barba P, González-Campos J, Barrios M, Lavilla E, Gil C, Bernal T, Escoda L, Abella E, Amigo ML, Moreno MJ, Bravo P, Guàrdia R, Hernández-Rivas JM, García-Guiñón A, Piernas S, Ribera JM, Martínez-López J (2017).

Clinical characteristics of patients with central nervous system relapse; in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of; characterizing ABL1 mutations in cerebrospinal fluid

ANNALS OF HEMATOLOGY. Article. 96(7):1069-1075.
[doi:10.1007/s00277-017-3002-1]
Mingot-Castellano ME, Grande-García C, Valcárcel-Ferreiras D, Conill-Cortés C, de Olivar-Oliver L (2017).

Sustained Remission in Patients with Primary Immune Thrombocytopenia; after Romiplostim Tapering and Discontinuation: A Case Series in Real; Life Management in Spain

Case Reports In Hematology. Article. 2017:4109605-4109605.
[doi:10.1155/2017/4109605]
Mateos MV, Bladé J, Lahuerta JJ, San-Miguel J (2017).

Management of smoldering myeloma: Recommendations of the Spanish Myeloma; Group

MEDICINA CLINICA. Editorial Material. 148(11):517-523.
[doi:10.1016/j.medcli.2017.02.012]
Hernández P, Gorrochategui J, Primo D, Robles A, Rojas JL, Espinosa AB, Gómez C, Martínez-López J, Bennett TA, Ballesteros J (2017).

Drug Discovery Testing Compounds in Patient Samples by Automated Flow; Cytometry

SLAS technology. Article. 22(3):325-337.
[doi:10.1177/2472630317700346]
López-Blanco R, de Fuenmayor-Fernández de la Hoz CP, González de la Aleja J, Martínez-Sánchez P, Ruiz-Morales J (2017).

Hyperammonemic encephalopathy associated with multiple myeloma

NEUROLOGIA. Letter. 32(5):339-341.
[doi:10.1016/j.nrl.2015.08.003]
Martinez-Lopez J, Sanchez-Vega B, Barrio S, Cuenca I, Ruiz-Heredia Y, Alonso R, Rapado I, Marin C, Cedena MT, Paiva B, Puig N, Mateos MV, Ayala R, Hernández MT, Jimenez C, Rosiñol L, Martínez R, Teruel AI, Gutiérrez N, Martin-Ramos ML, Oriol A, Bargay J, Bladé J, San-Miguel J, Garcia-Sanz R, Lahuerta JJ (2017).

Analytical and clinical validation of a novel in-house deep-sequencing; method for minimal residual disease monitoring in a phase II trial for; multiple myeloma

LEUKEMIA. Letter. 31(6):1446-1449.
[doi:10.1038/leu.2017.58]
Crooke A, Martínez-Henández J, Martínez-López J, Cruz-Jentoft A, Huete-Toral F, Pintor J (2017).

Low expression of CD39 and CD73 genes in centenarians compared with; octogenarians

IMMUNITY & AGEING. Article. 14:11-11.
[doi:10.1186/s12979-017-0094-3]
Fulciniti M, Martinez-Lopez J, Senapedis W, Oliva S, Lakshmi Bandi R, Amodio N, Xu Y, Szalat R, Gulla A, Samur MK, Roccaro A, Linares M, Cea M, Baloglu E, Argueta C, Landesman Y, Shacham S, Liu S, Schenone M, Wu SL, Karger B, Prabhala R, Anderson KC, Munshi NC (2017).

Functional role and therapeutic targeting of p21-activated kinase 4 in; multiple myeloma

BLOOD. Article. 129(16):2233-2245.
[doi:10.1182/blood-2016-06-724831]
Hernández-Boluda JC, Correa JG, García-Delgado R, Martínez-López J, Alvarez-Larrán A, Fox ML, García-Gutiérrez V, Pérez-Encinas M, Ferrer-Marín F, Mata-Vázquez MI, Raya JM, Estrada N, García S, Kerguelen A, Durán MA, Albors M, Cervantes F (2017).

Predictive factors for anemia response to erythropoiesis-stimulating; agents in myelofibrosis

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 98(4):407-414.
[doi:10.1111/ejh.12846]
Montalbán C, Díaz-López A, Dlouhy I, Rovira J, Lopez-Guillermo A, Alonso S, Martín A, Sancho JM, García O, Sánchez JM, Rodríguez M, Novelli S, Salar A, Gutiérrez A, Rodríguez-Salazar MJ, Bastos M, Domínguez JF, Fernández R, Gonzalez de Villambrosia S, Queizan JA, Córdoba R, de Oña R, López-Hernandez A, Freue JM, Garrote H, López L, Martin-Moreno AM, Rodriguez J, Abraira V, García JF, GELTAMO-IPI Project Investigators (2017).

Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL):; the addition of beta(2)-microglobulin yields a more accurate GELTAMO-IPI

BRITISH JOURNAL OF HAEMATOLOGY. Article. 176(6):918-928.
[doi:10.1111/bjh.14489]
Musto P, Anderson KC, Attal M, Richardson PG, Badros A, Hou J, Comenzo R, Du J, Durie BG, San Miguel J, Einsele H, Chen WM, Garderet L, Pietrantuono G, Hillengass J, Kyle RA, Moreau P, Lahuerta JJ, Landgren O, Ludwig H, Larocca A, Mahindra A, Cavo M, Mazumder A, McCarthy PL, Nouel A, Rajkumar SV, Reiman A, Serra ER, Sezer O, Terpos E, Turesson I, Usmani S, Weiss BM, Palumbo A, International Myeloma Working Group (2017).

Second primary malignancies in multiple myeloma: an overview and IMWG; consensus

ANNALS OF ONCOLOGY. Review. 28(2):228-245.
[doi:10.1093/annonc/mdw606]
Macauda A, Calvetti D, Maccari G, Hemminki K, Försti A, Goldschmidt H, Weinhold N, Houlston R, Andersen V, Vogel U, Buda G, Varkonyi J, Sureda A, Martinez Lopez J, Watek M, Butrym A, Sarasquete ME, Dudzinski M, Jurczyszyn A, Druzd-Sitek A, Kruszewski M, Subocz E, Petrini M, Iskierka-Jazdzewska E, Razny M, Szombath G, Marques H, Zawirska D, Chraniuk D, Halka J, Hove Jacobsen SE, Mazur G, García Sanz R, Dumontet C, Moreno V, Stepien A, Beider K, Pelosini M, Manuel Reis R, Krawczyk-Kulis M, Rymko M, Avet-Loiseau H, Lesueur F, Grzasko N, Ostrovsky O, Jamroziak K, Vangsted AJ, Jerez A, Tomczak W, Zaucha JM, Kadar K, Sainz J, Nagler A, Landi S, Gemignani F, Canzian F (2017).

Identification of miRSNPs associated with the risk of multiple myeloma

INTERNATIONAL JOURNAL OF CANCER. Article. 140(3):526-534.
[doi:10.1002/ijc.30465]
Paiva B, Puig N, Cedena MT, de Jong BG, Ruiz Y, Rapado I, Martinez-Lopez J, Cordon L, Alignani D, Delgado JA, van Zelm MC, Van Dongen JJ, Pascual M, Aguirre X, Prosper F, Martín-Subero JI, Vidriales MB, Gutierrez NC, Hernandez MT, Oriol A, Echeveste MA, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Morgan GJ, Orfao A, Blade J, Mateos MV, Lahuerta JJ, Miguel JF (2017).

Differentiation stage of myeloma plasma cells: biological and clinical; significance

LEUKEMIA. Article. 31(2):382-392.
[doi:10.1038/leu.2016.211]
Nomdedeu M, Pereira A, Ramos F, Valcárcel D, Costa D, Arnan M, Calvo X, Pomares H, Luño E, Díaz-Campelo M, Collado R, de Paz R, Falantes JF, Pedro C, Marco J, Oirtzabal I, Sánchez-García J, Tormo M, Cedena MT, Nomdedeu B, Sanz G, Spanish MDS Group. (2017).

Excess mortality in the myelodysplastic syndromes

AMERICAN JOURNAL OF HEMATOLOGY. Article. 92(2):149-154.
[doi:10.1002/ajh.24606]
Barrios, MP, Martin, RL, Peerez, SP, Tamariz, VV, Yolanda, R, de Miguel, RA, Algarra, AC, de la Cruz, EG, Romero, PO, Peralto, JR (2017).

Phacomatosis Pigmentokeratotica: Mosaic RASopathies as a key to better; understand cancer

JOURNAL OF INVESTIGATIVE DERMATOLOGY. Meeting Abstract. 137(10):229-229.
[doi:10.1016/j.jid.2017.07.214]
Weisel K, Doyen C, Dimopoulos M, Yee A, Lahuerta JJ, Martin A, Travers K, Druyts E, Toor K, Abildgaard N, Lu J, Van Droogenbroeck J, Geraldes C, Petrini M, Voillat L, Voog E, Facon T (2017).

A systematic literature review and network meta-analysis of treatments; for patients with untreated multiple myeloma not eligible for stem cell; transplantation

LEUKEMIA & LYMPHOMA. Review. 58(1):153-161.
[doi:10.1080/10428194.2016.1177772]
Jimenez-Ubieto, A, Grande, C, Caballero, D, Yanez, L, Novelli, S, Hernandez, MT, Manzanares, M, Arranz, R, Ferreiro, JJ, Bobillo, S, Mercadal, S, Galego, A, Jimenez, JL, Moraleda, JM, Vallejo, C, Albo, C, Perez, E, Marrero, C, Magnano, L, Palomera, L, Jarque, I, Coria, E, Rodriguez, A, Martin, A, Lopez-Guillermo, A, Salar, A, Lahuerta, JJ, GELTAMO Grp Espanol Linfomas (2017).

Progression-free survival at 2years post-autologous transplant: a; surrogate end point for overall survival in follicular lymphoma

Cancer Medicine. Article. 6(12):2766-2774.
[doi:10.1002/cam4.1217]
Ballesteros, J, Montesinos, P, Martinez-Cuadron, D, Martinez-Lopez, J, Gorrochategui, J, Rojas, JL, Gomez, C, Hernandez, P, Robles, A (2017).

A new precision medicine test to guide personalized treatments decision; for acute myeloid leukemia patients.

CLINICAL CANCER RESEARCH. Meeting Abstract. 23(24):47-48.
Primo, D, Hernandez, P, Gorrochategui, J, Vincente, ML, Gomez, C, Cuadron, DM, Montesinos, P, Martinez-Lopez, J, Ballesteros, J (2017).

Pharmacologic evaluation of bispecific antibodies: A novel method to; quantify their in vitro activity in hematologic samples.

CLINICAL CANCER RESEARCH. Meeting Abstract. 23(24):46-47.
Jimenez, Cristina, Jara-Acevedo, Maria, Corchete, Luis A., Castillo, David, Ordonez, Gonzalo R., Sarasquete, Maria E., Puig, Noemi, Martinez-Lopez, Joaquin, Prieto-Conde, Maria I., Garcia-Alvarez, Maria, Chillon, Maria C., Balanzategui, Ana, Alcoceba, Miguel, Oriol, Albert, Rosinol, Laura, Palomera, Luis, Teruel, Ana I., Lahuerta, Juan J., Blade, Joan, Mateos, Maria V., Orfao, Alberto, San Miguel, Jesos F., Gonzalez, Marcos, Gutierrez, Norma C., Garcia-Sanz, Ramon (2017).

A Next-Generation Sequencing Strategy for Evaluating the Most Common; Genetic Abnormalities in Multiple Myeloma

JOURNAL OF MOLECULAR DIAGNOSTICS. Article. 19(1):99-106.
[doi:10.1016/j.jmoldx.2016.08.004]
Alvarez-Larrán A, Pérez-Encinas M, Ferrer-Marin F, Hernández-Boluda JC, Ramírez MJ, Martínez-López J, Magro E, Cruz Y, Mata MI, Aragües P, Fox ML, Cuevas B, Montesdeoca S, Hernández-Rivas JA, García-Gutiérrez V, Gómez-Casares MT, Steegmann JL, Durán MA, Gómez M, Kerguelen A, Bárez A, García MC, Boqué C, Raya JM, Martinez C, Albors M, Garcia F, Burgaleta C, Besses C (2017).

Risk of thrombosis according to need of phlebotomies in patients with; polycythemia vera treated with hydroxyurea

HAEMATOLOGICA. Article. 102(1):103-109.
[doi:10.3324/haematol.2016.152769]
Cabrero M, Martin A, Briones J, Gayoso J, Jarque I, López J, Grande C, Heras I, Arranz R, Bernal T, Perez-Lopez E, López-Godino O, Conde E, Caballero D (2017).

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of; Reduced-Intensity Conditioning (with Melphalan, Fludarabine Thiotepa); for Allogeneic Transplantation in Relapsed or Refractory Aggressive B; Cell Lymphoma: A GELTAMO Trial

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Article. 23(1):53-59.
[doi:10.1016/j.bbmt.2016.10.003]
Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Brunet S, Bergua J, Tormo M, García-Boyero R, Sarrà J, Del Potro E, Grande C, Barba P, Bernal T, Amigo ML, Grau J, Cervera J, Feliu E, PETHEMA Group, Spanish Society of Hematology (2017).

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements; in adult patients with acute lymphoblastic leukemia treated with; risk-adapted protocols

LEUKEMIA & LYMPHOMA. Article. 58(1):145-152.
[doi:10.1080/10428194.2016.1177182]

2016

Mateos MV, Oriol A, Martínez-López J, Teruel AI, Bengoechea E, Palomera L, de Arriba F, Esseltine DL, Cakana A, Pei L, van de Velde H, Miguel JS (2016).

Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials

ANNALS OF HEMATOLOGY. Article. 95(12):2033-2041.
[doi:10.1007/s00277-016-2835-3]
Gutierrez-Gonzalez, A, Martinez-Moreno, M, Samaniego, R, Arellano-Sanchez, N, Salinas-Munoz, L, Relloso, M, Valeri, A, Martinez-Lopez, J, Corbi, AL, Hidalgo, A, Garcia-Pardo, A, Teixido, J, Sanchez-Mateos, P (2016).

Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma

BLOOD. Article. 128(18):2241-2252.
[doi:10.1182/blood-2016-01-695395]
Mateos MV, Granell M, Oriol A, Martinez-Lopez J, Blade J, Hernandez MT, Martín J, Gironella M, Lynch M, Bleickardt E, Paliwal P, Singhal A, San-Miguel J (2016).

Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma

BRITISH JOURNAL OF HAEMATOLOGY. Article. 175(3):448-456.
[doi:10.1111/bjh.14263]
Maribel, FC, Cristina, R, Eva, L, Maria, HSJ, Rocio, B, Jordi, R, Lourdes, E, Pere, B, Carmen, O, Mar, T, Javier, M, Estrella, C, Ignacio, D, Carlos, G, Alfonso, GD, Luis, GJ, Sara, GB, Josep-Maria, R, Maria, HRJ (2016).

THE EVALUATION OF CHANGES IN THE TP53, TCF3, ID3 AND GNA13 GENES BY MASS; SEQUENCING AND MICROARRAYS TO IDENTIFY GENOMIC LESIONS ASSOCIATED WITH; LOWER SURVIVAL OF BURKITT'S LYMPHOMA PATIENTS TREATED WITH BURKIMAB

HAEMATOLOGICA. Meeting Abstract. 101:15-15.
Pau, M, Juan, B, David, MC, Joaquin, ML, Josefina, S, Jaime, PD, Mar, T, Juan, B, Pascual, F, Belen, V, Pilar, H, Gabriela, RM, Susana, V, Raimundo, G, Angeles, FM, Esperanza, L, Antonio, PSJ, Santiago, J, Marta, G, Julian, G, Luis, RJ, Jesus, V, Federico, M, Inaki, T, Angel, SM (2016).

A NEW TEST OF PERSONAL MEDICINE EX VIVO USING NATIVE MICROENVIRONMENT; SHOWS HIGH CLINICAL CORRELATION WITH RESPONSES TO FIRST LINE OF; TREATMENT IN ACUTE MYELOID LEUKEMIA

HAEMATOLOGICA. Meeting Abstract. 101:197-197.
Maria, SPJ, Gonzalo, CGT, Estela, MC, Joaquin, ML (2016).

ANALYTICAL CHARACTERISTICS OF METASTASIC INFILTRATION OF MEDULA OSEA BY; NON HEMATOLOGICAL TUMOURS. MORE FREQUENT ETIOLOGY. ROLE OF LACITHOLOGY

HAEMATOLOGICA. Meeting Abstract. 101:110-111.
Dolors, CB, Arturo, PS, Teresa, BD, Elisa, LF, Santiago, BB, Guillermo, SS, Montserrat, AS, Helena, PM, Fernando, RO, Itziar, OO, Carme, PO, Beatriz, AA, Salut, BM, Josefa, MB, Mar, TD, Maria, DC, David, VF, Victor, MB, Teresa, CRM, Rosa, CN, Marta, FG, Blanca, XC, Jordi, ER, Xavier, CG, Meritxell, NF (2016).

STUDY OF CLINICAL CHARACTERISTICS AND PROGNOSIS OF MYELODYSPLASTIC; SYNDROMES WITH ISOLATED Y CHROMOSOME DELAY

HAEMATOLOGICA. Meeting Abstract. 101:145-145.
Josep-Maria, R, Mireia, M, Juana, C, Pau, M, Mar, T, Jose, GC, Rodrigo, M, Susana, V, Cristina, G, Santiago, M, Teresa, B, Lourdes, E, Raimundo, GB, Ramon, G, Pere, B, Luz, AM, Arancha, B, Antonia, C, Jose, MM, Pilar, M, Jesus-Maria, HR, Patricia, F, Juan, B, Evarist, F, Alberto, O (2016).

LACK OF PROGNOSTIC SIGNIFICANCE OF THE EXPRESSION OF CD20 IN ADULTS WITH; PRECURSORS B CELL OF ALL WITHOUT PHILADELPHIA CHROMOSOMES TREATED; ACCORDING TO RESIDUAL ILLNESS

HAEMATOLOGICA. Meeting Abstract. 101:156-157.
Carmen, AP, Marta, LG, Claudia, SS, Jose, CZ, Esperanza, ST, Mariam, IC, Laia, PV, Rosa, AD, Pau, MF, David, MC, Rebeca, RV, Blanca, BP, Jaime, SC, Anabel, RG, Elvira, MC, Leonor, SP, Amparo, ST, Miguel, SA, Eva, BG (2016).

DISTRIBUTION AND PROGNOSTIC VALUE OF RECURRENT MUTATIONS IN AML; DETERMINED BY MEANS OF NEXT GENERATION SEQUENCING

HAEMATOLOGICA. Meeting Abstract. 101:157-157.
Jordi, R, Mar, M, Lurdes, Z, Neus, S, Ramon, G, Santiago, M, Lourdes, E, Josep, N, Marta, P, Jordi, E, Joaquin, ML, Mar, T, Sanchez, J, Rocio, R, Erica, M, Marta, C, Silvia, M, Diana, D, Isabel, G, Jordi, J, Eulalia, G, Fuensanta, M, Evarist, F, Francesc, S, Maria, RJ (2016).

COMPARISON OF GENOMIC ANALYSIS IN 5 ADULT PATIENTS WITH LAL OF B; PRECURSORS IN DIAGNOSIS AND IN RELAPSE

HAEMATOLOGICA. Meeting Abstract. 101:163-164.
Maria, RSJ, Olga, G, Cristina, G, Pau, M, Rodrigo, M, Jose, GC, Santiago, M, Pere, B, Mar, T, Arancha, B, Juan, B, Ramon, G, Teresa, B, Pilar, MM, Daniel, GB, Aurelio, L, Carmen, MM, Jose, MM, Maria, HRJ, Ferran, VL, Lourdes, E, Antonia, C, Angel, HRJ, Esperanza, L, Evarist, F (2016).

INTENSIVE AGAINST SEMI-INTENSIVE CHEMOTHERAPY IN ADULT PATIENTS OF; ADVANCED AGE (55-65 YEARS) WITH ACUTE LYMPHOBLASTIC LEUKAEMIA (LAL); WITHOUT PHILADELPHIA CHROMOSOME (PH-NEG)

HAEMATOLOGICA. Meeting Abstract. 101:165-166.
Maria, L, Luz, MM, Alicia, A, Ivana, Z, Maria, AR, Nerea, C, Inmaculada, R, Angel, QFM, Joaquin, ML (2016).

TRAMETINIB ENHANCES RESPONSE AGAINST TYROSINE KINASE INHIBITORS IN; PRECLINICAL MODELS OF MYELOID LEUKAEMIA

HAEMATOLOGICA. Meeting Abstract. 101:175-175.
Francisca, R, Alicia, S, Teresa, GCM, Carlos, HBJ, Manuel, PE, Jose, RM, Ana, K, Joaquin, M, Jose, R, Carlos, B, Alberto, AL (2016).

TREATMENT WITH ANAGRELIDE IN PATIENTS WITH POLYCYTHEMIA VERA

HAEMATOLOGICA. Meeting Abstract. 101:189-189.
Adolfo, D, Jose, TM, Antonio, G, Marta, C, Antonio, GMJ, Dolores, GMM, Javier, D, Gascon, G, Isabel, M, Laura, GS, Monica, B, Celina, B, Isidro, J, Juliana, OG, Paola, B, Raquel, D, Carlos, M, Monica, E, Rebeca, I, Elena, P, Antonio, DL, Patricia, B (2016).

FIRST LINE OF BENDAMUSTIN-RITUXIMAB TREATMENT IN PATIENTS WITH CHRONIC; LYMPHATIC LEUKEMIA

HAEMATOLOGICA. Meeting Abstract. 101:199-199.
Lucia, LA, Cecilia, CF, Victoria, MM, Laura, R, Albert, O, Isabel, TA, Ana, LD, Enrique, B, Luis, P, Felipe, D, Mariano, HJ, Yolanda, G, Miquel, G, Javier, PF, Juan, B, Benigno, MR, Teodoro, HM, Norma, G, Paloma, P, Ramon, GS, Joan, B, Jesus, S, Jose, LJ, Joaquin, ML (2016).

THE SERUM FREE LIGHT CHAINS TEST (FLCS) MAY BE SUPERIOR TO; ELECTROPHORESIS IN URINE (EEFO) FOR DEFINING THE RESPONSE IN MMBJ

HAEMATOLOGICA. Meeting Abstract. 101:92-92.
Ana, GN, Ana, JU, Jimena, CO, Alejandro, MGS, Carlos, P, Maria, C, Jose, GLT, Victor, N, Andres, L, Reyes, A (2016).

BENDAMUSTIN IN THE FIRST LINE TREATMENT OF MANTLE CELL LYMPHOMA:; PRELIMINARY RESULTS OF GELTAMO RLMB-PL STUDY

HAEMATOLOGICA. Meeting Abstract. 101:226-227.
Neus, RX, Manuela, FG, Luisa, MRM, Teresa, GM, Margarita, O, Maria, CL, Adela, BM, Angel, PAM, Isabel, V, Rocio, S, Eva, A, Sandra, AHM, Jose, CAM, David, IS, Dolors, C, Antonia, GM, Jose, DD, Elisabet, T, Fuensanta, MS, Evarist, FF, Maria, RSJ, Francesc, SR, Isabel, GF (2016).

APPLICATION OF THE DETERMINATION OF THE REALIGNMENT OF GEN KMT2A (MLL); THROUGH FISH IN ACUTE LEUKAEMIAS (AL). COLABORATIVE STUDY OF THE SPANISH; COOPERATIVE GROUP OF HEMATOLOGICAL CYTOGENETICS (GCECGH)

HAEMATOLOGICA. Meeting Abstract. 101:236-237.
Teresa, DR, Denis, ZT, Gonzalo, CT, Jose, SP, Jose, GM, Mario, RR, Sandra, GR, Joaquin, ML (2016).

PYRUVATE KINASE DEFICIT, EXTRAMEDULAR HEMATOPOIESIS AND PULMONARY; HYPERTENSION

HAEMATOLOGICA. Meeting Abstract. 101:260-261.
Maria, SPJ, Rosa, AD, Fatima, MC, Teresa, CR, Joaquin, ML (2016).

HYPERLEUCOCYTOSIS AND LEUCOSTASIS IN ACUTE MYELOBLASTIC LEUKEMIA:; ASSOCIATED CLINICAL AND BIOLOGICAL FACTORS

HAEMATOLOGICA. Meeting Abstract. 101:317-317.
Leyre, LG, Sandra, GR, Francisco, GZI, Javier, CFF, Cristina, GS, Alvaro, BG, Joaquin, ML (2016).

LEAD INTOXICATION IN A GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIT. ABOUT; A CASE

HAEMATOLOGICA. Meeting Abstract. 101:261-261.
Jose, GM, Sandra, GR, Rosa, A, Mariliz, P, Estela, MC, Ignacio, GG, Joaquin, M (2016).

FAMILIAL MYELODISPLASTIC SYNDROME. ABOUT A CASE WITH 2 NEW MUTATIONS

HAEMATOLOGICA. Meeting Abstract. 101:266-266.
Felipe, CML, Patricia, MR, Aleksandra, Z, Cinira, L, Paloma, GG, Nawab, Q, Belen, S, Ignacio, M, Joaquin, ML (2016).

CHARACTERISTICS OF THE PROGRESSION OF DISEASE AND TREATMENT OF MULTIPLE; MYELOMA IN RELAPSE OR REFRACTORY IN SPAIN: RESULTS OF THE PREMIERE STUDY

HAEMATOLOGICA. Meeting Abstract. 101:301-301.
Luisa, MRM, Manuela, FG, Carlos, GG, Angel, MGM, Fatima, MC, Estela, MC, Isabel, PB, Miguel, FN, Paloma, DR, Jose, GRM, Palacios, JJL (2016).

TRIPLE HIT IN BURKIT LYMPHOMA VS UNCLASSIFIABLE B-CELL LYMPHOMA; ASSOCIATED TO A COMPLEX KARYOTYPE INCLUDING T (3;14;12), T (8;14), AND; T(18;22)

HAEMATOLOGICA. Meeting Abstract. 101:320-321.
Adrian, A, Fernando, E, Mercedes, G, Juan, B, Carmen, MC, Aurelio, L, Esther, G, Abelardo, B, Nieves, S, Ernesto, PP, Alexia, SC, Belen, IR, Alfons, S, Antonia, S, Ana, GF, Juan, L, Yolanda, G, Marta, D, David, V, Carlos, FD (2016).

DO PATIENTS WITH MULTIPLE MYELOMA BENEFIT FROM AN EARLY TREATMENT BEFORE; A BIOLOGICAL RELAPSE? PRELIMINARY RESULTS OF A PROSPECTIVE OBSERVATIONAL; NATIONAL REGISTRY

HAEMATOLOGICA. Meeting Abstract. 101:99-99.
Carlos, HBJ, Gonzalo, CJ, Maria, F, Joaquin, ML, Alberto, AL, Laura, FM, Valentin, GG, Manuel, PE, Nataly, I, Isabel, MVM, Maria, RJ, Natalia, E, Anabel, R, Ana, K, Antonia, DM, Manuel, A, Francisco, C (2016).

TREATMENT WITH ERYTHROPOIETIC AGENTS OF ANAEMIA ASSOCIATED WITH; MYELOFIBROSIS: EFFICACY AND PROGNOSTIC RESPONSE FACTORS

HAEMATOLOGICA. Meeting Abstract. 101:84-84.
Eva, GB, Estrella, C, Carlos, G, Alejandro, M, Santiago, M, Eva, DD, Monica, C, Santiago, MM, Jaime, PD, Concepcion, N, Maria, RJ, Jose, RM, Javier, L, Luis, P, Manuel, SJ, Carmen, A, Javier, PF, Armando, LG, Angel, HJ, Joan, B, Isidro, J, Jose, RM, Angel, CM, Eulogio, C, Dolores, C (2016).

PRELIMINARY RESULTS OF A RANDOMIZED CLINICAL TRIAL PHASE 2 OF FIRST LINE; TREATMENT OF YOUNG PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL); OF HIGH RISK WITH RCHOP VS BORTEZOMIB-RCAP (BRCAP)

HAEMATOLOGICA. Meeting Abstract. 101:17-17.
Laura, M, Sara, AA, Miguel, A, Alfredo, RD, Marcio, AC, Guillermo, R, Manuel, SJ, Santiago, M, Antonio, S, Reyes, A, Jose, TM, Ana, J, Sonia, GD, Luis, BJ, Lourdes, L, Silvana, N, Anna, M, Erik, D, Stefania, IM, Emilia, P, Miguel, C, Marcos, G, Alejandro, M, Dolores, CM, Armando, LG (2016).

PATIENTS WITH FOLLICULAR LYMPHOMA (FL) WHO ACHIEVED COMPLETE RESPONSE; (CR) AND SUPPORT IT TO 30 MONTHS PRESENTED A SIMILAR SURVIVAL TO THE; GENERAL POPULATION OF THE SAME AGE AND SEX. STUDY OF THE GELTAMO GROUP

HAEMATOLOGICA. Meeting Abstract. 101:9-10.
Joaquin, ML, Mariateresa, F, Maria, L, Stefania, O, Rajya, LB, Annamaria, G, Raphael, LS, Mehmet, KS, Yan, X, Nicola, A, Michele, C, William, S, Erkan, B, Christian, A, Kenneth, CA, Nikhil, CM (2016).

IMPORTANCE OF SERINE/THREONINE KINASE PAK4 IN MULTIPLE MYELOMA:; THERAPEUTIC APPLICATIONS OF A NEW CLASS OF INHIBITORS

HAEMATOLOGICA. Meeting Abstract. 101:21-21.
Beatriz, SV, Barrio, S, Ruiz-Heredia, Y, Cuenca, I, Rapado, I, Jimenez, C, Aguirre, X, Cervera, J, Ayala, R, Cedena, T, Paiva, B, Mateos, MV, Marin, C, Rosinol, L, Blade, J, Miguel, JS, Garcia-Sanz, R, Lahuerta, JJ, Martinez-Lopez, J (2016).

CLINICAL VALIDATION OF SIMPLIFIED METHOD OF MASSIVE SEQUENCING FOR; QUANTIFICATION OF RESIDUAL DISEASE IN MULTIPLE MYELOMA

HAEMATOLOGICA. Meeting Abstract. 101:22-23.
Rafael, AF, Beatriz, SV, Santiago, B, Isabel, C, Yanira, RH, Carlos, M, Inmaculada, R, Cristina, J, Xabier, A, Jose, C, Rosa, A, Teresa, C, Bruno, P, Victoria, MM, Laura, R, Joan, B, Jesus, SM, Jose, LJ, Ramon, GS, Joaquin, ML (2016).

ANALYSIS OF PROGNOSTIC IMPACT OF MOLECULAR RESPONSE ASSESSED BY 2; METHODS OF NGS IN MULTIPLE MYELOMA

HAEMATOLOGICA. Meeting Abstract. 101:23-24.
Irena, MK, Elizabeta, R, Luis, C, Vanesa, G, Teresa, P, Isabel, I, Joaquin, ML, Ramon, GS, Albert, O, Joan, B, Jose, LJ, Jesus, SM, Victoria, MM, Norma, G (2016).

IMPACT OF PROTEIN EXPRESSION OF CEREBLON, IKAROS, AIOLOS, CYCLIN D1 AND; CYCLIN D2 QUANTIFIED BY MEANS OF CAPILLARY IMMUNOASSAY IN THE SURVIVAL; OF PATIENTS WITH MYELOMA

HAEMATOLOGICA. Meeting Abstract. 101:23-23.
Belen, LMC, Rafael, RT, Daniele, C, Thomas, H, Niels, W, Joaquin, ML, Andres, J, Stefano, L, Krzysztof, J, Charles, D, Manuel, RR, Artur, J, Ulla, V, Gabriele, B, Ramon, GS, Enrico, O, Mario, P, Annette, JV, Federica, G, Asta, F, Hartmut, G, Kari, H, Federico, C, Manuel, JC, Juan, SP (2016).

A FUNCTIONAL VARIANT IN THE HNF1B GENE ASSOCIATED WITH THE OVERALL; SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA: RESULTS OF IMMENSE; CONSORTIUM AND META-ANALYSIS

HAEMATOLOGICA. Meeting Abstract. 101:24-25.
Rafael, AF, Antonio, VL, Teresa, CRM, Fatima, MC, Estela, MC, Jose, LPJ, Joaquin, ML (2016).

EVALUATION OF RESIDUAL DISEASE BY FLOW CYTOMETRY AND PET/CT IN PATIENTS; WITH MULTIPLE MYELOMA IN THE TREATMENT OF LENALIDOMIDE MAINTENANCE

HAEMATOLOGICA. Meeting Abstract. 101:26-26.
Alejandra, LA, Inmaculada, RM, Lucia, FC, Antonio, PM, Dario, C, Jose, LPJ, Joaquin, ML (2016).

THE NATURAL KILLER ECLULAS ACTIVATED AND EXPANDED STRUTEN THE INCOMING; CELLS OF MULTIPLE MYELOMA TUMOR

HAEMATOLOGICA. Meeting Abstract. 101:63-63.
Ana, JU, Carlos, GG, Dolores, C, Lucrecia, Y, Silvana, N, Miguel, HG, Maria, M, Reyes, A, Javier, FJ, Sabella, B, Santiago, M, Andrea, G, Javier, LJ, Moraleda, JM, Carlos, V, Carmen, A, Elena, P, Carmen, M, Laura, M, Luis, P, Isidro, J, Erica, C, Armando, LG, Antonio, S, Jose, LPJ (2016).

INCIDENCE AND PROGNOSTIC IMPACT OF SECOND MALIGNANCIES IN PATIENTS WITH; FOLLICULAR LYMPHOMA (FL) SUBJECTED TO AN AUTOLOGOUS TRANSPLANTATION OF; HAEMATOPOIETIC PROGENITORS (AHPT). AN ANALYSIS WITH VERY LONG MONITORING; OF THE GELTAMO REGISTRATION

HAEMATOLOGICA. Meeting Abstract. 101:11-12.
Carlos, RM, David, MC, Juan, B, Cristina, G, Gonzalo, SL, Blanca, B, Celina, B, Pilar, MS, Mar, T, Jose, SM, Pilar, H, Teresa, B, Raimundo, GB, Rosa, FM, Gabriela, RM, Aurelio, L, Maite, O, Azueg, H, Angel, SM, Pau, M (2016).

RETROSPECTIVE VALIDATION OF PROGNOSTIC SCORES TO PREDICT PROBABILITY OF; SURVIVAL IN ELDERLY AML PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY

HAEMATOLOGICA. Meeting Abstract. 101:6-6.
Ana, ML, Monica, D, Cristina, R, Alicia, A, Rocio, B, Inmaculada, R, Rosa, A, Jesus, HS, Natalia, D, Marta, C, Felix, LC, Guillermo, M, Erik, D, Jorge, L, Alejandro, C, Carmen, O, Jose, A, Carlos, A, Joaquin, M, Jose, GP, Jesus, HR (2016).

PROGNOSTIC IMPACT OF THE STUDY THROUGH MASS SEQUENCING OF THE MUTATIONS; OF THE GENES INVOLVED IN MYELOFIBROSIS

HAEMATOLOGICA. Meeting Abstract. 101:83-84.
Esther, O, Inmaculada, R, Maria, L, Jose, S, Marta, L, Eva, B, Pau, M, Joaquin, ML, Rosa, A (2016).

MUTATIONAL PROFILE IN THE CLINICAL EVOLUTION OF ACUTE MYELOID LEUKEMIA; ASSOCIATED WITH RESISTANCE, REFRACTORY AND RELAPSE

HAEMATOLOGICA. Meeting Abstract. 101:5-6.
Marta, LG, Claudia, SS, Carmen, AP, Mariam, IC, Jose, CZ, Esperanza, ST, Laia, PV, Pau, MF, Sarai, PS, Inmaculada, DJ, Rosa, ME, Blanca, DB, Rosa, AD, Miguel, SA, Eva, BG (2016).

PROFILE OF MIRNAS IN THE FUNCTIONAL CATEGORIES OF THE AML

HAEMATOLOGICA. Meeting Abstract. 101:3-3.
Esther, O, Joan, B, David, MC, Jose, R, Maria, L, Jose, S, Teresa, C, Inmaculada, R, Pilar, M, Rebeca, RV, Blanca, B, Marta, L, Eva, B, Yanira, R, Carmen, B, Pilar, H, Pilar, H, Jaime, PD, Julio, GS, Joaquin, ML, Pau, M, Rosa, A (2016).

PREDICTION OF RESPONSE TO TREATMENT OF ACUTE MIELOID LEUKEMIA:; MUTATIONAL PROFILE (NGS) AND EX VIVO PHARMACOLOGICAL TEST

HAEMATOLOGICA. Meeting Abstract. 101:3-4.
Neus, RX, Mireia, M, Luisa, MRM, Teresa, GM, Adoracion, B, Ismael, B, Mireia, A, Beatriz, EV, Maria, MA, Isabel, V, Angeles, S, Jose, LM, Rosa, CN, Emma, T, Anna, A, Salut, BM, Montserrat, AS, David, GG, Marta, CC, Susana, VP, Evarist, FF, Francesc, SR, Maria, RSJ, Isabel, GF (2016).

PROGNOSTIC SIGNIFICANCE OF REARRANGEMENTS OF THE GENE KMT2A (MLL) IN; ACUTE MYELOID LEUKEMIA (LAM). COLLABORATIVE STUDY OF THE SPANISH; COOPERATIVE GROUP OF HEMATOLOGICAL CYTOGENICS (GCECGH) SPANISH CITOGEN; TICA HEMATOLOGIC (GCECGH)

HAEMATOLOGICA. Meeting Abstract. 101:2-2.
Felix, LC, Blanca, X, Elisa, L, Monica, C, Carme, P, Marisa, C, Benet, N, Teresa, C, Beatriz, A, Marta, G, Carlos, C, Carlos, CBJ, Rosa, C, Gemma, A, Teresa, AM, Antonio, MJ, Jose, RRM, Joan, B, Jesus, AMM, Adriana, S, Consuelo, D, Maria, DC (2016).

CLINICAL AND BIOLOGICAL FACTORS RELATED TO THE TRANSFUSIONAL DEPENDANCE; IN SMD DIAGNOSED PATIENTS (5Q) AND TRANSFUSIONAL INDEPENDENCE TO; DIAGNOSIS

HAEMATOLOGICA. Meeting Abstract. 101:65-66.
Teresa, CM, Inmaculada, R, Rosa, A, Esther, O, Maria, A, Esperanza, S, Fernando, R, Jose, C, Guillermo, S, Jesus, HR, Joaquin, ML (2016).

MUTATIONS IN TYP53 AND EZH2 IMPLICATE WORST PROGNOSIS IN PATIENTS WITH; SMD TREATED WITH HYPOMETHYLATION

HAEMATOLOGICA. Meeting Abstract. 101:67-68.
Valentin, GG, Felipe, C, Fermin, SG, Rosa, A, Concepcion, B, Blanca, X, Isabel, M, Cesar, S, Raquel, D, Joaquin, M, Beatriz, C, Luis, SJ (2016).

EFFICACY AND SAFETY OF DASATINIB IN PATIENTS WITH UNDERSTIMATED LATE; RESPONSE TOWARDS IMATINIB. RESULTS OF DASAPOST PHASE II, MULTICENTRIC,; OPEN AND NON RANDOMIZED STUDY

HAEMATOLOGICA. Meeting Abstract. 101:79-79.
Elisabet, VT, Ana, K, Carlos, HBJ, Manuel, PE, Francisca, FM, Isabel, MM, Beatriz, C, Pilar, A, Teresa, GCM, Valentin, GG, Laura, F, Concepcion, B, Joaquin, M, Carlos, B, Alberto, AL (2016).

RISK FACTORS OF THROMBOSIS AND INDICATIONS OF DEBULKING TREATMENT IN; PATIENTS WITH POLYCYTHEMIA VERA OF LOW RISK TREATED WITH PHLEBOTOMY

HAEMATOLOGICA. Meeting Abstract. 101:82-83.
Mario, RR, Maria, SPJ, Jose, GM, Rosa, AD, Angeles, FGM, Valentin, GG, Santiago, OP, Joaquin, ML (2016).

SURVIVAL ANALYSIS AND CHARACTERISTICS OF PATIENTS DIAGNOSED WITH CML IN; THE TYROSINE KINASE INHIBITORS ERA

HAEMATOLOGICA. Meeting Abstract. 101:346-346.
Ramon, GS, Anna, S, Fatima, D, Antonia, R, Pilar, GA, Antonio, S, Eva, D, Miriam, M, Javier, L, Luis, PJ, Gabriela, RM, Miguel, C, Jose, RSM, Antonio, G, Dolores, CM, Carmen, M (2016).

BRENTUXIMAB VEDOTIN MORE ETOPOSIDE, SOLUMODERIN, HIGH DOSES OF ARA-CE; AND PLATINUM (BRESHAP) IS HIGHLY EFFICIENT IN PATIENTS WITH RESISTANT; AND RELAPSING HODGKINS' LYMPHOMA: TRIAL PHASE I-II OF GELTAMO

HAEMATOLOGICA. Meeting Abstract. 101:18-19.
Zinzani PL, Karlin L, Radford J, Caballero D, Fields P, Chamuleau ME, D' Amore F, Haioun C, Thieblemont C, González-Barca E, Grande García C, Johnson PW, van Imhoff GW, Ng T, Dwyer K, Morschhauser F (2016).

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

HAEMATOLOGICA. Letter. 101(10):407-410.
[doi:10.3324/haematol.2016.146977]
Martínez-Flores JA, Serrano M, Pérez D, Cámara A G, Lora D, Morillas L, Ayala R, Paz-Artal E, Morales JM, Serrano A (2016).

Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. Article. 23(10):1242-1253.
[doi:10.5551/jat.34488]
Rios-Tamayo, Rafael, Belen Lupianez, Carmen, Campa, Daniele, Hielscher, Thomas, Weinhold, Niels, Martinez-Lopez, Joaquin, Jerez, Andres, Landi, Stefano, Jamroziak, Krzysztof, Dumontet, Charles, Watek, Marzena, Lesueur, Fabienne, Reis, Rui Manuel, Marques, Herlander, Jurczyszyn, Artur, Vogel, Ulla, Buda, Gabriele, Garcia-Sanz, Ramon, Orciuolo, Enrico, Petrini, Mario, Vangsted, Annette J., Gemignani, Federica, Foersti, Asta, Goldschmidt, Hartmut, Hemminki, Kari, Canzian, Federico, Jurado, Manuel, Sainz, Juan (2016).

A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis

Oncotarget. Article. 7(37):59029-59048.
[doi:10.18632/oncotarget.10665]
Bergua, JM, Montesinos, P, Martinez-Cuadron, D, Fernandez-Abellan, P, Serrano, J, Sayas, MJ, Prieto-Fernandez, J, Garcia, R, Garcia-Huerta, AJ, Barrios, M, Benavente, C, Perez-Encinas, M, Simiele, A, Rodriguez-Macias, G, Herrera-Puente, P, Rodriguez-Veiga, R, Martinez-Sanchez, MP, Amador-Barciela, ML, Riaza-Grau, R, Sanz, MA, PETHEMA group (2016).

A prognostic model for survival after salvage treatment with FLAG-Ida plus /- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia

BRITISH JOURNAL OF HAEMATOLOGY. Article. 174(5):700-710.
[doi:10.1111/bjh.14107]
Cross NC, White HE, Ernst T, Welden L, Dietz C, Saglio G, Mahon FX, Wong CC, Zheng D, Wong S, Wang SS, Akiki S, Albano F, Andrikovics H, Anwar J, Balatzenko G, Bendit I, Beveridge J, Boeckx N, Cerveira N, Cheng SM, Colomer D, Czurda S, Daraio F, Dulucq S, Eggen L, El Housni H, Gerrard G, Gniot M, Izzo B, Jacquin D, Janssen JJ, Jeromin S, Jurcek T, Kim DW, Machova-Polakova K, Martinez-Lopez J, McBean M, Mesanovic S, Mitterbauer-Hohendanner G, Mobtaker H, Mozziconacci MJ, Pajic T, Pallisgaard N, Panagiotidis P, Press RD, Qin YZ, Radich J, Sacha T, Touloumenidou T, Waits P, Wilkinson E, Zadro R, Müller MC, Hochhaus A, Branford S (2016).

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

LEUKEMIA. Article. 30(9):1844-1852.
[doi:10.1038/leu.2016.90]
Santos-Lozano A, Morales-Gonzalez A, Sanchis-Gomar F, Cristi-Montero C, Fiuza-Luces C, Pareja-Galeano H, Martínez-López J, Garatachea N, Lucia A (2016).

Response rate to the treatment of Waldenstrom macroglobulinemia: A meta-analysis of the results of clinical trials

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. Review. 105:118-126.
[doi:10.1016/j.critrevonc.2016.06.004]
Palumbo A, Chanan-Khan A, Weisel K, Nooka AK, Masszi T, Beksac M, Spicka I, Hungria V, Munder M, Mateos MV, Mark TM, Qi M, Schecter J, Amin H, Qin X, Deraedt W, Ahmadi T, Spencer A, Sonneveld P, CASTOR Investigators (2016).

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

NEW ENGLAND JOURNAL OF MEDICINE. Article. 375(8):754-766.
[doi:10.1056/NEJMoa1606038]
Alvarez-Larran, A, Pereira, A, Guglielmelli, P, Hernandez-Boluda, JC, Arellano-Rodrigo, E, Ferrer-Marin, F, Samah, A, Griesshammer, M, Kerguelen, A, Andreasson, B, Burgaleta, C, Schwarz, J, Garcia-Gutierrez, V, Ayala, R, Barba, P, Gomez-Casares, MT, Paoli, C, Drexler, B, Zweegman, S, McMullin, MF, Samuelsson, J, Harrison, C, Cervantes, F, Vannucchi, AM, Besses, C (2016).

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

HAEMATOLOGICA. Article. 101(8):926-931.
[doi:10.3324/haematol.2016.146654]
Osorio S, Casado LF, Giraldo P, Maestro B, Andrade M, Redondo S, García-Gutiérrez V, Ayala R, Garcia N, Steegmann JL (2016).

Chronic myeloid leukaemia in Spain: Its presentation characteristics have changed. Spanish section of the EUTOS population-based registry

REVISTA CLINICA ESPANOLA. Article. 216(6):293-300.
[doi:10.1016/j.rce.2016.03.001]
Mateos MV, Hernández MT, Giraldo P, de la Rubia J, de Arriba F, Corral LL, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Arguiñano JM, Quintana N, García JL, Bladé J, Lahuerta JJ, Miguel JF (2016).

Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial

LANCET ONCOLOGY. Article. 17(8):1127-1136.
[doi:10.1016/S1470-2045(16)30124-3]
Kantarjian HM, Stein AS, Bargou RC, Grande Garcia C, Larson RA, Stelljes M, Gökbuget N, Zugmaier G, Benjamin JE, Zhang A, Jia C, Topp MS (2016).

Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies

CANCER. Article. 122(14):2178-2185.
[doi:10.1002/cncr.30031]
Ríos-Tamayo R, Sáinz J, Martínez-López J, Puerta JM, Chang DY, Rodríguez T, Garrido P, García de Veas JL, Romero A, Moratalla L, López-Fernández E, González PA, Sánchez MJ, Jiménez-Moleón JJ, Jurado M, Lahuerta JJ (2016).

Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients

AMERICAN JOURNAL OF HEMATOLOGY. Article. 91(7):700-704.
[doi:10.1002/ajh.24389]
Weisel KC, Dimopoulos MA, Moreau P, Lacy MQ, Song KW, Delforge M, Karlin L, Goldschmidt H, Banos A, Oriol A, Alegre A, Chen C, Cavo M, Garderet L, Ivanova V, Martinez-Lopez J, Knop S, Yu X, Hong K, Sternas L, Jacques C, Zaki MH, San Miguel J (2016).

Analysis of renal impairment in MM-003, a phase III study of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in refractory or relapsed and refractory multiple myeloma

HAEMATOLOGICA. Article. 101(7):872-878.
[doi:10.3324/haematol.2015.137083]
De La Serna J, Sanz J, Bermúdez A, Cabrero M, Serrano D, Vallejo C, Gómez V, Moraleda JM, Perez SG, Caballero MD, Conde E, Lahuerta JJ, Sanz G (2016).

Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS

BONE MARROW TRANSPLANTATION. Article. 51(7):961-966.
[doi:10.1038/bmt.2016.42]
Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, Flores-Montero J, Gutierrez NC, Martín-Ramos ML, Martinez-Lopez J, Ocio EM, Hernandez MT, Teruel AI, Rosiñol L, Echeveste MA, Martinez R, Gironella M, Oriol A, Cabrera C, Martin J, Bargay J, Encinas C, Gonzalez Y, Van Dongen JJ, Orfao A, Bladé J, Mateos MV, Lahuerta JJ, San Miguel JF (2016).

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

BLOOD. Article. 127(25):3165-3174.
[doi:10.1182/blood-2016-03-705319]
Paiva, B, Martinez-Lopez, J, Corchete, LA, Sanchez-Vega, B, Rapado, I, Puig, N, Barrio, S, Sanchez, ML, Alignani, D, Lasa, M, García de Coca A, Pardal, E, Oriol, A, Gonzalez Garcia ME, Escalante, F, Gonzalez-Lopez, TJ, Palomera, L, Alonso, J, Prosper, F, Orfao, A, Vidriales, MB, Mateos, MV, Lahuerta, JJ, Gutierrez, NC, San Miguel, JF (2016).

Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis

BLOOD. Article. 127(24):3035-3039.
[doi:10.1182/blood-2015-10-673095]
Gallardo, M., Hornbaker, M. H., Zhang, X., McArthur, M., Manshouri, T., Martinez-Lopez, J., Post, S. M. (2016).

HNRNP K: A NOVEL ONCOGENE THAT DRIVES C-MYC-DEPENDENT LYMPHOMAS AS A POTENTIAL THERAPY TARGET

HAEMATOLOGICA. Meeting Abstract. 101(1):269-269.
Dumontet, C., Hulin, C., Dimopoulos, M. A., Belch, A., Dispenzieri, A., Ludwig, H., Rodon, P., Van Droogenbroeck, J., Qiu, L., Cavo, M., Van de Velde, A., Lahuerta, J. J., Allangba, O., Lee, J. H., Boyle, E., Civet, A., Costa, B., Tinel, A., Gaston-Mathe, Y., Facon, T. (2016).

DEVELOPMENT OF A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH MULTIPLE MYELOMA NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANT AT RISK FOR SEVERE INFECTIONS USING DATA FROM THE FIRST TRIAL

HAEMATOLOGICA. Meeting Abstract. 101(1):254-255.
Ibanez, M., Alonso, C., LLop, M., Onecha, E., Such, E., Barragan, E., Ayala, R., Neef, A., Martinez-Lopez, J., Raspado, I., de Matteo, B., Company, D., Andreu, R., Montesinos, P., Sanz, M. A., Cervera, J. (2016).

DEEP SEQUENCING OF 23 GENES DESIGNATED BY TCGA STUDY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE

HAEMATOLOGICA. Meeting Abstract. 101(1):366-367.
Fernandez Delarrea, C., Escalante, F., Alegre, A., Bergua, J. M., Martinez Chamorro, C., Lopez, A., Gonzalez, E., Barez, A., Somolinos, N., Perez Persona, E., Suarez Cabrera, A., Inigo Rodriguez, B., Soler, A., Sampol, A., Garcia Feria, A., Lahuerta, J. J., Gonzalez, Y., Duran, M., Vilanova, D., Gironella, M. (2016).

DO MULTIPLE MYELOMA R/R PATIENTS BENEFIT FROM EARLY TREATMENT AT BIOLOGICAL RELAPSE? PRELIMINARY RESULTS OF A SPANISH OBSERVATIONAL PROSPECTIVE REGISTRY

HAEMATOLOGICA. Meeting Abstract. 101(1):262-262.
Martinez-Cuadron, D., Montesinos, P., Ossenkoppele, G., Gonzalez-Huerta, A. J., Salamero, O., Holowiecka, A., Brunet, S., Fernandez, P., Benavente, C., Ribera, J. M., Perez Encinas, M., De la Serna, J., Esteve, J., Rubio, V., Gonzalez, J., Escoda, L., Amutio, M. E., Lowenberg, B., Sanz, M. A. (2016).

LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ANTHRACYCLINE MONOTHERAPY AND ATRA-BASED PETHEMA PROTOCOLS

HAEMATOLOGICA. Meeting Abstract. 101(1):178-178.
Montesinos, P., Ballesteros, J., Martinez Cuadron, D., Martinez Lopez, J., Serrano, J., Perez de Oteyza, J., Fernandez, P., Rodriguez Macias, G., Vidriales, B., Herrera, P., Tormo, M., Bergua, J., Garcia, R., Vives, S., Fernandez, M. A., Lavilla, E., Jimenez, S., Perez Simon, J. A., Simiele, A., Gonzalez, A., Gonzalez, B., Burgaleta, C., Lopez, J. A., Bethancourt, C., Bautista, G., Alonso, A., Colorado, M., Sierra, J., Navas, B., Hernandez Rivas, J. A., Vera, J. A., Amador, L., Cordoba, R., de la Fuente, A., Ramos, F., Cervero, C. J., Rayon, C., Salamero, O., Marti, E., Loez, A., Olave, T., Gaspar, M., Gorrochategui, J., Rojas, J. L., Gomez, C., Hernandez, P., Robles, A., Ortega, I., Villoria, J., Moscardo, F., Troconiz, I., Sanz, M. A. (2016).

AN EX VIVO NATIVE ENVIRONMENT PRECISION MEDICINE TEST SHOWS HIGH CLINICAL CORRELATION WITH RESPONSES TO FIRST LINE ACUTE MYELOID LEUKEMIA TREATMENT

HAEMATOLOGICA. Meeting Abstract. 101(1):216-216.
Ballesteros, J., Scarfo, L., Mattsson, M., Xochelli, A., Ranghetti, P., Primo, D., Robles, A., Gorrochategui, J., Martinez Lopez, J., de la Serna, J., Gonzalez, M., Munugalavadla, V., Tannheimer, S., Rosenquist, R., Stamatopoulos, K., Ghia, P. (2016).

EX VIVO LYMPH NODE NATIVE MICROENVIRONMENT ASSAY SHOWS NOVEL ANTIPROLIFERATIVE ACTIVITY FOR IDELALISIB AND IBRUTINIB ON CLL CELLS

HAEMATOLOGICA. Meeting Abstract. 101(1):426-426.
Ribera, J. M., Morgades, M., Ciudad, J., Montesinos, P., Tormo, M., Gonzalez-Campos, J., Martino, R., Vives, S., Gil, C., Mercadal, S., Bernal, T., Escoda, L., Garcia-Boyero, R., Guardia, R., Barba, P., Amigo, M., Bermudez, A., Cladera, A., Moreno, M., Martinez, P., Hernandez-Rivas, J. M., Font, P., Bergua, J., Feliu, E., Orfao, A. (2016).

LACK OF PROGNOSTIC SIGNIFICANCE OF CD20 EXPRESSION IN ADULTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE, B-CELL PRECURSOR ALL TREATED ACCORDING TO MRD-ORIENTED PROTOCOLS

HAEMATOLOGICA. Meeting Abstract. 101(1):202-203.
Misiewicz-Krzeminska, I., Rojas, E., Corchete, L., Gutierrez, V., Prieto, T., Isidro, I., Martinez-Lopez, J., Garcia-Sanz, R., Oriol, A., Blade, J., Lahuerta, J. J., San Miguel, J., Mateos, M. V., Gutierrez, N. C. (2016).

QUANTIFICATION OF CYCLIN D1, CYCLIN D2, IKAROS, AIOLOS AND CEREBLON PROTEINS BY CAPILARY IMMUNOASSAY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AND ANALYSIS OF THEIR IMPACT ON PATIENT SURVIVAL

HAEMATOLOGICA. Meeting Abstract. 101(1):78-78.
Senin, A., Fernandez, C., Bellosillo, B., Arellano-Rodrigo, E., Gomez, M., Ferrer-Marin, F., Martinez, J., Camacho, L., Reyes, S., Colomer, D., Cervantes, F., Besses, C., Hernandez-Boluda, J. C., Alvarez-Larran, A. (2016).

IMPACT OF THE MOLECULAR PROFILE ON THE RISK OF ACUTE MYELOID TRANSFORMATION IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA

HAEMATOLOGICA. Meeting Abstract. 101(1):163-163.
Jimenez Ubieto, A., Grande, C., Caballero, D., Salar, A., Yanez, L., Novelli, S., Lopez-Guillermo, A., Rodriguez, M. J., Manzanares, M., Arranz, R., Ferreiro, J. J., Bobillo, S., Mercadal, S., Galego, A., Lopez-Jimenez, J., Vallego, C., Albo, C., Perez, E., Marrero, C., Magnano, L., Palomera, L., Jarque, I., Martinez-Sanchez, P., Coria, E., Palomero, T., Lahuerta, J. J. (2016).

ANALYSIS OF SECONDARY NEOPLASIAS AFTER HIGH DOSE THERAPY SUPPORTED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN FOLICULAR LYMPHOMA PATIENTS. A LONG TERM FOLLOW-UP ANALYSIS FROM THE GELTAMO REGISTRY.

HAEMATOLOGICA. Meeting Abstract. 101(1):156-157.
Ibanez, M., Martinez-Rubio, M., Onecha, E., Ines, G. S., Such, E., Barragan, E., Ayala, R., Llop, M., Lopez-Pavia, M., Jorge, S., Neef, A., Martinez-Lopez, J., Raspado, I., de Matteo, B., Company, D., Andreu, R., Leonor, S., Montesinos, P., Sanz, M. A., Cervera, J. (2016).

GENOME-WIDE ANALYSIS OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPS) IN PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE

HAEMATOLOGICA. Meeting Abstract. 101(1):368-368.
Cedena, M. T., Rapado, I., Ayala, R. M., Onecha, E., Abaigar, M., Such, E., Ramos, F., Cervera, J. V., Hernandez-Rivas, J. M., Sanz, G., Martinez-Lopez, J. (2016).

TP53 AND EZH2 MUTATIONS PREDICT POOR SURVIVAL IN PATIENTS TREATED WITH HYPOMETHYLATING AGENTS IN MDS

HAEMATOLOGICA. Meeting Abstract. 101(1):68-68.
De La Fuente, A., Beneit, P., Gutierrez, A., Callejas, M., Garcia Marco, J. A., Garcia Malo, M. D., de la Serna, J., Gonzalez Gascon y Marin, I., Garcia Sanchis, L., Ballesteros, M., Jarque, I., Ochoa Grullon, J., Iglesias, R., Estevez, M., de Ona, R., Prieto, E., Diaz-Lopez, A., Baltasar, P. (2016).

BENDAMUSTINE PLUS RITUXIMAB IN 65 YEAR AND ABOVE UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

HAEMATOLOGICA. Meeting Abstract. 101(1):445-445.
Capdevila, F., Olavarria, E., Perez Encinas, M., de Paz Arias, R., Ayala Diaz, R. M., Garcia Omena, N., Ferrer Marin, F., Bautista Carrascosa, G., Conesa Garcia, V., Steegmann, J. L., OBOTGED Leucemia Mieloide Cronica (2016).

CMREGISTRY: AN OBSERVATIONAL, MULTI CENTER, PROSPECTIVE FOLLOW-UP REGISTRY OF PATIENTS WITH CHRONIC PHASE CML WITH A HIGH PROBABILITY OF OBTAINING A STABLE DEEP MOLECULAR RESPONSE >CMR4 (IS)

HAEMATOLOGICA. Meeting Abstract. 101(1):459-460.
Rios-Tamayo, R., Sainz, J., Alba, A. M., Cruz, A. J., Perez, J. A., Morente, E., Cornejo, E., Garcia de Veas, J. L., Rodriguez, T., Jurado, M., Martinez-Lopez, J., Lahuerta, J. J. (2016).

THE IMPACT OF THE TYPE OF MYELOMA-DEFINING EVENT ON EARLY MORTALITY AND SURVIVAL

HAEMATOLOGICA. Meeting Abstract. 101(1):544-545.
Jimenez-Ubieto, A., Garcia-Gigorro, R., Martinez-Sanchez, P., Rodriguez, A., Montejano, L., Grande, C. (2016).

ICU AND LONG-TERM MORTALITY ANALISIS OF HEMATOLOGOGICAL MALIGNANCIES ADMITTED IN ICU. A UNICENTRIC SEVEN YEARS REVIEW IN A SPANISH HOSPITAL

HAEMATOLOGICA. Meeting Abstract. 101(1):598-598.
Llop, M., Alonso, C. M., Ibanez, M., Cervera, J., Such, E., Pedrola, L., Martin, I., Onecha, E., Ayala, R., Sanz, M. A., Barragan, E. (2016).

TECHNICAL VALIDATION OF A NEXT-GENERATION SEQUENCING PANEL FOR ACUTE MYELOID LEUKEMIA DIAGNOSIS

HAEMATOLOGICA. Meeting Abstract. 101(1):665-665.
Alonso, C. M., Llop, M., Ibanez, M., Cervera, J., Such, E., Pedrola, L., Martin, I., Onecha, E., Ayala, R., Montesinos, P., Sanz, M. A., Barragan, E. (2016).

MUTATIONAL ANALYSIS OF ACUTE MYELOID LEUKEMIA WITH A NEXT-GENERATION SEQUENCING PANEL

HAEMATOLOGICA. Meeting Abstract. 101(1):666-666.
Rios-Tamayo, R., Lahuerta, J. J., Sainz, J., Sanchez, M. J., Chang, D. Y. L., Jimenez-Moleon, J. J., Puerta, J. M., Rodriguez, T., Garcia de Veas, J. L., Garrido, P., Gonzalez, P. A., Moratalla, L., Lopez-Fernandez, E., Romero, A., Jurado, M., Martinez-Lopez, J. (2016).

THE ROLE OF COMORBIDITY ON EARLY MORTALITY IN MULTIPLE MYELOMA. A SINGLE INSTITUTION POPULATION-BASED STUDY EMPHASIZING THE NEED FOR STANDARDIZATION

HAEMATOLOGICA. Meeting Abstract. 101(1):787-787.
Martin Lopez, A. A., del Rey, M., Robledo, C., Arenas, A., Benito, R., Rayado, I., Ayala, R., Hernandez-Sanchez, J. M., de las Heras, N., Castellanos, M., Lopez Cadenas, F., Martin, G., de Cabo, E., Labrador, J., Corrales, A., Olivier, C., Alonso, J. M., Aguilar, C., Gonzalez-Porras, J. R., Hernandez-Rivas, J. M. (2016).

MUTATIONAL STUDY OF GENES INVOLVED IN MYELOFIBROSIS BY MASSIVE SEQUENCING

HAEMATOLOGICA. Meeting Abstract. 101(1):94-95.
Gallardo, M., Hornbaker, M. J., Lee, H. J., Zhang, X., Bueso-Ramos, C., Pageon, L. R., McArthur, M., Multani, A., Manshouri, T., Parker-Thornburg, J., Hu, P., Rapado, I., Quintas-Cardama, A., Kornblau, S. M., Martinez-Lopez, J., Post, S. M. (2016).

HNRNP K: AN ONCOGENE AND TUMOR SUPPRESSOR, TWO DISCRETE PATHS TO AML THROUGH ON GENE

HAEMATOLOGICA. Meeting Abstract. 101(1):11-12.
Sanchez, R., Ayala, R., Alonso, R. A., Ribera, J., Garcia, O., Mercadal, S., Montesinos, P., Martino, R., Barba, P., Gonzalez-Campos, J., Barrios, M., Lavilla, E., Gil, C., Bernal, T., Escoda, L., Abella, E., Amigo, M. L., Moreno, M. J., Bravo, P., Guardia, R., Hernandez-Rivas, J. M., Garcia-Guinon, A., Piernas, S., Ribera, J. M., Martinez-Lopez, J. (2016).

PATTERN OF CNS RELAPSE IN ACUTE LYMPHOBLASTIC LEUKEMIA BCR-ABL POSITIVE, THE IMPORTANCE OF CHARACTERIZATION OF ABL1 MUTATIONS IN CEREBROSPINAL FLUID

HAEMATOLOGICA. Meeting Abstract. 101(1):354-354.
Vilches Moreno, A. S., Guerrero Fernandez, L., Gonzalez Medina, J., Ayala Diaz, R., Martinez Lopez, J., Monteagudo Saiz, D., Andreu Costa, M. A., Robles Marinas, V. (2016).

ESSENTIAL THROMBOCYTHEMIA WITH JAK2 V617F OR CALR MUTATION: TWO DIFFERENT PHENOTYPES

HAEMATOLOGICA. Meeting Abstract. 101(1):811-811.
Martinez-Lopez, J., Martin-Regueira, P., Zagorska, A., Lefevre, C., Roldan Acevedo, C., Qizilbash, N., San Jose, B., Mendez, I., Casado Montero, L. F. (2016).

REAL-WORLD CHARACTERISTICS, TREATMENT PATHWAYS AND HEALTHCARE RESOURCE USE IN PATIENTS TREATED FOR RELAPSED REFRACTORY MULTIPLE MYELOMA IN SPAIN: PRELIMINARY RESULTS FROM THE PREMIERE STUDY

HAEMATOLOGICA. Meeting Abstract. 101(1):835-835.
Forero-Castro, M., Robledo, C., Benito, R., Abaigar, M., Hernandez-Sanchez, M., Hernandez-Sanchez, J. M., Quijada-Alamo, M., Fuster, J. L., Arefi, M., de las Heras, N., Rodriguez, J. N., Hermosin, L., Ribera, J., Bodega Mayor, I., Rapado, I., Sanchez-Pina, J. M., Camos Guijosa, M., Ramirez-Orellana, M., de Heredia Rubio, C. Diaz, Barragan, E., Martinez, J., Fernandez-Ruiz, E., Ribera, J. M., Hernandez-Rivas, J. M. (2016).

MUTATIONS IN TP53 AND JAK2 GENES ARE ASSOCIATED WITH POOR PROGNOSIS IN PEDIATRIC AND ADULT PATIENTS WITH B-CELL PRECURSOR ALL

HAEMATOLOGICA. Meeting Abstract. 101(1):200-200.
Alvarez-Larran, A., Perez-Encinas, M., Ferrer-Marin, F., Hernandez-Boluda, J. C., Ramirez, M. J., Martinez, J., Burgaleta, C., Cruz, Y., Mata, M. I., Aragues, P., Fox, L., Cuevas, B., Montesdeoca, S., Hernandez-Rivas, J. A., Garcia-Gutierrez, V., Gomez-Casares, M. T., Steegman, J. L., Duran, M. A., Gomez, M., Kerguelen, A., Barez, A., Garcia, M. C., Boque, C., Raya, J. M., Martinez, C., Albors, M., Garcia, F., Besses, C. (2016).

PREVENTION OF THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA TREATED WITH HYDROXUYUREA PLUS PHLEBOTOMIES OR HYDROXYUREA ALONE

HAEMATOLOGICA. Meeting Abstract. 101(1):95-96.
Perea J, Arriba M, Rueda D, Sánchez R, García JL, Pérez J, Rodríguez Y, González-Sarmiento R, Urioste M (2016).

Comment on `Wild-type APC prediction of poor prognosis in microsatellite-stable proximal colorectal cancer differs according to the age of onset'

BRITISH JOURNAL OF CANCER. Editorial Material. 114(10).
[doi:10.1038/bjc.2016.53]
Arriba M, García JL, Inglada-Pérez L, Rueda D, Osorio I, Rodríguez Y, Álvaro E, Sánchez R, Fernández T, Pérez J, Hernández JM, Benítez J, González-Sarmiento R, Urioste M, Perea J (2016).

DNA copy number profiling reveals different patterns of chromosomal instability within colorectal cancer according to the age of onset

MOLECULAR CARCINOGENESIS. Article. 55(5):705-716.
[doi:10.1002/mc.22315]
Peñalver FJ, Delgado J, Loscertales J, Sastre JL, Peña A, Olave MT, Osorio S, de la Fuente A, Salar A, Grande C, Pérez Ceballos E, Debén G, Echeveste A, Casado F, de la Rubia J, Lahuerta JJ, Mateos MV (2016).

Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 96(5):532-540.
[doi:10.1111/ejh.12633]
Paiva B, Corchete LA, Vidriales MB, Puig N, Maiso P, Rodriguez I, Alignani D, Burgos L, Sanchez ML, Barcena P, Echeveste MA, Hernandez MT, García-Sanz R, Ocio EM, Oriol A, Gironella M, Palomera L, De Arriba F, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Lahuerta JJ, Blade J, Orfao A, Mateos MV, San Miguel JF (2016).

Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance

BLOOD. Article. 127(15):1896-1906.
[doi:10.1182/blood-2015-08-665679]
Batlle-Lopez, Ana, Gonzalez de Villambrosia, Sonia, Mazorra, Francisco, Malatxeberria, Sefora, Saez, Anabel, Montalban, Carlos, Sanchez, Lydia, Garcia, Juan F., Gonzalez-Barca, Eva, Lopez, Andres, Ruiz-Marcellan, M. C., Mollejo, Manuela, Grande, Carlos, Richards, K. L., Hsi, E. D., Tzankov, Alexandar, Visco, Carlo, Xu-Monette, ZijunY, Cao, Xin, Young, Ken H., Angel Piris, Miguel, Conde, Eulogio, Montes-Moreno, Santiago (2016).

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker

Oncotarget. Article. 7(14):18036-18049.
[doi:10.18632/oncotarget.7495]
Garcia-Munoz, Ricardo, Lopez-Diaz-de-Cerio, Ascension, Feliu, Jesus, Panizo, Angel, Giraldo, Pilar, Rodriguez-Calvillo, Mercedes, Grande, Carlos, Pena, Esther, Olave, Mayte, Panizo, Carlos, Inoges, Susana (2016).

Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity

IMMUNOLOGIC RESEARCH. Article. 64(2):548-557.
[doi:10.1007/s12026-015-8747-9]
Sanz-Motilva V, Castellanos-González M, Martínez Sánchez P, Ortiz de Frutos J, Ortiz-Romero PL, Rodríguez-Peralto JL, Vanaclocha-Sebastián F (2016).

Lesiones eccematosas y cuadro ictiosiforme adquirido como forma de presentación de un linfoma anaplásico de células grandes CD30.

MEDICINA DE FAMILIA-SEMERGEN. Letter. 42(3):208-210.
[doi:10.1016/j.semerg.2015.02.010]
Nomdedeu, M, Calvo, X, Pereira, A, Carrio, A, Sole, F, Luño E, Cervera, J, Vallespi, T, Muñoz C, Gomez, C, Arias, A, Such, E, Sanz, G, Grau, J, Insunza, A, Calasanz, MJ, Ardanaz, MT, Hernandez-Rivas, JM, Azaceta, G, Alvarez, S, Sanchez, J, Martin, ML, Bargay, J, Gomez, V, Cervero, CJ, Allegue, MJ, Collado, R, Campo, E, Esteve, J, Nomdedeu, B, Costa, D, Spanish Grp Myelodysplastic Syndro (2016).

Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes

GENES CHROMOSOMES & CANCER. Article. 55(4):322-327.
[doi:10.1002/gcc.22333]
Besses, C, Hernandez-Boluda, JC, Perez Encinas, M., Raya, JM, Hernandez-Rivas, JM, Jimenez Velasco, A., Martinez Lopez, J., Vicente, V, Burgaleta, C, GEMFIN (2016).

Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method

ANNALS OF HEMATOLOGY. Article. 95(5):719-732.
[doi:10.1007/s00277-016-2614-1]
Martínez-Moreno M, Leiva M, Aguilera-Montilla N, Sevilla-Movilla S, Isern de Val S, Arellano-Sánchez N, Gutiérrez NC, Maldonado R, Martínez-López J, Buño I, García-Marco JA, Sánchez-Mateos P, Hidalgo A, García-Pardo A, Teixidó J (2016).

In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by alpha 4 beta 1 cytoplasmic-binding proteins

LEUKEMIA. Article. 30(4):861-872.
[doi:10.1038/leu.2015.332]
Paiva B, Mateos MV, Sanchez-Abarca LI, Puig N, Vidriales MB, López-Corral L, Corchete LA, Hernandez MT, Bargay J, de Arriba F, De La Rubia J, Teruel AI, Giraldo P, Rosiñol L, Prosper F, Oriol A, Hernández J, Esteves G, Lahuerta JJ, Blade J, Perez-Simon JA, San Miguel JF (2016).

Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis

BLOOD. Article. 127(9):1151-1162.
[doi:10.1182/blood-2015-10-662320]
Corral, D., Valentin, J., Bueno, D., Carrasco, P., de Paz, R., Rodriguez, R., Fernandez, L., Balas, A., Vicario, J. L., Campana, D., Martinez, J., Perez Martinez, A. (2016).

IL-15/4-1BBL activated and expanded Natural Killer cells in paediatric patients with refractory acute leukaemia

BONE MARROW TRANSPLANTATION. Meeting Abstract. 51(1):255-256.
Vallejo, C., Gonzalez, A. J., Montesinos, P., Brunet, S., Diez, J. L., de la Serna, J., Rosell, A., Cuevas, B., Xicoy, B., Yanez, L., Pethema-GETH (2016).

Atg Plus Cyclosporine in Aplastic Anemia Patients Unresponsive to A First Immunosuppresive Therapy Course

BONE MARROW TRANSPLANTATION. Meeting Abstract. 51(1):287-287.
Alvarez-Larran, A, Kerguelen, A, Hernandez-Boluda, JC, Perez-Encinas, M, Ferrer-Marin, F, Barez, A, Martinez-Lopez, J, Cuevas, B, Isabel Mata, M., Garcia-Gutierrez, V, Araguees, Pilar, Montesdeoca, S, Burgaleta, C, Caballero, G, Angel Hernandez-Rivas, J., Antonia Duran, M., Teresa Gomez-Casares, M., Besses, C, Grp Espanol de Enfermedades Mielop (2016).

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

BRITISH JOURNAL OF HAEMATOLOGY. Article. 172(5):786-793.
[doi:10.1111/bjh.13886]
Gómez M, Guillem V, Pereira A, Ferrer-Marín F, Álvarez-Larrán A, Kerguelen A, Estrada N, Martínez-López J, Angona A, Amat P, Navarro B, Besses C, Hernández-Boluda JC (2016).

Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 96(3):285-290.
[doi:10.1111/ejh.12588]
Forero-Castro, Maribel, Robledo, Cristina, Lumbreras, Eva, Benito, Rocio, Hernandez-Sanchez, Jesus M., Hernandez-Sanchez, Maria, Garcia, Juan L., Corchete-Sanchez, Luis A., Tormo, Mar, Barba, Pere, Menarguez, Javier, Ribera, Jordi, Grande, Carlos, Escoda, Lourdes, Olivier, Carmen, Carrillo, Estrella, Garcia de Coca, Alfonso, Ribera, Josep-Maria, Hernandez-Rivas, Jesus M. (2016).

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab

BRITISH JOURNAL OF HAEMATOLOGY. Article. 172(3):428-438.
[doi:10.1111/bjh.13849]
Ribera, JM, Garcia, O, Oriol, A, Gil, C, Montesinos, P, Bernal, T, Gonzalez-Campos, J, Lavilla, E, Ribera, J, Brunet, S, Martinez, MF, Tormo, M, Genesca, E, Barba, P, Sarra, J, Monteserin, MC, Soria, B, Colorado, M, Cladera, A, Garcia-Guinon, A, Calbacho, M, Serrano, A, Ortin, X, Pedreno, M, Amigo, ML, Escoda, L, Feliu, E, Spanish Soc Hematology (2016).

Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group

LEUKEMIA RESEARCH. Article. 41:12-20.
[doi:10.1016/j.leukres.2015.11.012]
Mateos, MV, Martinez-Lopez, J, Hernandez, MT, Ocio, EM, Rosiñol L, Martinez, R, Teruel, AI, Gutierrez, NC, Martín Ramos ML, Oriol, A, Bargay, J, Bengoechea, E, Gonzalez, Y, Pérez de Oteyza J, Gironella, M, Encinas, C, Martin, J, Cabrera, C, Paiva, B, Cedena, MT, Puig, N, Blade, J, Lahuerta, JJ, San-Miguel, J (2016).

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM

BLOOD. Article. 127(4):420-425.
[doi:10.1182/blood-2015-08-666537]
Kelleher, N, Garcia, O, Gallardo, D, Gonzalez-Campos, J, Hernandez-Rivas, JM, Montesinos, P, Sarra, J, Gil, C, Barba, P, Guardia, R, Brunet, S, Bernal, T, Martinez, MP, Abella, E, Bermudez, A, Sanchez-Delgado, M, Antonia, C, Gayoso, J, Calbacho, M, Ribera, JM, Pethema Grp, Spanish Soc Hematology (2016).

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

LEUKEMIA & LYMPHOMA. Article. 57(1):86-91.
[doi:10.3109/10428194.2015.1040013]
Cordoba R, Sanchez-Beato M, Herreros B, Domenech E, Garcia-Marco J, Garcia JF, Martinez-Lopez J, Rodriguez A, Garcia-Raso A, Llamas P, Piris MA (2016).

Two distinct molecular subtypes of chronic lymphocytic leukemia give new insights on the pathogenesis of the disease and identify novel therapeutic targets

LEUKEMIA & LYMPHOMA. Article. 57(1):134-142.
[doi:10.3109/10428194.2015.1034706]
Giraldo P, Pérez-López J, Núñez R, de la Puebla RF, Luño E, Saura-Grau S, Bureo JC, Plaza S, de la Serna J (2016).

Patients with type 1 Gaucher disease in Spain: A cross-sectional evaluation of health status

BLOOD CELLS MOLECULES AND DISEASES. Article. 56(1):23-30.
[doi:10.1016/j.bcmd.2015.10.001]
Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C, Rimashevskaya E, Pika T, Gaidano G, Weisel K, Goranova-Marinova V, Schwarer A, Minuk L, Masszi T, Karamanesht I, Offidani M, Hungria V, Spencer A, Orlowski RZ, Gillenwater HH, Mohamed N, Feng S, Chng WJ, ENDEAVOR Investigators (2016).

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

LANCET ONCOLOGY. Article. 17(1):27-38.
[doi:10.1016/S1470-2045(15)00464-7]
Leivas, Alejandra, Perez-Martinez, Antonio, Jesus Blanchard, Maria, Martin-Clavero, Estela, Fernandez, Lucia, Jose Lahuerta, Juan, Martinez-Lopez, Joaquin (2016).

Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma

OncoImmunology. Article. 5(12).
[doi:10.1080/2162402X.2016.1250051]
Post, Sean M., Gallardo, Miguel, Hornbaker, Marisa J., Zhang, Xiaorui, Bueso-Ramos, Carlos, Parker-Thornburg, Jan, Hu, Peter, Rapado, Inmaculada, Quintas-Cardama, Alfonso, Komblau, Steven M., Martinez-Lopez, Joaquin (2016).

Identification of novel regulators and therapeutic targets in hematologic malignancies

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. Meeting Abstract. 38(1):53-53.
Gonzalez-Barca, Eva, Canales, Miguel A., Salar, Antonio, Ferrer, Secundino, Domingo-Domenech, Eva, Vidal, Maria-Jesus, Grande, Carlos, Bargay, Joan, Gardella, Santiago, Oriol, Albert, Briones, Javier, Garcia-Frade, Javier, Bello, Jose L., Sanchez-Blanco, Jose J., Javier Penalver, Francisco, Francisco Tomas, Jose, Asensio, Antonio, Lopez, Andres, Caballero, Dolores, GELTAMO Grp Grp Espanol de Linfoma (2016).

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients

ACTA HAEMATOLOGICA. Article. 136(2):76-84.
[doi:10.1159/0004/1/1625]

2015

Arana, Paula, Paiva, Bruno, Puig, Noemi, Cedena, Teresa, Cordon, Lourdes, Belen Vidriales, Maria, Martinez-Lopez, Joaquin, Ocio, Enrique M., Hernandez, Miguel T., Isabel Teruel, Ana, Gironella, Mercedes, Asuncion Echeveste, M., Rosinol, Laura, Martinez, Rafael, Oriol, Albert, Blade, Joan, Jose Lahuerta, Juan, Mateos, Maria-Victoria, San Miguel, Jesus (2015).

Prognostic Value of Immune Profiling Multiple Myeloma Patients during Minimal Residual Disease Monitoring in the Pethema/GEM2010MAS65 Study

BLOOD. Meeting Abstract. 126(23).
Garcia Gigorro R, Jiménez-Ubieto A, Marín H, Morales-Varas G, Grande-García C, Montejo-González JC (2015).

Icu and long-term mortality analisis of hematology patients admitted in icu. a 7 years review from a single spanish center.

Intensive care medicine experimental. Article. 3(Suppl 1).
[doi:10.1186/2197-425X-3-S1-A244]
Sánchez-Castro J, Marco-Betés V, Gómez-Arbonés X, García-Cerecedo T, López R, Talavera E, Fernández-Ruiz S, Ademà V, Marugan I, Luño E, Sanzo C, Vallespí T, Arenillas L, Marco Buades J, Batlle A, Buño I, Martín Ramos ML, Blázquez Rios B, Collado Nieto R, Vargas MT, González Martínez T, Sanz G, Solé F (2015).

Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes

LEUKEMIA & LYMPHOMA. Article. 56(11):3183-3188.
[doi:10.3109/10428194.2015.1028053]
Mateos MV, Ocio EM, Paiva B, Rosiñol L, Martínez-López J, Bladé J, Lahuerta JJ, García-Sanz R, San Miguel JF (2015).

Treatment for patients with newly diagnosed multiple myeloma in 2015

BLOOD REVIEWS. Review. 29(6):387-403.
[doi:10.1016/j.blre.2015.06.001]
Ribera J, Morgades M, Zamora L, Montesinos P, Gómez-Seguí I, Pratcorona M, Sarrà J, Guàrdia R, Nomdedeu J, Tormo M, Martínez-Lopez J, Hernández-Rivas JM, González-Campos J, Barba P, Escoda L, Genescà E, Solé F, Millá F, Feliu E, Ribera JM (2015).

Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols

CANCER. Article. 121(21):3809-3817.
[doi:10.1002/cncr.29579]
Gallardo, Miguel, Lee, Hun Ju, Zhang, Xiaorui, Bueso-Ramos, Carlos, Pageon, Laura R., McArthur, Mark, Multani, Asha, Nazha, Aziz, Manshouri, Taghi, Parker-Thornburg, Jan, Rapado, Inmaculada, Quintas-Cardama, Alfonso, Kornblau, Steven M., Martinez-Lopez, Joaquin, Post, Sean M. (2015).

hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies

CANCER CELL. Article. 28(4):486-499.
[doi:10.1016/j.ccell.2015.09.001]
Grande Garcia, C., Kantarjian Hagop, M., Stein, A. S., Bargou Ralf, C., Larson, R. A., Stelljes, M., Benjamin, J., Jia, C., Topp Max, S. (2015).

SAFETY AND ACTIVITY OF BLINATUMOMAB IN TWO PHASE-2 TRIALS IN ELDERLY PATIENTS WITH RELAPSED OR REFRACTORY B-PRECURSOR ACUTE LYMBOBLASTIC LEUKEMIA

HAEMATOLOGICA. Meeting Abstract. 100(4):19-19.
San Miguel JF, Weisel KC, Song KW, Delforge M, Karlin L, Goldschmidt H, Moreau P, Banos A, Oriol A, Garderet L, Cavo M, Ivanova V, Alegre A, Martinez-Lopez J, Chen C, Renner C, Bahlis NJ, Yu X, Teasdale T, Sternas L, Jacques C, Zaki MH, Dimopoulos MA (2015).

Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

HAEMATOLOGICA. Article. 100(10):1334-1339.
[doi:10.3324/haematol.2015.125864]
Dimopoulos MA, Weisel KC, Song KW, Delforge M, Karlin L, Goldschmidt H, Moreau P, Banos A, Oriol A, Garderet L, Cavo M, Ivanova V, Alegre A, Martinez-Lopez J, Chen C, Spencer A, Knop S, Bahlis NJ, Renner C, Yu X, Hong K, Sternas L, Jacques C, Zaki MH, San Miguel JF (2015).

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

HAEMATOLOGICA. Article. 100(10):1327-1333.
[doi:10.3324/haematol.2014.117077]
Jimenez-Ubieto, A., Grande, G. C., Lopez, G. A., Salar, A., Caballero, D., Yanez, L., Novelli, S., Rodriguez, M. J., Manzanares, M., Arranz, R., Ferreiro, J. J., Bobillo, S., Mercadel, S., Galeo, A., Lopez Jimenez, J., Vallejo, C., Albo, C., Moraleda, J. M., Marrero, C., Magnano, L., Palomera, L., Jarque, I, Coria, E., Palomo, T., Martinez-Sanchez, P., Lahuerta Palacios, J. J. (2015).

CHARACTERISTICS OF RELAPSE AFTER THE AUTOLOGOUS TRANSPLANT OF HEMATOPOIETIC PROGENITORS (TAPH) IN FOLICULAR LYMPHOMA (LF): AN ANALYSIS WITH LONG FOLLOW UP OF THE GELTAMO RECORD

HAEMATOLOGICA. Meeting Abstract. 100(4):13-14.
Alonso Fernandez, R., Ayala Diaz, R., De la Serna Torroba, F. J., Grande Garcia, C., Rodriguez Izquierdo, A., Martinez Sanchez, P., Cedena Romero, M. T., Lahuerta Palacios, J. J., Gilsanz Rodriguez, F., Martinez Lopez, J. (2015).

ANALYSIS OF RESULTS OBTAINED IN CLINICAL TRIAL PHASE I/II FOR HAEMATOLOGICAL PATHOLOGY. EXPERIENCE IN THE HOSPITAL 12TH OCTOBER

HAEMATOLOGICA. Meeting Abstract. 100(4):117-118.
Segura, Jimenez R., Rosinol Dachs, L., Oriol Rocafiguera, A., Blanchard Rodriguez, Ma J., Palomera Bernal, L., Mateos Manteca, V, Ma, De la Rubia Comas, J., Hernandez Garcia, M. T., Diaz Medievilla, J., Hernandez Martin, M., Motllo Borrella, C., Lahuerta Palacios, J. J., San Miguel Izquierdo, J., Blade Creixenti, B. (2015).

TREATMENT OF RENAL INSUFFICIENCY IN PATIENTS WITH MULTIPLE MYELOMA DIAGNOSED AGAIN WITH BORTEZOMIB AND DEXAMETHASONE: RESULTS OF A STUDY PHASE II OF THE PETHEMA/ GEM (RENVEL) GROUP

HAEMATOLOGICA. Meeting Abstract. 100(4):47-48.
Alonso Alvarez, S., Alcoceba, M., Magnano, L., Garcia-Alvarez, M., Andrade, M., Coutinho, R., Rodriguez, G., Garcia-Pasarolls, F., Salar, A., Terol, M. J., Vega, E., Grande, C., Pardal, E., Martin, A., Lopez-Guillermo, A., Caballero, M. D. (2015).

TREATMENT OF FOLICULAR LYMPHOMA TRANSFORMED: MULTICENTRIC RETROSPECTIVE ANALYSIS OF THE SPANISH GROUP OF LYMPHOMA AND AUTOLOGOUS TRANSPLANT OF MEDULA OSEA (GELTAMO)

HAEMATOLOGICA. Meeting Abstract. 100(4):162-163.
Garcia Gutierrez, V, Colom, B., Kreutzman, A., Casado, Lf, Sanchez Guijo, F., Ayala, R., Boque, C., Xicoy, B., Montero, I, De Paz, R., Soto, C., Martinez, J., Munoz, C., Steegmann Juan, L. (2015).

INDUCED LYMPHOCYTOSIS FOLLOWING THE INTAKE OF DASATINIB IS ASSOCIATED WITH THE INHIBITION OF LYMPHOCYTARY MIGRATION AND MODIFICATION OF THE EXPRESSION OF CHEMOKINE RECEPTORS, AND SUCH INHIBITION APPEARS TO BE ASSOCIATED WITH AN EARLY RESPONSE. PRELIMINARY RESULTS OF THE CLINICAL TRIAL PHASE 2 DASAPOST

HAEMATOLOGICA. Meeting Abstract. 100(4):25-26.
Besses, C., Bello-Lopez, J. L., De la Serna, J., Hernandez-Boluda, J. C., Loscertales, J., Griesshammer, M., Gugliotta, L., Harrison, C., Kiladjian, J. J., Hamdani, M., Achenbach, H., Birgegard, G. (2015).

TREATMENT OF ESSENTIAL THROMBOCYTHEMIA IN EUROPE: OBSERVATIONAL STUDY OF 3649 PATIENTS OF HIGH RISK (EXELS)

HAEMATOLOGICA. Meeting Abstract. 100(4):29-29.
Carreno Gomez-Tarragona, G., Miras Calvo, F., Montejano Ortega, L., Cedena Romero, M. T., Martinez Lopez, J. (2015).

DARATUMUMAB INTERFERES IN THE PRE-TRANSFUSION TESTS IN THE BLOOD BANK

HAEMATOLOGICA. Meeting Abstract. 100(4):36-36.
Ruiz-Xiville, N., Morgades, M., Vives, S., Hoyos, M., Aventin, A., Espinet, B., Costa, D., Talavera, E., Navarro, B., Guardia, R., Arnan, M., Lopez-Ferre, R., Vicent, A., Calasanz, Ma J., Martin-Ramos, Ma L., Perez-Juana Del Casal, A., Such, E., Perera, M., Feliu, E., Milla, F., Brunet, S., Sierra, J., Ribera, J. M. (2015).

PROGNOSTIC SIGNIFICANCE OF HYPERDIPLOIDS IN ACUTE MYELOID LEUKEMIA (LAM)

HAEMATOLOGICA. Meeting Abstract. 100(4):145-146.
De la Iglesia, S., Cedena, T., Gomez Roncero, I, M., Arrizabalaga, B., Villegas, A. (2015).

HOW WE TREAT SURGICAL PNH PATIENTS: EXPERIENCE OF THE HPN SPANISH REGISTRY

HAEMATOLOGICA. Meeting Abstract. 100(4):30-31.
Sanchez Perez, R., Ayala Diaz, R., Alonso Fernandez, R. A., Martinez Sanchez, P., Grande, C., Ribera, J., Ribera Santasusana, J. M., Martinez Lopez, J. (2015).

ABL QUINASE DOMAIN MUTATIONS IN LCR IN TWO PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA PHI plus WITH RELAPSE IN CENTRAL NERVOUS SYSTEM

HAEMATOLOGICA. Meeting Abstract. 100(4):256-256.
Mateos Manteca, V, Ma, De la Rubia, J., Martinez, J., Perez Simon, J. A., Garrido, T. (2015).

CURRENT MANAGEMENT OF THE TREATMENT OF MULTIPLE MYELOMA IN SPAIN: MEETING OF EXPERTS OF 41 HOSPITALS

HAEMATOLOGICA. Meeting Abstract. 100(4):248-249.
Osorio Prendes, S., Casado, L. F., Giraldo, P., Redondo, S., Villalon, L., Coza, A., Garcia, D., Flores, R., Del Campo, J. F., Cordoba, R., Gongora, E., Burgaleta, C., Gomez, E., Ruiz, E., Diaz Mediavilla, J., Salvatierra, M. G., Bautista, G., Martinez Lopez, J., Jarilla, M., Calle, C., Bermon, J. S., Cervero, C., Solano, F., Lopez Gomez, L., Asensio, A., Perella, M., Gonzalez, N., Palomera, L., Benito, L., Steegmann, J. L. (2015).

CHRONIC MYELOID LEUKEMIA (LMC) IS CURRENTLY DIAGNOSED IN LESS ADVANCED SITUATION, AND IN SPAIN IN LOW RISK STAGES THAN IN NEIGHBOURING COUNTRIES

HAEMATOLOGICA. Meeting Abstract. 100(4):193-193.
Jimenez-Ubieto, A., Bellosillo, B., Gallardo, M., Ayala Diaz, R., Barrio, S., Besses, C., Martinez Lopez, J. (2015).

DEREGULATION OF MICRO RNA'S IN PATIENTS WITH POLYCYTHEMIA VERA (PV) AND ESSENTIAL THROMBOSIS (TE)

HAEMATOLOGICA. Meeting Abstract. 100(4):191-191.
Gomez Calafat, M., Alvarez-Larran, A., Ferrer-Marin, F., Raya Jose, M., Boque, C., Kerguelen, A., Garcia-Gutierrez, V, Barba, P., Luno, E., Xicoy, B., Martinez-Lopez, J., Mata, I, M., Duran, M. A., Martinez-Dominguez, J., Cuevas, B., Ramirez, M. J., Arbelo, E., Magro, E., Sonmolinos, N., Perera, M., Besses, C., Hernandez-Boluda, J. C. (2015).

SPANISH RECORD OF MYELOFIBROSIS: DESCRIPTIVE ANALYSIS

HAEMATOLOGICA. Meeting Abstract. 100(4):189-189.
Quiroz Cervantes, Keina S., Guillen Rienda, C., Ayala Diaz, R., Martinez Lopez, J. (2015).

EXPRESSION OF RPS14 IN THE MYELODYSPLASTIC SYNDROMES

HAEMATOLOGICA. Meeting Abstract. 100(4):188-188.
Jimenez-Ubieto, A., Grande Garcia, C., Lopez Guillermo, A., Salar, A., Caballero, D., Yanez, L., Novelli, S., Rodriguez, M. J., Manzanares, M., Arranz, R., Ferreiro, J. J., Bobillo, S., Mercadel, S., Galeo, A., Lopez Jimenez, J., Vallejo, C., Albo, C., Moraleda, J. M., Marrero, C., Magnano, L., Palomera, L., Jarque, I, Coria, E., Palomo, T., Martinez-Sanchez, P., Lahuerta Palacios, J. J. (2015).

IMPACT OF PREVIOUS EXPOSURE TO RITUXIMAB IN PATIENTS WITH FOLLICULAR LYMPHOMA (LF) INTENSIFIED WITH AUTOLOGOUS TRANSPLANT OF HEMATOPOIETIC PROGENITORS (TAPH): A RETROSPECTIVE ANALYSIS OF THE RECORD OF GELTAMO

HAEMATOLOGICA. Meeting Abstract. 100(4):166-167.
Lopez-Anglada, L., Alcoceba, M., Garcia-Alvarez, M., Diaz-Galvez, F. J., Bourgeois, M., Queizan, J. A., Abdolah, A., Cantalejo, R. H., Martin, G., Graciani, I. F., De Cabo, E., Montes-Fernandez, M. C., Fernandez-Ferrero, S., Alonso, J. M., Gonzalez-Diaz, M., Vidriales, M. B. (2015).

IMPACT OF THE MUTATIONAL STATE OF IGHV IN LYMPHOPROLIFERATIVE SYNDROMES CD19+CD5+(NO LLC) WITH AND WITHOUT T (11,14): IMMUNOPHENOTYPIC CHARACTERIZATION AND CLINICAL BEHAVIOUR

HAEMATOLOGICA. Meeting Abstract. 100(4):155-155.
Lopez-Anglada, L., Cueto-Felgueroso, C., Mateos Maria, V, Rosinol, L., Oriol, A., Teruel, I, A., Lopez de la Guia, A., Bengoechea, E., Palomera, L., De Arriba, F., Hernandez, J. M., Granell, M., Penalver, F. J., Garcia-Sanz, R., Besalduch, J., Gonzalez, Y., Martinez Rafael, B., Hernandez, M. T., Gutierrez, N. C., Puerta, P., Blade, J., San Miguel, J., Lahuerta, J. J., Matinez-Lopez, J. (2015).

VALUE OF THE RATIO OF FREE LIGHT CHAINS AND POTENTIAL CLINICAL UTILITY OF THE TEST OF HEAVY/ LIGHT CHAINS IN THE CONTEXT OF THREE CLINICAL ESSAYS (PETHEMA/ GEM)

HAEMATOLOGICA. Meeting Abstract. 100(4):43-44.
Genesca Ferrer, E., Berbis Serrat, G., Morgades Delafe, M., Ribera Sala, J., Guardia Sanchez, R., Montesinos Fernandez, P., Mercadal Vichez, S., Tormo Diaz, M., Almeida Parra, M., Garcia Montero, A., Gonzalez Campos, J., Fox Bueno, L., Zamora Plana, L., Vives Polo, S., Batlle Massana, M., Martinez Lopez, J., Hernandez-Rivas, J-M, Sole Ristrol, F., Feliu Frasnedo, E., Ribera, J-M (2015).

IDENTIFICATION OF ALTERATIONS IN THE NUMBER OF COPIES (CNA) AND IMPLIED MUTATIONS IN THE PROGRESION AND RELAPSE OF LAL-T

HAEMATOLOGICA. Meeting Abstract. 100(4):150-150.
Ribera, J., Morgades, M., Zamora, L., Granada, I, Junca, J., Genesca, E., Cabezon, M., Marce, S., Dominguez, D., Ruiz-Xiville, N., Guardia, R., Mercadal, S., Escoda, L., Nomdedeu, J., Esteve, J., Pratcorona, M., Brunet, S., Tormo, M., Collado, M., Martinez, J., Martinez, P., Sole, F., Milla, F., Feliu, E., Ribera, J. M. (2015).

ALTERATIONS IN THE NUMBER OF COPIES IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA OF B PRECURSORS IN 1(a) RELAPSE TREATED WITH CARE PROTOCOLS OF THE PETHEMA GROUP

HAEMATOLOGICA. Meeting Abstract. 100(4):148-148.
Ballesteros, J., Martinez Lopez, J., Martinez, D., Serrano, J., Fernandez Abellan, P., Garcia Boyero, R., Rodriguez, G., Herrera Puente, P., Vidriales Ma, B., Fernandez Ma, A., Perez Simon, J. A., Lavilla Rubira, E., Bravo De Laguna, Jimenez S., Gonzalez Fernandez, A., Alonso De Ozalla, Burgaleta C., Tormo Diaz, M., Vives Polo, S., Alonso Alonso, A., Simiele, A., Llamas, P., Martinez-Sanchez, P., Hernandez Rivas, J. A., Sierra Gil, J., Perez De Oteyza, J., Montesinos Fernandez, P. (2015).

TEST OF PERSONALIZED MEDICINE FOR PHARMACOLOGY EX VIVO IN NATIVE ENVIRONMENT FOR ACUTE MYELOID LEUKEMIA

HAEMATOLOGICA. Meeting Abstract. 100(4):145-145.
Talarn Forcadell, C., Escoda Teigell, L., Montesinos Fernandez, P., Amutio Diez, E., Pinan Frances, M. A., Gimenez Perez, T., Bru Orobal, N., Vicent Castello, A., Zamora Plana, L., Barragan Gonzalez, E., Granada Font, I, Esteve Reyner, J., Fernandez Abellan, P., Martinez Lopez, J., Brunet Mauri, S., Ribera Santasusana, J. M., Gonzalez-Campos, J., Sanz Alonso, M. A. (2015).

ACUTE PROMYELOCYTIC LEUKEMIA VARIANT. INCIDENCE AND CHARACTERISTICS OF THE REPORTED CASES IN THE PEHTEMA-LPA CASE

HAEMATOLOGICA. Meeting Abstract. 100(4):144-144.
Martin Martin, L., Lopez, A., Vidriales, B., Caballero, M. D., Silva Rodrigues, A., Ferreira, I, S., Lima, M., Almeida, S., Valverde, B., Martinez, P., Ferrer, A., Candeias, J., Ruiz-Cabello, F., Marco Buadesa, J., Sempere, A., Villamor, N., Orfao, A., Almeida, J. (2015).

CLINICAL- BIOLOGICAL CHARACTERISTICS OF THE NEOPLASMS OF BLASTIC PLASMOCYTOID DENDRITIC CELLS IN FUNCTION OF THE MATURATION STAGE OF THE TUMOUR CELLS

HAEMATOLOGICA. Meeting Abstract. 100(4):138-138.
Jimenez-Ubieto, A., Garcia-Gigorro, R., Grande Garcia, C., Martinez-Sanchez, P., Rodriguez Izquierdo, A. (2015).

SICK HAEMATO-ONCOLOGICAL ADMITTED IN AN INTENSIVE CARE UNIT(UCI). SHORT AND LONG TERM PROGNOSTICS. A REFLECTION ON ITS EFFICIENCY

HAEMATOLOGICA. Meeting Abstract. 100(4):117-117.
Segura Raquel, J., Rosinol, L., Teruel, I, A., De la Rubia, J., Mateos, V, Ma, Hernandez, M. T., Hernandez, D., Blanchard, Ma J., Inigo, B., Palomera, L., Krsnik, I, Francisco Tomas, J., Gutierrez, C. N., San Miguel, J., Lahuerta, J. J., Blade, J., Grp Espanol de Mieloma PETHEMA GEM (2015).

RESULTS OF 66 PATIENTS WITH EXTRAMEDULLARY PLASMACYTOMAS (PE) INCLUDED IN THE STUDY PHASE III OF THE PETHEMA/ GEM GROUP OF THERAPY OF INDUCTION PREVIOUS TO AUTOLOGOUS TRANSPLANT OF HEMATOPOIETIC PROGENITORS IN MULTIPLE MYELOMA

HAEMATOLOGICA. Meeting Abstract. 100(4):42-42.
de Lacalle Juega, Lopez A., Cedena Romero, M. T., Ayala Diaz, R., Martinez Lopez, J., Gilsanz Rodriguez, F. (2015).

ASSESSMENT OF IMPACT OF TP53 IN DIFFERENT HAEMATOLOGICAL NEOPLASIAS

HAEMATOLOGICA. Meeting Abstract. 100(4):81-82.
Canal Lopez, A., Rueda, D., Martinez, L. J. (2015).

HEALTHY BONE MARROW STROMAL CELLS INDUCE APOPTOSIS OF CELLS OF MYELOMA COOPERATING WITH ANTIMYELOMA DRUGS

HAEMATOLOGICA. Meeting Abstract. 100(4):63-64.
Canal Lopez, A., Rueda, D., Atanasio, P., Diaz-Rodriguez, E., Martinez, J. (2015).

PHARMACOLOGICAL INHIBITION OF MET DESTROYS MULTIPLE MYELOMA CLONOGENIC TUMOR CELL

HAEMATOLOGICA. Meeting Abstract. 100(4):61-61.
Sanchez-Vega Carrion, B., Ruiz, Y., Barrios, S., Maldonado, R., Marin, C., Rapado, I, Ayala, R., Cedena, T., Paiva, B., Garcia-Sanz, R., Jimenez, C., Mateos, V, M., Rosinol, L., Blade, J., San Miguel, J., Lahuerta, J. J., Martinez, L. J. (2015).

PROGNOSTIC VALUE OF SEQUENCING-BASED MINIMAL RESIDUAL DISEASE DETECTION IN PATIENTS WITH MULTIPLE MYELOMA

HAEMATOLOGICA. Meeting Abstract. 100(4):60-60.
Ruiz Heredia, Y., Sanchez-Vega, B., Rapado, I, Ayala, R., Garcia-Sanz, R., Jimenez, C., Sanchez Guijarro, M. L., Mateos, M., Blade, J., San Miguel, J., Lahuerta, J. J., Martinez-Lopez, J. (2015).

IMPLEMENTATION OF A MULTIPLE MYELOMA SPECIFIC CUSTOM 77-GENE MUTATION PANEL

HAEMATOLOGICA. Meeting Abstract. 100(4):60-60.
Leivas, A., Perez-Martinez, A., Blanchard, M. J., Campana, D., Lahuerta, J. J., Martinez-Lopez, J. (2015).

REPEATED INFUSIONS OF NK AUTOLOGOUS CELLS ACTIVATED AND EXPANDED IN COMBINATION WITH ANTIMYELOMA DRUGS: A NEW THERAPEUTIC OPTION AGAINST REFRACTORY MULTIPLE MYELOMA

HAEMATOLOGICA. Meeting Abstract. 100(4):50-51.
Montesdeoca, R. S., Kerguelen, A., Hernandez Boluda, J. C., Perez Encinas, M., Araguees, P., Ferrer, F., Mata, M., Redondo, S., Gar, V, Martinez Lopez, J., Cuevas, B., Barez, A., Burgaleta, E., De la Fuente, I, Hernandez Rivas, J. A., Xicoy, B., Duran, M. A., Gomez, M. T., Boque, C., Caballero, M., Besses, C., Alvarez Larran, A. (2015).

TREATMENT OF POLYCYTHEMIA VERA WITH HYDROXYUREA: RATE OF RESPONSE, RESISTANCE/ INTOLERANCE AND EVOLUTIVE COMPLICATIONS IN A SERIES OF 1165 PATIENTS

HAEMATOLOGICA. Meeting Abstract. 100(4):24-24.
Onecha De La Fuente, M. E., Rapado, I, Barrio, S., Castro, N., Alonso, R., Sanchez, J. M., Martinez-Sanchez, P., Barragan, E., Martinez Lopez, J., Ayala, R. (2015).

MUTATIONAL PROFILE STUDY OF DIAGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) BY NEXT GENERATION SEQUENCING (NGS)

HAEMATOLOGICA. Meeting Abstract. 100(4):19-20.
Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, Richardson P, Caltagirone S, Lahuerta JJ, Facon T, Bringhen S, Gay F, Attal M, Passera R, Spencer A, Offidani M, Kumar S, Musto P, Lonial S, Petrucci MT, Orlowski RZ, Zamagni E, Morgan G, Dimopoulos MA, Durie BG, Anderson KC, Sonneveld P, San Miguel J, Cavo M, Rajkumar SV, Moreau P (2015).

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

JOURNAL OF CLINICAL ONCOLOGY. Article. 33(26):2863-2863.
[doi:10.1200/JCO.2015.61.2267]
Cibeira, Maria T., Oriol, Albert, Lahuerta, Juan J., Mateos, Maria-Victoria, de la Rubia, Javier, Hernandez, Miguel T., Granell, Miquel, Fernandez de Larrea, Carlos, San Miguel, Jesus F., Blade, Joan (2015).

A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis

BRITISH JOURNAL OF HAEMATOLOGY. Article. 170(6):804-813.
[doi:10.1111/bjh.13500]
Martinez-Lopez, Joaquin, Paiva, Bruno, Lopez-Anglada, Lucia, Mateos, Maria-Victoria, Cedena, Teresa, Vidriales, Maia-Belen, Auxiliadora Saez-Gomez, Maria, Contreras, Teresa, Oriol, Albert, Rapado, Inmaculada, Teruel, Ana-Isabel, Cordon, Lourdes, Jesus Blanchard, Maria, Bengoechea, Enrique, Palomera, Luis, de Arriba, Felipe, Cueto-Felgueroso, Cecilia, Orfao, Alberto, Blade, Joan, San Miguel, Jesus F., Jose Lahuerta, Juan, Grp Espanol Mieloma Multiple, Programa Estudio Terapeutica Hemop (2015).

Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality

BLOOD. Article. 126(7):858-862.
[doi:10.1182/blood-2015-04-638742]
Martín-Martín L, López A, Vidriales B, Caballero MD, Rodrigues AS, Ferreira SI, Lima M, Almeida S, Valverde B, Martínez P, Ferrer A, Candeias J, Ruíz-Cabello F, Buadesa JM, Sempere A, Villamor N, Orfao A, Almeida J (2015).

Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile

Oncotarget. Article. 6(22):19204-19216.
[doi:10.18632/oncotarget.4146]
Sanz, Miguel A., Montesinos, Pau, Kim, Haesook T., Ruiz-Argueelles, Guillermo J., Undurraga, Maria S., Uriarte, Maria R., Martinez, Lem, Jacomo, Rafael H., Gutierrez-Aguirre, Homero, Melo, Raul A. M., Bittencourt, Rosane, Pasquini, Ricardo, Pagnano, Katia, Fagundes, Evandro M., Vellenga, Edo, Holowiecka, Alexandra, Gonzalez-Huerta, Ana J., Fernandez, Pascual, De la Serna, Javier, Brunet, Salut, De Lisa, Elena, Gonzalez-Campos, Jose, Ribera, Jose M., Krsnik, Isabel, Ganser, Arnold, Berliner, Nancy, Ribeiro, Raul C., Lo-Coco, Francesco, Lowenberg, Bob, Rego, Eduardo M., IC-APL Grp, PETHEMA Grp, HOVON Grp (2015).

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

ANNALS OF HEMATOLOGY. Article. 94(8):1347-1356.
[doi:10.1007/s00277-015-2393-0]
Carreno-Tarragona, Gonzalo, Trapiello-Valbuena, Francisco, Aranda-Salom, Judit, Martinez-Lopez, Joaquin, Lumbreras, Carlos, Oliveira-Ramirez, Encarnacion, Diaz-Pedroche, Carmen (2015).

Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III

ANNALS OF HEMATOLOGY. Letter. 94(8):1411-1412.
[doi:10.1007/s00277-015-2379-y]
Mateos MV, Oriol A, Rosiñol L, de Arriba F, Puig N, Martín J, Martínez-López J, Echeveste MA, Sarrá J, Ocio E, Ramírez G, Martínez R, Palomera L, Payer A, Iglesias R, De la Rubia J, Alegre A, Chinea AI, Bladé J, Lahuerta JJ, San Miguel JF (2015).

Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial

HAEMATOLOGICA. Article. 100(8):1096-1102.
[doi:10.3324/haematol.2015.124818]
Castro N, Rapado I, Ayala R, Martinez-Lopez J (2015).

CALR mutations screening should not be studied in splanchnic vein thrombosis

BRITISH JOURNAL OF HAEMATOLOGY. Letter. 170(4):588-589.
[doi:10.1111/bjh.13314]
Rios, Rafael, Belen Lupianez, Carmen, Campa, Daniele, Martino, Alessandro, Martinez-Lopez, Joaquin, Martinez-Bueno, Manuel, Varkonyi, Judit, Garcia-Sanz, Ramon, Jamroziak, Krzysztof, Dumontet, Charles, Jerez Cayuela, Andres, Wetek, Marzena, Landi, Stephano, Rossi, Anna Maria, Lesueur, Fabienne, Reis, Rui Manuel, Moreno, Victor, Marques, Herlander, Jurczyszyn, Artur, Andersen, Vibeke, Vogel, Ulla, Buda, Gabriele, Orciuolo, Enrico, Jacobsen, Svend E. H., Petrini, Mario, Vangsted, Annette J., Gemignani, Federica, Canzian, Federico, Jurado, Manuel, Sainz, Juan (2015).

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium

ENDOCRINE-RELATED CANCER. Article. 22(4):545-559.
[doi:10.1530/ERC-15-0029]
Martinez-Lopez, Joaquin, Jimenez, Ana, Sanchez-Calero, Jorge, Monteagudo, Dolores, Urbanowicz, Maria, Canamares-Orbis, Irene, Cortijo-Cascajares, Susana, Ayala, Rosa (2015).

Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor

ANNALS OF HEMATOLOGY. Letter. 94(7):1237-1239.
[doi:10.1007/s00277-015-2352-9]
Casado, Luis-Felipe, Garcia-Gutierrez, Jose-Valentin, Massague, Isabel, Giraldo, Pilar, Perez-Encinas, Manuel, de Paz, Raquel, Martinez-Lopez, Joaquin, Bautista, Guiomar, Osorio, Santiago, Requena, Maria-Jose, Palomera, Luis, Penarrubia, Maria-Jesus, Calle, Carmen, Hernandez-Rivas, Jose-Angel, Burgaleta, Carmen, Maestro, Begona, Garcia-Ormena, Nuria, Steegmann, Juan-Luis (2015).

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months

Cancer Medicine. Article. 4(7):995-1002.
[doi:10.1002/cam4.440]
Panizo, Carlos, Jaramillo Rodriguez, Anny, Gutierrez, Gonzalo, Javier Diaz, Francisco, Gonzalez-Barca, Eva, de Ona, Raquel, Grande, Carlos, Manuel Sancho, Juan, Flor Garcia-Alvarez, Maria, Sanchez-Gonzalez, Blanca, Javier Penalver, Francisco, Cannata, Jimena, Espeso, Manuel, Jose Requena, Maria, Gardella, Santiago, Duran, Soledad, Pilar Gonzalez, Ana, Alfonso, Ana, Dolores Caballero, Marla, Grp Espanol Linfomas, Trasplante Autologo Medula Osea GE (2015).

Evaluation of Clinical and Biological Prognostic Factors in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients After Previous Treatment With Rituximab and Chemotherapy: Results of the PRO-R-IPI Study

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Article. 15(7):398-403.
[doi:10.1016/j.clml.2015.02.029]
Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzinski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Vangsted AJ, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C (2015).

Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

NATURE COMMUNICATIONS. Article. 6:7539-7539.
[doi:10.1038/ncomms8539]
Arellano-Rodrigo, E., Hernandez-Boluda, J. C., Cervantes, F., Alvarez-Larran, A., Gomez, M., Barba, P., Mata, I, M., Gonzalez-Porras, J. R., Ferrer-Marin, F., Garcia-Gutierrez, V, Magro, E., Moreno, M., Kerguelen, A., Perez-Encinas, M., Estrada, N., Ayala, R., Besses, C., Pereira, A., Grp Espanolde Enfermedades (2015).

Oral anticoagulant therapy for the prevention of recurrent thrombosis in patients with polycythemia vera or essential thrombocythemia

JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Meeting Abstract. 13(2, SI):683-683.
Hernandez-Boluda, Juan-Carlos, Arellano-Rodrigo, Eduardo, Cervantes, Francisco, Alvarez-Larran, Alberto, Gomez, Montse, Barba, Pere, Mata, Maria-Isabel, Gonzalez-Porras, Jose-Ramon, Ferrer-Marin, Francisca, Garcia-Gutierrez, Valentin, Magro, Elena, Moreno, Melania, Kerguelen, Ana, Perez-Encinas, Manuel, Estrada, Natalia, Ayala, Rosa, Besses, Carles, Pereira, Arturo, Grp Espanol Enfermedades (2015).

Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia

ANNALS OF HEMATOLOGY. Article. 94(6):911-918.
[doi:10.1007/s00277-015-2330-2]
Pineda M, González-Acosta M, Thompson BA, Sánchez R, Gómez C, Martínez-López J, Perea J, Caldés T, Rodríguez Y, Landolfi S, Balmaña J, Lázaro C, Robles L, Capellá G, Rueda D (2015).

Detailed characterization of MLH1 p.D41H and p.N710D variants coexisting in a Lynch syndrome family with conserved MLH1 expression tumors

CLINICAL GENETICS. Article. 87(6):543-548.
[doi:10.1111/cge.12467]
Sanchez-Tome, E., Rivera, B., Perea, J., Pita, G., Rueda, D., Mercadillo, F., Canal, A., Gonzalez-Neira, A., Benitez, J., Urioste, M. (2015).

Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X

JOURNAL OF GASTROENTEROLOGY. Article. 50(6):657-666.
[doi:10.1007/s00535-014-1009-0]
Valcarcel, David, Sanz, Guillermo, Ortega, Margarita, Nomdedeu, Benet, Luno, Elisa, Diez-Campelo, Maria, Teresa Ardanaz, Maria, Pedro, Carmen, Montoro, Julia, Collado, Rosa, Andreu, Rafa, Marco, Victor, Teresa Cedena, Maria, de Paz, Raquel, Tormo, Mar, Xicoy, Blanca, Ramos, Fernando, Bargay, Joan, Gonzalez, Bernardo, Brunet, Salut, Antonio Munoz, Juan, Gomez, Valle, Bailen, Alicia, Sanchez, Joaquin, Merchan, Brayan, del Canizo, Consuelo, Vallespi, Teresa, Grp Espanol Sindromes Mielodisplas (2015).

Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study

Lancet Haematology. Article. 2(6):260-266.
[doi:10.1016/S2352-3026(15)00067-8]
Paíno T, Paiva B, Sayagués JM, Mota I, Carvalheiro T, Corchete LA, Aires-Mejía I, Pérez JJ, Sanchez ML, Barcena P, Ocio EM, San-Segundo L, Sarasquete ME, García-Sanz R, Vidriales MB, Oriol A, Hernández MT, Echeveste MA, Paiva A, Blade J, Lahuerta JJ, Orfao A, Mateos MV, Gutiérrez NC, San-Miguel JF (2015).

Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

LEUKEMIA. Article. 29(5):1186-1194.
[doi:10.1038/leu.2014.321]
Font, Patricia, Loscertales, Javier, Soto, Carlos, Ricard, Pilar, Munoz-Novas, Carolina, Martin-Clavero, Estela, Lopez-Rubio, Montserrat, Garcia-Alonso, Luis, Callejas, Marta, Bermejo, Alfredo, Benavente, Celina, Ballesteros, Monica, Cedena, Teresa, Calbacho, Maria, Urbina, Raquel, Villarrubia, Jesus, Gil, Santiago, Maria Bellon, Jose, Luis Diez-Martin, Jose, Villegas, Ana (2015).

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

ANNALS OF HEMATOLOGY. Article. 94(4):565-573.
[doi:10.1007/s00277-014-2252-4]
Campa D, Martino A, Varkonyi J, Lesueur F, Jamroziak K, Landi S, Jurczyszyn A, Marques H, Andersen V, Jurado M, Brenner H, Petrini M, Vogel U, García-Sanz R, Buda G, Gemignani F, Ríos R, Vangsted AJ, Dumontet C, Martínez-López J, Moreno MJ, Stepien A, Watek M, Moreno V, Dieffenbach AK, Rossi AM, Butterbach K, Jacobsen SE, Goldschmidt H, Sainz J, Hillengass J, Orciuolo E, Dudzinski M, Weinhold N, Reis RM, Canzian F (2015).

Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

INTERNATIONAL JOURNAL OF CANCER. Article. 136(5):351-358.
[doi:10.1002/ijc.29101]
Ferra, Christelle, Sanz, Jaime, Diaz-Perez, Miguel-Angel, Morgades, Mireia, Gayoso, Jorge, Cabrera, Jose-Rafael, Villaescusa, Teresa, Sampol, Maria-Antonia, Fernandez-Aviles, Francesc, Solano, Carlos, Ortin, Miguel, Duarte, Rafael, Cuesta, Marian, Heras, Inmaculada, de la Serna, Javier, Moraleda, Jose-Maria, Barrenetxea, Cristina, Gonzalez-Vicent, Marta, Sanz, Guillermo, Ribera, Josep-Maria, Grp Espanol Trasplante Hematopoyet (2015).

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

LEUKEMIA & LYMPHOMA. Article. 56(3):656-662.
[doi:10.3109/10428194.2014.930849]
Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, Raje N, Sezer O, Zweegman S, Shah J, Badros A, Shimizu K, Moreau P, Chim CS, Lahuerta JJ, Hou J, Jurczyszyn A, Goldschmidt H, Sonneveld P, Palumbo A, Ludwig H, Cavo M, Barlogie B, Anderson K, Roodman GD, Rajkumar SV, Durie BG, Terpos E (2015).

Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement

JOURNAL OF CLINICAL ONCOLOGY. Article. 33(6):657-186.
[doi:10.1200/JCO.2014.57.9961]
Paiva B, Chandia M, Puig N, Vidriales MB, Perez JJ, Lopez-Corral L, Ocio EM, Garcia-Sanz R, Gutierrez NC, Jimenez-Ubieto A, Lahuerta JJ, Mateos MV, San Miguel JF (2015).

The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma

HAEMATOLOGICA. Letter. 100(2):53-55.
[doi:10.3324/haematol.2014.115162]
Blanes, Margarita, Gonzalez, Jose D., Lahuerta, Juan J., Ribas, Paz, Lorenzo, Ignacio, Boluda, Blanca, Sanz, Miguel A., de la Rubia, Javier (2015).

Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma

LEUKEMIA & LYMPHOMA. Article. 56(2):415-419.
[doi:10.3109/10428194.2014.922182]
Perez-Lopez, Jordi, Giraldo, Pilar, Nunez, Ramiro, Fernandez de la Puebla, Rafael, Luno, Elisa, Saura-Grau, Salvador, Carlos Bureo, Juan, de la Serna, Javier, Plaza, Sylvia, Navas, Victor (2015).

Epidemiological assessment of Spanish patients with type 1 Gaucher disease using the therapeutic goals MAP Tool (R)

MOLECULAR GENETICS AND METABOLISM. Meeting Abstract. 114(2):92-93.
[doi:10.1016/j.ymgme.2014.12.206]
Fulciniti, Mariateresa, Munshi, Nikhil C., Martinez-Lopez, Joaquin (2015).

Deep Response in Multiple Myeloma: A Critical Review

BIOMED RESEARCH INTERNATIONAL. Review. 2015:832049-832049.
[doi:10.1155/2015/832049]
Saumell, Silvia S, Florensa, Lourdes F, Rodriguez-Rivera, Maria R, Pedro, Carme P, Maria Hernandez-Rivas, Jesus M, Lumbreras, Eva L, Abaigar, Maria A, Collado, Rosa C, Ivars, David I, Carbonell, Felix C, Marugan, Isabel M, Toromo, Mar T, Botia, Mercedes B, Angeles Pinan, Maria A, Ancin, Idoia A, Gonzalez, Teresa G, Diaz Varela, Nicholas D, Grau, Javier G, Granada, Isabel G, Ruiz, Neus R, Luisa Martin, Maria L, Fernandez-Guijarro, Manuela F, Duarte, Jose-Joaquin D, Jose Calasanz, Maria J, Jose Larrayoz, Maria J, Sole, Francesc S (2015).

Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia

LEUKEMIA & LYMPHOMA. Letter. 56(1):242-243.
[doi:10.3109/10428194.2014.914197]
Lopez A, Mateos MV, Oriol A, Valero M, Martínez J, Lorenzo JI, Perez M, Martinez R, de Paz R, Granell M, De Arriba F, Blanchard MJ, Peñalver FJ, Bello JL, Martin ML, Bargay J, Blade J, Lahuerta JJ, San Miguel JF, de la Rubia J (2015).

Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.

Leukemia research reports. Article. 4(2):64-69.
[doi:10.1016/j.lrr.2015.09.002]
Lapthorn, Cris, Pullen, Frank S., Chowdhry, Babur Z., Wright, Patricia, Perkins, George L., Heredia, Yanira (2015).

How useful is molecular modelling in combination with ion mobility mass spectrometry for 'small molecule' ion mobility collision cross-sections?

Analyst. Article. 14(20):6814-6823.
[doi:10.1039/c5an00411j]
Hernández JA, Lahuerta JJ (2015).

Biclonal gammopathies: A different significance?

REVISTA CLINICA ESPANOLA. Editorial Material. 215(1):31-32.
[doi:10.1016/j.rce.2014.10.007]

2014

Motllo, Cristina, Ribera, Josep-Maria, Morgades, Mireia, Granada, Isabel, Montesinos, Pau, Gonzalez-Campos, Jose, Fernandez-Abellan, Pascual, Tormo, Mar, Bethencourt, Concepcion, Brunet, Salut, Hernandez-Rivas, Jesus-Maria, Moreno, Maria-Jose, Sarra, Josep, del Potro, Eloy, Barba, Pere, Bernal, Teresa, Grande, Carlos, Grau, Javier, Cervera, Jose, Feliu, Evarist, PETHEMA Grp, Spanish Soc Hematology (2014).

Prognostic Significance of Complex Karyotype and Monosomal Karyotype in Adult Patients With Acute Lymphoblastic Leukemia Treated With Risk-Adapted Protocols

CANCER. Article. 120(24):3958-3964.
[doi:10.1002/cncr.28950]
Paiva, Bruno, Puig, Noemi, Vidriales, Maria-Belen, Carmen Gutierrez, Norma, Hernandez, Miguel T., Rosinol, Laura, Ocio, Enrique M., Oriol, Albert, Asuncion Echeveste, Mara, Gonzalez, Yolanda, Gironella, Mercedes, Prieto, Julio, Jose Moreno, Maria, Giraldo, Pilar, Palomera, Luis, Aoiz, Intza, Blade, Joan, Jose Lahuerta, Juan, Mateos, Maria-Victoria, San Miguel, Jesus F. (2014).

Defining the Differentiation Stage of Multiple Myeloma Plasma Cells: Biological and Clinical Significance

BLOOD. Meeting Abstract. 124(21).
Martin, Alejandro, Maria Redondo, Alba, Valcarcel, David, Pilar Gonzalez, Ana, Lopez-Guillermo, Armando, Luis Bello, Jose, Canales, Miguel A., Gayoso, Jorge, Conde, Eulogio, Jarque, Isidro, Del Campo, Raquel, Arranz, Reyes, Terol, Maria-Jose, Rifon, Jose J., Rodriguez, Maria-Jose, Ramirez, Maria-Jose, Grande, Carlos, Sanchez, Andres, Lopez-Jimenez, Javier, Caballero, Dolores (2014).

A Phase 2 Study from Spanish Geltamo Group Investigating the Efficacy and Safety of Bendamustine As Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients with Aggressive Lymphomas: Second Interim Analysis

BLOOD. Meeting Abstract. 124(21).
Hernandez, Pilar, Montesinos, Pau, Serrano, Josefina, Herrera, Pilar, Pedro Bergua, Juan, Colorado, Mercedes, Gonzalez, Bernando J., Gomez, Cristina, Robles, Alicia, Gorrochategui, Julian, Sanchez, Jesus, Ballesteros, Joan, Moscardo, Federico, Martinez, David, Angel Sanz, Miguel, Perez de Oteyza, Jaime, Martinez, Joaquin (2014).

Novel Assay for Ex Vivo Evaluation of Antiproliferative Effect of Hypomethylating Agents 5-Azacytidine and Decitabine in AML Patient Samples

BLOOD. Meeting Abstract. 124(21).
Martinez-Laperche, Carolina, Kwon, Mi, Carolina Franco, Ana, Chillon, Carmen, Castro, Nerea, Anguita, Eduardo, Rodriguez, Carlos, Dolz, Sandra, Hermosn, Lourdes, Buces, Elena, Lopez-Parra, Miriam, Isabel Prieto, Maria, Ramos-Ortega, Fernando, Nicolas Rodriguez, J., Barragan, Eva, Gomez-Casares, Maite, Ayala, Rosa M., Martinez, Joaquin, Gonzalez, Marcos, Diez Martin, Jose Luis, Buno, Ismael (2014).

Wilms' Tumor 1 Expression Levels in Bone Marrow after Induction and/or Consolidation Therapy Allow a Better Stratification of Patients and Improves Treatment in Adult AML

BLOOD. Meeting Abstract. 124(21).
Paiva, Bruno, Angeles Montalban, Maria, Puig, Noemi, Cordon, Lourdes, Martinez-Lopez, Joaquin, Ocio, Enrique M., Hernandez, Miguel, Isabel Teruel, Ana, Gironella, Mercedes, Asuncion Echeveste, Maria, Rosinol, Laura, Martinez, Rafael, Oriol, Albert, Martin, Jesus, Encinas, Cristina, Carmen Gutierrez, Norma, Vidriales, Mara-Belen, Blade, Joan, Jose Lahuerta, Juan, Mateos, Maria-Victoria, San Miguel, Jesus F. (2014).

Clinical Significance of Sensitive Flow-MRD Monitoring in Elderly Multiple Myeloma Patients on the Pethema/GEM2010MAS65 Trial

BLOOD. Meeting Abstract. 124(21).
Mateos, Maria-Victoria, Hernandez, Miguel T., Giraldo, Pilar, De La Rubia, Javier, de Arriba, Felipe, Lopez-Corral, Luca, Rosinol, Laura, Paiva, Bruno, Palomera, Luis, Bargay, Joan, Oriol, Albert, Prosper, Felipe, Lopez, Javier, Olavarra, Eduardo, Quintana, Nuria, Luis Garcia, Jose, Blade, Joan, Jose Lahuerta, Juan, San Miguel, Jesus F. (2014).

Long Term Follow-up on the Tretament of High Risk Smoldering Myeloma with Lenalidomide Plus Low Dose Dex (Rd) (phase III spanish trial): Persistent Benefit in Overall Survival

BLOOD. Meeting Abstract. 124(21).
Rosinol, Laura, Oriol, Albert, Jesus Blanchard, M., Palomera, Luis, Mateos, Maria-Victoria, De La Rubia, Javier, Hernandez, Miguel T., Diaz-Mediavilla, Joaqui, Mariano Hernandez, Jose, Jimenez, Raquel, Motllo, Cristina, Jose Lahuerta, Juan, San Miguel, Jesus F., Blade, Joan (2014).

Tumor and Renal Response in Patients with Newly Diagnosed Multiple Mieloma and Renal Failure Treated with Bortezomib and Dexamethasone: Results of a Prospective Phase II Trial from Pethema/GEM

BLOOD. Meeting Abstract. 124(21).
Rosinol, Laura, Oriol, Albert, Teruel, Ana Isabel, Hernandez, Dolores, Jesus Blanchard, M., De La Rubia, Javier, Granell, Miquel, Besalduch, Juan, Palomera, Luis, Gonzalez, Yolanda, Ma Asuncion, Etxebeste, Diaz-Mediavilla, Joaquin, Hernandez, Miguel T., de Arriba, Felipe, Carmen Gutierrez, Norma, Mateos, Maria-Victoria, Martinez-Lopez, Joaquin, Alegre, Adrian, Feng, Huaibao, van de Velde, Helgi, Jose Lahuerta, Juan, San Miguel, Jesus F., Blade, Joan (2014).

Kinetics of Response to Bortezomib/Thalidomide/Dexamethasone (VTD) in Multiple Myeloma: Implications for the Choice and Design of Pretransplantation Induction Regimens

BLOOD. Meeting Abstract. 124(21).
Ribera, Jordi, Zamora, Lurdes, Genesca, Eulalia, Morgades, Mireia, Montesinos, Pau, Sarra, Jose, Guardia, Ramon, Gomez-Segui, Ines, Pratcorona, Marta, Esteve, Jordi, Nomdedeu, Josep F., Brunet, Salut, Escoda, Lourdes, Tormo, Mar, Collado, Maria, Martinez, Joaquin, Maria Hernandez-Rivas, Jesus, Martinez-Sanchez, Pilar, Gonzalez, Marcos, Gonzalez-Campos, Jose, Trujillo, Pablo, Barba, Pere, Granada, Isabel, Sole, Francesc, Milla, Fuensanta, Feliu, Evarist, Ribera, Josep-Maria (2014).

Genetic Markers Add Significant Prognostic Information to Age and WBC Count in High-Risk, Ph-Negative, B-Precursor Adult Acute Lymphoblastic Leukemia (ALL): Study of 96 Patients Treated According to Risk-Adapted Protocols from the Pethema Group

BLOOD. Meeting Abstract. 124(21).
Primo, Daniel, De la Serna, Javier, Martinez, Joaquin, Gonzalez, Marcos, Lopez, Javier, Barez, Abelardo, Ortiz, Macarena, Loscertales, Javier, Vidyn, Julian, Rodriguez, Alicia, Polo, Marta, Irhaeta, Sandra, Maria Alonso, Jose, Antonio Queizan, Jose, Hernandez Rivas, Jose Angel, Jesus Penarrubia, Maria, Gorrochategui, Julian, Belen Espinosa, Ana, Arroyo, Elena, Oates, Melanie, Pettit, Andrew R., Ballesteros, Joan, Hernandez, Pilar (2014).

Development of a High-Throughput Screening Assay with Nurse-like Cell-Based Microenviroment in Chronic Lymphoid Leukemia Cells.

BLOOD. Meeting Abstract. 124(21).
Garcia-Noblejas, Ana, Conde, Eulogio, Martin, Alejandro, Jesus Vidal, Maria, Rojas, Rafael, Grande, Carlos, Jose Ramirez, Mara, Cannata-Ortiz, Jimena, Carlos Garcia-Ruiz, Juan, Briones, Javier, Lopez, Andres, Ros Rull, Pablo, Noriega, Victor, Deben, Guillermo, Gonzalez Barca, Eva, Gonzalez de Villambrosia, Sonia, Javier Ferreiro, Jose, Jose Lahuerta, Juan, Dolores Caballero, Maria, Arranz, Reyes (2014).

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

BLOOD. Meeting Abstract. 124(21).
Nomdedeu, Meritxell, Calvo, Xavier, Pereira, Arturo, Costa, Dolors, Pedro, Carmen, Teresa Cedena, Maria, Lopez-Pavia, Maria, Africa Martin, Ana, Martinez de Sola, Montserrat, Marcel Merchan, Brayan, Teresa Ardanaz, Maria, Esteve, Jordi, Cobo, Francesc, Sanz, Guillermo F., Nomdedeu, Benet (2014).

Clinical Features and Prognostic Assessment in 233 Patients with Therapy-Related Myelodysplastic Syndromes: The IPSS-R Is a Powerful Predictor of Outcome

BLOOD. Meeting Abstract. 124(21).
Mateos, Maria-Victoria, Martinez-Lopez, Joaquin, Hernandez, Miguel-T, Martinez, Rafael, Rosinol, Laura, Ocio, Enrique M., Asuncion Echeveste, Maria, Perez de Oteyza, Jaime, Oriol, Albert, Bargay, Joan, Gironella, Mercedes, Martin, Jesus, Cabrera, Carmen, De La Rubia, Javier, Gutierrez, Norma C., Martin, Maria-Luisa, Paiva, Bruno, Angeles Montalban, Maria, Blade, Joan, Jose Lahuerta, Juan, San Miguel, Jesus F. (2014).

Comparison of Sequential Vs Alternating Administration of Bortezomib, Melphalan, Prednisone (VMP) and Lenalidomide Plus Dexamethasone (Rd) in Elderly Pts with Newly Diagnosed Multiple Myeloma (MM) Patients: GEM2010MAS65 Trial

BLOOD. Meeting Abstract. 124(21).
[doi:10.1182/blood.V124.21.178.178]
Zinzani, Pier Luigi, Coiffier, Bertrand, Radford, John, Caballero, Dolores, Fields, Paul, Chamuleau, Martine E. D., d'Amore, Francesco, Haioun, Corinne, Thieblemont, Catherine, Gonzalez Barca, Eva, Grande Garcia, Carlos, Johnson, Peter W., van Imhoff, Gustaaf W., Saunders, Andrew, Dwyer, Karen, Morschhauser, Franck (2014).

A Phase II Open- Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)

BLOOD. Meeting Abstract. 124(21).
[doi:10.1182/blood.V124.21.3088.3088]
Primo, Daniel, Ballesteros, Joan, Jimenez, Antonio, Gonzalez, Ataulfo, Hernandez, Miguel, Cordoba, Raul, Gonzalez, Yolanda, Jose Moreno, Hernan, Bailen, Alicia, Martin, Jesus, Chinea, Anabelle, Etxeveste, Asuncion, Mariano Hernandez, Jose, Oriol, Albert, Perez de Oteiza, Jaime, Palomera, Luis, Encinas, Cristina, Prosper, Felipe, Iglesias, Rebeca, Rosinol, Laura, Robles, Alicia, Gorrochategui, Julian, Garcia, Veronica, Hernandez, Pilar, Ocio, Enrique, Martinez, Joaquin (2014).

Novel Ex Vivo Assay Measures Drug-Induced Depletion of Hematopoietic Progenitors As an Estimate of Hematotoxicity

BLOOD. Meeting Abstract. 124(21).
Alegre, Adrian, Gironella, Merche, Miguel Bergua, Juan, Gonzalez, Esther, Escalante, Fernando, Soler, Alfon, Sampol, Antonia, Pilar Gonzalez, Ana, Cabanas, Valentin, Jose Lahuerta, Juan, Lopez, Aurelio, Dios, Ana, Barez, Abelardo, Ruiz, Antonio, Vilanova, David, Diaz-Mediavilla, Joaquin (2014).

Observational Prospective Registry for the Assessment of the Clinical Impact of Starting Anti-Myeloma Treatment at Biological Relapse

BLOOD. Meeting Abstract. 124(21).
Arenas, Alicia, Hernandez-Campo, Pilar, Gorrochategui, Julian, Primo, Daniel, Ayala, Rosa M., Ferrer-Lores, Blanca, Ballesteros, Joan, Martinez-Lopez, Joaquin (2014).

Ruxolitinib in Combination with Nilotinib and Prednisolone, a New Synergistic Approach to Treat Myelofibrosis

BLOOD. Meeting Abstract. 124(21).
Blade, Joan, Oriol, Albert, Jose Lahuerta, Juan, Mateos, Maria-Victoria, de la Rubia, Javier, Hernandez, Miguel T., Granell, Miquel, Fernandez de larrea, Carlos, San Miguel, Jesus F., Teresa Cibeira, M. (2014).

Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CYCLO-LEN-DEX) for Previously Untreated Patients with Light-Chain Amyloidosis (AL)

BLOOD. Meeting Abstract. 124(21).
Brown, Jennifer R., Klinger, Mark, Hervold, Kieran, Fernandes, Stacey M., Hoang, Kevin, Faham, Malek, Oki, Yasuhiro, Wolf, Jeffrey L., Martinez-Lopez, Joaquin (2014).

Chronic Lymphocytic Leukemia Patients Harbor Very Low Frequency Stereotypic Immunoglobulin CDR3 Sequences

BLOOD. Meeting Abstract. 124(21).
Canzian, Federico, Beider, Katia, Buda, Gabriele, de Arriba de la Fuente, Felipe, Dudzinski, Marek, Dumontet, Charles, Garcia-Sanz, Ramon, Handa, Hiroshi, Jamroziak, Krzysztof, Jurado, Manuel, Jurczyszyn, Artur J., Landi, Stefano, Lesueur, Fabienne, Marques, Herlander, Martinez-Lopez, Joaquin, Moreno, Victor, Murakami, Hirokazu, Nagler, Arnon, Petrini, Mario, Reis, Rui Manuel, Rios, Rafael, Sainz, Juan, Szemraj-Rogucka, Zofia, Vangsted, Annette Juul, Varkonyi, Judit, Vogel, Ulla, Watek, Marzena, Campa, Daniele (2014).

The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis

BLOOD. Meeting Abstract. 124(21).
Rosinol, Laura, Oriol, Albert, Isabel Teruel, Ana, Hernandez, Dolores, Jesus Blanchard, M., De La Rubia, Javier, Granell, Miquel, Besalduch, Juan, Palomera, Luis, Gonzalez, Yolanda, Asuncion Echebeste, M., Diaz-Mediavilla, Joaqun, Hernandez, Miguel T., de Arriba, Felipe, Carmen Gutierrez, Norma, Luisa Martin-Ramos, M., Teresa Cibeira, M., Victoria Mateos, Maria, Martinez-Lopez, Joaquin, Alegre, Adrian, Lahuerta, Juan Jose, San Miguel, Jesus F., Blade, Joan (2014).

Persistent Benefit of VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Long-Term Follow-up of a Randomized Phase 3 Pethema/GEM Study

BLOOD. Meeting Abstract. 124(21).
Giraldo, Pilar, Lopez, Andres, Rios, Eduardo, Carbonell, Felix, Lopez, Javier, Ramirez, Angel, Rodriguez, Alicia, Gomez, Marta, Garcia, Ricardo, Baltasar, Patricia, Duran, Maria, Perez, Raul, Garcia, Maria, Antonio Marquez, Jose, De la Serna, Javier (2014).

Prospective, Observational Study to Assess the Safety of Rituximab(R) in Combination with Chemotherapy in Patients with Previously-Untreated or Relapsed or Refractory B Cell-Lineage Chronic Lymphocytic Leukaemia (B-CLL): Final Results

BLOOD. Meeting Abstract. 124(21).
Gallardo, Miguel, Lee, Hun Ju, Bueso-Ramos, Carlos E., Zhang, Xiaorui, Pageon, Laura R., Multani, Asha, Rapado, Inmaculada, Quintas-Cardama, Alfonso, Kornblau, Steven M., Martinez-Lopez, Joaquin, Post, Sean M. (2014).

hnRNP K: A Tumor Suppressor or Oncogene?

BLOOD. Meeting Abstract. 124(21).
Ibarrondo, Paloma, Insunza, Andres, Gonzalez de Villambrosia, Sonia, Jose Calasanz, Maria, Belen Valencia, Ana, Santini, Valeria, Torricelli, Francesca, Gonzalez, Teresa, Fernandez, Miriam, Luno, Elisa, Sanzo, Carmen, Collado, Rosa, Espinet, Blanca, Valiente, Alberto, Nomdedeu, Benet, Diez, Maria, Canizo, Consuelo, Adema, Vera, Mallo, Mar, Ortega, Margarita, Montoro, Julia, De la Serna, Javier, Ardanaz, Maite, Marco, Victor, Grau, Javier, Cervera, Jose, Sanz, Guillermo F., Vallespi, Teresa, Valcarcel, David, Sole, Francesc, Batlle-Lopez, Ana (2014).

Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome

BLOOD. Meeting Abstract. 124(21).
Leivas, Alejandra, Risueno, Ruth M., Perez-Martinez, Antonio, Jesus Blanchard, Mara, Campana, Dario, Jose Lahuerta, Juan, Martinez-Lopez, Joaqun (2014).

Autologous Activated and Expanded Natural Killer Cells Kill Clonogenic Myeloma Cells: A New Therapeutic Option for Multiple Myeloma

BLOOD. Meeting Abstract. 124(21).
Jimenez Ubieto, Ana, Grande Garcia, Carlos, Yanez, Lucrecia, Caballero, Dolores, Novelli, Silvana, Jesus Rodriguez, Maria, Manzanares, Maria, Arranz, Reyes, Javier Ferreiro, Jose, Bobillo, Sabella, Mercadel, Santiago, Galeo, Andrea, Lopez, Javier, Vallejo, Carlos, Albo, Carmen, Perez, Elena, Marrero, Carmen, Magnano, Laura, Palomera, Luis, Jarque, Isidro, Coria, Erika, Palomo, Teresa, Jose Lahuerta, Juan, Lopez-Guillermo, Armando, Salar, Antonio (2014).

High Dose Therapy with Autologous Stem Cell Transplantation (HDT/ASCT) Support in Follicular Lymphoma (FL) a Very Long Follow-up Analysis of 640 Patients of Geltamo Spanish Group Suggests That FL Might be Cured, Even in High-Risk Patients

BLOOD. Meeting Abstract. 124(21).
Durrant, Simon, Koren-Michowitz, Maya, Lavie, David, Martinez-Lopez, Joaquin, Vannucchi, Alessandro M., Passamonti, Francesco, Stalbovskaya, Viktoriya, Atienza, Edric, Iommazzo, Dana, Gopalakrishna, Prashanth, Gisslinger, Heinz (2014).

HARMONY: An Open-Label, Multicenter, 2-Arm, Dose-Finding, Phase 1b Study of the Combination of Ruxolitinib and Buparlisib (BKM120) in Patients with Myelofibrosis (MF)

BLOOD. Meeting Abstract. 124(21).
Salar, Antonio, Domingo-Domenech, Eva, Panizo, Carlos, Nicolas, Concepcion, Bargay, Joan, Muntanola, Ana, Canales, Miguel, Luis Bello, Jose, Manuel Sancho, Juan, Francisco Tomas, Jose, Jose Rodriguez, Maria, Javier Penalver, Francisco, Grande, Carlos, Javier Sanchez-Blanco, Jose, Palomera, Luis, Arranz, Reyes, Conde, Eulogio, Garcia, Mar, Fernando Garcia, Juan, Caballero, Dolores, Montalban, Carlos, Grp Espanol Linfomas Trasplante Me (2014).

First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial

Lancet Haematology. Article. 1(3):104-111.
[doi:10.1016/S2352-3026(14)00021-0]
Osorio-Silla I, Brandariz L, Rueda D, Marín JC, Perea J (2014).

Surgical options for familial adenomatous polyposis depending on genetic factors

GASTROENTEROLOGIA Y HEPATOLOGIA. Letter. 37(10):565-567.
[doi:10.1016/j.gastrohep.2014.01.012]
Grande Garcia, Carlos, Martinez Martinez, Rafael, Valcarcel Ferreiras, David, Soc Espanola Hematologia Hemoterap, Soc Espanola Trombosis Hemostasia (2014).

Comparison of international guidelines for primary autoimmune thrombocytopenia

MEDICINA CLINICA. Article. 143(9):408-419.
[doi:10.1016/j.medcli.2014.02.002]
Garcia-Gutierrez, Valentin, Manuel Puerta, Jose, Maestro, Begona, Casado Montero, Luis Felipe, Muriel, Alfonso, Molina Hurtado, Jose Ramon, Perez-Encinas, Manuel, Moreno Romero, Maria Victoria, Barba Sunol, Pere, Sola Garcia, Ricardo, De Paz, Raquel, Ramirez Sanchez, Maria Jose, Osorio, Santiago, Mata Vazquez, Maria Isabel, Martinez Lopez, Joaquin, Luis Sastre, Jose, de los Angles Portero, Maria, Bautista, Guiomar, Duran Nieto, Maria Soledad, Giraldo, Pilar, Jimenez Jambrina, Margarita, Burgaleta, Carmen, Ruiz Aredondo, Joaquin, Jesus Penarrubia, Maria, Jose Requena, Maria, Fernandez Valle, Maria del Carmen, Calle, Carmen, Paz Coll, Antonio, Angel Hernandez-Rivas, Jose, Franco Osorio, Rafael, Cano, Pilar, Tallon Perez, David, Fernandez de la Mata, Margarita, Lopez Garrido, Pilar, Luis Steegmann, Juan (2014).

Do chronic myeloid leukemia patients with late ``warning'' responses benefit from ``watch and wait'' or switching therapy to a second generation tyrosine kinase inhibitor?

AMERICAN JOURNAL OF HEMATOLOGY. Article. 89(11):206-211.
[doi:10.1002/ajh.23816]
Pardal, Emilia, Coronado, Monica, Martin, Alejandro, Grande, Carlos, Marin-Niebla, Ana, Panizo, Carlos, Luis Bello, Jose, Conde, Eulogio, Hernandez, Miguel T., Arranz, Reyes, Bargay, Joan, Gonzalez-Barca, Eva, Perez-Ceballos, Elena, Montes-Moreno, Santiago, Dolores Caballero, Maria (2014).

.5 > Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial

BRITISH JOURNAL OF HAEMATOLOGY. Article. 167(3):327-336.
[doi:10.1111/bjh.13036]
García-Escobar I, Parrilla L, Ortega LM, Castellanos D, Pallarés MA, Cortés-Funés H (2014).

Clinical experience with plerixafor as a mobilization regimen for autologous peripheral blood stem cell transplantation in patients with refractory germ cell tumors.

Molecular and clinical oncology. Article. 2(6):923-926.
[doi:10.3892/mco.2014.362]
Ballesteros, J., Hernandez, P., Primo, D., Robles, A., Espinosa, A. B., Arroyo, E., Garcia-Navas, V., Sanchez-Fenoy, J., Jimenez, M., Gaspar, M., Rojas, J. L., Martinez-Lopez, J., Gorrochategui, J. (2014).

High correlation between clinical responses to first line AML patients treated with cytarabine and idarubicin and their pharmacological profiles in patient samples measured by ExviTech

EUROPEAN JOURNAL OF CANCER. Meeting Abstract. 50(6):77-78.
[doi:10.1016/S0959-8049(14)70356-9]
Rajkumar, S. Vincent, Dimopoulos, Meletios A., Palumbo, Antonio, Blade, Joan, Merlini, Giampaolo, Mateos, Maria-Victoria, Kumar, Shaji, Hillengass, Jens, Kastritis, Efstathios, Richardson, Paul, Landgren, Ola, Paiva, Bruno, Dispenzieri, Angela, Weiss, Brendan, Leleu, Xavier, Zweegman, Sonja, Lonial, Sagar, Rosinol, Laura, Zamagni, Elena, Jagannath, Sundar, Sezer, Orhan, Kristinsson, Sigurdur Y., Caers, Jo, Usmani, Saad Z., Lahuerta, Juan Jose, Johnsen, Hans Erik, Beksac, Meral, Cavo, Michele, Goldschmidt, Hartmut, Terpos, Evangelos, Kyle, Robert A., Anderson, Kenneth C., Durie, Brian G. M., San Miguel, Jesus F. (2014).

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

LANCET ONCOLOGY. Review. 15(12):538-548.
[doi:10.1016/S1470-2045(14)70442-5]
Ballesteros, J., Primo, D., Hernandez, P., Robles, A., Espinosa, A. B., Arroyo, E., Garcia-Navas, V., Sanchez-Fenoy, J., Jimenez, M., Gaspar, M., Rojas, J. L., Martinez-Lopez, J., Gorrochategui, J. (2014).

Hematotoxicity potential of new drug candidates measured in hematopoietic progenitors in bone marrow samples

EUROPEAN JOURNAL OF CANCER. Meeting Abstract. 50(6):136-137.
[doi:10.1016/S0959-8049(14)70553-2]
De La Serna, J., Carbonell, F., Giraldo, P., Lopez, A., Gonzalez, D., Garcia, C., Orofino, J., Roset, M., Pemlero, N., Rios, E. (2014).

CLINICAL UTILITY OF THE COLLECT SCALE TO ASSESS COMORBIDITIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

VALUE IN HEALTH. Meeting Abstract. 17(7):522-522.
[doi:10.1016/j.jval.2014.08.1632]
Munoz-Linares, Cristina, Ojeda, Emilio, Fores, Rafael, Pastrana, Miguel, Cabero, Martin, Morillo, Daniel, Bautista, Guiomar, Banos, Isolina, Monteserin, Carmen, Bravo, Pilar, Jaro, Esther, Cedena, Teresa, Luis Steegmann, Juan, Villegas, Ana, Rafael Cabrera, Jose (2014).

Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yr

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 93(4):309-319.
[doi:10.1111/ejh.12346]
Xicoy, Blanca, Ribera, Josep-Maria, Mueller, Markus, Garcia, Olga, Hoffmann, Christian, Oriol, Albert, Hentrich, Marcus, Grande, Carlos, Wasmuth, Jan-Christian, Esteve, Jordi, van Lunzen, Jan, del Potro, Eloy, Knechten, Heribert, Brunet, Salut, Mayr, Christoph, Escoda, Lourdes, Schommers, Philipp, Alonso, Natalia, Vall-Llovera, Ferran, Perez, Montserrat, Morgades, Mireia, Gonzalez, Jose, Fernandez, Angeles, Thoden, Jan, Goekbuget, Nicola, Hoelzer, Dieter, Faetkenheuer, Gerd, Wyen, Christoph, PETHEMA Grp, German HIV Lymphoma Cohort (2014).

Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients

LEUKEMIA & LYMPHOMA. Article. 55(10):2341-2348.
[doi:10.3109/10428194.2013.878933]
Ziv, Elad, Dean, Eric, Hu, Donglei, Martino, Alessandro, Serie, Daniel, Campa, Daniele, Aftab, Blake, Bracci, Paige, Buda, Gabriele, Caswell, Jennifer, Dumontet, Charles, Dudzinski, Marek, Fejerman, Laura, Greenberg, Alexandra, Hunstman, Scott, Jurczyszyn, Artur, Jamroziak, Krzysztof, Kumar, Shaji, Marques, Herlander, Martin, Thomas, Martinez-Lopez, Joaquin, Rajkumar, Vincent, Sainz, Juan, Vangsted, Annette Juul, Watek, Marzena, Wolf, Jeffrey, Slager, Susan, Canzian, Federico, Vachon, Celine (2014).

Genome wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

CANCER RESEARCH. Meeting Abstract. 74(19, S).
[doi:10.1158/1538-7445.AM2014-5078]
Mateos, Maria-Victoria, Oriol, Albert, Martinez-Lopez, Joaquin, Teruel, Ana-Isabel, Lopez de la Guia, Ana, Lopez, Javier, Bengoechea, Enrique, Perez, Montserrat, Martinez, Rafael, Palomera, Luis, de Arriba, Felipe, Gonzalez, Yolanda, Mariano Hernandez, Jose, Granell, Miquel, Bello, Jose-Luis, Bargay, Joan, Penalver, Francisco-Javier, Martin-Mateos, Maria-Luisa, Paiva, Bruno, Montalban, Maria-Angeles, Blade, Joan, Lahuerta, Juan-Jose, San-Miguel, Jesus F. (2014).

GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?

BLOOD. Article. 124(12):1887-1893.
[doi:10.1182/blood-2014-05-573733]
Montesinos, Pau, Martinez, David, Sierra, Jorge, Perez, Jaime, Garcia, Raimundo, Serrano, Josefina, Fernandez, Pascual, Herrera, Pilar, Fernandez, Angeles, Alonso, Arancha, Bethancourt, Concepcion, Gonzalez, Ataulfo, Rodriguez-Macias, Gabriela, Antonio Vera, Juan, Troconiz, Inaki, Bennett, Teresa, Ballesteros, Joan, Moscardo, Federico, Angel Sanz, Miguel, Martinez-Lopez, Joaquin (2014).

1st Line AML Equivalent Treatments Cytarabine Plus an Anthracyclin (Ida, Dau, Mit) Show Alternative Sensitive/Resistant Profiles in ex vivo Patient Sample Chemosensitivity; Could Personalizing be the Key Selection Criterion?

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Meeting Abstract. 14(3):117-118.
[doi:10.1016/j.clml.2014.06.036]
Montesinos, Pau, Martinez, David, Martinez-Lopez, Joaquin, Sierra, Jorge, Perez, Jaime, Garcia, Raimundo, Serrano, Josefina, Fernandez, Pascual, Herrera, Pilar, Fernandez, Angeles, Alonso, Arancha, Bethancourt, Concepcion, Gonzalez, Ataulfo, Rodriguez-Macias, Gabriela, Villoria, Jesus, Troconiz, Inaki, Bennett, Teresa, Ballesteros, Joan, Moscardo, Federico, Angel Sanz, Miguel (2014).

Efficient Identification of Response to Cytarabine Idarubicin in Newly Diagnosed Acute Myeloid Leukemia by a New Individualized Medicine Test Based on ex vivo Pharmacology

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Meeting Abstract. 14(3):118-119.
[doi:10.1016/j.clml.2014.06.037]
Ballesteros, Joan, Montesinos, Pau, Moscardo, Federico, Martinez, David, Angel Sanz, Miguel, Martinez-Lopez, Joaquin, Perez, Jaime, Garcia, Raimundo, Serrano, Josefina, Fernandez, Pascual, Herrera, Pilar, Fernandez, Angeles, Alonso, Arancha, Bethancourt, Concepcion, Gonzalez, Ataulfo, Hernandez-Campo, Pilar, Gorrochategui, Julian, Liebana, Belen, Troconiz, Inaki, Bennett, Teresa (2014).

The Pharmacological Profiles of Approved Cytotoxic AML Treatments ex vivo Identifies Sensitive vs Resistant Treatments in Patient's Leukemic Cells

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Meeting Abstract. 14(3):117-117.
[doi:10.1016/j.clml.2014.06.035]
Lopez-Corral, Lucia, Antonio Corchete, Luis, Eugenia Sarasquete, Maria, Victoria Mateos, Maria, Garcia-Sanz, Ramon, Ferminan, Encarna, Lahuerta, Juan-Jose, Blade, Joan, Oriol, Albert, Isabel Teruel, Ana, Luz Martino, Maira, Hernandez, Jose, Maria Hernandez-Rivas, Jesus, Javier Burguillo, Francisco, San Miguel, Jesus F., Gutierrez, Norma C. (2014).

Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies

HAEMATOLOGICA. Article. 99(8):1365-1372.
[doi:10.3324/haematol.2013.087809]
Bennett TA, Montesinos P, Moscardo F, Martinez-Cuadron D, Martinez J, Sierra J, García R, de Oteyza JP, Fernandez P, Serrano J, Fernandez A, Herrera P, Gonzalez A, Bethancourt C, Rodriguez-Macias G, Alonso A, Vera JA, Navas B, Lavilla E, Lopez JA, Jimenez S, Simiele A, Vidriales B, Gonzalez BJ, Burgaleta C, Hernandez Rivas JA, Mascuñano RC, Bautista G, Perez Simon JA, Fuente Ade L, Rayón C, Troconiz IF, Janda A, Bosanquet AG, Hernandez-Campo P, Primo D, Lopez R, Liebana B, Rojas JL, Gorrochategui J, Sanz MA, Ballesteros J (2014).

Pharmacological Profiles of Acute Myeloid Leukemia Treatments in Patient Samples by Automated Flow Cytometry: A Bridge to Individualized Medicine

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Article. 14(4):305-318.
[doi:10.1016/j.clml.2013.11.006]
Montes-Moreno S, Batlle A, de Villambrosía SG, Sánchez-Espiridión B, Cereceda L, González-Barca E, Purroy N, Pardal E, Martín A, Grande C, Mazorra F, Insunza A, Quero C, Aguiar D, Cruz MA, Rueda A, Llanos M, Codina JG, Arroyo FR, Caballero D, Conde E, López A, Provencio M, Piris M (2014).

Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis

HAEMATOLOGICA. Letter. 99(8):138-141.
[doi:10.3324/haematol.2014.104976]
Moreau, Philippe, Cavo, Michele, Sonneveld, Pieter, Rosinol, Laura, Attal, Michel, Pezzi, Annalisa, Goldschmidt, Hartmut, Lahuerta, Juan Jose, Marit, Gerald, Palumbo, Antonio, van der Holt, Bronno, Blade, Joan, Petrucci, Maria Teresa, Neben, Kai, san Miguel, Jesus, Patriarca, Francesca, Lokhorst, Henk, Zamagni, Elena, Hulin, Cyrille, Gutierrez, Norma, Facon, Thierry, Caillot, Denis, Benboubker, Lotfi, Harousseau, Jean-Luc, Leleu, Xavier, Avet-Loiseau, Herve, Mary, Jean-Yves (2014).

Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression-Related Death

JOURNAL OF CLINICAL ONCOLOGY. Article. 32(20):2173-2173.
[doi:10.1200/JCO.2013.53.0329]
Briones, Javier, Novelli, Silvana, Garcia-Marco, Jose A., Tomas, Jose F., Bernal, Teresa, Grande, Carlos, Canales, Miguel A., Torres, Antonio, Moraleda, Jose M., Panizo, Carlos, Jarque, Isidro, Palmero, Francisca, Hernandez, Miguel, Gonzalez-Barca, Eva, Lopez, Dulce, Caballero, Dolores, Grp Espanol Linfomas Trasplante Au (2014).

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

HAEMATOLOGICA. Letter. 99(7).
[doi:10.3324/haematol.2014.108308]
Lippert, Eric, Mansier, Olivier, Migeon, Marina, Denys, Barbara, Nilsson, Asa, Rosmond, Carolina, Lode, Laurence, Ugo, Valerie, Lascaux, Axelle, Bellosillo, Beatriz, Martinez-Lopez, Joaquin, Naguib, Dina, Gachard, Nathalie, Maroc, Nicolas, Hermouet, Sylvie (2014).

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

HAEMATOLOGICA. Letter. 99(7)-101.
[doi:10.3324/haematol.2014.107656]
Mateos, M. V., Oriol, A., Martinez-Lopez, J., Teruel, A. I., Lopez de la Guia, A., Blanchard, M. J., Bengoechea, E., Perez, M., Diaz-Mediavilla, J., Palomera, L., de Arriba, F., Gonzalez, Y., Hernandez, J. M., Granell, M., Bello, J. L., Bargay, J., Penalver, F. J., Martin, M. L., Paiva, B., Montalban, M. A., Blade, J., Lahuerta, J. J., San Miguel, J. (2014).

DO WE STILL NEED THE ALKYLATORS AS PART OF THE UPFRONT-TREATMENT OF ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS? UPDATED FOLLOW-UP OF GEM2005MAS65 SPANISH TRIAL COMPARING VMP VS VTP AS INDUCTION

HAEMATOLOGICA. Meeting Abstract. 99(1):221-221.
Post, S., Gallardo, M., Lee, H. J., Bueso-Ramos, C., Martinez Lopez, J., Quintas-Cardama, A. (2014).

IDENTIFICATION OF A POTENTIALLY NOVEL TUMOR SUPPRESSOR IN AML

HAEMATOLOGICA. Meeting Abstract. 99(1):257-257.
Hernandez-Campo, P., Montesinos, P., Moscardo, F., Martinez Cuadron, D., Sanz, M. A., Martinez Lopez, J., Garcia Boyero, R., Perez de Oteyza, J., Fernandez, P., Serrano, J., Fernandez, A., Herrera, P., Alonso, A., Gonzalez, A., Bethancourt, C., Lavilla, E., Vera, J. A., Navas, B., Rodriguez, G., Lopez, J. A., Jimenez, S., Simiele, A., Gonzalez, B., Hernandez Rivas, J. A., Cordoba, R., Rayon, C., Burgaleta, C., Sierra, J., Rojas, J. L., Bennett, T. A., Robles, A., Primo, D., Gaspar, M., Gorrochategui, J., Troconiz, I. F., Ballesteros, J. (2014).

PHARMACOLOGICAL PROFILES OF AML TREATMENTS IN PATIENT SAMPLES TO PERSONALIZE TREATMENT

HAEMATOLOGICA. Meeting Abstract. 99(1):292-292.
Martínez N, Almaraz C, Vaqué JP, Varela I, Derdak S, Beltran S, Mollejo M, Campos-Martin Y, Agueda L, Rinaldi A, Kwee I, Gut M, Blanc J, Oscier D, Strefford JC, Martinez-Lopez J, Salar A, Sole F, Rodriguez-Peralto JL, Diez-Tascón C, García JF, Fraga M, Sebastián E, Alvés J, Menárguez J, González-Carreró J, Casado LF, Bayes M, Bertoni F, Gut I, Piris MA (2014).

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

LEUKEMIA. Article. 28(6):1334-1340.
[doi:10.1038/leu.2013.365]
Velasco Rodriguez, Diego, Perez-Segura, G., Jimenez-Ubieto, A., Rodriguez, M. A., Montejano, L. (2014).

Hemolytic Disease of the Newborn Due to Anti-Jkb: Case Report and Review of the Literature

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION. Review. 30(2):135-138.
[doi:10.1007/s12288-012-0202-7]
Xicoy, Blanca, Jimenez, Maria-Jose, Garcia, Olga, Bargay, Joan, Martinez-Robles, Violeta, Brunet, Salut, Arilla, Maria-Jesus, Perez de Oteyza, Jaime, Andreu, Rafael, Casano, Francisco-Javier, Cervero, Carlos-Javier, Bailen, Alicia, Diez, Maria, Gonzalez, Bernardo, Vicente, Ana-Isabel, Pedro, Carme, Bernal, Teresa, Luno, Elisa, Cedena, Maria-Teresa, Palomera, Luis, Simiele, Adriana, Calvo, Jose-Manuel, Marco, Victor, Gomez, Eduardo, Gomez, Marta, Gallardo, David, Munoz, Juan, de Paz, Raquel, Grau, Javier, Ribera, Josep-Maria, Benlloch, Luis-Enrique, Sanz, Guillermo (2014).

Results of treatment with azacitidine in patients aged >= 75 years included in the Spanish Registry of Myelodysplastic Syndromes

LEUKEMIA & LYMPHOMA. Article. 55(6):1300-1303.
[doi:10.3109/10428194.2013.834532]
Cibeira, M. T., Oriol, A., Lahuerta, J. J., Mateos, M. V., de la Rubia, J., Hernandez, M., Granell, M., Fernandez de Larrea, C., San Miguel, J. F., Blade, J. (2014).

PHASE II TRIAL OF LENALIDOMIDE, DEXAMETHASONE AND CYCLOPHOSPHAMIDE (LENDEXAL) FOR PREVIOUSLY UNTREATED PATIENTS WITH LIGHT-CHAIN AMYLOIDOSIS

HAEMATOLOGICA. Meeting Abstract. 99(1):117-118.
Giraldo, P., Andrade, M., Alfonso, P., Irun, P., Atucha, L., Acedo, A., Diaz-Morant, V., Barez, A., Fernandez-Galan, M., Franco, R., Giner, V., Loyola, I., Luno, E., de la Serna, J., Villalon, L., Salamero, O., Pocovi, M. (2014).

TEN YEARS OF EXPERIENCE WITH MIGLUSTAT IN TREATMENT OF TYPE 1 GAUCHER DISEASE: THE SPANISH ZAGAL PROJECT

HAEMATOLOGICA. Meeting Abstract. 99(1):764-764.
Primo, D., Espinosa, A., Arroyo, E., Garcia-Navas, V., Sanchez-Fenoy, J., Jimenez, M., Martin Clavero, E., Paciello, M. L., Gorrochategui, J., Robles, A., Gaspar, M., Jimenez-Velasco, A., Ballesteros, J., Hernandez-Campo, P., Martinez-Lopez, J. (2014).

POTENTIAL HEMATOTOXICITY OF NEW DRUG CANDIDATES MEASURED IN HEMATOPOIETIC PROGENITORS IN BONE MARROW SAMPLES

HAEMATOLOGICA. Meeting Abstract. 99(1):728-728.
Garcia-Gutierrez, V., Puerta, J. M., Maestro, B., Casado Montero, L. F., Molina Hurtado, J. R., Perez-Encinas, M., Moreno Romero, M. V., Massague, I., Sola Garcia, R., De Paz, R., Ramirez Sanchez, M. J., Osorio, S., Mata Vazquez, M. I., Martinez, J., Sastre, J. L., Portero, M. D. L. A., Bautista, G., Duran Nieto, M. S., Giraldo, P., Jimenez Jambrina, M., Burgaleta, C., Ruiz Aredondo, J., Penarrubia, M. J., Requena, M. J., Fernandez Valle, M. D. C., Calle, C., Paz Coll, A., Hernandez-Rivas, J. A., Franco Osorio, R., Cano, P., Tallon Perez, D., Fernandez de la Mata, M., Lopez Garrido, P., Steegmann, J. L. (2014).

DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE ``WARNING'' RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?

HAEMATOLOGICA. Meeting Abstract. 99(1):327-328.
Mateos, M. V., Granell, M., Oriol Rocafiguera, A., Martinez Lopez, J., Blade, J., Hernandez, M. T., Martin Sanchez, J., Gironella, M., Lynch, M., Bleickardt, E., Paliwal, P., Singhal, A., San Miguel, J. (2014).

A PHASE II SINGLE-ARM SAFETY STUDY OF ELOTUZUMAB IN COMBINATION WITH THALIDOMIDE AND LOW DOSE DEXAMETHASONE IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

HAEMATOLOGICA. Meeting Abstract. 99(1):361-362.
Weisel, K. C., San Miguel, J. F., Song, K. W., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Banos, A., Oriol, A., Garderet, L., Cavo, M., Ivanova, V., Alegre, A., Martinez Lopez, J., Chen, C. I., Knop, S., Yu, X., Watkins, L., Sternas, L., Jacques, C., Zaki, M. H., Dimopoulos, M. A. (2014).

PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: MM-003 SUBANALYSIS OF ELDERLY PATIENTS (> 65 AND > 70 YEARS OF AGE)

HAEMATOLOGICA. Meeting Abstract. 99(1):364-365.
Dimopoulos, M. A., Weisel, K., Song, K. W., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Banos, A., Oriol, A., Garderet, L., Cavo, M., Ivanova, V., Alegre, A., Martinez-Lopez, J., Chen, C. I., Spencer, A., Knop, S., Bahlis, N. J., Renner, C., Yu, X., Hong, K., Sternas, L., Jacques, C., Zaki, M. H., San Miguel, J. F. (2014).

CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

HAEMATOLOGICA. Meeting Abstract. 99(1):365-365.
Martinez-Lopez, J., Lahuerta, J. J., Pepin, F., Gonzalez, M., Barrio, S., Ayala, R., Puig, N., Montalban, M. A., Paiva, B., Weng, L., Jimenez, C., Sopena, M., Cedena, T., Rapado, I., Mateo, M. V., Rosinol, L., Oriol, A., Blanchard, M. J., Martinez, R., Blade, J., San Miguel, J., Faham, M., Garcia-Sanz, R. (2014).

PROGNOSTIC VALUE OF DEEP SEQUENCING APPROACH FOR MINIMAL RESIDUAL DISEASE (MRD) DETECTION IN MULTIPLE MYELOMA PATIENTS

HAEMATOLOGICA. Meeting Abstract. 99(1):494-494.
Ferrer Lores, B., Martinez-Lopez, J., Ayala-Diaz, R. (2014).

CALR-MUTATED OR TRIPLE-NEGATIVE (JAK-2 AND MPL) IN ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS

HAEMATOLOGICA. Meeting Abstract. 99(1):658-658.
San Miguel, J. F., Weisel, K. C., Song, K. W., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Banos, A., Oriol, A., Garderet, L., Cavo, M., Ivanova, V., Alegre, A., Martinez-Lopez, J., Chen, C. I., Renner, C., Bahlis, N. Jacques, Yu, X., Teasdale, T., Sternas, L., Jacques, C., Zaki, M. H., Dimopoulos, M. A. (2014).

MM-003, A PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA: OUTCOMES BY PRIOR THERAPY AND RESPONSE DEPTH

HAEMATOLOGICA. Meeting Abstract. 99(1):110-110.
Mateos, Maria-Victoria, Bringhen, Sara, Richardson, Paul G., Jose Lahuerta, Juan, Larocca, Alessandra, Oriol, Albert, Boccadoro, Mario, Garcia-Sanz, Ramon, Di Raimondo, Francesco, Esseltine, Dixie-Lee, van de Velde, Helgi, Desai, Avinash, Londhe, Anil, San Miguel, Jesus F., Palumbo, Antonio (2014).

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy

HAEMATOLOGICA. Article. 99(6):1114-1122.
[doi:10.3324/haematol.2013.099341]
Barrena, S., Grigore, G., Santos, M., Perez-Andres, M., Gonzalez, M., Rabasa, P., Medina, A., Tomas, J. F., Solano, F., De La Serna, J., Garcia Marco, J. A., Allegue, M. J., Los Certales, J., Perez, I., Olave, T., Delgado, J., Bosch, F., Almeida, J., Orfao, A. (2014).

COMPARATIVE EFFECT OF BENDAMUSTINE PLUS RITUXIMAB ( R) vs FLUDARABINE PLUS CYCLOPHOSPHAMIDE PLUS R ON THE LEVELS OF PERIPHERAL BLOOD LEUCOCYTE POPULATIONS IN ADVANCED-STAGE CHRONIC LYMPHOCYTIC LEUKEMIA

HAEMATOLOGICA. Meeting Abstract. 99(1):324-324.
Primo, D., Gorrochategui, J., Robles, A., San Miguel, J., Oriol, A., Lahuerta Palacios, J. J., Diaz Mediavilla, J., Bailen, A., Cordoba Mascunano, R., Moreno Belmonte, M. J., Martin Sanchez, J., Hernandez Martin, J. M., Chinea, A., Palomera Bernal, L., Gonzalez Montes, Y., Prosper Cardoso, F., Iglesias del Barrio, R., Echeveste, A., Hernandez Garcia, M. T., Encinas, C., Perez de Oteyza, J., Gomez, C., Gaspar, M., Ballesteros, J., Hernandez-Campo, P., Ocio, E. M., Martinez-Lopez, J. (2014).

THE EFFECT OF BORTEZOMIB ON DIFFERENT CELL SUBSETS: AN APPROACH FOR AN INDIVIDUAL PERSONALIZED MEDICINE

HAEMATOLOGICA. Meeting Abstract. 99(1):97-98.
Leivas, A., Risueno, R. M., Perez-Martinez, A., Fernandez-Casanova, L., Lahuerta, J. J., Martinez-Lopez, J. (2014).

ACTIVATED AND EXPANDED NATURAL KILLER (NKAE) CELLS KILL MULTIPLE MYELOMA (MM) CLONOGENIC PLASMA CELLS THROUGH NKG2D AND NKP30 RECEPTORS AND THEIR LIGANDS

HAEMATOLOGICA. Meeting Abstract. 99(1):96-97.
Paiva, B., Mateos, M. V., Lopez-Corral, L., Vidriales, M. B., Sanchez-Abarca, I., Corchete, L. A., Hernandez, M. T., Bargay, J., de Arriba, F., de la Rubia, J., Teruel, A. I., Giraldo, P., Rosinol, L., Prosper, F., Oriol, A., Hernandez, J., Esteves, G., Leal da Costa, F., Perez Simon, J. A., Lahuerta, J. J., Blade, J., San Miguel, J. F. (2014).

HOW DOES LENALIDOMIDE/DEXAMETHASONE REDUCES RISK OF TRANSFORMATION IN HIGH-RISK SMOLDERING MULTIPLE MYELOMA? LONGITUDINAL IMMUNOPHENOTYPIC PROFILING OF IMMUNE EFFECTOR CELLS FROM THE QUIREDEX TRIAL

HAEMATOLOGICA. Meeting Abstract. 99(1):95-95.
Barrena, S., Grigore, G., Fierro, M., Perez-Andres, M., Gonzalez, M., Rabasa, P., Medina, A., Tomas, J. F., Solano, F., De La Serna, J., Garcia Marco, J. A., Allegue, M. J., Los Certales, J., Perez, I., Olave, T., Delgado, J., Bosch, F., Almeida, J., Orfao, A. (2014).

DISTRIBUTION OF CIRCULATING RESIDUAL NORMAL B-CELLS AND OTHER IMMUNE CELLS IN ADVANCED-STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ACCORDING TO THE NUMBER OF PRIOR TREATMENT LINES RECEIVED

HAEMATOLOGICA. Meeting Abstract. 99(1):47-47.
Montesinos, P., Martinez Cuadron, D., Martinez Lopez, J., Garcia Boyero, R., Perez de Oteyza, J., Fernandez, P., Serrano, J., Fernandez, A., Herrera, P., Alonso, A., Gonzalez, A., Bethancourt, C., Lavilla, E., Vera, J. A., Navas, B., Rodriguez-Macias, G., Lopez, J. A., Jimenez, S., Simiele, A., Gonzalez, B., Hernandez Rivas, J. A., Cordoba, R., Rayon, C., Burgaleta, C., Sierra, J., Troconiz, I. F., Ortega, I., Bosanquet, A. G., Primo, D., Hernandez-Campo, P., Gorrochategui, J., Bennett, T. A., Rojas, J. L., Gaspar, M., Villoria, J., Ballesteros, J., Moscardo, F., Sanz, M. A. (2014).

HIGH CORRELATION BETWEEN CLINICAL RESPONSES TO 1ST LINE AML PATIENTS TREATED WITH CYTARABINE AND IDARUBICIN AND THEIR PHARMACOLOGICAL PROFILES IN PATIENT SAMPLES MEASURED BY EXVITECH

HAEMATOLOGICA. Meeting Abstract. 99(1):37-38.
Arenas, A., Gorrochategui, J., Robles, A., Hernandez-Campo, P., Barrio, S., Ayala, R., Ballesteros, J., Martinez-Lopez, J. (2014).

HIGH THROUGHPUT SCREENING ON PERIFPERHAL BLOOD CD34 CELLS WITH A FLOW CYTOMETRY AUTOMATED PLATFORM (EXVITECH), TO IDENTIFY SENSITIVITY TO RUXOLITINIB IN MYELOFIBROSIS PATIENTS

HAEMATOLOGICA. Meeting Abstract. 99(1):124-125.
Ribera, Josep-Maria, Oriol, Albert, Morgades, Mireia, Montesinos, Pau, Sarra, Josep, Gonzalez-Campos, Jose, Brunet, Salut, Tormo, Mar, Fernandez-Abellan, Pascual, Guardia, Ramon, Bernal, Maria-Teresa, Esteve, Jordi, Barba, Pere, Moreno, Maria-Jose, Bermudez, Arancha, Cladera, Antonia, Escoda, Lourdes, Garcia-Boyero, Raimundo, del Potro, Eloy, Bergua, Juan, Amigo, Maria-Luz, Grande, Carlos, Rabunal, Maria-Jose, Hernandez-Rivas, Jesus-Maria, Feliu, Evarist (2014).

Treatment of High-Risk Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

JOURNAL OF CLINICAL ONCOLOGY. Article. 32(15):1595-102.
[doi:10.1200/JCO.2013.52.2425]
Martinez-Lopez, Joaquin, Lahuerta, Juan J., Pepin, Francois, Gonzalez, Marcos, Barrio, Santiago, Ayala, Rosa, Puig, Noemi, Montalban, Maria A., Paiva, Bruno, Weng, Li, Jimenez, Cristina, Sopena, Maria, Moorhead, Martin, Cedena, Teresa, Rapado, Immaculada, Victoria Mateos, Maria, Rosinol, Laura, Oriol, Albert, Blanchard, Maria J., Martinez, Rafael, Blade, Joan, San Miguel, Jesus, Faham, Malek, Gracia-sanz, Ramon (2014).

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

BLOOD. Article. 123(20):3073-3079.
[doi:10.1182/blood-2014-01-550020]
Goede, V., Fischer, K., Busch, R., Engelke, A., Eichhorst, B., Wendtner, C. M., Chagorova, T., Dela Serna, J., Dilhuydy, M. S., Opat, S., Owen, C. J., Samoylova, O., Kreuzer, K. A., Langerak, A. W., Ritgen, M., Stilgenbauer, S., Doehner, H., Asikanius, E., Humphrey, K., Wenger, M. K., Hallek, M. (2014).

Obinutuzumab (GA101) plus chlorambucil (Clb) versus rituximab plus Clb in patients with chronic lymphocytic leukaemia (CLL) and comorbidities: recently published results of the CLL11 trial

BRITISH JOURNAL OF HAEMATOLOGY. Meeting Abstract. 165(1, SI):19-19.
Martino A, Campa D, Jurczyszyn A, Martínez-López J, Moreno MJ, Varkonyi J, Dumontet C, García-Sanz R, Gemignani F, Jamroziak K, Stepien A, Jacobsen SE, Andersen V, Jurado M, Landi S, Rossi AM, Lesueur F, Marques H, Dudzinski M, Watek M, Moreno V, Orciuolo E, Petrini M, Reis RM, Ríos R, Sainz J, Vogel U, Buda G, Vangsted AJ, Canzian F (2014).

Genetic Variants and Multiple Myeloma Risk: IMMEnSE Validation of the Best Reported Associations-An Extensive Replication of the Associations from the Candidate Gene Era

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. Article. 23(4):670-674.
[doi:10.1158/1055-9965.EPI-13-1115]
Hernandez-Boluda JC, Pereira A, Gomez M, Boque C, Ferrer-Marin F, Raya JM, Garcia-Gutierrez V, Kerguelen A, Xicoy B, Barba P, Martínez J, Luño E, Alvarez-Larrán A, Martinez-Lopez J, Arbelo E, Besses C (2014).

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

HAEMATOLOGICA. Letter. 99(4):55-57.
[doi:10.3324/haematol.2013.101733]
Menezes, J., Acquadro, F., Wiseman, M., Gomez-Lopez, G., Salgado, R. N., Talavera-Casanas, J. G., Buno, I., Cervera, J. V., Montes-Moreno, S., Hernandez-Rivas, J. M., Ayala, R., Calasanz, M. J., Larrayoz, M. J., Brichs, L. F., Gonzalez-Vicent, M., Pisano, D. G., Piris, M. A., Alvarez, S., Cigudosa, J. (2014).

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

LEUKEMIA. Article. 28(4):823-829.
[doi:10.1038/leu.2013.283]
Morabito, Fortunato, Bringhen, Sara, Larocca, Alessandra, Wijermans, Pierre, Victoria Mateos, Maria, Gimsing, Peter, Mazzone, Carla, Gottardi, Daniela, Omede, Paola, Zweegman, Sonja, Jose Lahuerta, Juan, Zambello, Renato, Musto, Pellegrino, Magarotto, Valeria, Schaafsma, Martijn, Oriol, Albert, Juliusson, Gunnar, Cerrato, Chiara, Catalano, Lucio, Gentile, Massimo, Isabel Turel, Ana, Liberati, Anna Marina, Cavalli, Maide, Rossi, Davide, Passera, Roberto, Rosso, Stefano, Beksac, Meral, Cavo, Michele, Waage, Anders, San Miguel, Jesus, Boccadoro, Mario, Sonneveld, Pieter, Palumbo, Antonio, Offidani, Massimo (2014).

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study

AMERICAN JOURNAL OF HEMATOLOGY. Article. 89(4):355-362.
[doi:10.1002/ajh.23641]
Goede, Valentin, Fischer, Kirsten, Busch, Raymonde, Engelke, Anja, Eichhorst, Barbara, Wendtner, Clemens M., Chagorova, Tatiana, de la Serna, Javier, Dilhuydy, Marie-Sarah, Illmer, Thomas, Opat, Stephen, Owen, Carolyn J., Samoylova, Olga, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Doehner, Hartmut, Langerak, Anton W., Ritgen, Matthias, Kneba, Michael, Asikanius, Elina, Humphrey, Kathryn, Wenger, Michael, Hallek, Michael (2014).

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

NEW ENGLAND JOURNAL OF MEDICINE. Article. 370(12):1101-1110.
[doi:10.1056/NEJMoa1313984]
Ocio EM, Richardson PG, Rajkumar SV, Palumbo A, Mateos MV, Orlowski R, Kumar S, Usmani S, Roodman D, Niesvizky R, Einsele H, Anderson KC, Dimopoulos MA, Avet-Loiseau H, Mellqvist UH, Turesson I, Merlini G, Schots R, McCarthy P, Bergsagel L, Chim CS, Lahuerta JJ, Shah J, Reiman A, Mikhael J, Zweegman S, Lonial S, Comenzo R, Chng WJ, Moreau P, Sonneveld P, Ludwig H, Durie BG, Miguel JF (2014).

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

LEUKEMIA. Review. 28(3):525-542.
[doi:10.1038/leu.2013.350]
Mur, P., Pineda, M., Romero, A., del Valle, J., Borras, E., Canal, A., Navarro, M., Brunet, J., Rueda, D., Ramon y Cajal, T., Lazaro, C., Caldes, T., Blanco, I., Soto, J. L., Capella, G. (2014).

Identification of a founder EPCAM deletion in Spanish Lynch syndrome families

CLINICAL GENETICS. Article. 85(3):260-266.
[doi:10.1111/cge.12152]
Rojas, Silvia M., Diez-Campelo, Maria, Luno, Elisa, Cabrero, Monica, Pedro, Carme, Calabuig, Marisa, Nomdedeu, Benet, Cedena, Teresa, Arrizabalaga, Beatriz, Garcia, Marta, Cervero, Carlos, Collado, Rosa, Azaceta, Gemma, Teresa Ardanaz, Ma, Antonio Munoz, Juan, Xicoy, Blanca, Requena Rodriguez, Ma Jose, Bargay, Joan, Arilla Morell, Ma Jesus, Simiele, Adriana, del Canizo, Consuelo, Spanish Myelodysplastic Syndrome (2014).

Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis

LEUKEMIA RESEARCH. Article. 38(3):304-309.
[doi:10.1016/j.leukres.2013.11.005]
Briones, Javier, Novelli, Silvana, Garcia-Marco, Jose A., Tomas, Jose F., Bernal, Teresa, Grande, Carlos, Canales, Miguel A., Torres, Antonio, Moraleda, Jose M., Panizo, Carlos, Jarque, Isidro, Palmero, Francisca, Hernandez, Miguel, Gonzalez-Barca, Eva, Lopez, Dulce, Caballero, Dolores, GELTAMO (2014).

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

HAEMATOLOGICA. Article. 99(3):505-510.
[doi:10.3324/haematol.2013.093450]
Ayala, Rosa, Rapado, Inmaculada, Grande, Silvia, Moreno, Enrique, Martinez-Lopez, Joaquin (2014).

JAK2 exon 12 mutations were not found in liver transplant recipients with or without pretransplant portal vein thrombosis

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. Letter. 26(3):362-363.
[doi:10.1097/MEG.0000000000000021]
Luis Pinana, Jose, Montesinos, Pau, Martino, Rodrigo, Vazquez, Lourdes, Rovira, Montserrat, Lopez, Javier, Batlle, Montserrat, Figuera, Angela, Barba, Pere, Jose Lahuerta, Juan, Deben, Guillermo, Perez-Lopez, Cristina, Garcia, Raimundo, Rosique, Pedro, Lavilla, Esperanza, Gascon, Adriana, Martinez-Cuadron, David, Angel Sanz, Miguel (2014).

Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients

ANNALS OF HEMATOLOGY. Article. 93(2):299-307.
[doi:10.1007/s00277-013-1872-4]
Puig N, Sarasquete ME, Balanzategui A, Martínez J, Paiva B, García H, Fumero S, Jiménez C, Alcoceba M, Chillón MC, Sebastián E, Marín L, Montalbán MA, Mateos MV, Oriol A, Palomera L, de la Rubia J, Vidriales MB, Bladé J, Lahuerta JJ, González M, Miguel JF, García-Sanz R (2014).

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry

LEUKEMIA. Article. 28(2):391-397.
[doi:10.1038/leu.2013.217]
Papaemmanuil E, Rapado I, Li Y, Potter NE, Wedge DC, Tubio J, Alexandrov LB, Van Loo P, Cooke SL, Marshall J, Martincorena I, Hinton J, Gundem G, van Delft FW, Nik-Zainal S, Jones DR, Ramakrishna M, Titley I, Stebbings L, Leroy C, Menzies A, Gamble J, Robinson B, Mudie L, Raine K, O'Meara S, Teague JW, Butler AP, Cazzaniga G, Biondi A, Zuna J, Kempski H, Muschen M, Ford AM, Stratton MR, Greaves M, Campbell PJ (2014).

RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia

NATURE GENETICS. Article. 46(2):116-116.
[doi:10.1038/ng.2874]
Martinez-Lopez J (2014).

Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

NATURE GENETICS. Article. 46(2):107-107.
[doi:10.1038/ng.2854]
Perea, Jose, Rueda, Daniel, Canal, Alicia, Rodtiguez, Yolanda, Alvaro, Edurne, Osorio, Irene, Alegre, Cristina, Rivera, Barbara, Martinez, Joaquin, Benitez, Javier, Urioste, Miguel (2014).

Age at Onset Should Be a Major Criterion for Subclassification of Colorectal Cancer

JOURNAL OF MOLECULAR DIAGNOSTICS. Article. 16(1):116-126.
[doi:10.1016/j.jmoldx.2013.07.010]

2013

Martinez-Lopez J, Fernández-Redondo E, García-Sánz R, Montalbán MA, Martínez-Sánchez P, Pavia B, Mateos MV, Rosiñol L, Martín M, Ayala R, Martínez R, Blanchard MJ, Alegre A, Besalduch J, Bargay J, Hernandez MT, Sarasquete ME, Sanchez-Godoy P, Fernández M, Blade J, San Miguel JF, Lahuerta JJ (2013).

Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study

BRITISH JOURNAL OF HAEMATOLOGY. Article. 163(5):581-589.
[doi:10.1111/bjh.12576]
Gallardo M, Barrio S, Fernandez M, Paradela A, Arenas A, Toldos O, Ayala R, Albizua E, Jimenez A, Redondo S, Garcia-Martin RM, Gilsanz F, Albar JP, Martinez-Lopez J (2013).

Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera

MOLECULAR CANCER. Article. 12(1):142-142.
[doi:10.1186/1476-4598-12-142]
Paiva, Bruno, Corchete, Luis A., Gutierrez, Norma, Vidriales, Maria-Belen, Aires-Mejia, Irene, Sanchez, Maria Luz, Barcena, Paloma, Paino, Teresa, Echeveste, Maria Asuncion, Hernandez, Miguel, Garcia-Sanz, Ramon, Ocio, Enrique M., Oriol, Albert, Gironella, Mercedes, Palomera, Luis, de Arriba, Felipe, Gonzalez, Yolanda, Lahuerta, Juan-Jose, Blade, Joan, Orfao, Alberto, Mateos, Maria-Victoria, San Miguel, Jesus F. (2013).

Phenotypic and Genomic Analysis Of Multiple Myeloma (MM) Minimal Residual Disease (MRD) Clonal Plasma Cells (PCs)

BLOOD. Meeting Abstract. 122(21).
[doi:10.1182/blood.V122.21.402.402]
Schmidt-Hieber, Martin, Paiva, Bruno, Perez-Andres, Martin, Gutierrez, Maria Laura, Dybkaer, Karen, Rasillo, Ana, Tabernero, Maria Dolores, Lopez, Antonio, Kryukov, Fedor, Carrasco, Paloma, Sanchez, Maria Luz, Rosinol, Laura, Lopez, Joaquin Martinez, Oriol, Albert, de Arriba, Felipe, Palomera, Luis, Bengoechea, Enrique, Lahuerta, Juan Jose, Blade, Joan, Schmitz, Alex, Johnsen, Hans E., San Miguel, Jesus F., Orfao, Alberto (2013).

CD56(+) Clonal Plasma Cells In Multiple Myeloma Are Associated With Unique Disease Characteristics and Have a Counterpart Of CD56(+) Normal Plasma Cells With Increased Maturity

BLOOD. Meeting Abstract. 122(21).
Lopez, Aurelio, Valero, Marta, Lorenzo, Jose Ignacio, Mateos, Maria-Victoria, Oriol, Albert, Joaquin, Martinez, Perez, Montserrat, Martinez, Rafael, de Paz, Raquel, Granell, Miguel, De Arriba, Felipe, Blanchard, M. Jesus, Javier Penalver, Francisco, Bello, Jose Luis, Martin, Maria Luisa, Bargay, Joan, Blade, Joan, Lahuerta, Juan Jose, San Miguel, Jesus F., De La Rubia, Javier (2013).

Phase III Trial Of Bortezomib, Melphalan, and Prednisone (VMP) Versus Bortezomib, Thalidomide, and Prednisone (VTP) In Elderly Multiple Myeloma (MM) Patients: Update Follow-Up, Patterns Management Of First Relapse/Progression

BLOOD. Meeting Abstract. 122(21).
[doi:10.1182/blood.V122.21.1973.1973]
Mateos, Maria-Victoria, Martinez-Lopez, Joaquin, Hernandez, Miguel T., Martinez, Rafael, Rosinol, Laura, Ocio, Enrique M., Echeveste, Maria Asuncion, de Oteyza, Jaime Perez, Oriol, Albert, Joan, Bargay, Mercedes, Gironella, Martin, Jesus, Cabrera, Carmen, Gutierrez, Norma, Luisa, Martin Maria, de la Rubia, Javier, Blade, Joan, Lahuerta, Juan Jose, San Miguel, Jesus F. (2013).

Comparison Of Sequential Vs Alternating Administration Of Bortezomib, Melphalan and Prednisone (VMP) and Lenalidomide Plus Dexamethasone (Rd) In Elderly Patients With Newly Diagnosed Multiple Myeloma (MM) Patients: GEM2010MAS65 Trial

BLOOD. Meeting Abstract. 122(21).
[doi:10.1182/blood.V122.21.403.403]
Cavo, Michele, Salwender, Hans, Rosinol, Laura, Moreau, Philippe, Petrucci, Maria Teresa, Blau, Igor Wolgang, Blade, Joan, Attal, Michel, Patriarca, Francesca, Weisel, Katja, San Miguel, Jesus F., Avet-Loiseau, Herve, Testoni, Nicoletta, Pfreundschuh, Michael, Lahuerta, Juan Jose, Facon, Thierry, Pantani, Lucia, Scheid, Christof, Gutierrez, Norma, Marit, Gerald, Palumbo, Antonio, Martin, Maria Luisa, Caillot, Denis, Goldschmidt, Hartmut (2013).

Double Vs Single Autologous Stem Cell Transplantation After Bortezomib-Based Induction Regimens For Multiple Myeloma: An Integrated Analysis Of Patient-Level Data From Phase European III Studies

BLOOD. Meeting Abstract. 122(21).
[doi:10.1182/blood.V122.21.767.767]
Martinez-Lopez, Joaquin, Fulciniti, Mariateresa, Barrio, Santiago, Carlton, Victoria, Moorhead, Martin, Lahuerta, Juan Jose, Anderson, Kenneth C., Magrangeas, Florence, Minvielle, Stephane, Avet-Ioiseau, Herve, Faham, Malek, Munshi, Nikhil C. (2013).

Deep Sequencing Reveals Oligoclonality At The Immunoglobulin Locus In Multiple Myeloma Patients

BLOOD. Meeting Abstract. 122(21).
[doi:10.1182/blood.V122.21.401.401]
van Beurden-Tan, C., Rosinol, L., Diels, J., Wirth, D., Chirita, O., Lahuerta, J. J., Gaugris, S., Marsh, S., San Miguel, J., Spencer, M., Treur, M., Blade, J. (2013).

COST-EFFECTIVENESS OF INDUCTION TREATMENT WITH BORTEZOMIB ADDED TO THALIDOMIDE AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN GERMANY

VALUE IN HEALTH. Meeting Abstract. 16(7):409-410.
[doi:10.1016/j.jval.2013.08.498]
Paiva, B., Vidriales, M-B, Rosinol, L., Martinez-Lopez, J., Mateos, M-V, Ocio, E. M., Montalban, M-A, Cordon, L., Gutierrez, N. C., Corchete, L., Oriol, A., Terol, M-J, Echeveste, M-A, De Paz, R., De Arriba, F., Palomera, L., de la Rubia, J., Diaz-Mediavilla, J., Granell, M., Gorosquieta, A., Alegre, A., Orfao, A., Lahuerta, J-J, Blade, J., Miguel, J. F. San, PETHEMA Programa Estudio (2013).

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control (vol 27, pg 2112, 2013)

LEUKEMIA. Correction. 27(10):2112-2112.
[doi:10.1038/leu.2013.213]
Arranz, Reyes, Garcia-Noblejas, Ana, Grande, Carlos, Cannata-Ortiz, Jimena, Sanchez, Jose J., Garcia-Marco, Jose-Antonio, Alaez, Concepcion, Perez-Calvo, Javier, Martinez-Sanchez, Pilar, Sanchez-Gonzalez, Blanca, Canales, Miguel-Angel, Conde, Eulogio, Martin, Alejandro, Arranz, Eva, Terol, Maria-Jose, Salar, Antonio, Caballero, Dolores (2013).

First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with Y-90-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group

HAEMATOLOGICA. Article. 98(10):1563-1570.
[doi:10.3324/haematol.2013.088377]
San Miguel, Jesus, Weisel, Katja, Moreau, Philippe, Lacy, Martha, Song, Kevin, Delforge, Michel, Karlin, Lionel, Goldschmidt, Hartmut, Banos, Anne, Oriol, Albert, Alegre, Adrian, Chen, Christine, Cavo, Michele, Garderet, Laurent, Ivanova, Valentina, Martinez-Lopez, Joaquin, Belch, Andrew, Palumbo, Antonio, Schey, Stephen, Sonneveld, Pieter, Yu, Xin, Sternas, Lars, Jacques, Christian, Zaki, Mohamed, Dimopoulos, Meletios (2013).

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

LANCET ONCOLOGY. Article. 14(11):1055-1066.
[doi:10.1016/S1470-2045(13)70380-2]
Sarasquete, Maria E., Martinez-Lopez, Joaquin, Chillon, Maria C., Alcoceba, Miguel, Corchete, Luis A., Paiva, Bruno, Puig, Noemi, Sebastian, Elena, Jimenez, Cristina, Mateos, Maria-Victoria, Oriol, Albert, Rosinol, Laura, Palomera, Luis, Teruel, Ana I., Gonzalez, Yolanda, Lahuerta, Juan J., Blade, Joan, Gutierrez, Norma C., Fernandez-Redondo, Elena, Gonzalez, Marcos, San Miguel, Jesus F., Garcia-Sanz, Ramon (2013).

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma

BRITISH JOURNAL OF HAEMATOLOGY. Article. 163(2):223-234.
[doi:10.1111/bjh.12519]
Paiva, B., Vidriales, M-B, Rosinol, L., Martinez-Lopez, J., Mateos, M-V, Ocio, E. M., Montalban, M-A, Cordon, L., Gutierrez, N. C., Corchete, L., Oriol, A., Terol, M-J, Echeveste, M-A, De Paz, R., De Arriba, F., Palomera, L., de la Rubia, J., Diaz-Mediavilla, J., Granell, M., Gorosquieta, A., Alegre, A., Orfao, A., Lahuerta, J-J, Blade, J., San Miguel, J. F. (2013).

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control

LEUKEMIA. Article. 27(10):2056-2061.
[doi:10.1038/leu.2013.166]
Sonneveld P, Goldschmidt H, Rosiñol L, Bladé J, Lahuerta JJ, Cavo M, Tacchetti P, Zamagni E, Attal M, Lokhorst HM, Desai A, Cakana A, Liu K, van de Velde H, Esseltine DL, Moreau P (2013).

Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials

JOURNAL OF CLINICAL ONCOLOGY. Article. 31(26):3279-3279.
[doi:10.1200/JCO.2012.48.4626]
Puchades-Carrasco L, Lecumberri R, Martínez-López J, Lahuerta JJ, Mateos MV, Prósper F, San-Miguel JF, Pineda-Lucena A (2013).

Multiple Myeloma Patients Have a Specific Serum Metabolomic Profile That Changes after Achieving Complete Remission

CLINICAL CANCER RESEARCH. Article. 19(17):4770-4779.
[doi:10.1158/1078-0432.CCR-12-2917]
Alcoceba M, Sebastián E, Marín L, Balanzategui A, Sarasquete ME, Chillón MC, Jiménez C, Puig N, Corral R, Pardal E, Grande C, Bello JL, Albo C, de la Cruz F, Panizo C, Martín A, González-Barca E, Caballero MD, San Miguel JF, García-Sanz R, González M (2013).

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma

BLOOD. Article. 122(8):1448-1454.
[doi:10.1182/blood-2013-02-483420]
Castellanos-González M, Velasco Rodriguez D, Blanco Echevarría A, Postigo C, Ortiz Romero P, Díaz RA, Rodriguez-Peralto JL (2013).

Eosinophilic Fasciitis as a Manifestation of a Cutaneous T-Cell Lymphoma Not Otherwise Specified

AMERICAN JOURNAL OF DERMATOPATHOLOGY. Article. 35(6):666-670.
[doi:10.1097/DAD.0b013e3182892230]
Costa, Dolors, Munoz, Concha, Carrio, Ana, Nomdedeu, Meritxell, Calvo, Xavier, Sole, Francesc, Luno, Elisa, Cervera, Jose, Vallespi, Teresa, Berneaga, Daniela, Gomez, Candida, Arias, Amparo, Such, Esperanza, Sanz, Guillermo, Grau, Javier, Insunza, Andres, Calasanz, Maria J., Ardanaz, Maria T., Hernandez, Jesus M., Azaceta, Gemma, Alvarez, Sara, Sanchez, Joaquin, Martin, Maria L., Bargay, Joan, Gomez, Valle, Javier Cervero, Carlos, Allegue, Maria J., Collado, Rosa, Campo, Elias, Nomdedeu, Benet (2013).

Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: Review of 5,654 patients with an evaluable karyotype

GENES CHROMOSOMES & CANCER. Article. 52(8):753-763.
[doi:10.1002/gcc.22071]
Mateos, Maria-Victoria, Hernandez, Miguel-Teodoro, Giraldo, Pilar, de la Rubia, Javier, de Arriba, Felipe, Lopez Corral, Lucia, Rosinol, Laura, Paiva, Bruno, Palomera, Luis, Bargay, Joan, Oriol, Albert, Prosper, Felipe, Lopez, Javier, Olavarria, Eduardo, Quintana, Nuria, Garcia, Jose-Luis, Blade, Joan, Lahuerta, Juan-Jose, San Miguel, Jesus-F. (2013).

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

NEW ENGLAND JOURNAL OF MEDICINE. Article. 369(5):438-447.
[doi:10.1056/NEJMoa1300439]
Sanchez-Castro, Judit, Marco-Betes, Victor, Gomez-Arbones, Xavier, Arenillas, Leonor, Valcarcel, David, Vallespi, Teresa, Costa, Dolors, Nomdedeu, Benet, Jose Jimenez, Maria, Granada, Isabel, Grau, Javier, Ardanaz, Maria T., de la Serna, Javier, Carbonell, Felix, Cervera, Jose, Sierra, Adriana, Luno, Elisa, Cervero, Carlos J., Falantes, Jose, Calasanz, Maria J., Gonzalez-Porras, Jose R., Bailen, Alicia, Luz Amigo, M., Sanz, Guillermo, Sole, Francesc (2013).

Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome

LEUKEMIA RESEARCH. Article. 37(7):769-776.
[doi:10.1016/j.leukres.2013.04.010]
Barrio S, Gallardo M, Arenas A, Ayala R, Rapado I, Rueda D, Jimenez A, Albizua E, Burgaleta C, Gilsanz F, Martinez-Lopez J (2013).

Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm

BRITISH JOURNAL OF HAEMATOLOGY. Article. 161(5):667-676.
[doi:10.1111/bjh.12308]
Bringhen, Sara, Victoria Mateos, Maria, Zweegman, Sonja, Larocca, Alessandra, Falcone, Antonietta Pia, Oriol, Albert, Rossi, Davide, Cavalli, Maide, Wijermans, Pierre, Ria, Roberto, Offidani, Massimo, Jose Lahuerta, Juan, Liberati, Anna Marina, Mina, Roberto, Callea, Vincenzo, Schaafsma, Martijn, Cerrato, Chiara, Marasca, Roberto, Franceschini, Luca, Evangelista, Andrea, Teruel, Ana-Isabel, van der Holt, Bronno, Montefusco, Vittorio, Ciccone, Giovannino, Boccadoro, Mario, San Miguel, Jesus, Sonneveld, Pieter, Palumbo, Antonio (2013).

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials

HAEMATOLOGICA. Article. 98(6):980-987.
[doi:10.3324/haematol.2012.075051]
Martinez-Lopez, Joaquin, Garcia-Sanz, Ramon, Pepin, Francois, Ayala, Rosa, Angeles Montalban, Maria, Paiva, Bruno, Weng, Li, Barrio, Santiago, Montejano, Laura, Rapado, Immaculada, Martinez, Rafael, Jesus Blachard, Maria, Sanchez-Godoy, Pedro, Blade, Joan, San-Miguel, Jesus F., Faham, Malek, Jose Lahuerta, Juan (2013).

Prognostic value of deep sequencing method for minimal residual disease (MRD) detection in multiple myeloma

JOURNAL OF CLINICAL ONCOLOGY. Meeting Abstract. 31(15, S).
Giraldo, P., De La Serna, J., Espinos, B. (2013).

COST-UTILITY OF VELAGLUCERASE ALPHA FOR THE TREATMENT OF TYPE I GAUCHER DISEASE IN SPAIN

VALUE IN HEALTH. Meeting Abstract. 16(3):119-119.
[doi:10.1016/j.jval.2013.03.571]
Ribera, Josep-Maria, Garcia, Olga, Grande, Carlos, Esteve, Jordi, Oriol, Albert, Bergua, Juan, Gonzalez-Campos, Jose, Vall-Ilovera, Ferran, Tormo, Mar, Hernandez-Rivas, Jesus-Maria, Garcia, Daniel, Brunet, Salut, Alonso, Natalia, Barba, Pere, Miralles, Pilar, Llorente, Andreu, Montesinos, Pau, Moreno, Maria-Jose, Hernandez-Rivas, Jose-Angel, Bernal, Teresa (2013).

Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status Final Results of a Phase 2 Study (Burkimab)

CANCER. Article. 119(9):1660-1668.
[doi:10.1002/cncr.27918]
Parrondo J, Grande C, Ibáñez J, Palau J, Páramo JA, Villa G (2013).

Evaluación económica del tratamiento de la trombocitopenia inmune primaria crónica refractaria con agonistas del receptor de la trombopoyetina.

FARMACIA HOSPITALARIA. Abstract of Published Item. 37(3):182-191.
[doi:10.7399/FH.2013.37.3.526]
Adema, Vera, Maria Hernandez, Jesus, Abaigar, Maria, Lumbreras, Eva, Such, Esperanza, Calull, Anna, Dominguez, Esther, Arenillas, Leonor, Mallo, Mar, Cervera, Jose, Marugan, Isabel, Tormo, Mar, Garcia, Francisca, Gonzalez, Teresa, Luno, Elisa, Sanzo, Carmen, Luisa Martin, Maria, Fernandez, Manuela, Costa, Dolors, Blazquez, Beatriz, Barrena, Beatriz, Marco, Fernando, Batlle, Ana, Buno, Ismael, Martinez-Laperche, Carolina, Noriega, Victor, Collado, Rosa, Ivars, David, Carbonell, Felix, Vallcorba, Isabel, Melero, Josefa, Delgado, Elena, Teresa Vargas, Maria, Grau, Javier, Salido, Marta, Espinet, Blanca, Melero, Carme, Florensa, Lourdes, Pedro, Carmen, Sole, Francesc (2013).

Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does-7/7q-detection by FISH have prognostic value?

LEUKEMIA RESEARCH. Article. 37(4):416-421.
[doi:10.1016/j.leukres.2012.12.010]
Fernandez de larrea, C., Kyle, R. A., Durie, B. G. M., Ludwig, H., Usmani, S., Vesole, D. H., Hajek, R., San Miguel, J. F., Sezer, O., Sonneveld, P., Kumar, S. K., Mahindra, A., Comenzo, R., Palumbo, A., Mazumber, A., Anderson, K. C., Richardson, P. G., Badros, A. Z., Caers, J., Cavo, M., Leleu, X., Dimopoulos, M. A., Chim, C. S., Schots, R., Noeul, A., Fantl, D., Mellqvist, U-H, Landgren, O., Chanan-Khan, A., Moreau, P., Fonseca, R., Merlini, G., Lahuerta, J. J., Blade, J., Orlowski, R. Z., Shah, J. J., Int Myeloma Working Grp (2013).

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

LEUKEMIA. Review. 27(4):780-791.
[doi:10.1038/leu.2012.336]
Rio-Machin, A., Ferreira, B. I., Henry, T., Gomez-Lopez, G., Agirre, X., Alvarez, S., Rodriguez-Perales, S., Prosper, F., Calasanz, M. J., Martinez, J., Fonseca, R., Cigudosa, J. C. (2013).

Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype

LEUKEMIA. Article. 27(4):925-931.
[doi:10.1038/leu.2012.302]
De la Serna, Javier, Jarque, Isidro, Lopez-Jimenez, Javier, Maria Fernandez-Navarro, Jose, Gomez, Valle, Jurado, Manuel, Pascual, Adriana, Serrano, Josefina, Romero, Monica, Vallejo, Carlos (2013).

Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles

REVISTA ESPANOLA DE QUIMIOTERAPIA. Article. 26(1):64-69.
Valcarcel, David, Adema, Vera, Sole, Francesc, Ortega, Margarita, Nomdedeu, Benet, Sanz, Guillermo, Luno, Elisa, Canizo, Consuelo, de la Serna, Javier, Ardanaz, Maite, Marco, Victor, Collado, Rosa, Grau, Javier, Montoro, Julia, Mallo, Mar, Vallespi, Teresa (2013).

Complex, Not Monosomal, Karyotype Is the Cytogenetic Marker of Poorest Prognosis in Patients With Primary Myelodysplastic Syndrome

JOURNAL OF CLINICAL ONCOLOGY. Article. 31(7):916-922.
[doi:10.1200/JCO.2012.41.6073]
Avet-Loiseau H, Durie BG, Cavo M, Attal M, Gutierrez N, Haessler J, Goldschmidt H, Hajek R, Lee JH, Sezer O, Barlogie B, Crowley J, Fonseca R, Testoni N, Ross F, Rajkumar SV, Sonneveld P, Lahuerta J, Moreau P, Morgan G (2013).

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

LEUKEMIA. Article. 27(3):711-717.
[doi:10.1038/leu.2012.282]
Blanes, Margarita, Lahuerta, Juan J., Gonzalez, Jose D., Ribas, Paz, Solano, Carlos, Alegre, Adrian, Blade, Joan, San Miguel, Jesus F., Sanz, Miguel A., de la Rubia, Javier (2013).

Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myelotha: A Matched Comparison to a Melphalan-Only Approach

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Article. 19(1):69-74.
[doi:10.1016/j.bbmt.2012.08.009]
Pessoa de Magalhaes, Roberto J., Vidriales, Maria-Belen, Paiva, Bruno, Fernandez-Gimenez, Carlos, Garcia-Sanz, Ramon, Mateos, Maria-Victoria, Gutierrez, Norma C., Lecrevisse, Quentin, Blanco, Juan F., Hernandez, Jose, de las Heras, Natalia, Martinez-Lopez, Joaquin, Roig, Monica, Sobral Costa, Elaine, Ocio, Enrique M., Perez-Andres, Martin, Maiolino, Angelo, Nucci, Marcio, De La Rubia, Javier, Lahuerta, Juan-Jose, San-Miguel, Jesus F., Orfao, Alberto, Spanish Myeloma Grp GEM, Grp Castellano-Leones de Gammapati (2013).

Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry

HAEMATOLOGICA. Article. 98(1):79-86.
[doi:10.3324/haematol.2012.067272]

2012

Barrio, Santiago, Gallardo, Miguel, Arenas, Alicia, Ayala, Rosa M., Rapado, Inmaculada, Rueda, Daniel, Jimenez, Ana, Albizua, Enriqueta, Burgaleta, Carmen, Gilsanz, Florinda, Martinez, Joaquin (2012).

Inhibition of Related JAK/STAT Pathways with Molecular Targeted Drugs Shows Strong Synergy with Ruxolitinib in Chronic Myeloproliferative Neoplasms

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.5054.5054]
Ocio, Enrique M., Herrera, Pilar, Olave, Teresa, Brunet, Salut, Oriol, Albert, Martinez-Sanchez, Maria-Pilar, Sanz, Miguel A., Mateos, Marta, Aliseda, Pilar, Winiger, Ivo J., Hardikar, Sushant, Victoria Mateos, Maria, Lopez, Javier, San-Miguel, Jesus F. (2012).

Initial Results of the Phase I/II Panobidara Study of Panobinostat in Combination with Idarubicin and Cytarabine in Patients Aged 65 Years or Older with Newly Diagnosed Acute Myeloblastic Leukaemia (AML)

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.1512.1512]
Valentin Garcia-Gutierrez, J., Maestro, Begona, Felipe Casado, Luis, Perez-Encinas, Manuel, Massague, Isabel, de Paz, Raquel, Osorio, Santiago, Martinez, Joaquin, Bautista, Guiomar, Giraldo, Pilar, Burgaleta, Carmen, Jesus Penarrubia, Maria, Jose Requena, Maria, Calle, Carmen, Angel Hernandez-Rivas, Jose, Cano, Pilar, Luis Steegmann, Juan (2012).

Outcomes of Chronic Myeloid Leukemia (CML) Patients Who Stopped Second Generation Tyrosine Kinase Inhibitors (2GTKIs) As Second Line Treatment. Results of the CML Spanish National Registry (RELMC)

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.3764.3764]
Valentin Garcia-Gutierrez, J., Maestro, Begona, Felipe Casado, Luis, Perez-Encinas, Manuel, Massague, Isabel, De Paz, Raquel, Osorio, Santiago, Martinez, Joaquin, Bautista, Guiomar, Giraldo, Pilar, Burgaleta, Carmen, Jesus Penarrubia, Maria, Jose Requena, Maria, Calle, Carmen, Angel Hernandez-rivas, Jose, Cano, Pilar, Luis Steegmann, Juan (2012).

Switching to a Second Generation TKI in Chronic Myeloid Leukemia Patients with Late Suboptimal Response with Imatinib Obtained Better Molecular Responses That the ``Watch and Wait'' Approach. an Experience of a Multicenter Registry in Patients Outside Clinical Trials

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.3768.3768]
Valcarcel, David, Sanz, Guillermo, Ortega, Margarita, Nomdedeu, Benet, Luno, Elisa, Diez-Campelo, Maria, Teresa Ardanaz, M., Pedro, Carmen, Montoro, Julia, Collado, Rosa, Andreu, Rafa, Marco, Victor, Teresa Cedena, Maria, de Paz, Raquel, Tormo, Mar, Xicoy, Blanca, Ramos, Fernando, Bargay, Joan, Gonzalez, Bernardo, Brunet, Salut, Antonio Muaoz, Juan, Gomez, Valle, Bailen, Alicia, Sanchez', Joaquin, Vallespi, Teresa (2012).

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.702.702]
Ruedas, Angel, Guisado, Pablo, Aguado, Beatriz, Perez, Ricardo, Martinez, Joaquin, Valentin Garcia-Gutierrez, J., Jesus Blanchard, M., Bravo, Pilar, Montalban, Carlos (2012).

Personalized Treatment with low doses of Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma in frail or Elderly Patients

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.5049.5049]
Rosinnol, Laura, Oriol, Albert, Isabel Teruel, Ana, Hernandez, Dolores, Lopez-Jimenez, Javier, De La Rubia, Javier, Granell, Miquel, Besalduch, Juan, Palomera, Luis, Gonzalez, Yolanda, Asuncion Etxebeste, Maria, Diaz-Mediavilla, Joaquin, Teodoro Hernandez, Miguel, de Arriba, Felipe, Alegre, Adrian, Teresa Cibeira, Maria, Victoria Mateos, Maria, Martinez, Joaquin, Jose Lahuerta, Juan, San Miguel, Jesus F., Blade, Joan (2012).

Maintenance Therapy After Stem-Cell Transplantation for Multiple Myeloma with Bortezomib/Thalidomide Vs. Thalidomide Vs. alfa2b-Interferon: Final Results of a Phase III Pethema/GEM Randomized Trial

BLOOD. Meeting Abstract. 120(21).
Rosinnol, Laura, Oriol, Albert, Isabel Teruel, Ana, Hernandez, Dolores, Lopez-Jimenez, Javier, De La Rubia, Javier, Granell, Miquel, Besalduch, Juan, Palomera, Luis, Gonzalez, Yolanda, Asuncion Etxebeste, Maria, Diaz-Mediavilla, Joaquin, Teodoro Hernandez, Miguel, de Arriba, Felipe, Alegre, Adrian, Teresa Cibeira, Maria, Victoria Mateos, Maria, Martinez, Joaquin, Jose Lahuerta, Juan, San Miguel, Jesus F., Blade, Joan (2012).

Maintenance Therapy After Stem-Cell Transplantation for Multiple Myeloma with Bortezomib/Thalidomide Vs. Thalidomide Vs. alfa2b-Interferon: Final Results of a Phase III Pethema/GEM Randomized Trial

BLOOD. Meeting Abstract. 120(21).
Panizo, Carlos, Inoges, Susana, Lopez Diaz de Cerio, Ascension, Garcia Munoz, Ricardo, Pastor, Fernando, Grande Garcia, Carlos, Olave, Mayte, Palomera, Luis, Rifon, Jose J., Barea, Sara, Alfonso, Ana, Bendandi, Maurizio (2012).

Immunotherapy with LAK Cells and Anti-CD20 Monoclonal Antibodies for Follicular Lymphoma: Enhanced Antibody-Dependent Cell Cytotoxicity of LAK Cells in Association with GA101 Rather Than Rituximab

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.4881.4881]
Salar, Antonio, Domingo-Domenech, Eva, Panizo, Carlos, Nicolas, Concepcion, Bargay, Joan, Muntanola, Ana, Canales, Miguel, Luis Bello, Jose, Manuel Sancho, Juan, Francisco Tomas, Jose, Jose Rodriguez, Mara, Penalver, Francisco-Javier, Palomera, Luis, Grande, Carlos, Sanchez-Blanco, Jose J., Arranz, Reyes, Conde, Eulogio, Caballero, Dolores, Montalban, Carlos (2012).

Final Results of a Multicenter Phase II Trial with Bendamustine and Rituximab As First Line Treatment for Patients with MALT Lymphoma (MALT-2008-01)

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.3691.3691]
Montes-Moreno, Santiago, Batlle, Ana, Gonzalez de Villambrosia, Sonia, Sanchez-Espiridion, Beatriz, Cereceda, Laura, Gonzalez-Barca, Eva, Noelia, Purroy, Pardal, Emilia, Sebastian, Elena, Martin, Alejandro, Grande, Carlos, Mazorra, Francisco, Insunza, Andres, Rueda, Antonio, Llanos, Marta, Gomez Codina, Jose, Garcia Arroyo, Francisco Ramon, Caballero, Dolores, Conde, Eulogio, Lopez, Andres, Provencio, Mariano, Piris, Miguel (2012).

Risk Adapted-High Dose Therapies Modulate the Impact of Biological Classification in Diffuse Large B Cell Lymphoma Prognosis. Analysis of Biological Markers in Patients From Clinical Trials in Geltamo and Gotel Spanish Collaborative Groups.

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.2672.2672]
Briones, Javier, Novelli, Silvana, Garcia Marco, Jose Antonio, Francisco Tomas, Jose, Bernal, Teresa, Grande, Carlos, Canales, Miguel, Torres, Antonio, Moraleda, Jose M., Panizo, Carlos, Palmero, Fernanda, Jarque, Isidro, Hernandez, Miguel, Gonzalez Barca, Eva, Lopez, Dulce, Caballero, Dolores (2012).

Autologous Stem Cell Transplantation with Yttriumm-90-Ibritumomab Tiuxetan (Zevalin) Plus BEAM Conditioning in Patients with Refractory Non-Hodgkin Diffuse Large B-Cell Lymphoma: Results of a Prospective, Multicenter, Phase II Clinical Trial

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.1978.1978]
Lopez Corral, Luca, Antonio Corchete, Luis, Victoria Mateos, Maria, Garcia-Sanz, Ramon, Ferminan, Encarna, Jose Lahuerta, Juan, Blade, Joan, Oriol, Albert, Isabel Teruel, Ana, Luz Martino, Maria, Hernandez, Jose, Hernandez-Rivas, Jesus M., San Miguel, Jesus F., Gutierrez, Norma (2012).

Transcriptome Analysis Reveals Molecular Profiles Associated with Evolving Steps of Monoclonal Gammopathies

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.2914.2914]
Garcia-Vela, Jose A., Lopez, Javier, Ferrer, Secundino, Giraldo, Pilar, Gonzalez-Barca, Eva, Conde, Eulogio, Gonzalez, Marcos, Guzman, Jose-Luis, De la Serna, Javier, Osma, Mar, Deben, Guillermo, Monzo, Encarna, De Paz, Raquel, Penalver, Francisco-Javier, Jarque, Isidro, Martinez, Rafael, Burgaleta, Carmen, Perez de Oteiza, Jaime, Angeles Andreu, M., Carbonell, Felix, Garcia-Marco, Jose A. (2012).

Assessment of Minimal Residual Disease Levels in B-CLL After Front-Line Treatment with FC-R and Rituximab Maintenance

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.4599.4599]
Felipe Casado, Luis, Maestro, Begona, Valentin Garcia-Gutierrez, J., Helene Dumas, Marie, Massague, Isabel, Giraldo, Pilar, Perez-Encinas, Manuel, de Paz, Raquel, Martinez-Lopez, Joaqun, Bautista, Guiomar, Osorio, Santiago, Jose Requena, Maria, Palomera, Luis, Jesus Penarrubia, Maria, Calle, Carmen, Angel Hernandez-Rivas, Jose, Burgaleta, Carmen, Andrade, Sr., Marcio M., Garcia-Ormena, Nuria, Luis Steegmann, Juan (2012).

A Good Adherence to ELN 09 Recommendations in Chronic Myeloid Leukemia (CML) Treatment with Imatinib, Is Associated with Better Outcomes in Patients Treated Outside Clinical Trials

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.3762.3762]
Diez-Campelo, Maria, Itzykson, Raphael, Rojas, Silvia M., Berthon, Celine, Luno, Elisa, Beyne-Rauzy, Odile, Perez-Oteyza, Jaime, Vey, Norbert, Bargay, Joan, Park, Sophie, Cedena, Teresa, Bordessoule, Dominique, Munoz, Juan A., Gyan, Emmanuel, Such, Esperanza, Visanica, Sorin, Benlloch, Luis, de Botton, Stephane, Hernandez-Rivas, Jesus M., Ame, Shanti, Stamatoullas, Aspasia, Delaunay, Jacques, Salanoubat, Celia, Isnard, Francoise, Sanz, Guillermo, Guieze, Romain, Canizo, Consuelo, Fenaux, Pierre (2012).

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.1713.1713]
Martinez Lopez, Joaquin, Sanchez Beato, Margarita, Nerea, Martinez, Varela, Ignacio, Derdak, Sophia, Rapado, Inmaculada, Beltran, Sergi, Martinez Sayalero, Sara, Cereceda, Laura, Bayes, Monica, Gut, Marta, Gut, Ivo G., Angel Piris, Miguel (2012).

Characterization of Subclonal Changes Along Progression in Multiple Myeloma

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.2924.2924]
Coronado, Monica, Pardal, Emilia, Couto, Rosa, de la Cruz, Fatima, Panizo, Carlos, Grande, Carlos, Arranz, Reyes, Jose Ramirez, Maria, Hernandez, Roberto, Martin, Alejandro, Caballero, Dolores (2012).

Prognostic Value of Interim PET/CT in Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL). Experience of the Spanish Geltamo Group

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.5076.5076]
Cavo, Michele, Sonneveld, Pieter, Moreau, Philippe, Blade, Joan, Goldschmidt, Hartmut, San Miguel, Jesus F., Attal, Michel, Avet-Loiseau, Herve, Blau, Wolgang Igor, Facon, Thierry, Gutierrez, Norma, Harousseau, Jean-Luc, van der Holt, Bronno, Jose Lahuerta, Juan, Lokhorst, Henk, Marit, Gerald, Luisa Martin, Maria, Marzocchi, Giulia, Palumbo, Antonio, Patriarca, Francesca, Petrucci, Maria Teresa, Rosinol, Laura, Salwender, Hans, Terragna, Carolina (2012).

Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies

BLOOD. Meeting Abstract. 120(21).
[doi:10.1182/blood.V120.21.749.749]
Giraldo, P., Lopez, A., Rios, E., Gonzalez-Grande, I, Roset, M., Castro-Gomez, A., De La Serna, J., Carbonell, F. (2012).

PRELIMINARY VALIDATION OF COLLECT SCALE: A CO-MORBIDITY ASSESSMENT TOOL FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA

VALUE IN HEALTH. Meeting Abstract. 15(7):508-508.
[doi:10.1016/j.jval.2012.08.1725]
Paiva, Bruno, Vidriales, Maria-Belen, Montalban, Maria-Angeles, Perez, Jose J., Gutierrez, Norma C., Rosinol, Laura, Martinez-Lopez, Joaquin, Mateos, Maria-Victoria, Cordon, Lourdes, Oriol, Albert, Terol, Maria-Jose, Echeveste, Maria-Asuncion, De Paz, Raquel, De Arriba, Felipe, Palomera, Luis, de la Rubia, Javier, Diaz-Mediavilla, Joaquin, Sureda, Anna, Gorosquieta, Ana, Alegre, Adrian, Martin, Alejandro, Lahuerta, Juan-Jose, Blade, Joan, Orfao, Alberto, San Miguel, Jesus F. (2012).

Multiparameter Flow Cytometry Evaluation of Plasma Cell DNA Content and Proliferation in 595 Transplant-Eligible Patients with Myeloma Included in the Spanish GEM2000 and GEM2005 < 65y Trials

AMERICAN JOURNAL OF PATHOLOGY. Article. 181(5):1870-1878.
[doi:10.1016/j.ajpath.2012.07.020]
Mateos, Maria-Victoria, Oriol, Albert, Martinez-Lopez, Joaquin, Gutierrez, Norma, Teruel, Ana-Isabel, Lopez de la Guia, Ana, Lopez, Javier, Bengoechea, Enrique, Perez, Montserrat, Polo, Marta, Palomera, Luis, de Arriba, Felipe, Gonzalez, Yolanda, Hernandez, Jose-Mariano, Granell, Miquel, Bello, Jose-Luis, Bargay, Joan, Penalver, Francisco-Javier, Ribera, Jose-Maria, Martin-Mateos, Maria-Luisa, Garcia-Sanz, Ramon, Lahuerta, Juan-Jose, Blade, Joan, San-Miguel, Jesus F. (2012).

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

BLOOD. Article. 120(13):2581-2588.
[doi:10.1182/blood-2012-05-427815]
Arefi, Maryam, Garcia, Juan L., Montserrat Briz, M., de Arriba, Felipe, Rodriguez, Juan N., Martin-Nunez, Guillermo, Martinez, Joaquin, Lopez, Javier, Suarez, Julio G., Jose Moreno, M., Angeles Merino, M., Gutierrez, Norma C., Maria Hernandez-Rivas, Jesus (2012).

Response to imatinib mesylate in patients with hypereosinophilic syndrome

INTERNATIONAL JOURNAL OF HEMATOLOGY. Article. 96(3):320-326.
[doi:10.1007/s12185-012-1141-7]
Lopez-Corral, Lucia, Victoria Mateos, Maria, Corchete, Luis A., Eugenia Sarasquete, Maria, de la Rubia, Javier, de Arriba, Felipe, Lahuerta, Juan-Jose, Garcia-Sanz, Ramon, San Miguel, Jesus F., Gutierrez, Norma C. (2012).

Genomic analysis of high-risk smoldering multiple myeloma

HAEMATOLOGICA. Article. 97(9):1439-1443.
[doi:10.3324/haematol.2011.060780]
Rosinol, Laura, Oriol, Albert, Isabel Teruel, Ana, Hernandez, Dolores, Lopez-Jimenez, Javier, de la Rubia, Javier, Granell, Miquel, Besalduch, Joan, Palomera, Luis, Gonzalez, Yolanda, Asuncion Etxebeste, Ma, Diaz-Mediavilla, Joaquin, Hernandez, Miguel T., de Arriba, Felipe, Gutierrez, Norma C., Luisa Martin-Ramos, Ma, Teresa Cibeira, Ma, Victoria Mateos, Ma, Martinez, Joaquin, Alegre, Adrian, Jose Lahuerta, Juan, San Miguel, Jesus, Blade, Joan, Programa Estudio & Terapeutica Hem (2012).

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

BLOOD. Article. 120(8):1589-1596.
[doi:10.1182/blood-2012-02-408922]
Ayala, Rosa, Grande, Silvia, Bustelos, Rosalia, Ribera, Carmen, Garcia-Sesma, Alvaro, Jimenez, Carlos, Moreno, Enrique, Martinez-Lopez, Joaquin (2012).

Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients

BMC GASTROENTEROLOGY. Article. 12(114):114-114.
[doi:10.1186/1471-230X-12-114]
Paiva, B., Gutierrez, N-C, Chen, X., Vidriales, M-B, Montalban, M-A, Rosinol, L., Oriol, A., Martinez-Lopez, J., Mateos, M-V, Lopez-Corral, L., Diaz-Rodriguez, E., Perez, J-J, Fernandez-Redondo, E., de Arriba, F., Palomera, L., Bengoechea, E., Terol, M-J, de Paz, R., Martin, A., Hernandez, J., Orfao, A., Lahuerta, J-J, Blade, J., Pandiella, A., San Miguel, J-F (2012).

Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients

LEUKEMIA. Article. 26(8):1862-1869.
[doi:10.1038/leu.2012.42]
Martinez-Lopez, Joaquin, Castro, Nerea, Rueda, Daniel, Canal, Alicia, Grande, Carlos, Ayala, Rosa (2012).

Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3

BRITISH JOURNAL OF HAEMATOLOGY. Letter. 158(4):555-558.
[doi:10.1111/j.1365-2141.2012.09189.x]
Swift, Brenna E., Williams, Brent A., Kosaka, Yoko, Wang, Xing-Hua, Medin, Jeffrey A., Viswanathan, Sowmya, Martinez-Lopez, Joaquin, Keating, Armand (2012).

Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model

HAEMATOLOGICA. Article. 97(7):1020-1028.
[doi:10.3324/haematol.2011.054254]
Ayala, Rosa, Martinez-Lopez, Joaquin, Gilsanz, Florinda (2012).

Acute myeloid leukemia and transcription factors: role of erythroid Kruppel-like factor (EKLF)

CANCER CELL INTERNATIONAL. Article. 12(1):25-25.
[doi:10.1186/1475-2867-12-25]
Barba, Pere, Sampol, Antonia, Calbacho, Maria, Gonzalez, Jose, Serrano, Josefina, Martinez-Sanchez, Pilar, Fernandez, Pascual, Garcia-Boyero, Raimundo, Bueno, Javier, Maria Ribera, Josep, Programa Estudio Tratamiento, Programa Espanol Tratamiento (2012).

Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience

AMERICAN JOURNAL OF HEMATOLOGY. Letter. 87(6):631-634.
[doi:10.1002/ajh.23167]
Sopeña M, Clavero EM, Villa P, Martínez-López J (2012).

Efficacy and safety of reduced-intensity induction therapy with a bortezomib-based regimen in elderly patients with multiple myeloma.

Therapeutic Advances In Hematology. Article. 3(3):147-154.
[doi:10.1177/2040620712440589]
Sanchez-Gonzalez B, Peñalver FJ, Medina A, Guillén H, Calleja M, Gironella M, Arranz R, Sebastian E, de Oña R, Cánovas A, de la Fuente I, Grande C, Sancho JM, Perez R, Domingo E, Lopez-Lorenzo JL, Prieto E, Panizo C, Gorosquieta A, Perez I, Cervera JM, Marin M, Mencha C, Ramila E, Salar A (2012).

Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain

LEUKEMIA RESEARCH. Article. 36(6):709-714.
[doi:10.1016/j.leukres.2011.10.024]
Osorio, Irene, Jose, Perea, Daniel, Rueda, Alvaro, Edurne, Perez, Ana, Alegre, Cristina, Urioste, Miguel (2012).

SURGICAL APPROACH TO THE FAMILIAL ADENOMATOUS POLYPOSIS ACCORDING TO THE GENETIC BASIS

ANNALS OF ONCOLOGY. Meeting Abstract. 23(4):97-97.
Alvaro, Edurne, Perea, Jose, Rueda, Daniel, Rodriguez, Yolanda, Canal, Alicia, Alegre, Cristina, Garcia, Javier, Osorio, Irene, Urioste, Miguel (2012).

COLORECTAL CANCER AND MICROSATELLITE INSTABILITY: DIFFERENT FEATURES AND MOLECULAR BASIS ACCORDING TO THE AGE OF ONSET

ANNALS OF ONCOLOGY. Meeting Abstract. 23(4):88-88.
Osorio, Irene, Perea, Jose, Rueda, Daniel, Perez, Ana, Alvaro, Edurne, Alegre, Cristina, Urioste, Miguel (2012).

COMPARATIVE ANALYSIS OF CpG ISLAND METHYLATOR PHENOTYPE BETWEEN DIFFERENT GROUPS OF COLORECTAL CANCER ACCORDING TO THE AGE OF ONSET

ANNALS OF ONCOLOGY. Meeting Abstract. 23(4):97-97.
Alvaro, Edurne, Perea, Jose, Rueda, Daniel, Alegre, Cristina, Canal, Alicia, Rodriguez, Yolanda, Osorio, Irene, Urioste, Miguel (2012).

EARLY-ONSET COLORECTAL CANCER: THE COMPARATIVE MOLECULAR CLASSIFICATION SUGGESTS THE EXISTENCE OF TWO NEW DIFFERENT GROUPS WITHIN COLORECTAL CANCER

ANNALS OF ONCOLOGY. Meeting Abstract. 23(4):89-89.
Manuel Alonso-Dominguez, Juan, Tenorio, Maria, Velasco, Diego, Abalo, Lorena, Lozano, Sara, Villarrubia, Jesus, Lopez-Jimenez, Javier, Grande, Silvia, Ayala, Rosa (2012).

Correlation of WT1 expression with the burden of total and residual leukemic blasts in bone marrow samples of acute myeloid leukemia patients

CANCER GENETICS. Letter. 205(4):190-191.
[doi:10.1016/j.cancergen.2012.02.008]
Delgado, Julio, Espinet, Blanca, Oliveira, Ana C., Abrisqueta, Pau, de la Serna, Javier, Collado, Rosa, Loscertales, Javier, Lopez, Montserrat, Hernandez-Rivas, Jose A., Ferra, Christelle, Ramirez, Angel, Roncero, Josep M., Lopez, Cristina, Aventin, Anna, Puiggros, Anna, Abella, Eugenia, Carbonell, Felix, Costa, Dolors, Carrio, Anna, Gonzalez, Marcos, GELLC, Grp Espanol Citogenetica Hematolog (2012).

Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results

BRITISH JOURNAL OF HAEMATOLOGY. Article. 157(1):67-74.
[doi:10.1111/j.1365-2141.2011.09000.x]
Richardson, P. G., Delforge, M., Beksac, M., Wen, P., Jongen, J. L., Sezer, O., Terpos, E., Munshi, N., Palumbo, A., Rajkumar, S. V., Harousseau, J. L., Moreau, P., Avet-Loiseau, H., Lee, J. H., Cavo, M., Merlini, G., Voorhees, P., Chng, W. J., Mazumder, A., Usmani, S., Einsele, H., Comenzo, R., Orlowski, R., Vesole, D., Lahuerta, J. J., Niesvizky, R., Siegel, D., Mateos, M-V, Dimopoulos, M., Lonial, S., Jagannath, S., Blade, J., San Miguel, J., Morgan, G., Anderson, K. C., Durie, B. G. M., Sonneveld, P., Int Myeloma Working Grp (2012).

Management of treatment-emergent peripheral neuropathy in multiple myeloma

LEUKEMIA. Review. 26(4):595-608.
[doi:10.1038/leu.2011.346]
Rosinol, Laura, Garcia-Sanz, Ramon, Jose Lahuerta, Juan, Hernandez-Garcia, Miguel, Granell, Miquel, de la Rubia, Javier, Oriol, Albert, Hernandez-Ruiz, Belen, Rayon, Consuelo, Navarro, Isabel, Carlos Garcia-Ruiz, Juan, Besalduch, Joan, Gardella, Santiago, Lopez Jimenez, Javier, Diaz-Mediavilla, Joaquin, Alegre, Adrian, San Miguel, Jesus, Blade, Joan (2012).

Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease

HAEMATOLOGICA. Article. 97(4):616-621.
[doi:10.3324/haematol.2011.051441]
Blanes, M., Lahuerta, J. J., Gonzalez, J. D., Ribas, P., Solano, C., Alegre, A., Blade, J., San Miguel, J. F., Sanz, M. A., de la Rubia, J. (2012).

Intravenous busulfan and melphalan as conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-based approach

BONE MARROW TRANSPLANTATION. Meeting Abstract. 47(1):330-331.
Rosinol, L., Cibeira, M. T., Mateos, M. V., Martinez, J., Oriol, A., Teruel, A. I., Hernandez, D., Lopez Jimenez, J., de la Rubia, J., Granell, M., Besalduch, J., Palomera, L., Gonzalez, Y., Etxebeste, M. A., Diaz-Mediavilla, J., Hernandez, M., de Arriba, F., Alegre, A., Lahuerta, J. J., San Miguel, J., Blade, J. (2012).

A phase III PETHEMA/GEM randomised trial of post-transplant maintenance in multiple myeloma: superiority of bortezomib

BONE MARROW TRANSPLANTATION. Meeting Abstract. 47(1):2-2.
Angel Sanz, Miguel, Vicente Garcia, Vicente, Fernandez, Antonio, Fernanda Lopez, M., Grande, Carlos, Jarque, Isidro, Martinez, Rafael, Eva Mingot, Maria, Monteagudo, Emilio, Ribera, Josep Ma, Valcarcel, David (2012).

Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia

MEDICINA CLINICA. Editorial Material. 138(6):261-261.
[doi:10.1016/j.medcli.2011.11.011]
Perea, Jose, Rueda, Daniel (2012).

Methylation in colorectal cancer

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. Editorial Material. 104(3):107-110.
Paiva, Bruno, Gutierrez, Norma C., Rosinol, Laura, Vidriales, Maria-Belen, Montalban, Maria-Angeles, Martinez-Lopez, Joaquin, Mateos, Maria-Victoria, Cibeira, Maria-Teresa, Cordon, Lourdes, Oriol, Albert, Terol, Maria-Jose, Echeveste, Maria-Asuncion, de Paz, Raquel, de Arriba, Felipe, Palomera, Luis, de la Rubia, Javier, Diaz-Mediavilla, Joaquin, Sureda, Anna, Gorosquieta, Ana, Alegre, Adrian, Martin, Alejandro, Hernandez, Miguel T., Lahuerta, Juan-Jose, Blade, Joan, San Migue, Jesus F. (2012).

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

BLOOD. Article. 119(3):687-691.
[doi:10.1182/blood-2011-07-370460]
Fuster, Oscar, Barragan, Eva, Bolufer, Pascual, Such, Esperanza, Valencia, Ana, Ibanez, Mariam, Dolz, Sandra, de Juan, Inmaculada, Jimenez, Antonio, Teresa Gomez, Maria, Buno, Ismael, Martinez, Joaquin, Cervera, Jose, Montesinos, Pau, Moscardo, Federico, Angel Sanz, Miguel (2012).

Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia

ANNALS OF HEMATOLOGY. Article. 91(1):1-7.
[doi:10.1007/s00277-011-1234-z]
Kumar, S. K., Lee, J. H., Lahuerta, J. J., Morgan, G., Richardson, P. G., Crowley, J., Haessler, J., Feather, J., Hoering, A., Moreau, P., LeLeu, X., Hulin, C., Klein, S. K., Sonneveld, P., Siegel, D., Blade, J., Goldschmidt, H., Jagannath, S., Miguel, J. S., Orlowski, R., Palumbo, A., Sezer, O., Rajkumar, S. V., Durie, B. G. M., Int Myeloma Working Grp (2012).

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

LEUKEMIA. Article. 26(1):149-157.
[doi:10.1038/leu.2011.196]

2011

Barberan, Jose, Mensa, Josep, Vallejo Llamas, Juan Carlos, Jarque Ramos, Isidro, Garcia Ruiz, Juan Carlos, Cabrera Marin, Jose Rafael, Baltasar Tello, Patricia, Battle Massana, Montse, Besalduch Vidal, Juan, Calvo Vinas, Jose Manuel, Capote Huelva, Francisco Javier, Carreras Pons, Enric, Diaz Mediavilla, Joaquin, Diaz Morfa, Miguel L., Escalante Barrigon, Fernando, Fernandez Avellan, Pascual, Garzon Lopez, Sebastian, Grande Garcia, Carlos, Hernandez Maraver, Dolores, de la Guia, Ana Lopez, Lopez Jimenez, Javier, Martin Chacon, Eusebio, Olave Rubio, Mayte, Perez de Oteyza, Jaime, Ramirez Ramirez, Gemma, Rojas Contreras, Rafael, Roman Barbero, Alejandro, Rovira Tarrats, Montserrat, Rubio Felix, Daniel, Sanchez Godoy, Pedro, Sanchez Salinas, Andres, Sanz Alonso, Miguel A., de la Serna Torroba, Javier, Valcarcel Ferreiras, David, Vazquez Lopez, Lourdes, Aguado Garcia, Jose M., Azanza Perea, Jose Ramon, Canton Moreno, Rafael, Cisterna Cancer, Ramon, Fortun Abete, Jesus, Garcia Rodriguez, Julio, Gomez Gomez, Joaquin, Gomez Garcia de la Pedrosa, Elia, Montejo Baranda, Jose Miguel, Javier Pernan Garcia, F., Ruiz Camps, Isabel, Salavert Lleti, Miguel, de la Torre Cisneros, Julian (2011).

Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient

REVISTA ESPANOLA DE QUIMIOTERAPIA. Article. 24(4):263-270.
Linares, Maria, Albizua, Enriqueta, Mendez, Dario, Rubio, Jose M., Martinez-Serna, Alejandra, Martinez, Miguel A., Salto, Efren, Puyet, Antonio, Diez, Amalia, Martinez-Lopez, Joaquin, Bautista, Jose M. (2011).

Malaria Hidden in a Patient with Diffuse Large-B-Cell Lymphoma and Sickle-Cell Trait

JOURNAL OF CLINICAL MICROBIOLOGY. Article. 49(12):4401-4404.
[doi:10.1128/JCM.00911-11]
Ayala, Rosa, Martinez-Lopez, Joaquin, Cedena, Teresa, Bustelos, Rosalia, Jimenez, Carlos, Moreno, Enrique, Ribera, Carmen (2011).

Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients

BMC GASTROENTEROLOGY. Article. 11(130):130-130.
[doi:10.1186/1471-230X-11-130]
Paiva, Bruno, Victoria Mateos, Maria, Lopez-Corral, Lucia, Vidriales, Maria-Belen, Hernandez, Miguel T., Bargay, Joan, de Arriba, Felipe, De la Rubia, Javier, Teruel, Ana-Isabel, Giraldo, Pilar, Rosinol, Laura, Prosper, Felipe, Oriol, Albert, Hernandez, Jose, Esteves, Graca, da Costa, Fernando Leal, Jose Lahuerta, Juan, Blade, Joan, San Miguel, Jesus F. (2011).

Influence of Lenalidomide Treatment on Immune Effector Cells From High-Risk Smoldering Multiple Myeloma (SMM) Patients

BLOOD. Meeting Abstract. 118(21):1686-1686.
Mateos, Maria-Victoria, Lopez-Corral, Lucia, Hernandez, Miguel, Giraldo, Pilar, De La Rubia, Javier, de Arriba, Felipe, Rosinol, Laura, Jose Lahuerta, Juan, Palomera, Luis, Bargay, Joan, Oriol, Albert, Prosper, Felipe, Lopez, Javier, Olavarria, Eduardo, Luz Martino, Maria, Teruel, Ana-Isabel, Mariano Hernandez, Jose, Esteves, Graca, Mariz, Jose Mario J. S., Leal-da-Costa, Fernando, Alegre, Adrian, Guzman, Jose-Luis, Lopez de la Guia, Ana, Baquero, Jose, Quintana, Nuria, Luis Garcia, Jose, San Miguel, Jesas F. (2011).

Smoldering Multiple Myeloma (SMM) At High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) As Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

BLOOD. Meeting Abstract. 118(21):452-453.
De la Serna, Javier, Sanz, Jaime, Bermudez, Arancha, Vallejo, Carlos, Serrano, David, Caballero, Dolores, De La Camara, Rafael, Moraleda, Jose M., Gonzalez, Sonia, Garcia-Noblejas, Ana, Cabrero, M., Jose Lahuerta, Juan, Iriondo, Arturo, Benlloch, Luis, Sanz, Guillermo (2011).

Myeloablative Conditioning with Intravenous Busulfan In One Daily Dose and Fludarabine (BUF) for HLA-Identical Sibling Allogeneic HSCT In Myeloid Malignancies

BLOOD. Meeting Abstract. 118(21):1296-1297.
Gallardo, Miguel, Fernandez, Marisol, Paradela, Alberto, Toldos, Oscar, Garcia-Martin, Rosa-Maria, Barrio, Santiago, Ayala, Rosa M., Albizua, Enriqueta, Rapado, Inmaculada, Jimenez, Ana, Candelas, Marisa, Gilsanz, Florinda, Martinez-Lopez, Joaquin (2011).

Proteomic Analysis Identifies HSP70 As a Novel Target Therapy to Polycythemia Vera

BLOOD. Meeting Abstract. 118(21):1218-1218.
Battle Lopez, Ana, Glez de Villambrosia, Sonia, Montes-Moreno, Santiago, Mazorra, Francisco, Insunza, Andres, Saez, Anabel, Montalban, Carlos, Sanchez, Lydia, Garcia, Juan F., Gonzalez-Barca, Eva, Lopez, A., Ruiz-Marcellan, M. C., Mollejo, Manuela, Grande, Carlos, Dunphy, Cherie H., His, E. D., Go, Ronald S., Visco, Carlo, Xu-Monette, Zijun Y., Young, Ken H., Piris, Miguel, Conde, Sr., Eulogio (2011).

Prognostic Value of cMYC Gene Abnormalities in Diffuse Large B Cell Lymphoma Treated with Chemo-Immunotherapy

BLOOD. Meeting Abstract. 118(21):1144-1144.
[doi:10.1182/blood.V118.21.2664.2664]
Swift, Brenna E., Williams, Brent A., Kosaka, Yoko, Martinez-Lopez, Joaquin, Wang, Xinghua, Keating, Armand (2011).

Efficacy of NK-92 Against Human Multiple Myeloma in a NOD/SCID Gamma Null Mouse Model

BLOOD. Meeting Abstract. 118(21):807-807.
Valcarcel, David, Adema, Vera, Mallo, Mar, Ortega, Margarita, Nomdedeu, Benet, Sanz, Guillermo, Luno, Elisa, Consuelo, Del CaA'izo, De la Serna, Javier, Ardanaz, Maita, Marco, Victor, Collado, Rosa, Xicoy, Blanca, Sole, Francesc, Vallespi, Teresa (2011).

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

BLOOD. Meeting Abstract. 118(21):751-751.
[doi:10.1182/blood.V118.21.1724.1724]
Castilla-Llorente, Cristina, de Arriba, Felipe, Perez-Andreu, Virginia, Victoria Mateos, Maria, Gonzalez-Conejero, Rocio, Rivera Pozo, Jose, Oriol, Albert, Martinez-Lopez, Joaquin, Isabel Teruel, Ana, de Paz, Raquel, Garcia-Larana, Jose, Bengoechea, Enrique, Martin, Alejandro, Diaz-Mediavilla, Joaquin, Palomera, Luis, Gonzalez, Yolanda, Mariano Hernandez, Jose, Sureda, Anna, Luis Bello, Jose, Bargay, Joan, Javier Penalver, Francisco, Martin Mateos, Maria Luisa, Teresa Cibeira, Maria, Jose Lahuerta, Juan, Blade, Joan, San Miguel, Jesus F. (2011).

Influence of Genetic Polymorphisms in CYP1A2, CYP2C19, CYP3A4, GSTP1, MDR1 and PSMB5 Genes in Toxicity and Response to Induction Therapy in Multiple Myeloma Patients Included in the Trial of the Spanish PETHEMA/GEM 05 for Newly Diagnosed MM Elderly Patients (Age 65 or More)

BLOOD. Meeting Abstract. 118(21):615-615.
Pessoa Magalhaes, Roberto J., Vidriales, Maria-Belen, Paiva, Bruno, Mateos, Maria-Victoria, Gutierrez, Norma C., Garcia-Sanz, Ramon, Blanco, Juan F., Hernandez, Jose, de las Heras, Natalia, Martinez, Joaquin, Costa, Elaine Sobral, Maiolino, Angelo, Nucci, M., De La Rubia, Javier, Lahuerta, Juan-Jose, Qrfao, Alberto, San Miguel, Sr., Jesus F. (2011).

Multidimensional Flow Cytometric (MFC) Analysis of the Immune System of Multiple Myeloma (MM) Patients Achieving Long Term Disease Control

BLOOD. Meeting Abstract. 118(21):367-368.
Fernandez Redondo, Elena, Martinez-Lopez, Joaquin, Garcia-Sanz, Ramon, Montalban, Maria-Angeles, Martinez-Sanchez, Pilar, Paiva, Bruno, Mateos, Maria-Victoria, Rosinol, Laura, Luisa Martin, Maria, Ayala, Rosa M., Martinez, Rafael, Lopez, Javier, Alegre, Adrian, Besalduch, Joan, Bargay, Joan, Hernandez, M. T., Eugenia Sarasquete, Maria, Sanchez-Godoy, P., Callis, Manuel, Fernandez, Manuela, Blade, Joan, San Miguel, Jesus F., Jose Lahuerta, Juan (2011).

Under Scope of the Current Redefinition Process of Optimal Response in Multiple Myeloma: Assesment of Molecular Response by Fluorescent PCR of Ig Genes Has Similar Applicability and Prognosis Impact to Immunophenotypic Response. (A GEM/PETHEMA study)

BLOOD. Meeting Abstract. 118(21):1689-1690.
Paiva, Bruno, Gutierrez, Norma C., Rosinol, Laura, Vidriales, Maria-Belen, Montalban, Maria-Angeles, Martinez-Lopez, Joaquin, Victoria Mateos, Maria, Teresa Cibeira, Maria, Courdon, Lourdes, Oriol, Albert, Jose Terol, Maria, Echebeste, Maria-Asuncion, de Paz, Raquel, de Arriba, Felipe, Palomera, Luis, De La Rubia, Javier, Diaz-Mediavilla, Joaquin, Sureda, Anna, Gorosquieta, Ana, Alegre, Adrian, Martin, Alejandro, Hernandez, Miguel T., Jose Lahuerta, Juan, Blade, Joan, San Miguel, Jesus F. (2011).

High-Risk Cytogenetics and Persistent Minimal Residual Disease (MRD) by Multiparameter Flow Cytometry (MFC) Predict Unsustained Complete Response (CR) After Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)

BLOOD. Meeting Abstract. 118(21):287-288.
Mateos, Maria-Victoria, Oriol, Albert, Teruel, Ana-Isabel, Bengoechea, Enrique, Perez, Montse, Lopez, Javier, Diaz-Mediavilla, Joaquin, Mariano Hernandez, Jose, de Arriba, Felipe, Gonzalez, Yolanda, Blade, Joan, Jose Lahuerta, Juan, San Miguel, Jesas F. (2011).

Maintenance Therapy with Bortezomib Plus Thalidomide (VT) or Bortezomib Plus Prednisone (VP) In Elderly Myeloma Patients Included In the GEM2005MAS65 Spanish Randomized Trial

BLOOD. Meeting Abstract. 118(21):222-222.
Papaemmanuil, Elli, Rapado, Inmaculada, Ford, Anthony M., Raine, Keiran, Hinton, Jonathan, Jones, David, Marshall, John, Mudie, Laura J., Zuna, Jan, Cazzaniga, Giovanni, Kempski, Helena, Pombo de Oliveira, Maria S., Stratton, Mike R., Futreal, P. Andrew, Campbell, Peter, Greaves, Mel (2011).

The Genomic Landscape of TEL-AML1+ (ETV6-RUNX1) Acute Lymphoblastic Leukaemia

BLOOD. Meeting Abstract. 118(21):185-185.
Paiva, Bruno, Gutierrez, Norma C., Chen, Xi, Vidriales, Maria-Belen, Montalban, Maria-Angeles, Rosinol, Laura, Oriol, Albert, Martinez-Lopez, Joaquin, Victoria Mateos, Maria, Lopez-Corral, Lucia, Diaz-Rodriguez, Elena, Perez, Jose J., Fernandez-Redondo, Elena, de Arriba, Felipe, Palomera, Luis, Bengoechea, Enrique, Jose Terol, Maria, de Paz, Raquel, Martin, Alejandro, Hernandez, Jose, Orfao, Alberto, Jose Lahuerta, Juan, Blade, Joan, Pandiella, Atanasio, San Miguel, Jesus F. (2011).

Biological and Clinical Significance of CD81 Expression by Clonal Plasma Cells in High-Risk Smoldering and Symptomatic Multiple Myeloma (MM) Patients

BLOOD. Meeting Abstract. 118(21):1682-1683.
Rosinol, Laura, Teresa Cibeira, Maria, Victoria Mateos, Maria, Martinez, Joaquin, Oriol, Albert, Isabel Teruel, Ana, Hernandez, Dolores, Lopez, Javier, de la Rubia, Javier, Granell, Miquel, Besalduch, Juan, Palomera, Luis, Gonzalez, Yolanda, Asuncion Etxebeste, Maria, Diaz-Mediavilla, Joaquin, Hernandez, Miguel T., de Arriba, Felipe, Alegre, Adrian, Jose Lahuerta, Juan, San Miguel, Jesus F., Blade, Joan (2011).

A Phase III PETHEMA/GEM Randomized Trial of Postransplant (ASCT) Maintenance in Multiple Myeloma: Superiority of Bortezomib/Thalidomide Compared with Thalidomide and Alfa-2b Interferon

BLOOD. Meeting Abstract. 118(21):1694-1695.
Kumar, Shaji, Lee, Jae Hoon, Jose Lahuerta, Juan, Morgan, Gareth J., Richardson, Paul G., Crowley, John, Haessler, Jeff, Feather, John, Hoering, Antje, Moreau, Philippe, Leleu, Xavier, Hullin, Cyril, Klein, Saskia K., Sonneveld, Pieter, Siegel, David S., Blade, Joan, Goldschmidt, Hartmut, Jagannath, Sundar, San Miguel, Jesus F., Orlowski, Robert Z., Palumbo, Antonio, Sezer, Orhan, Rajkumar, S. Vincent, Durie, Brian G. M. (2011).

Differences in Patterns of Treatment and Outcome Among Patients with Relapsed Refractory Myeloma From United States, Europe and Asia

BLOOD. Meeting Abstract. 118(21):1707-1708.
Paiva, Bruno, Vidriales, Maria-Belen, Montalban, Maria-Angeles, Perez, Jose J., Gutierrez, Norma C., Rosinol, Laura, Martinez-Lopez, Joaquin, Victoria Mateos, Maria, Courdon, Lourdes, Oriol, Albert, Jose Terol, Maria, Asuncion Etxebeste, Maria, de Paz, Raquel, de Arriba, Felipe, Palomera, Luis, De la Rubia, Javier, Diaz-Mediavilla, Joaquin, Sureda, Anna, Gorosquieta, Ana, Alegre, Adrian, Martin, Alejandro, Hernandez, Miguel T., Jose Lahuerta, Juan, Blade, Joan, San Miguel, Jesus F. (2011).

Multiparameter Flow Cytometry (MFC) Evaluation of Plasma Cell (PC) DNA Ploidy Status and Proliferative Rate in 595 Multiple Myeloma (MM) Patients (pts) Included in the Spanish GEM2000 and GEM2005 < 65years Trials: Clinical Value and Biological Insights

BLOOD. Meeting Abstract. 118(21):1683-1684.
Paiva, Bruno, Vidriales, Maria-Belen, Montalban, Maria-Angeles, Blade, Joan, Lahuerta, Juan-Jose, Orfao, Alberto, San Miguel, Jesus F. (2011).

RESPONSE ASSESSMENT IN MULTIPLE MYELOMA: CLINICAL SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE MONITORING

CYTOMETRY PART B-CLINICAL CYTOMETRY. Meeting Abstract. 80B(6):390-390.
Barrio, S., Gallardo, M., Albizua, E., Jimenez, A., Rapado, I., Ayala, R., Gilsanz, F., Martin-Subero, J. I., Martinez-Lopez, J. (2011).

Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation

JOURNAL OF CLINICAL PATHOLOGY. Article. 64(11):1010-1013.
[doi:10.1136/jclinpath-2011-200175]
Perea, Jose, Rodriguez, Yolanda, Rueda, D, Marin, Jose C., Diaz-Tasende, Jose, Alvaro E, Alegre, Cristina, Osorio, Irene, Colina, Francisco, Lomas, Manuel, Hidalgo, Manuel, Benitez, Javier, Urioste, Miguel (2011).

Early-Onset Colorectal Cancer is an Easy and Effective Tool to Identify Retrospectively Lynch Syndrome

ANNALS OF SURGICAL ONCOLOGY. Article. 18(12):3285-3291.
[doi:10.1245/s10434-011-1782-4]
Mateos, Mara-Victoria, Gutierrez, Norma C., Martin-Ramos, Maria-Luisa, Paiva, Bruno, Montalban, Maria-Angeles, Oriol, Albert, Martinez-Lopez, Joaquin, Teruel, Ana-Isabel, Bengoechea, Enrique, Martin, Alejandro, Diaz-Mediavilla, Joaquin, de Arriba, Felipe, Palomera, Luis, Hernandez, Jose-Mariano, Sureda, Anna, Bargay, Joan, Penalver, Francisco-Javier, Ribera, Josep-Maria, Martin-Mateos, Maria-Luisa, Fernandez, Manuela, Garcia-Sanz, Ramon, Vidriales, Maria-Belen, Blade, Joan, Lahuerta, Juan-Jose, San Miguel, Jesus F. (2011).

Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance

BLOOD. Article. 118(17):4547-4553.
[doi:10.1182/blood-2011-04-345801]
de la Serna, J., Lopez, J., Jarque, I., Moraleda, J. M., Cuetara, M., Garcia-Noblejas, A., Olazabal, I., Yanez, L., Martinez, P. (2011).

Retrospective study of prognostic factors having influence in the incidence and outcome of breakthrough invasive fungal infections occurring in neutropenic or allogeneic hematopoietic transplant patients

MYCOSES. Meeting Abstract. 54(2, SI):94-95.
Fernandez-Ruiz, Mario, de la Serna, Javier, Ruiz, Juan, Lopez-Medrano, Francisco (2011).

Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. Letter. 29(8):636-637.
[doi:10.1016/j.eimc.2011.03.013]
Sierra-Hidalgo, F., Ruiz, J., Morales-Cartagena, A., Martinez-Salio, A., de la Serna, J., Hernandez-Gallego, J. (2011).

Infiltrative cervical lesions causing symptomatic occipital neuralgia

CEPHALALGIA. Article. 31(14):1493-1496.
[doi:10.1177/0333102411418693]
Ramajo, M., Redondo, S., Navarro-Dorado, J., Ostos, F., Martinez, J., Gallardo, M., Barrio, S., Reguillo, F., Tejerina, T. (2011).

EFFECT ANTI-CD44 AND ANTI-CD62L ON HUMAN ENDOTHELIAL PROGENITOR CELLS: IMPLICATIONS FOR AN ALTERED VASCULAR FUNCTION IN CHRONIC MYELOPROLIFERATIVE NEO

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. Meeting Abstract. 109(2, SI):33-33.
Barragan, Eva, Montesinos, Pau, Camos, Mireia, Gonzalez, Marcos, Calasanz, Maria J., Roman-Gomez, Jose, Gomez-Casares, Maria T., Ayala, Rosa, Lopez, Javier, Fuster, Oscar, Colomer, Dolors, Chillon, Carmen, Larrayoz, Maria J., Sanchez-Godoy, Pedro, Gonzalez-Campos, Jose, Manso, Felix, Amador, Maria L., Vellenga, Edo, Lowenberg, Bob, Sanz, Miguel A., PETHEMA Grp, HOVON Grp (2011).

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

HAEMATOLOGICA. Article. 96(10):1470-1477.
[doi:10.3324/haematol.2011.044933]
Felipe Casado, Luis, Garcia Marco, Jose Antonio, Gilsanz, Florinda, Gonzalez, Marcos, Rios, Eduardo, de la Serna, Javier, Urbano, Alvaro, Vicente, Vicente, Rubio-Terres, Carlos, Castro, Antonio J. (2011).

Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia (vol 25, pg 274, 2011)

GACETA SANITARIA. Correction. 25(5):444-444.
[doi:10.1016/j.gaceta.2011.09.002]
Albizua, Enriqueta, Gallardo, Miguel, Barrio, Santiago, Rapado, Inmaculada, Jimenez, Ana, Ayala, Rosa, Rueda, Daniel, Sanchez-Espiridion, Beatriz, Puigdecanet, Eulalia, Espinet, Blanca, Florensa, Lourdes, Besses, Carles, Martinez-Lopez, Joaquin (2011).

Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia

ANNALS OF HEMATOLOGY. Article. 90(8):939-946.
[doi:10.1007/s00277-011-1179-2]
Montes-Moreno, Santiago, Martinez, Nerea, Sanchez-Espiridion, Beatriz, Diaz Uriarte, Ramon, Elena Rodriguez, Maria, Saez, Anabel, Montalban, Carlos, Gomez, Gonzalo, Pisano, David G., Fernando Garcia, Juan, Conde, Eulogio, Gonzalez-Barca, Eva, Lopez, Andres, Mollejo, Manuela, Grande, Carlos, Angel Martinez, Miguel, Dunphy, Cherie, Hsi, Eric D., Rocque, Gabrielle B., Chang, Julie, Go, Ronald S., Visco, Carlo, Xu-Monette, Zijun, Young, Ken H., Piris, Miguel A. (2011).

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy

BLOOD. Article. 118(4):1034-1040.
[doi:10.1182/blood-2010-11-321554]
Martinez-Lopez, Joaquin, Blade, Joan, Mateos, Maria-Victoria, Grande, Carlos, Alegre, Adrian, Garcia-Larana, Jose, Sureda, Anna, de la Rubia, Javier, Conde, Eulogio, Martinez, Rafael, de Arriba, Felipe, Viguria, Maria C., Besalduch, Joan, Cabrera, Rafael, Gonzalez-San Miguel, Jose D., Luis Guzman-Zamudio, Jose, Carmen Gomez del Castillo, Ma, Ma Moraleda, Jose, Garcia-Ruiz, Juan C., San Miguel, Jesus, Jose Lahuerta, Juan (2011).

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation

BLOOD. Article. 118(3):529-534.
[doi:10.1182/blood-2011-01-332320]
Felipe Casado, Luis, Garcia Marco, Jose Antonio, Gilsanz, Florinda, Gonzalez, Marcos, Rios, Eduardo, de la Serna, Javier, Urbano, Alvaro, Vicente, Vicente, Rubio-Terres, Carlos, Castro, Antonio J. (2011).

Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia

GACETA SANITARIA. Article. 25(4):274-281.
[doi:10.1016/j.gaceta.2011.03.005]
Amir, Eitan, Seruga, Bostjan, Martinez-Lopez, Joaquin, Kwong, Ryan, Pandiella, Atanasio, Tannock, Ian F., Ocana, Alberto (2011).

Oncogenic Targets, Magnitude of Benefit, and Market Pricing of Antineoplastic Drugs

JOURNAL OF CLINICAL ONCOLOGY. Article. 29(18):2543-2549.
[doi:10.1200/JCO.2011.35.2393]
Pardal, E., Grande, C., Martin, A., Marin-Niebla, A., Panizo, C., Conde, E., Bello, J., Hernandez, M., Perez, E., Gonzalez-Barca, E., Arranz, R., Bargay, J., Ramirez, M., Salar, A., Canales, M., Caballero, M. (2011).

TREATMENT DESCALATION BASED ON EARLY FDGPET IN PATIENTS WITH POOR RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). A PROSPECTIVE PHASE II GELTAMO TRIAL

ANNALS OF ONCOLOGY. Meeting Abstract. 22(4):193-193.
Garcia-Marco, J., Lopez, J., Gonzalez, E., Giraldo, P., Conde, E., De La Serna, J., Gonzalez, M., Carbonell, F., Garcia-Vela, J. (2011).

RITUXIMAB MAINTENANCE AFTER COMBINED FCR IN PREVIOUSLY UNTREATED PATIENTS WITH ACTIVE B-CELL CLL: INTERIM ANALYSIS OF AN ONGOING PHASE II MULTICENTER TRIAL ON BEHALF OF THE SPANISH CLL STUDY GROUP (GELLC)

ANNALS OF ONCOLOGY. Meeting Abstract. 22(4):172-172.
de la Rubia, Javier, Lahuerta, Juan J. (2011).

Impact of the Conditioning Regimen in Patients With Multiple Myeloma Who Undergo Autologous Transplantation

JOURNAL OF CLINICAL ONCOLOGY. Letter. 29(15):449-449.
[doi:10.1200/JCO.2010.33.7832]
Martinez, Pilar, Casis, Begona, Gomez, Gonzalo Jesus, Vega, Juan Antonio Chirinos, Sanchez, Fernando, Manrique, Alejandro, Colina, Francisco, Castellano, Gregorio (2011).

Solid Organ Transplantation and Inflammatory Bowel Disease

GASTROENTEROLOGY. Meeting Abstract. 140(5, 1):793-793.
Paiva, Bruno, Martinez-Lopez, Joaquin, Vidriales, Maria-Belen, Mateos, Maria-Victoria, Montalban, Maria-Angeles, Fernandez-Redondo, Elena, Alonso, Lourdes, Oriol, Albert, Teruel, Ana-Isabel, de Paz, Raquel, Larana, Jose-Garcia, Bengoechea, Enrique, Martin, Alejandro, Diaz Mediavilla, Joaquin, Palomera, Luis, de Arriba, Felipe, Blade, Joan, Orfao, Alberto, Lahuerta, Juan-Jose, San Miguel, Jesus F. (2011).

Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma

JOURNAL OF CLINICAL ONCOLOGY. Article. 29(12):1627-1633.
[doi:10.1200/JCO.2010.33.1967]
Rosinol, L., Cibeira, M. T., Mateos, M. V., Gutierrez, N., Martinez, J., Oriol, A., Teruel, A. I., Hernandez, D., Garcia-Larana, J., de la Rubia, J., Sureda, A., Besalduch, J., Palomera, L., Gonzalez, Y., Etxebeste, M. A., Diaz-Mediavilla, J., Hernandez, M. T., de Arriba, F., Alegre, A., Lahuerta, J. J., San Miguel, J., Blade, J. (2011).

Results of pre- and post-autologous stem cell transplantation with three induction regimens in multiple myeloma: superiority of VTD (bortezomib/thalidomide/dexamethasone) over TD and VBMCP/VBAD plus bortezomib (VBMCP/VBAD/V)

BONE MARROW TRANSPLANTATION. Meeting Abstract. 46(1):38-38.
De la Serna, J., Lopez, J., Jarque, I., Moraleda, J. M., Cuetara, M., Garcia, A., Olazabal, I., Yanez, L., Martinez, P. (2011).

A study of prognostic factors affecting the incidence and outcome of invasive fungal infections occurring in neutropenic and allogeneic transplant patients receiving prior antifungal agents

BONE MARROW TRANSPLANTATION. Meeting Abstract. 46(1):216-216.
Paiva, B., Perez-Andres, M., Vidriales, M-B, Almeida, J., de las Heras, N., Mateos, M-V, Lopez-Corral, L., Gutierrez, N. C., Blanco, J., Oriol, A., Hernandez, M. T., de Arriba, F., de Coca, A. G., Terol, M-J, de la Rubia, J., Gonzalez, Y., Martin, A., Sureda, A., Schmidt-Hieber, M., Schmitz, A., Johnsen, H. E., Lahuerta, J-J, Blade, J., San-Miguel, J. F., Orfao, A., GEM Grp Espanol MM Cooperative Stu, PETHEMA Programa Estudio Terapeuti, Myeloma Stem Cell Network MSCNET (2011).

Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma

LEUKEMIA. Article. 25(4):697-706.
[doi:10.1038/leu.2010.320]
Rivero, Ana, Rapado, Inmaculada, Tomas, Jose F., Montalban, Carlos, de Ona, Raquel, Paz-Carreira, Jose, Canales, Miguel, Martinez, Rafael, Sanchez-Godoy, Pedro, Fernandez de Sevilla, Alberto, de la Serna, Javier, Martinez-Lopez, Joaquin (2011).

Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma

LEUKEMIA RESEARCH. Article. 35(4):431-437.
[doi:10.1016/j.leukres.2010.09.026]
Francisco Tomas, Jose, Montalban, Carlos, Fernandez De Sevilla, Alberto, Martinez-Lopez, Joaquin, Diaz, Nicolas, Canales, Miguel, Martinez, Rafael, Sanchez-Godoy, Pedro, Dolores Caballero, Maria, Penalver, Javier, Prieto, Elena, Salar, Antonio, Burgaleta, Carmen, Antonio Queizan, Jose, Bajo, Roberto, De Ona, Raquel, De La Serna, Javier (2011).

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03)

LEUKEMIA & LYMPHOMA. Review. 52(3):409-416.
[doi:10.3109/10428194.2010.543717]
Alegre, Adrian, Aguado, Beatriz, Giraldo, Pilar, Rios, Eduardo, Canovas, Araceli, Ibanez, Angela, Castillo, Inmaculada, Hernandez, Miguel T., Oriol, Albert, Palomera, Luis, Rodriguez, Juan-N., Garcia, Flor-L., Calvo, Jose M., Martinez-Chamorro, Carmen, de la Serna, Javier, Lahuerta, Juan-J. (2011).

Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients

INTERNATIONAL JOURNAL OF HEMATOLOGY. Article. 93(3):351-360.
[doi:10.1007/s12185-011-0785-z]
Martínez Torrente F, Carrascosa Fernández AJ, García Miranda MC, Pérez-Cerdá Silvestre F, Gilsanz Rodríguez F (2011).

Bloqueo neuromuscular inducido por neostigmina en el músculo Corrugator supercilii.

REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION. Abstract of Published Item. 58(3):147-150.
Montesinos, Pau, Rayon, Chelo, Vellenga, Edo, Brunet, Salut, Gonzalez, Jose, Gonzalez, Marcos, Holowiecka, Aleksandra, Esteve, Jordi, Bergua, Juan, Gonzalez, Jose D., Rivas, Concha, Tormo, Mar, Rubio, Vicente, Bueno, Javier, Manso, Felix, Milone, Gustavo, de la Serna, Javier, Perez, Inmaculada, Perez-Encinas, Manuel, Krsnik, Isabel, Ribera, Josep M., Escoda, Lourdes, Lowenberg, Bob, Sanz, Miguel A., PETHEMA Grp, HOVON Grp (2011).

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

BLOOD. Article. 117(6):1799-1805.
[doi:10.1182/blood-2010-04-277434]
De la Serna, J., Bermudez, A., Sanz, J., Caballero, D., De la Camara, R., Vallejo, C., Serrano, D., Moraleda, J. M., Benlloch, L., Sanz, G. (2011).

MYELOABLATIVE CONDITIONING WITH INTRAVENOUS BUSULPHAN IN A SINGLE DAILY DOSE AND FLUDARABINE (BUF) FOR HLA-IDENTICAL SIBLING ALLOGENEIC HSCT IN MYELOID MALIGNANCIES

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Meeting Abstract. 17(2, 2):299-299.
[doi:10.1016/j.bbmt.2010.12.436]
Vallejo, Carlos, Rios, Eduardo, de la Serna, Javier, Jarque, Isidro, Ferra, Christelle, Sanchez-Godoy, Pedro, Solano, Carlos, de la Camara, Rafael, Isabel Rosell, Ana, Varela, Rosario, Dolores Garcia, Maria, Gonzalez-Barca, Eva, Lopez, Javier, Perez, Elena, Ferrer, Secundino, Felipe Casado, Luis, Vazquez, Lourdes, Villalon, Lucia, Garcia-Marcot, Jose A. (2011).

Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

EXPERT REVIEW OF HEMATOLOGY. Review. 4(1):9-16.
[doi:10.1586/EHM.10.77]
Fernandez-Miranda, Consuelo, Luisa Manzano, Maria, Fernandez, Inmaculada, Lopez-Alonso, Guadalupe, Gomez, Pilar, Ayala, Rosa, Lora, David, Castellano, Gregorio (2011).

Association of hyperhomocysteinemia with liver steatosis in patients with chronic hepatitis C

MEDICINA CLINICA. Article. 136(2):45-49.
[doi:10.1016/j.medcli.2010.05.024]
Giraldo, Pilar, Irun, Pilar, Alfonso, Pilar, Dalmau, Jaime, Fernandez-Galan, Maria A., Figueredo, Antonio, Hernandez-Rivas, Jesus M., Julia, Antonio, Luno, Elisa, Marin-Jimenez, Francisca, Martin-Nunez, Guillermo, Montserrat, Jorge L., de la Serna, Javier, Vidaller, Antonio, Villalon, Lucia, Pocovi, Miguel (2011).

Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage

BLOOD CELLS MOLECULES AND DISEASES. Article. 46(1, SI):115-118.
[doi:10.1016/j.bcmd.2010.09.005]

2010

Tallman, Martin S., Kim, Haesook T., Montesinos, Pau, Appelbaum, Frederick R., de la Serna, Javier, Bennett, John M., Deben, Guillermo, Bloomfield, Clara D., Gonzalez, Jose, Feusner, James H., Gonzalez, Marcos, Gallagher, Robert, Gonzalez-San Miguel, Jose D., Larson, Richard A., Milone, Gustavo, Paietta, Elisabeth, Rayon, Chelo, Rowe, Jacob M., Rivas, Concha, Schiffer, Charles A., Vellenga, Edo, Shepherd, Lois, Slack, James L., Wiernik, Peter H., Willman, Cheryl L., Sanz, Miguel A. (2010).

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

BLOOD. Article. 116(25):5650-5659.
[doi:10.1182/blood-2010-02270819]
Felipe Casado, Luis, Massague, Isabel, Giraldo, Pilar, Perez-Encinas, Manuel, De Paz, Raquel, Martinez-Lopez, Joaquin, Bautista, Guiomar, Osorio, Santiago, Jose Requena, Maria, Palomera, Luis, Jesus Penarrubia, Maria, Calle, Carmen, Maestro, Begona, Luis Steegmann, Juan (2010).

Survival and Response Outcomes to Different Treatment Schedules in CML Patients Starting Therapy with Imatinib. Results from the CML Spanish Registry (RELMC).

BLOOD. Meeting Abstract. 116(21):528-529.
Rosinol, Laura, Teresa Cibeira, Maria, Victoria Mateos, Maria, Martinez, Joaquin, Oriol, Albert, Isabel Teruel, Ana, Hernandez, Dolores, Garcia-Larana, Jose, De La Rubia, Javier, Sureda, Anna, Besalduch, Juan, Palomera, Luis, Gonzalez, Yolanda, Asuncion Etxebeste, Maria, Diaz-Media-villa, Joaquin, Hernandez, Miguel T., de Arriba, Felipe, Alegre, Adrian, Jose Lahuerta, Juan, San Miguel, Jesus F., Blade, Joan (2010).

A Phase III PETHEMA/GEM Study of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma: Superiority of VTD (Bortezomib/Thalidomide/Dexamethasone) Over TD and VBMCP/VBAD Plus Bortezomib

BLOOD. Meeting Abstract. 116(21):139-140.
[doi:10.1182/blood.V116.21.307.307]
Mateos, Maria-Victoria, Lopez-Corral, Lucia, Hernandez, Miguel, Giraldo, Pilar, De La Rubia, Javier, de Arriba, Felipe, Rosinol, Laura, Lahuerta, Juan-Jose, Palomera, Luis, Bargay, Joan, Oriol, Albert, Prosper, Felipe, Garcia-Larana, Jose, Olavarria, Eduardo, Luz Martino, Maria, Teruel, Ana-Isabel, Hernandez, Jose, Esteves, Graca, Mariz, Jose Mario, Leal-da-Costa, Fernando, Alegre, Adrian, Guzman, Jose-Luis, Lopez de la Guia, Ana, Quintana, Nuria, Baquero, Jose, Luis Garcia, Jose, San Miguel, Jesus F. (2010).

Smoldering Multiple Myeloma (SMM) at High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) as Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

BLOOD. Meeting Abstract. 116(21):805-805.
Mateos, Maria-Victoria, Gutierrez, Norma C., Paiva, Bruno, Oriol, Albert, Martinez-Lopez, Joaquin, Isabel Teruel, Ana, de Paz, Raquel, Garcia-Larana, Jose, Bengoechea, Enrique, Martin, Alejandro, Diaz-Mediavilla, Joaquin, Palomera, Luis, Gonzalez, Yolanda, Mariano Hernandez, Jose, Sureda, Ana, Luis Bello, Jose, Bargay, Joan, Penalver, Francisco-Javier, Ribera, Josep-Maria, Martin-Mateos, Maria-Luisa, Garcia-Sanz, Ramon, Teresa Cibeira, Maria, Martin-Ramos, Maria-Luisa, Vidriales, Maria-Belen, Montalban, Maria-Angeles, Lahuerta, Juan-Jose, Blade, Joan, San Miguel, Sr., Jesus F. (2010).

Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed Myeloma Patients Treated with A Bortezomib-Based Combination

BLOOD. Meeting Abstract. 116(21):140-141.
Paiva, Bruno, Perez-Andres, Martin, Vidriales, Marid-Belen, Almeida, Julia, de las Heras, Natalia, Mateos, Maria-Victoria, Lopez-Corral, Lucia, Gutierrez, Norma C., Blanco, Juan, Oriol, Albert, Hernandez, Miguel T., de Arriba, Felipe, Garcia de Coca, Alfonso, Jose Terol, Maria, De la Rubia, Javier, Gonzalez, Yolanda, Martin, Alejandro, Sureda, Anna, Schmidt-Hieber, Martin, Schmitz, Alexander, Johnsen, Hans E., Lahuerta, Juan-Jose, Blade, Joan, San Miguel, Jesus F., Orfao, Alberto (2010).

Competition Between (Mono)Clonal Plasma Cells and Normal Cells for Potentially Overlapping Bone Marrow Niches Is Associated with a Progressively Altered Cellular Distribution In MGUS Vs. Myeloma

BLOOD. Meeting Abstract. 116(21):271-271.
Garcia-Marco, Jose A., Lopez-Jimenez, Javier, Ferrer, Secundino, Giraldo, Pilar, Gonzalez-Barca, Eva, Navarro, Belen, Conde, Eulogio, Gonzalez, Marcos, Guzman, Jose L., Perez, Ernesto, De la Serna, Javier, Osma, Mar, Deben, Guillermo, Monzo, Encarna, de Paz, Raquel, Angeles Ruiz, M., Penalver, Francisco-Javier, Jarque, Isidro, Banas, Helena, Carmen Fernandez, M., Martinez, Rafael, Burgaleta, Carmen, Perez de Oteiza, Jaime, Angeles Andreu, M., Carral, Ana, Fuentes, Inmaculada, Donato, Eva, Leon, Paola, Carbonell, Felix, Garcia-Vela, Jose A. (2010).

Rituximab Maintenance Treatment After Combined Fludarabine, Cyclophosphamide and Rituximab In Previously Untreated Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (CLL): Interim Analysis of An Ongoing Phase II Multicenter Trial On Behalf of the Spanish CLL Study Group (GELLC)

BLOOD. Meeting Abstract. 116(21):1016-1016.
Herreros, Beatriz, Bischoff, James R., Rodriguez, Maria E., Sanchez-Beato, Margarita, Domenech, Elena, Blanco, Carmen, Gomez-Abad, Cristina I., Cordoba, Raul, Delgado, Julio, Garcia-Marco, Jose A., Garcia, Juan F., Tomas, Jose Francisco, Martinez-Lopez, Joaquin, Rodriguez, Antonia, Villuendas, Raquel, Piris, Miguel A. (2010).

Pharmacological Inhibition of PIM Kinases In Chronic. Lymphocytic Leukemia Cases with Unfavorable Prognosis Markers

BLOOD. Meeting Abstract. 116(21):1025-1025.
Herreros, Beatriz, Wang, Shaomeng, Rodriguez, Maria E., Sanchez-Beato, Margarita, Domenech, Elena, Cordoba, Raul, Delgado, Julio, Garcia-Marco, Jose A., Garcia, Juan F., Francisco Tomas, Jose, Martinez-Lopez, Joaquin, Luis Bello, Jose, Rodriguez, Antonia, Villuendas, Raquel, Piris, Miguel A. (2010).

Targeting the Apoptotic Pathway by TW-37, a Novel Bcl-2 Family Small Molecule Inhibitor, In CLL Primary Samples

BLOOD. Meeting Abstract. 116(21):1026-1026.
Paiva, Bruno, Vidriales, Marfa-Belen, Montalban, Maria-Angeles, Mateos, Maria-Victoria, Rosinol, Laura, Martinez, Joaquin, Teresa Cibeira, Maria, Courdon, Lourdes, Oriol, Albert, Jose Terol, Maria, Echebeste, Maria-Asuncion, de Paz, Raquel, de Arriba, Felipe, Palomera, Luis, De La Rubia, Javier, Diaz-Mediavilla, Joaquin, Garcia-Larana, Jose, Sureda, Anna, Gorosquieta, Ana, Alegre, Adrian, Martin, Alejandro, Hernandez, Miguel T., Gonzalez, Yolanda, Blade, Joan, Jose Lahuerta, Juan, San Miguel, Jestis F. (2010).

Analysis of Immunophenotypic Response (IR) by Multiparameter Flow Cytometry In 516 Myeloma Patients Included In Three Consecutive Spanish Trials

BLOOD. Meeting Abstract. 116(21):796-797.
Blanes, Margarita, De La Rubia, Javier, Lahuerta, Juan-Jose, David Gonzalez, Jose, Ribas, Paz, Solano, Carlos, Angel Sanz, Miguel (2010).

Outcomes In Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation Using Intravenous Busulfan and Melphalan: A Matched Comparison to a Double Autologous Transplant Strategy

BLOOD. Meeting Abstract. 116(21):1464-1465.
[doi:10.1182/blood.V116.21.3560.3560]
Paiva, Bruno, Perez-Andres, Martin, Vidriales, Maria-Belen, Almeida, Julia, de Las Heras, Natalia, Mateos, Maria-Victoria, Lopez-Corral, Lucia, Gutierrez, Norma C., Blanco, Juan, Oriol, Albert, Hernandez, Miguel T., de Arriba, Felipe, Garcia de Coca, Alfonso, Terol, Maria-Jose, de la Rubia, Javier, Gonzalez, Yolanda, Martin, Alejandro, Sureda, Anna, Schmidt-Hieber, Martin, Schmitz, Alexander, Johnsen, Hans E., Lahuerta, Juan-Jose, Blade, Joan, San Miguel, Jesus F., Orfao, Alberto, GEM Cooperative Study Grp, PETHEMA Cooperative Study Grp, MSCNET (2010).

PROGRESSIVELY ALTERED DISTRIBUTION OF NORMAL AND NEOPLASTIC CELLS COMPETING FOR SDF-1 ASSOCIATED BONE MARROW NICHES IN MGUS VERSUS MYELOMA

CYTOMETRY PART B-CLINICAL CYTOMETRY. Meeting Abstract. 78B(6):433-433.
Paiva, Bruno, Vidriales, Maria-Belen, Gutierrez, Norma C., Montalban, Maria-Angeles, Oriol, Albert, Martinez-Lopez, Joaquin, Mateos, Maria-Victoria, Lopez-Corral, Lucia, Perez, Jose-J, Sarasquete, Maria-Eugenia, Larana, Jose-G, de Arriba, Felipe, Palomera, Luis, Echebeste, Maria-A, Terol, Maria-Jose, de Paz, Raquel, Martin, Alejandro, Hernandez, Jose, Gonzalez, Yolanda, Blade, Joan, Lahuerta, Juan-Jose, Orfao, Alberto, San Miguel, Jesus-F, PETHEMA Programa Estudio (2010).

THE CLINICAL AND BIOLOGICAL SIGNIFICANCE OF THE IMMUNOPHENOTYPIC ASSESSMENT OF CD81 IN MULTIPLE MYELOMA CLONAL PLASMA CELLS

CYTOMETRY PART B-CLINICAL CYTOMETRY. Meeting Abstract. 78B(6):445-446.
Paiva, Bruno, Vidriales, Maria-Belen, Montalban, Maria A., Martinez, Joaquin, Fernandez-Redondo, Elena, Mateos, Maria-Victoria, Gutierrez, Norma C., Lopez-Corral, Lucia, Perez, Jose J., Martin, Alejandro, Terol, Maria J., Gonzalez, Yolanda, Echebeste, Maria A., Hernandez, Jose, De Arriba, Felipe, De Paz, Raquel, Blade, Joan, Lahuerta, Juan J., Orfao, Alberto, San Miguel, Jesus F. (2010).

IMMUNOPHENOTYPIC REMISSIONS CAN BE ACHIEVED IN ELDERLY MULTIPLE MYELOMA PATIENTS TREATED WITH NOVEL AGENTS

CYTOMETRY PART B-CLINICAL CYTOMETRY. Meeting Abstract. 78B(6):454-454.
Jose Lahuerta, Juan, Victoria Mateos, Maria, Martinez-Lopez, Joaquin, Grande, Carlos, de la Rubia, Javier, Rosinol, Laura, Sureda, Anna, Garcia-Larana, Jose, Diaz-Mediavilla, Joaquin, Hernandez-Garcia, Miguel T., Carrera, Dolores, Besalduch, Joan, de Arriba, Felipe, Oriol, Albert, Escoda, Lourdes, Garcia-Frade, Javier, Rivas-Gonzalez, Concepcion, Alegre, Adrian, Blade, Joan, San Miguel, Jesus F. (2010).

Busulfan 12 mg/kg plus melphalan 140 mg/m(2) versus melphalan 200 mg/m(2) as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study

HAEMATOLOGICA. Article. 95(11):1913-1920.
[doi:10.3324/haematol.2010.028027]
Mateos, Maria-Victoria, Oriol, Albert, Martinez-Lopez, Joaquin, Gutierrez, Norma, Teruel, Ana-Isabel, de Paz, Raquel, Garcia-Larana, Jose, Bengoechea, Enrique, Martin, Alejandro, Diaz Mediavilla, Joaquin, Palomera, Luis, de Arriba, Felipe, Gonzalez, Yolanda, Hernandez, Jose-Mariano, Sureda, Ana, Bello, Jose-Luis, Bargay, Joan, Penalver, Francisco-Javier, Ribera, Jose-Maria, Martin-Mateos, Maria-Luisa, Garcia-Sanz, Ramon, Cibeira, Maria-Teresa, Martin Ramos, Maria-Luisa, Vidriales, Maria-Belen, Paiva, Bruno, Montalban, Maria-Angeles, Lahuerta, Juan-Jose, Blade, Joan, San Miguel, Jesus-Fernando (2010).

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

LANCET ONCOLOGY. Article. 11(10):934-941.
[doi:10.1016/S1470-2045(10)70187-X]
Montesinos, Pau, Gonzalez, Jose D., Gonzalez, Jose, Rayon, Chelo, de Lisa, Elena, Amigo, Maria L., Ossenkoppele, Gert J., Penarrubia, Maria J., Perez-Encinas, Manuel, Bergua, Juan, Deben, Guillermo, Sayas, Maria J., de la Serna, Javier, Ribera, Josep M., Bueno, Javier, Milone, Gustavo, Rivas, Concha, Brunet, Salut, Lowenberg, Bob, Sanz, Miguel (2010).

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy

JOURNAL OF CLINICAL ONCOLOGY. Article. 28(24):3872-3879.
[doi:10.1200/JCO.2010.29.2268]
Lopez-Villar, Isabel, Ayala, Rosa, Wesselink, Jan, Diego Morillas, Juan, López, Elena, Carlos Marin, Jose, Diaz-Tasende, Jose, Gonzalez, Sara, Robles, Luis, Martinez-Lopez, Joaquin (2010).

Simplifying the detection of MUTYH mutations by high resolution melting analysis

BMC CANCER. Article. 10(408):408-408.
[doi:10.1186/1471-2407-10-408]
Heimpel, Hermann, Matuschek, Andreas, Ahmed, Momin, Bader-Meunier, Brigitte, Colita, Adriana, Delaunay, Jean, Garcon, Loic, Gilsanz, Florinda, Goede, Jeroen, Hoegel, Josef, Kohne, Elisabeth, Leichtle, Rosi, Munoz, Juan, Perrotta, Silverio, Piscopo, Carlo, Renella, Raffaele, Schwarz, Klaus, Smolenska-Sym, Gabriela, Wickramasinghe, Sunitha, Zanella, Alberto, Iolascon, Achille (2010).

Frequency of congenital dyserythropoietic anemias in Europe

EUROPEAN JOURNAL OF HAEMATOLOGY. Article. 85(1):20-25.
[doi:10.1111/j.1600-0609.2010.01440.x]
Luis Pinana, Jose, Martino, Rodrigo, Gayoso, Jorge, Sureda, Anna, de la Serna, Javier, Luis Diez-Martin, Jose, Vazquez, Lourdes, Arranz, Reyes, Francisco Tomas, Jose, Sampol, Antonia, Solano, Carlos, Delgado, Julio, Sierra, Jorge, Caballero, Dolores, GELTAMO Grp (2010).

Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials

HAEMATOLOGICA. Article. 95(7):1176-1182.
[doi:10.3324/haematol.2009.017608]
Sanz, Miguel A., Montesinos, Pau, Rayon, Chelo, Holowiecka, Alexandra, de la Serna, Javier, Milone, Gustavo, de Lisa, Elena, Brunet, Salut, Rubio, Vicente, Ribera, Jose M., Rivas, Concha, Krsnik, Isabel, Bergua, Juan, Gonzalez, Jose, Diaz-Mediavilla, Joaquin, Rojas, Rafael, Manso, Felix, Ossenkoppele, Gert, Gonzalez, Jose D., Lowenberg, Bob, PETHEMA Grp, HOVON Grp (2010).

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

BLOOD. Article. 115(25):5137-5146.
[doi:10.1182/blood-2010-01-266007]
Meije, Yolanda, Lizasoain, Manuel, Garcia-Reyne, Ana, Martinez, Pilar, Rodriguez, Virginia, Lopez-Medrano, Francisco, San Juan, Rafael, Lalueza, Antonio, Maria Aguado, Jose (2010).

Emergence of Cytomegalovirus Disease in Patients Receiving Temozolomide: Report of Two Cases and Literature Review

CLINICAL INFECTIOUS DISEASES. Editorial Material. 50(12):73-76.
[doi:10.1086/653011]
Victoria Mateos, Maria, Teresa Cibeira, Maria, Richardson, Paul G., Prosper, Felipe, Oriol, Albert, de la Rubia, Javier, Jose Lahuerta, Juan, Garcia-Sanz, Ramon, Extremera, Sonia, Szyldergemajn, Sergio, Corrado, Claudia, Singer, Harald, Mitsiades, Constantine S., Anderson, Kenneth C., Blade, Joan, San Miguel, Jesus (2010).

Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma

CLINICAL CANCER RESEARCH. Article. 16(12):3260-3269.
[doi:10.1158/1078-0432.CCR-10-0469]
Paiva, B., Vidriales, M., Martinez, J., Oriol, A., Redondo, E., Montalban, M., Mateos, M., Gutierrez, N., Lopez-Corral, L., Perez, J., Martin, A., Terol, M., Gonzalez, Y., Echebeste, M., Hernandez, J., De Arriba, F., De Paz, R., Blade, J., Lahuerta, J., San Miguel, J. (2010).

IMMUNOPHENOTYPIC RESPONSES CAN BE ACHIEVED IN ELDERLY MULTIPLE MYELOMA PATIENS TREATED WITH NOVEL AGENTS

HAEMATOLOGICA. Meeting Abstract. 95(2):236-236.
Calvo, J. M., Alegre, A., Garcia-Sanchez, R., Hernandez, M. T., Giraldo, P., Zudaire, M., Gusmao, B., Rodriguez, J. N., Calle, C., Ramirez, G., Inigo, B., Martinez, J., Oriol, A. (2010).

EFFICACY AND SAFETY OF LENALIDOMIDE IN PATIENTS WITH MULTIPLE MYELOMA COMPLICATED BY EXTRAMEDULLARY PLASMACYTOMAS

HAEMATOLOGICA. Meeting Abstract. 95(2):588-588.
De la Serna, J., Jarque, I., Lopez, J., Mar, R., Gomez-Garcia, V., Serrano, J., Barez, A., Sampol, A., Amat, P., Berrenetxea, C., Del Campo, R. (2010).

THE EFFECTIVENESS OF LIPOSOMAL AMPHOTERICIN IN THE TREATMENT OF INVASIVE FUNGAL INFECTIONS IS NOT AFFECTED BY PRIOR AZOLE ADMINISTRATION: THE AMBI-PROF STUDY

HAEMATOLOGICA. Meeting Abstract. 95(2):433-434.
Paiva, B., Vidriales, M., Gutierrez, N., Montalban, M., Oriol, A., Martinez, J., Mateos, M., Lopez-Corral, L., Perez, J., Sarasquete, M., Larana, J., De Arriba, F., Palomera, L., Echebeste, M., Terol, M., De Paz, R., Martin, A., Hernandez, J., Gonzalez, Y., Martinez, R., Blade, J., Lahuerta, J., Miguel, J. San (2010).

THE CLINICAL AND BIOLOGICAL SIGNIFICANCE OF THE IMMUNOPHENOTYPIC ASSESSMENT OF CD81 IN MULTIPLE MYELOMA CLONAL PLASMA CELLS

HAEMATOLOGICA. Meeting Abstract. 95(2):215-216.
Paiva, B., Vidriales, M. B., Montalban, M. A., Mateos, M. V., Gutierrez, N. C., Lopez-Corral, L., Oriol, A., Blade, J., Lahuerta, J. J., San Miguel, J. F. (2010).

The clinical and biological significance of the immunophenotypic assessment of CD81 in multiple myeloma clonal plasma cells

EJC SUPPLEMENTS. Meeting Abstract. 8(5):151-152.
[doi:10.1016/S1359-6349(10)71396-3]
Oriol, Albert, Vives, Susana, Hernandez-Rivas, Jesus-Maria, Tormo, Mar, Heras, Inmaculada, Rivas, Concepcion, Bethencourt, Concepcion, Moscardo, Federico, Bueno, Javier, Grande, Carlos, del Potro, Eloy, Guardia, Ramon, Brunet, Salut, Bergua, Juan, Bernal, Teresa, Moreno, Maria-Jose, Calvo, Carlota, Bastida, Pilar, Feliu, Evarist, Ribera, Josep-Maria, Programa Espanol Tratamiento Hemat (2010).

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

HAEMATOLOGICA. Article. 95(4):589-596.
[doi:10.3324/haematol.2009.014274]
Garcia-Sanz, Ramon, Alegre, Adrian, Javier Capote, Francisco, Mariano Hernandez, Jose, Rosinol, Laura, de la Rubia, Javier, Sureda, Anna, de Arriba, Felipe, Bargay, Joan, Diaz Mediavilla, Joaquin, Garcia-Larana, Jose, Jose Lahuerta, Juan, Victoria Mateos, Maria, Prosper, Felipe, San Miguel, Jesus, Blade, Joan (2010).

Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group

MEDICINA CLINICA. Editorial Material. 134(6):268-278.
[doi:10.1016/j.medcli.2009.07.040]
Rovira, M., Blade, J., Cibeira, M. T., Garcia-Sanz, R., Silva, L., Lahuerta, J. J., Escoda, L., de la Rubia, J., de la Camara, R., Montserrat, J., Petit, J., Cuesta, M., Fernandez-Aviles, F., Carreras, E. (2010).

Autologous stem cell transplantation for POEMS syndrome treatment: the Spanish experience

BONE MARROW TRANSPLANTATION. Meeting Abstract. 45(2):20-20.
Vallejo, C., Colado, E., Montesinos, P., Rosell, A., Xicoy, B., Brunet, S., Cordoba, R., Perez-Ceballos, E., Petit, J., Sevilla, J., Martin, A., Arranz, R., de la Serna, J., Espigado, I., Cedillo, A. (2010).

Comparison between lymphoglobulin- and thymoglobulin-based immunosuppressive therapy as first-line treatment for patients with aplastic anaemia

BONE MARROW TRANSPLANTATION. Meeting Abstract. 45(2):25-25.
Chirinos Vega, J. A., Perez Carreras, M., Fernandez-Miranda, C., Lopez-Alonso, G., Ayala, R., Arribas, C., Castellano, G. (2010).

HYPERHOMOCYSTEINEMIA AND C677T METHYLENETETRAHIDROFOLATE REDUCTASE GENE POLYMORPHISMS IN SPANISH PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE

JOURNAL OF HEPATOLOGY. Meeting Abstract. 52(1):140-141.
[doi:10.1016/S0168-8278(10)60338-8]
Mason, Philip J., Bautista, Jose M., Gilsanz, Florinda (2010).

G6PD deficiency: The genotype-phenotype association (vol 21, pg 267, 2007)

BLOOD REVIEWS. Correction. 24(1):49-49.
[doi:10.1016/j.blre.2009.07.007]

Zozaya N, Villaseca J, Abdalla F, Calleja MA, Díez-Martín JL, Estévez J, García-Sanz R, Martínez-López J, Sierra J, Vera R, Hidalgo-Vega A ().

A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper.

CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 1-13.
[doi:10.1007/s12094-021-02757-9]
San-Juan R, Fernández-Ruiz M, López-Medrano F, Carretero O, Lalueza A, Maestro de la Calle G, Pérez-Jacoiste Asín MA, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Parra P, Ripoll M, Ruiz-Merlo T, Trujillo H, Pablos JL, Paz-Artal E, Lumbreras C, Aguado JM ().

Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Article. 117:56-64.
[doi:10.1016/j.ijid.2022.01.040]
Hernández-Boluda JC, Martínez-Cuadrón D, Pereira A, Rodríguez-Veiga R, Boluda B, Gil C, Casal-Marini S, Serrano J, Martínez-López J, Bergua J, Algarra L, Bernal T, López-Lorenzo JL, Colorado M, López A, Tormo M, Sayas MJ, Trigo F, López-Pavía M, Pérez-Simón JA, Lavilla-Rubira E, Rodríguez-Medina C, Rodríguez-Gutiérrez JI, Sanz-Caballer MA, Montesinos P, PETHEMA group ().

Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry.

LEUKEMIA RESEARCH. Article. 115:106821-106821.
[doi:10.1016/j.leukres.2022.106821]
Rojas EA, Corchete LA, De Ramón C, Krzeminski P, Quwaider D, García-Sanz R, Martínez-López J, Oriol A, Rosiñol L, Bladé J, Lahuerta JJ, San Miguel JF, González M, Mateos MV, Bourdon JC, Misiewicz-Krzeminska I, Gutiérrez NC ().

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma.

AMERICAN JOURNAL OF HEMATOLOGY. Article.
[doi:10.1002/ajh.26507]
Rodriguez-Otero P, Mateos MV, Martinez-Lopez J, Martin-Calvo N, Hernandez MT, Ocio EM, Rosinol L, Martinez R, Teruel AI, Gutierrez NC, Bargay J, Bengoechea E, Gonzalez Y, de Oteyza JP, Gironella M, Encinas C, Martin J, Cabrera C, Palomera L, de Arriba F, Cedena MT, Paiva B, Puig N, Oriol A, Blade J, Lahuerta JJ, Miguel JFS ().

Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.

LEUKEMIA. Article.
[doi:10.1038/s41375-019-0408-x]
Puig N, Sanfeliciano TC, Agullo Roca C, Martinez-Lopez J, Oriol A, Blanchard MJ, Rios-Tamayo R, Martín Sánchez J, Iñigo MB, Sureda A, Hernandez Garcia MT, de la Rubia J, Gonzalez-Calle V, Krsnik I, Cabañas V, Palomera L, Moraleda JM, Bargay J, Cedena MT, Paiva B, Rosiñol L, Bladé J, San-Miguel JF, Lahuerta JJ, Mateos MV ().

Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma.

Blood Advances. Article.
[doi:10.1182/bloodadvances.2021006762]
Jiménez-Ubieto A, Rodriguez A, Martinez Sánchez P, Gómez A, Rodriguez Y, Carreño-Tarragona G, Martinez-López J, Grande C ().

Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. Article.
[doi:10.1177/1078155217743069]
Martín-Hernández E, García-Silva MT, Quijada-Fraile P, Rodríguez-García ME, Hernández-Laín A, Coca-Robinot D, Rivera H, Fernández-Toral J, Arenas J, Martín M, Martínez-Azorín F ().

Myopathic mtDNA Depletion Syndrome Due to Mutation in TK2 Gene.

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY. Article.
[doi:10.2350/15-12-1749-CR.1]
Ríos-Tamayo R, Lupiañez CB, Campa D, Hielscher T, Weinhold N, Martínez-López J, Jerez A, Landi S, Jamroziak K, Dumontet C, Watek M, Lesueur F, Reis RM, Marques H, Jurczyszyn A, Vogel U, Buda G, García-Sanz R, Orciuolo E, Petrini M, Vangsted AJ, Gemignani F, Försti A, Goldschmidt H, Hemminki K, Canzian F, Jurado M, Sainz J ().

A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis.

Oncotarget. Article.
[doi:10.18632/oncotarget.10665]
Guerrero C, Puig N, Cedena MT, Goicoechea I, Perez C, Garcés JJ, Botta C, Calasanz MJ, Gutierrez NC, Martin-Ramos ML, Oriol A, Rios R, Hernandez MT, Martinez-Martinez R, Bargay J, de Arriba F, Palomera L, Gonzalez-Rodriguez AP, Mosquera-Orgueira A, Gonzalez-Perez MS, Martinez-Lopez J, Lahuerta JJ, Rosiñol L, Blade J, Mateos MV, San-Miguel JF, Paiva B, Programa para el Estudio de la Terapéutica en Hemopatías Malignas (PETHEMA)/Grup ().

A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma.

CLINICAL CANCER RESEARCH. Article.
[doi:10.1158/1078-0432.CCR-21-3430]